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Abstract 
 
Sickness absence and presenteeism are estimated to cost the UK economy £100 billion a year. 
Vocational Rehabilitation (VR) has been advocated within the UK, and internationally, as an 
effective means to address ill-health within the workplace; however, there is a paucity of 
research exploring its cost-effectiveness. A robust economic model, using evidence-based 
assumptions would assist in developing an evidence-base, as well as enable organisations to 
assess the cost-effectiveness of VR services they utilise. Within the UK, there is no economic 
tool for evaluating VR for the employed population. This research adapted an existing cost-
benefit analysis (CBA) model creating a new practical CBA tool able to capture and analyse 
the effects of VR from an organisational perspective. 
 
A mixed methods explanatory sequential design, with two distinctly independently yet 
interactive phases was used. The quantitative phase consisted of three elements, firstly a 
systematic review to develop the outcomes in the CBA tool, namely sickness absence due to 
musculoskeletal and mental health conditions, presenteeism, and turnover. In order to develop 
these outcomes, new reference and intervention cases specifically for VR interventions were 
created using a mirror image of the traditional CBA model. Secondly, in order to generate data 
to test the new CBA tool, two pre-experimental repeated-measures within-group (time series) 
studies were conducted, exploring two in-house VR services, for employees with 
musculoskeletal and mental health conditions. Lastly, the new CBA tool was implemented and 
tested, and sensitivity and scenario analysis of the results were conducted. The qualitative phase 
consisted of an analysis of a focus group of VR service personnel to explore the practical utility 
of the new CBA tool.  
 
This research produced a practical CBA tool, capable of analysing the costs and benefits of VR 
services. The scenario and sensitivity analysis indicated that in order for the CBA results to be 
robust sufficient sample sizes would be needed. Organisation 1’s results (Net present value 
(NPV) = -£84,122.01, BCR = 0.05, n = 127) indicated that the VR service was not cost effective. 
Organisation 2’s results (NPV = £4,940.61, BCR = 1.17%, n = 43) indicate that the VR service 
was cost effective. Organisation 1 did not include turnover data and had known errors in the 
sickness absence data, which may account for this difference. The CBA tool was well-received 
by the VR personnel (n = 4), indicating that it was user-friendly, would help with objectively 
assessing the economic value of VR in different settings, and assist service design through 
xii 
 
identifying where to allocate resources.  The new CBA tool is still in its early stages and can be 
developed further as the evidence-base in VR grows. This model lays the foundations for 
organisations to assess the costs/benefits of the services they provide or receive and for 
researchers to use in their economic evaluations of VR interventions. 
1 
 
1. Introduction 
 
The introduction will outline the background and rationale for this research, the aims and 
objectives, an overview of the thesis, and the context in which the research is situated. This will 
be achieved firstly by providing a synopsis of the current costs and causes of sickness absence 
and presenteeism in the UK and internationally, thereby highlighting the need to manage ill-
health effectively within the workplace.  Secondly, an overview of the UK government policy 
and reforms within health and work is presented, summarising the national drivers to address 
sickness absence and presenteeism, and the growing advocacy for Vocational Rehabilitation 
(VR) as a means to achieve this.  Thirdly, the rationale for using VR to address sickness absence 
and presenteeism will be explored.  Following this the research aims and objectives will be 
outlined. And, lastly a brief overview of the thesis, synthesising the content in each chapter, 
and a description of the two VR services evaluated will be provided to give context to the thesis.  
 
1.1 Background and Rationale 
 
1.1.1 Current UK costs of ill-health within the workplace 
 
Sickness-absence is defined as nonattendance at work, with the employee attributing this to 
sickness and the employer accepting it as such (Reetoo, Burrows, & Macdonald, 2009; 
Whitaker, 2001). Presenteeism is defined as employees choosing to attend work, whilst they 
are not well enough to be at work, and working at reduced productivity (Hampson, Soneji, 
Jacob, Mecu, & Mc Gahan, 2017; Aronsson, Gustafsson, & Dallner, 2000; Brown, Burton, 
Gilson, & Brown, 2014; Bergstrom, Bodin, Hagberg, Aronsson, & Josephson, 2009; Claes et 
al., 2011). Both sickness absence and presenteeism result in poor economic and health outcomes 
for organisations, individuals and society (Stevenson & Farmer, 2017; Chartered Institute of 
Personnel and Development (CIPD), 2014a; Black, 2008; Bevan, Passmore, & Mahdon, 2007). 
It is estimated that within the UK ill-health among working age individuals costs the economy 
£100 billion a year; moreover, employers face an annual bill of around £9 billion for sickness 
absence costs and turnover due to ill-health (Department for Work and Pensions (DWP) & 
Department of Health (DH), 2016; Black & Frost, 2011). Turnover is defined as ‘employees 
leaving and being replaced in the workforce’ (Hampson et al., 2017). In addition to the cost to 
the economy, sickness absence has a financial cost that society bears, ‘through costs to the 
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health service (estimated at £5–11 billion a year) and to the government directly through 
payment of benefits (£29 billion a year) and the loss of tax revenue (£28–36 billion)’ (Baker-
McClearn, Greasley, Dale, & Griffith, 2010, p312), as well as losses to the employees in terms 
of reduced income (Stevenson & Farmer, 2017; CIPD, 2014a; Black, 2008). These costs of 
sickness absence are reflected internationally, with the European Foundation for the 
Improvement of Living and Working Conditions (2010) reporting an average rate of absence 
between 3% and 6% of working time, and estimating the cost of sickness absence in 27 EU 
member states and Norway as 2.5% of gross domestic product (GDP).  According to the CIPD 
& Simply Health’s (2016) annual survey of absence management, the most common causes of 
short-term sickness absence are minor illnesses, such as colds, flu, upset stomachs, headaches 
and migraines, stress, musculoskeletal disorders (MSDS), mental health conditions and 
home/family/carer responsibilities. MSDs, back pain, mental health conditions, stress, and 
acute medical conditions are the top 5 most common causes of long-term sickness absence 
(CIPD & Simply Health, 2016). The term MSD is defined by the Health and Safety Executive 
(HSE) (2013) as ‘covering any injury, damage or disorder of the joints or other tissues in the 
upper/lower limbs or the back’ (HSE, 2013, N.P.). Mental health is defined by the World Health 
Organisation (WHO) (2018) as ‘a state of well-being in which every individual realises his or 
her own potential, can cope with the normal stresses of life, can work productively and 
fruitfully, and is able to make a contribution to her or his community’ (p.1). Moreover, MSDs 
and mental health conditions are leading causes of global disability (Joyce, Modini, 
Christensen, & Mykletun, 2015; Hoy et al., 2014). The UK has faced a challenging economic 
climate in the last decade with the double dip recession in 2012 (Office for National Statistics 
(ONS), 2012a) and more recently the uncertainty surrounding the predicted impact of Brexit 
resulting in projections of the economy slowing down in 2017/2018 (Organisation for 
Economic and Co-operation Development (OECD), 2017). Thus, it is imperative that ill-health 
is managed effectively to reduce costs to the economy. 
 
1.1.2 Current UK sickness absence and presenteeism statistics 
 
Figures from two different Annual Surveys indicate a downward trend of the number of 
working days lost in the UK and working days lost per employee from 2003 to the present. 
The ONS (2014) reported that the number of days lost in the UK in 2013 (131 million days) 
had decreased from the 1993 figure (178 million days).  Similarly, the number of working days 
lost per employee had dropped from 7.2 days per employee in 1993 to 4.4 days per employee 
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in 2013. According to the ONS (2014) report ‘Sickness Absence in the Labour Market’ the 
number of days lost due to sickness absence remained constant in the 1990’s and up to 2003 
(ONS, 2012b), after which a decline was noticed until 2011, where numbers appeared to 
plateau.  However, the plateau was not noticed in the CIPD’s 2014(a) Annual Survey Report: 
‘Absence Management’ which reported a decrease in the number of days lost per employee 
from 7.6 days in 2013 to 6.6 days in 2014. The differences in the reported sickness absence 
trends in the ONS and the CIPD may be explained by the fact that the CIPD relies on appropriate 
representatives within the responding companies to summarise sickness absence data, and also 
by the low number of respondents to the survey (n=518 organisations).  Thus, whilst the figures 
differ, the trend towards decreasing sickness absence between 2003 and 2013 is broadly 
supported by both the CIPD and ONS.  For the years 2014 and 2015 there was a slight increase 
in levels of sickness absence however, looking at the latest data from the ONS on sickness 
absence (137.2 million days) the overall trend of decreasing levels of sickness absence has 
continued (ONS, 2016). The CIPD & Simply Health Sickness Absence Annual Survey (2016) 
supported these findings, although giving slightly different figures. This survey reported the 
average number of days’ absence per employee in 2016 as 6.3 days, a drop from 2013, where, 
according to their figures, it was 7.6 days per employee. This recent downward trend is also 
noted in the public-sector sickness absence figures reported: 2014: 7.9 days; 2013: 8.7 days; 
2012: 7.9 days; 2011:9.1; 2010: 9.3 (CIPD, 2014a). However, there is still a notable difference 
in the amount of sickness absence between the public and the private sectors with public sector 
employees on average having 3 more days’ sickness absence per year (CIPD & Simply Health, 
2016). The Confederation of British Industry (CBI) (2013) estimates that if the public sector 
could decrease their sickness absence levels to those of the private sector it would save the 
taxpayer around £1.2 billion a year.  
 
Although absence rates are decreasing overall, sickness absence due to mental health conditions 
has increased by 5% since 2009 (Stevenson & Farmer, 2017).  This increase may be due to 
increased reporting and improved awareness of mental health (Hampson et al., 2017). 
Additionally, it is important to consider that low absence rates do not necessarily indicate good 
sickness absence management (Centre for Mental Health, 2011), nor better employee health, 
but might reflect job market pressures. Studies suggest that levels of presenteeism are increasing 
annually (Stevenson & Farmer, 2017). The focus on reducing absenteeism may possibly 
exacerbate presenteeism through the use of workplace absence management policies such as 
return-to-work (RTW) interviews and trigger points (Garrow, 2016).  Presenteeism losses, 
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usually associated with reduced productivity, increased mistakes and lowering of the company 
standards (Garrow, 2016; Schultz & Edington, 2007, cited in Brown et al., 2014), ‘have been 
shown to incur 5.1 times more costs than those incurred for absenteeism’ (p.241).  Moreover, 
presenteeism, is linked to an increase in future sickness absence (Bergstrom et al.., 2009; 
Caverly, Cunningham and MacGregor, 2007; Hansen & Andersen, 2009; Hansson et al., 2006; 
Kivimaki et al.., 2005; Schultz, Chen, & Edington, 2009; Schultz & Edington, 2007; all cited 
in Claes, 2011). On average, it is estimated that an individual with a mental health disorder will 
have an additional 8.0 days of reduced-qualitative functioning, and those with physical 
disorders an additional 3.5 days of reduced-qualitative functioning (De Graaf, Tuithof, van 
Dorsselaer, ten Have, 2012). The impacts of presenteeism are more pronounced when co-
morbidities are present (Holden et al., 2011), therefore, it is important when considering 
workplace health to be mindful of not solely focusing on sickness absence, which is easily 
measurable, at the expense of truly understanding the workplace health needs, potentially 
failing to proactively manage presenteeism (Stevenson & Farmer, 2017; Garrow, 2016; Cocker 
et al., 2014; Pauly, Nicholson, Polsky, Berger, & Shard, 2008).  
 
1.1.3 Overview of UK government policy and reforms within health and work 
between 2005-2017 
 
In 2005, the UK government published a strategy for the improving and maintaining the health 
of working age individuals, the ‘Health, work and wellbeing: caring for our Future’ (DWP, DH 
& HSE, 2005). Wellbeing, defined as thriving/functioning across multiple domains of life 
(Diener, Scollon, & Lucas, 2013, cited in Alder & Seligman, 2016; DH, 2014), is commonly 
used as an indicator of national progress beyond living standards, accordingly informing the 
design and assessment of public policies (Alder & Seligman, 2016; La Placa & Knight, 2014).  
The ‘Health, work and wellbeing’ strategy formed part of the wider welfare reform agenda that 
was outlined in the Government’s 2004 White Paper ‘Choosing Health: Making Healthier 
Choices Easier’ (DH, 2004). The drivers for this strategy were economic, because whilst the 
UK had successfully reduced accidents at work by 10% since 1997, at the time, an estimated 
40 million working days were being lost per year to occupational ill health and injury, with an 
estimated cost of £12 billion, not including the impact on the health of the individuals, their 
families, the cost to colleagues and the overall impact on productivity across the economy (HM 
Government, 2005). In addition, it was noted that one third of individuals in receipt of the 
Incapacity Benefit had originally been employed. The aims of the strategy were to improve and 
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maintain the health and wellbeing of the working age population, and supporting individuals to 
remain or RTW and contribute effectively to society.  
 
As a result of this strategy, sickness absence and health at work became a priority, and research 
into how to maintain a healthy workforce was commissioned. This led to Waddell and Burton 
(2006) independent review ‘Is work good for your health and wellbeing?’  The review 
concluded that there are ‘economic, social and moral arguments that work is the most effective 
way to improve the wellbeing of individuals, their families and their communities' (p7). It can 
minimise harmful effects of long-term sickness absence, improve quality of life and physical 
and mental health, improve social inclusion and reduce poverty (Waddell & Burton, 2006; 
Waddell, Burton, & Kendall, 2008). There is a consensus, within the UK and internationally, 
that good work (i.e. work that is appropriate for the individual, fair and decent, allowing for the 
employee to develop and be fulfilled (Taylor, Marsh, Nicol, & Broadbent, 2017)) not only 
improves physical and mental health, it also promotes recovery and aids rehabilitation, and is 
protective of health (Royal Australasian College of Physicians, 2011; Black & Frost, 2011; 
Marmot, 2010; WHO, 2007; Waddell & Burton, 2006; Waddell et al., 2008).  
 
In 2008, Dame Carol Black’s report ‘Working for a healthier tomorrow’ identified various 
challenges for improving health at work. Challenges included: general practitioners (GP’s) who 
do not feel adequately trained to offer advice to patients on how to remain in work or RTW; the 
sick note which focused on what could not be done, as opposed to what could be done; poor 
information and assistance for employers; and ‘a weak and declining academic base, a lack of 
good quality data and a focus solely on those in work, which impedes the profession’s capacity 
to analyse and address the full needs of the working age population’ (p.16). Following the 
recommendations in this review, several initiatives were trialled, such as ‘Fit for Work Service 
pilots’; ‘OH advice services for small businesses and GP’s’; and the ‘fit note’, a revision to the 
sick note which allows GP’s to advise on whether an individual may be fit to work with light 
or alternative duties, was rolled out. Moreover, as the high costs of mental health were clearly 
documented, estimated to be £77 billion in England in 2002/03 (Sainsbury Centre for Mental 
Health, 2003), a supplementary report focusing on mental health and work (DWP, 2011) was 
commissioned alongside Dame Carol Black’s review. The findings of this report (DWP, 2011) 
echoed the conclusions in Dame Carol Black’s review as to interventions that appeared to be 
effective in assisting individuals with mental health conditions to RTW, such as early access to 
healthcare; and workplace education and support.  
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Concurrent to the Mental Health and Work report, and Dame Carol Black’s review, Waddell et 
al.’s (2008) scientific review ‘VR: What works, for whom and when?’ assessed the evidence-
base, synthesising 450 reviews and reports, on the effectiveness and cost benefits of VR. 
Waddell et al. (2008) define VR as “whatever helps someone with a health problem to stay at 
or RTW” (p.5), although definitions of VR vary, (see section 2.2.1.1), there is a consensus that 
VR follows the key principles of early rehabilitation, work-focused health-care and 
accommodating workplaces, which have been shown as effective strategies in RTW 
(Schaafsma et al., 2013; Higgins, O’Halloran, & Porter, 2012; Desiron, DeRijk, Van Hoof, & 
Donceel, 2011; Accident Compensation Corporation (2004), cited in Ellis et al., 2010; 
Schaafsma et al., 2010; Lambeek et al., 2010). Waddell et al.’s (2008) review provided practical 
suggestions on which VR interventions were likely to work, so as to inform policies around 
work and health. The review concluded that many aspects of VR are effective and cost effective. 
This conclusion was later supported with Black and Frost’s (2011) review of sickness absence 
advocating VR as an effective means of addressing sickness absence, due to its multi-faceted 
bio-psychosocial approach. 
 
The financial market crisis of 2007-2008 and ensuing global recession of 2008-2009 left the 
UK feeling the effects of deep recession into 2014 (UK Commission for Employment and 
Skills, 2014). Moreover, in 2010, the UK election resulted in the formation of a new coalition 
government; the Conservatives and Liberal Democrats replaced the previous Labour 
administration. The financial crisis and change in leadership in the UK resulted in policy 
changes not only encouraging the reduction of sickness absence and assistance of individuals 
to stay in work, but also providing a parallel reform to the benefit system, aimed at assisting 
individuals back into the workforce (UK Commission for Employment and Skills, 2014). The 
Welfare Reform Act of 2007, led to the Incapacity Benefit being replaced by the Employment 
and Support Allowance (ESA) (Clayton et al., 2010). Further reforms to the benefit system 
were planned, and the Universal Credit (UC) system was rolled out across the UK from April 
2013, with ESA to be subsumed into this in 2017 (Parliament.uk, 2014a).  
 
ESA is a two-tiered benefit linked to a Work Capability Assessment (WCA). The WCA, 
through focusing on a person’s ability, discriminates whether individuals are unfit for work due 
to health conditions, fit for work, or with workplace adjustments able to RTW (Harrington, 
2010). The result of the WCA impacts on the benefits received (Harrington, 2010). The 
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systematic review by Clayton et al. (2010) of UK studies into RTW initiatives, found that the 
introduction of WCA had a number of potential implications, with the evidence reviewed 
suggesting that the existing programme would need to be modified if it was to meet the complex 
needs of this population. Moreover, there have been a large number of complaints surrounding 
the results of the WCA and implementation of them (Citizens Advice Bureau, 2010). However, 
despite the criticism, as a result of the WCA, in 2014, according to a House of Commons 
Speaker (Mike Penning), 1 million incapacity benefit assessments have been conducted, 
resulting in 700,000 people been helped into work or looking for work (Parliament.UK, 2014b).  
The roll out of the UC has been on-going, and in 2017 every job centre had access to the UC. 
The target population of the UC differs between job centres, with some centres offering this to 
single unemployed individuals and other centres offering the UC to all claimants i.e. the full 
service. It is envisioned that by 2022 all claimants will be migrated onto the full service. The 
on-going roll out was evaluated in terms of the short-term impact on the labour market. The 
evaluation was limited to single unemployed individuals with no children and is a piece of work 
that is developing and being updated continuously. The latest 2017 results analysed data from 
27,000 claimants across 94 offices. Preliminary results indicate that claimants on UC (63%) are 
more likely to have been in work at any point in the 6-months following the initiation of their 
claim than matched claimants on the Job Seekers Allowance benefits (59%) (DWP, 2017). 
However, the planned roll out has been criticised by a variety of individuals, such as Labour, 
SNP and Tory MP’s, Dame Louise Casey, and Sarah Wollaston, chairwoman of the Health 
committee, stating that the system is flawed and calling for a pause to its roll out (Howarth, 
2017; Butler, 2017). These flaws have resulted in some claimants being without money for 6 
weeks, incurring rent arrears, losing their homes and in some cases becoming reliant on food 
banks (Watts, 2017). Following the criticism of the rollout, there was a vote in parliament 
calling on the government to pause the roll out of the UCs (Howarth, 2017), which prompted 
an emergency parliamentary debate on the 24th October 2017 (Parliament.uk, 2017). Following 
the debate, the decision was made to continue with the roll-out of Universal Credit.    
 
When considering the health of the working population a key concern is that of the ageing 
workforce (Sundstrup et al., 2018). According to the DWP (2013) estimates, by 2024 nearly 
50% of the adult population will be 50 years or over and many of these will leave work early 
due to ill health. This will have extensive consequences, both for the economy and individuals 
in terms of self-provision for later life (Sundstrup et al., 2018; DWP, 2013). In 2007, the UK 
government introduced reforms to the pension system, ‘The Pensions Act 2007’, increasing the 
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State pension age for men and women from 65 to 67 years between 2026 and 2028 and 
potentially further increasing it from 67 to 68 years between 2044 and 2046 (Gov.UK, 2014). 
The state pension age is regularly reviewed and these projections may change (Gov.UK, 2014). 
In addition to the raising of the retirement age, the mandatory default retirement age was phased 
out (Weyman, Wainwright, O’Hara, Jones, & Buckingham, 2012). However, when considering 
the retirement age increase, Marmot’s review ‘Fair Society, Healthy Lives’ (2010), states that 
‘with the levels of disability shown, more than three-quarters of the population do not have 
disability-free life expectancy as far as the age of 68’ (p.12).   In light of the reality of an older 
working population, the knowledge that poor health is a barrier to extending working lives 
(Edge, Cooper & Coffey, 2017) and the evidence of ill-health increasing as one ages, the general 
health of the workforce needs to be maintained. This is alongside the need for effective services 
to be provided to assist those with injuries and ill-health to be active members of the workforce. 
 
‘Health at Work - an independent review of sickness absence’, carried out by Dame Carol Black 
and David Frost (2011), explored ways in which the current sickness absence system could be 
changed to assist individuals to stay-at-work (SAW), reducing costs to the individual, 
organisations and society.  The report recommended that expenditure by employers on services 
targeted at assisting employees to SAW, such as VR, should attract tax relief (Black & Frost, 
2011).  In 2013, the government released a response to this review, that was ‘shaped to 
complement both health and welfare reforms and the growth agenda by introducing measures 
that directly supported people with health conditions to stay in work, whilst also addressing 
business concerns about the sickness absence system’ (DWP, 2013, p.7). The plans were multi-
tiered, focussing on: improving sickness absence management within organisations; supporting 
health care practitioners in assisting individuals to stay in work; introducing a Health and Work 
Assessment and Advisory Service (in 2014) to make occupational health (OH) more easily 
available; to save employers money on statutory sick pay and increase productivity; and 
reforming the benefits available to job seekers and those off work due to ill-health (DWP, 
2013). In addition, the government outlined a commitment to assist individuals to SAW thereby 
limiting the number of people falling out of work and on to benefits. Improving the health of 
the workforce was re-emphasised, as well as plans for future foci such as addressing the health 
and resilience of the ageing workforce and preparing the youth for entering the workforce 
(DWP, 2013). The response was further elaborated on in the report: ‘Improving health and 
work: changing lives, the Government's Response to Dame Carol Black's Review of the health 
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of Britain's working-age population’ (DWP & DH, 2013). In this response, the government 
outlined the strategies for support they will put in place, namely; 
 Creating new perspectives on health and work; through educating GP’s; providing an 
electronic fit note; introducing health, work and wellbeing co-ordinators; and forming 
a National Centre for Working Age Health and Wellbeing. 
 Improving work and workplaces; through providing a business health check tool; 
developing a national strategy for mental health and employment; expanding NHS Plus, 
which currently looks at developing clinical and OH standards; providing an OH Help 
line for smaller businesses; and providing a challenge fund for innovative workplace 
health approaches. 
 Supporting people to work; through piloting early interventions; and improving and 
changing Access to Work.  
 
Building on these reforms, the Work, Health and Disability Green Paper 2016 (DWP & DH, 
2016) was presented to parliament and opened out to consultation. The green paper contains 
policies aimed to address the current inequality within the workplace regarding disabled 
employees. The paper highlights the current situation i.e. only 48% of disabled individuals are 
in employment as opposed to 80% of the non-disabled population. The paper outlines the need 
for change and the various agencies within which change needs be implemented e.g. employers, 
health-care providers, and employers. Moreover, it proposes solutions to the identified 
problems and inequalities. In response to this Green Paper consultation, and a number of related 
consultations and reviews, Improving Lives: the future of Work, Health and Disability (DWP 
& DH, 2017) outline the government strategy to meet the vision of one million more disabled 
people in work within the following ten years. The strategy highlighted the importance of 
preventing ill-health resulting in unemployment i.e. assisting people to SAW. Moreover, it 
outlined the need for all individuals accessing support regardless of their health condition, 
ensuring the mental health conditions and MSDs are a key part of their programme (DWP & 
DH, 2017).  The Improving Life’s: the future of Work, Health and Disability (DWP & DH, 
2017) paper groups VR services under the umbrella title of OH, and as part of the strategy, is 
the vision of early access to occupational/vocational support for all employed individuals, 
reducing the risk of people falling out of work (DWP & DH, 2017).  
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1.1.4 Rationale for using Vocational Rehabilitation as an intervention to reduce 
sickness absence and presenteeism 
 
Sickness-absence and presenteeism behaviour are influenced by a variety of factors; personal 
motivations, workplace and societal (Sheppard & Frost, 2016; Yeomans, 2011; Chatterji & 
Tilley, 2002). To address the multifaceted nature of sickness-absence, VR’s bio-psychosocial 
approach, i.e. considering the individual, their health problem and the social aspects impacting 
on their health (Waddell, 2002), has recently been advocated as an effective intervention in the 
UK for sickness-absence (DWP & DH, 2017, Black & Frost, 2011; Boorman, 2009; Carroll, 
Rick, Pilgrim, Cameron, & Hillage, 2009; Waddell et al., 2008).  VR is widely adopted 
internationally as an intervention to assist in aiding employees to SAW, with international 
research on the definition of VR drawing on practitioners from: Africa, the Americas, Eastern 
Mediterranean, Europe, South-East Asia, and Western Pacific (Escorpizo, Finger, Glassel & 
Cieza, 2011a). VR concepts such as inclusive rehabilitation, early intervention, prevention of 
ill-health, employer engagement and responsibility in RTW, case management and effective 
multi-disciplinary teams are well established in a number of European countries namely: 
Austria, Denmark, Germany, Sweden, Finland, and Norway (Belin, Dupont, Oules, Kuipers, & 
Fries-Tersch, 2016; Matthews et al., 2013; Wells, 2016; Burstrom, Nylen, Clayton, & 
Whitehead, 2011; European Foundation for the Improvement of Living and Working 
Conditions, 2009). Belgium, France, Iceland, Italy, Luxembourg, Switzerland and the UK 
although having well-established frameworks for rehabilitation and RTW are limited in the co-
ordination and implementation of RTW processes (Belin et al, 2016). However, recent 
developments and policies within the UK imply a recognition of the need for integrated and 
comprehensive RTW approaches (Belin et al, 2016). A commonly accepted definition of VR is 
‘whatever helps someone with a health problem to SAW, return to and remain in work: it is an 
idea and an approach as much as an intervention or a service’ (Waddell et al., 2008, p.5) (see 
section 2.2.1.1. for further discussion on the definition of VR). In light of the multi-faceted 
underpinning biopsychosocial model and all-encompassing definition of VR, a VR service may 
include a number of different elements or interventions following the same key principles of 
early rehabilitation, work-focused health care and accommodating workplaces (Schaafsma et 
al., 2013; Higgins et al., 2012; Desiron et al., 2011; Accident Compensation Corporation, 2004, 
cited in Ellis et al., 2010; Schaafsma et al., 2010; Lambeek et al., 2010). Examples of 
interventions or elements included in VR are case management, liaison with the workplace, 
workplace modifications, physical or mental health care treatments. The bio-psychosocial 
model’s graphic representation (see Figure 1) implies equal weighting across all spheres, 
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however, this does not account for the fact that ill-health is transient and changing over time, 
thus the relevance and influence of each domain can vary between patients and as the 
disease/condition progresses (Jull, 2017).  
 
Figure 1: Biopsychosocial Model 
 
 
 
A recent critique of the bio-psychosocial model is that it tends to focus interventions, and 
subsequently research, on the individual risk factors, as opposed to considering the wider 
systemic influences such as compensation/benefits systems, ‘lack of role clarity for relevant 
personnel, poor co-ordination of RTW activities, lack of knowledge and understanding of 
standard procedures, poor communication and conflicting demands from other stakeholders’  
(Bartys, Frederiksen, Bendix, & Burton, 2017, p. 907). In spite of these critiques, currently the 
bio-psychosocial model underpins VR practice (Bartys et al., 2017).  
 
Following Waddell and Burton’s 2008 review, in 2012, the government commissioned a rapid 
review of the evidence into the effectiveness of interventions for people with common health 
conditions in helping them stay in work or RTW. This review ‘Quantifying the effectiveness of 
interventions for people with common health conditions in enabling them to stay in or return to 
work: A rapid evidence assessment’ (Dibben, Wood, Nicolson, & O’Hara, 2012), found that 
the evidence-base on work-related interventions for this population had not changed 
significantly since 2008. The review similarly highlighted the limitations of the current 
evidence-base on work-related interventions, namely: limited studies incorporating robust 
employment outcomes; few cost-benefit analyses (CBA’s) of work related interventions; and 
Biological
SocialPsychological
Health 
12 
 
although a well-established intervention internationally, particularly in Germany, Denmark, 
Austria and Scandinavian countries (Belin et al, 2016), there is restricted research into work-
related interventions conducted within the UK (Dibben et al., 2012). The best evidence of cost-
effectiveness was for multidisciplinary, workplace-based interventions for MSDs, notably for 
employees with lower back pain (LBP) (van Vilsteren, et al., 2015; Dibben et al., 2012). MSDs 
result in 8.3 million working days lost per annum in the UK, with an estimated 2.8 million of 
these due to LBP (HSE, 2014).  Reasonably strong evidence for positive work-related outcomes 
was reported for VR, workplace rehabilitation and cognitive behavioural therapy (CBT) for 
LBP (Dibben et al., 2012).  Concerning mental health, Dibben et al. (2012) reported reasonably 
strong evidence for the effectiveness of psychological interventions for depression and 
supported employment for people with severe mental health conditions. However, the review 
of Van Vilsteren et al.’s (2015): ‘Workplace interventions to prevent work disability in workers 
on sick leave’ concluded that the evidence for the effectiveness of workplace interventions on 
mental health is low and does not show an effect.  
 
Waddell et al.’s (2008) review concluded that best practice case studies of VR in the UK 
indicate that VR is effective, and with the limited economic analyses included in these case 
studies, it points towards VR being a cost-effective intervention. However, within the hierarchy 
of evidence, case studies are considered to be of a lower quality, limiting the ability to draw 
robust conclusions from them, therefore, highlighting that further high-quality research into the 
cost and benefits of VR interventions within the UK is necessary (Waddell et al., 2008). This 
was supported by Dibben et al. (2012) who summarised the gaps in the VR evidence, with one 
of the key gaps being quantitative data for employment outcomes, especially those with costs, 
as currently it is difficult to provide an economic case for the interventions due to a lack of data. 
When considering international evidence on sickness absence and interventions to address this, 
the generalisability to the UK context needs to be borne in mind. Internationally, sickness 
absence definitions vary in terms of causes recorded -for example some countries include 
maternity leave as sickness absence; lengths of absence recorded, as well as in some countries 
estimates are made either on the stated days of absence or the potential number of working days 
lost (Gimeno et al., 2014; European Foundation for the Improvement of Living and Working 
Conditions, 2010). The sources of absenteeism figures may also vary between countries, with 
the two main sources being health insurance statistics or surveys of employers or individuals 
(European Foundation for the Improvement of Living and Working Conditions, 2010). Both 
sources limit comparability, as insurance statistics may be missing shorter absences where no 
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claims were made, and surveys may include incorrect estimates or vary across countries; for 
example in Norway a doctor’s certificate is not needed for the first 14 days of sickness absence 
(Pichler, 2014) whereas in the UK a doctor’s certificate is required after 7 days and in Germany 
after 4 days (Gimeno et al., 2014; European Foundation for the Improvement of Living and 
Working Conditions, 2010).  These factors limit the comparability of international sickness 
absence data. In respect of interventions to address sickness absence, there are a number of 
extraneous variables that may impact on the generalisability of international studies to the UK 
context such as international variations within sickness absence policies and pay regulations 
(Pichler, 2014; Barmby, Ercolani, & Treble, 2002), access to healthcare and OH, characteristics 
of populations (Gimeno et al., 2014), and attitudes towards sickness absence (Holmas, Dahl, 
Skjeret, 2008). Moreover, there is variability within the UK itself with regards to employee 
access to OH and VR services (Black & Frost, 2011), and population characteristics. Thus, 
although studies suggest VR may be an effective solution to addressing sickness absence, more 
research is needed, in the UK context, to be able to draw robust conclusions (Van Vilsteren et 
al., 2015; Dibben et al., 2012; Waddell et al., 2008), and establish cost effectiveness. 
 
1.1.5 Summary 
 
Within the UK, the health of the workforce remains a national priority (DWP & DH, 2016; 
DWP & DH; 2013; Black & Frost, 2011), with the added considerations of the ageing 
workforce (Edge et al., 2017; Marmot, 2010), and increased numbers of individuals with 
disabilities or injuries being assessed as fit-for-work (Parliament.UK, 2014a). Sickness absence 
and employee ill-health has far-reaching economic/financial repercussions for the individual, 
the employer and society (Stevenson & Farmer, 2017; CIPD, 2014a; Black, 2008; Bevan et al, 
2007). It is imperative therefore, that effective and cost-effective interventions are used to 
enable employees to be active contributors to the workplace, reducing sickness absence and 
presenteeism. VR has been advocated, internationally and within the UK,  as an effective means 
to reduce sickness absence and presenteeism (Black & Frost, 2011; Boorman, 2009; Carroll et 
al., 2009; Waddell et al., 2008), this has resulted in an increasing number of employers in the 
UK using VR services/approaches, as well as the DWP and DH recommending VR as part of a 
wider national 10-year strategy to increase the employment levels of individuals with 
disabilities (DWP & DH, 2017). However, the evidence of its cost effectiveness is limited 
(Dibben et al., 2012; Waddell et al., 2008). In today’s economic climate it is imperative to 
evaluate the costs and benefits of all interventions implemented so as to ensure the best use of 
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scarce resources (HM Treasury, 2011). Moreover, the financial implications of health 
interventions for employees are valued by decision makers (van Dongen et al., 2013). Yet 
according to van Dongen et al.’s (2013) review, decision-makers’ economic evaluation skill 
sets are lacking and decisions are often made without consulting the literature. Therefore, in the 
current UK context it is important that organisations are supported to determine the cost-
benefits of their investments without relying on academic support or costly research budgets 
(Burton, 2010). Thus, it is imperative that a practical tool that is easily used by the lay person 
is produced to economically evaluate interventions aimed at improving employee health and 
reducing sickness absence and associated costs in the UK working age population. 
 
1.2 Research aims and objectives 
 
1. To develop economic outcomes, to be used within an existing CBA model, in order to 
ascertain the efficacy of a practical CBA tool in evaluating the costs and benefits of VR 
interventions and services. 
2. To implement and explore the practical application of the revised CBA tool, including the 
developed outcomes, using data from two VR services. 
 
Objectives: 
 
Phase 1: 
 
1. To identify from the published literature the outcomes of VR interventions for 
organisations and employed individuals. 
2. To revise the GM New Economy CBA model to ensure that the practical CBA tool 
developed is capable of analysing the costs and benefits of VR interventions. 
 
Phase 2: 
 
3. To collect the relevant data required to populate the revised practical CBA tool from 
two VR Services and the organisations to which VR is provided. 
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Phase 3: 
 
4. To implement and test the revised practical CBA tool incorporating the developed 
outcomes to identify the cost-benefits of the VR interventions and services in a real-
world setting. 
 
Phase 4: 
 
5. To appraise the value of the revised practical CBA tool to the VR provider and the 
organisation to which VR is provided. 
 
Figure 2 provides a visual representation of the four phases of the research and the sources of 
data used in each phase. 
 
Figure 2: Diagrammatic representation of the 4 phases of this research project 
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1.3 Overview of the thesis 
 
The aim of this thesis is to adapt and develop an existing CBA model into a practical economic 
tool capable of assessing the cost and benefits of VR for employed individuals with physical 
and mental health conditions, which could be used by organisations and researchers alike. 
  
Currently within the UK there is no practical, user-friendly economic tool for clinicians and/or 
researchers to use. The development of such a tool would facilitate advancing the evidence-
base for the cost effectiveness of VR, which is of high social relevance. This is the first CBA 
tool of this nature focused on capturing the costs and benefits of VR services for the SAW 
population, laying the foundation for future research and practice. 
  
In order to develop the existing CBA model, to enable it to capture the costs and benefits of VR 
for employed individuals, the research was divided into four phases which were completed 
sequentially. This thesis has been organised into six chapters. The first two chapters, the 
introduction and the literature review, provide the background, rationale, context and overview 
of the evidence-base for the thesis. The next three chapters, the methodology, results, and 
discussion, outline the relevant information for each of the four phases in turn.  And lastly the 
conclusion and recommendations chapter summarises the key findings from the research. An 
outline of the next five chapters follows. 
 
Chapter 2 explores the literature underpinning the thesis. It draws on the evidence-base to 
develop an understanding of the current influences on the use of economic analyses within VR 
for the working population, such as the definition of VR, and the patterns, causes and 
consequences of sickness absence and presenteeism. It lays the foundations for this research 
through describing the different economic evaluation models and rationalising the choice of a 
CBA model for this research. It also summarises the evidence-base for the cost-effectiveness 
of VR for employees who are either off work or struggling to SAW. This review of the evidence 
identifies the gaps in the literature that a practical economic tool, such as the CBA tool 
developed in this thesis, would help to address. 
 
Chapter 3 critically discusses and outlines the methodology used in each phase of this study. 
The chapter first explores the philosophical assumptions of the research, as this informs the 
choice of research philosophy/paradigm and ultimately the chosen methodology. It then 
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provides an overview of the existing model which forms the basis of the new CBA tool. This 
enables the reader to contextualise the methodology of each phase. The methodology for each 
phase is then discussed in turn.   
 
In phase 1 the outcomes to be included in the new CBA tool are identified, namely: sickness 
absence due to MSDs and mental health conditions, presenteeism and turnover. Following this, 
the methodology to adapt an existing CBA model so that it is capable of including these 
outcomes is outlined. This includes identifying new reference and intervention cases, 
establishing the net effectiveness VR and the unit costs, and calculating the counterfactual, i.e. 
what would happen if the intervention was not in place, for each outcome.  In order to calculate 
these components of the outcomes, the traditional CBA model was flipped, creating a mirror 
image. The utilisation of a CBA tool in this manner is unique to this thesis and is described in 
this chapter. 
 
The findings from Phase 1 informed Phase 2 in terms of the relevant data to collect. Phase 2 
evaluates two in-house VR services in two separate organisations. This section of Chapter 3 
outlines the aims and research methodology of each evaluation.   
 
Chapter 3 then outlines the methodology for phase 3, which uses the data collected from the 
two VR service evaluations to run and test the new CBA tool. And lastly, the methodology for 
phase 4, a focus group to ascertain the usability of the CBA tool within the commercial context, 
is described. 
 
Chapter 4 presents the results from each phase in detail, clearly showing how the results from 
each phase inform the next.  
 
Chapter 5 discusses the research in relation to the outlined objectives, considering the 
evidence-base and findings from this research. The possible implications of the findings on VR 
practice and further research are highlighted. 
 
Chapter 6 concludes the thesis by summarising the key findings and putting forward 
recommendations for future research and practice, as well as acknowledging the limitations of 
this research. 
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1.4 Description of the two VR services (organisation 1 and 2) researched 
within this project 
 
This section provides a description of the two VR services (organisation 1 and 2) used in the 
organisations so as to provide a reference for the PhD. 
 
1.4.1 Organisation 1 
 
Organisation 1 was a Primary Care Trust (PCT) in the North-West of England that was piloting 
a new in-house VR service between 2010-2012. As the VR service formed part of a trial of a 
new VR model, it was limited to MSD conditions only. The main aims of the service were to 
reduce sickness absence in employees who were off work with MSDs and enable employees 
who were struggling at work due to an MSD to stay in work, which was anticipated would 
result in a decrease in sickness absence costs. Additional aims of the service were to increase 
employees’ job satisfaction and mental health. By meeting these aims, it was hypothesised that 
the service would lead to improved efficiency and effectiveness of the NHS staff within the 
Primary Care Trust, resulting in improved quality of health- care and patient satisfaction of 
patients being treated within the PCT.  
 
This service used a VR worker-centred model for employees with MSDs, incorporating the 
following elements of VR: 
 Case management, liaising with the workplace (line managers, HR, OH), liaising with 
and referral to GP’s and other health care professionals such as counselling and 
podiatrists as required.  
 Bio-psychosocial work focussed assessments, conducting workplace assessments and 
functional capacity evaluations where required.  
 Accommodating workplaces in terms of temporary work modifications. 
 Providing quick access to physiotherapy treatment, offering appointments at flexible 
times to accommodate shift workers. 
 On-going support via telephone or email to facilitate a sustained RTW. 
 Promoting and encouraging healthy workplace practices and physical activity. 
 
The service was provided by a specialist occupational physiotherapist, with the capacity to refer 
patients to the outpatient physiotherapy team where appropriate. In addition, the VR service, 
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through introducing workplace health champions, encouraged healthy workplace practices such 
as increasing physical activity at work.  
 
1.4.2 Organisation 2 
 
The VR service is an in-house service for a national organisation. The organisation provides 
employment services and specialist support for employees with disabilities. This VR service is 
for all health conditions as opposed to organisation 1 which was solely for MSDs, and thus 
there are more facets to the service which will be detailed. 
 
The VR service was set up in 2010 as a pilot in 2 regions of the UK and was rolled out nationally 
in August 2011. The purpose of the VR service is to provide services commercially outside of 
the organisation, as well as providing an internal service. The service was introduced internally 
in response to criticisms of their previous VR providers, who: focused on the medical view 
point and thus did not provide appropriate workplace information for line-managers to assist 
employees to RTW; did not adequately address concerns which resulted in re-referrals; and the 
wait for reports was too long. In addition, an in-house service made sense, as: having an external 
provider of VR resulted in extra work for managers and HR; an external organisation was 
unable to ensure that adjustments were implemented; an in-house service would have internal 
knowledge of the business and who to contact to resolve issues; ergonomic assessments 
provided by Access To Work (ATW), took a long time, delaying a possible RTW; and lastly, it 
was thought to be a more cost-effective way of providing VR. 
 
The VR service consisted of 10 VR Case Managers (VRCMs) who are internal to the 
organisation and 14 associates (contract VR case managers). Of the 10 internal, 5 VRCMs were 
dedicated to the organisations internal contract. 
 
The VR service aims to support the health of employees, providing advice to line-managers and 
employees on how to enable the employee to continue to work or RTW whilst considering their 
health condition and/or disability. This is achieved through assessments with the employees, 
discussions with the line managers, and liaising with medical professionals such as GP’s and 
consultants. 
 
Additionally, the service has an external OH provider to whom employees are referred to if: 
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 The employee is not aware or not sure of their condition, health, prognosis and they 
have not been to see a consultant or their GP. 
 Medical confirmation is required to enable the VRCMs to consider medical retirement.  
 The individual does not want to be assessed by an employee of the organisation.  
 
Following the assessment and above actions, a report with an action plan recommending 
adjustments or interventions is produced and provided to the line manager. If necessary, 
VRCMs will attend RTW meetings with the line manager and employee in order to mediate. In 
addition, if an employee is suffering from continuous ill-health and it is considered by both the 
employees GP and the VRCM that the employee is unlikely to RTW within 5 years, an 
employee may be retired on medical grounds.  
 
Examples of adjustments or interventions that may be recommended are:  
 Work station assessment 
 Phased RTW 
 Changes to working arrangements e.g. adjusted or changed role, working hours, break 
arrangements, start/finish times, the place of work or environment 
 Modifications to the workplace and/or equipment 
 Additional training or coaching 
 Physiotherapy  
 Support worker, reader or interpreter 
 Additional supervision or support from a colleague 
 Travel to work support 
 Mediation or RTW meeting 
 Mental health support services 
 Counselling and/or EAP intervention 
 Support groups, websites 
 Liaison with support workers and/or families 
 Job demands analysis 
 Dyslexia assessments 
 HR liaison 
 Conference calls 
 Advice and guidance 
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The most common of these adjustments has been a phased RTW. It was reported that 
approximately 50% of the referrals to the service were off-sick, and that they all had a phased 
RTW in their action plan. The organisation had a workplace adjustments policy. 
 
The referral process was that employees were referred by line managers to Human Resources 
(HR) following a trigger, namely: having been continuously absent for four weeks, having had 
frequent short-term absences, or having difficulties at work due to a health condition or 
disability. Alternatively, a request can be made by an employee, as recommended in the ‘People 
Handbook’ if an employee is feeling stressed. Each case is reviewed by the HR business 
partners, and if appropriate, referred to the service. At this point the service would allocate a 
VRCMs. At the time of the study there was no ability to self-refer into the service. The referral 
was acknowledged by the administration team. The VRCM would conduct the triage within 
seven days. A face to face assessment or telephone assessment was subsequently undertaken 
within seven days of the triage, and a report was produced within five days of the assessment. 
Each case was labelled as basic, intermediate or complex. The number of assessments and 
weeks of case management was determined by this classification.  
 
 Basic (one telephone assessment and 8 weeks case management) 
 Intermediate (one telephone or face to face assessment and 12 weeks case management)  
 Complex (one face to face assessment and 16-26 weeks case management) 
Each case was reviewed every 2 weeks. 
 
In addition, the VR service provided the following services to the organisation: 
 Advice and guidance on specific workplace adjustments 
 Health promotion, through health awareness days 
 Organisation of workplace assessments via a private supplier of ergonomic and posture 
equipment and/or Access to Work, a DWP scheme to support employees with 
disabilities 
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2. Literature review 
 
2.1 Introduction  
 
The literature review will firstly identify current influences on the use of economic analyses 
within VR for the working population. This will be achieved by discussing the difficulties in 
defining VR, proposing that VR is an essentially contested concept (ECC), outlining what a VR 
approach is and discussing the differences between OH and VR; reviewing sickness absence 
and presenteeism, the patterns, causes and consequences; and exploring the use of VR as an 
intervention to address sickness absence and presenteeism.  Secondly, it will outline the 
different economic evaluation models, and explore the cost effectiveness of VR interventions 
for employed individuals/employees who are either off sick or struggling to SAW. This will 
form the main body of the literature review, in line with the aim of the research project, and 
will be achieved through examining the evidence of the cost-effectiveness of VR for the SAW 
population; the evidence of the use of CBA in VR, in the SAW population; and through 
examining the evidence-base for the cost-effectiveness of various workplace interventions that 
VR may draw on to enable an employee to RTW or SAW.  
 
2.2 Current influences on the use of economic analyses within VR for the 
working population  
 
The following section explores the concept of VR, grappling with its definition, proposing that 
VR is an ECC, discussing who provides VR, and providing an overview of the overarching aim 
and approach of VR for the employed population and, lastly it discusses the 
differences/similarities between VR and OH.  
 
2.2.1 Vocational Rehabilitation 
 
The following search strategy was used to identify articles to inform the discussion on the 
definition of VR. The following databased were searched: EBSCO host: Including Medline, 
Business Source Premium, Academic Search Premier, Sports Discuss and Cinahl; Web of 
Science (core database), OVID host: including Psychinfo, HMIC, Ovid Medline; Cochrane. In 
addition, citation tracking was utilised.  Key terms: Vocational Rehabilitation, Define, 
Definition, Defined, Definition of meaning, theoretical models, practitioners. Limitations 
applied: publication year 2007 – 2017, academic journal article.  
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2.2.1.1 Definition of VR 
 
VR, although gaining attention both in government and private sectors over the last decade, is 
a term that is commonly misunderstood within the UK and internationally (Langman, 2012; 
Escorpizo et al., 2011b). The DWP defines VR as ‘a process to overcome the barriers that an 
individual faces when accessing, remaining or returning to work after an injury, illness or 
impairment. This process includes the procedures in place to support the individual and/or 
employer or others (e.g. family and carers), including help to access VR and to practically 
manage the delivery of VR.’ (DWP, 2004, p.14). Waddell et al. (2008) define VR as ‘whatever 
helps someone with a health problem to SAW, return to and remain in work: it is an idea and 
an approach as much as an intervention or a service’ (p.5). The VR Association (VRA) further 
expands and clarifies the definition of VR defining VR as ‘any process that enables people with 
functional, physical, psychological, developmental, cognitive or emotional impairments to 
overcome obstacles to accessing, maintaining or returning to employment or other useful 
occupation’ (VRA, 2013, p. 7).  These definitions have relied on ‘perceived main activity, not 
bounded by reference to organisational or individual accreditation, qualification, skills or any 
legislative framework’ (Langman, 2012, p. 9). This is due to the fact that there are currently no 
mandatory organisational or individual accreditation requirements specifying VR practitioner 
standards (Langman, 2012). In 2014, the VRA produced a document outlining the VRA 
Standards of Practice; however, as yet there is not a legal requirement for VR practitioners to 
follow these. 
 
When analysing commonly accepted definitions of VR, within the UK, namely those from the: 
DWP, 2004; National Institute of Health and Care Excellence (NICE), 2009b; VRA, 2013; and 
Waddell & Burton, 2008 (see Table 1) it is apparent that the definitions describe a process, or 
a set of activities, with the common goals of gaining or maintaining employment. Whilst these 
definitions provide an umbrella term, they do not clarify which underpinning processes are 
involved, or provide a theoretical model.  
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Table 1: Definitions of Vocational Rehabilitation 
 
Source Definition 
Fadyl, Mcpherson, Nicholls (2015) ‘In the context of health care, VR refers to practices directed at 
enabling people who are experiencing work disability (either pre-
existing or due to current illness or injury) to obtain and maintain work 
or employment. When and how VR occurs, and the details of what it 
entails are specific to the historical and cultural context in which it is 
situated’ (p.506) 
VRA (2013) ‘Any process that enables people with functional, physical, 
psychological, developmental, cognitive or emotional impairments to 
overcome obstacles to accessing, maintaining or returning to 
employment or other useful occupation’ (p.7). 
NICE (2009b). ‘This involves helping those who are ill, injured or who have a 
disability to access, maintain or return to employment or another useful 
occupation. It may involve liaison between OH, management, human 
resources and other in-house or external facilitators. It may result in 
transitional working arrangements, training, social support and 
modifications to the usual tasks’ (p.47). 
Waddell et al. (2008) ‘Whatever helps someone with a health problem to SAW, return to and 
remain in work: it is an idea and an approach as much as an 
intervention or a service’ (p.5) 
DWP (2004) ‘A process to overcome the barriers that an individual faces when 
accessing, remaining or returning to work after an injury, illness or 
impairment. This process includes the procedures in place to support 
the individual and/or employer or others (e.g. family and carers), 
including help to access VR and to practically manage the delivery of 
VR.’ (p.14) 
 
Moreover, VR has expanded from historically focusing on gaining employment for individuals 
with health conditions, to including enabling the employed population to SAW (American 
College of Occupational and Environmental Medicine (ACOEM), 2006). Correspondingly, the 
spectrum of ways of delivering VR has increased as individual services use elements of existing 
VR activities to design their own practices for their specific target population. Thus, as VR has 
evolved, it has been suggested that it is now more appropriate to refer to it as an approach where 
'there is a wide spectrum of VR approaches that vary by type and intensity' (Waddell, et al., 
2008 p. 12).   
 
In 2012, 23 international experts developed a set of ‘activity and participation’ categories 
highlighting target areas for VR interventions (Finger et al., 2012).  The categories include 
traditional work domains (e.g. undertaking multiple tasks); non-traditional work domains (e.g. 
toileting and dressing); and environmental factors (e.g. support for people, including for 
example technology, drugs policies and systems). The Core Set was developed using the 
International Classification of Functioning, Disability and Health (ICF) conceptual framework, 
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to provide a much needed ‘common language among clinicians, researchers, insurers, and 
policymakers in the implementation of successful VR’ (Finger et al., 2012, p. 429).  Due to the 
complexities of VR it is questioned whether the ICF model has sufficient work specific 
categories and personal factor categories to adequately capture the VR experience (Finger, de 
Bie, Selb, & Escorpizo, 2016).  Finger et al. (2016) mapped VR concepts from the literature 
and a focus group to the ICF model. In doing this the authors enriched the model with VR 
specific constructs, however, it is acknowledged that further work is required to explore 
personal factors related to VR. Moreover, exploration of themes complementary to the ICF such 
as wellbeing and quality of life is needed (Finger et al., 2016). 
 
During the Core Set’s development, it was noted that although there is a common understanding 
of VR, ‘there is no common definition of VR at the conceptual level’ (Finger et al., 2012, p.436).  
This lack of a definition at the conceptual level makes evaluating the effectiveness of VR 
interventions problematic, particularly when we consider the Medical Research Councils’ 
(MRCs) guidance (Craig, Macintyre, Mitchie, Nazareth, & Petticrew, 2008) which 
recommends that health interventions are generally described fully, so that they can be 
implemented properly for evaluation purposes and replicated by others. Moreover, the MRC 
(Craig et al., 2008) assert that the intervention should have a coherent theoretical basis, and that 
this theory is systematically used to develop the intervention, highlighting the importance of 
having a theoretical model. 
 
Considering the above, it could be argued that VR is an essentially contested concept (paper in 
preparation) i.e. ‘a group of concepts exist which inevitably leads to endless disputes about the 
proper meaning of these concepts’ (Choi & Majumda, 2014, p 363).  Should this be accepted, 
this would validate various interpretations and adaptations of practice, and emphasises the need 
to clearly describe interventions when researching VR.  
 
Using the above outlined current definitions of VR, it can be concluded that it is a process of 
assisting those who have been sick or injured to RTW using any relevant intervention, such as 
case management of individuals, prevention of injury or illness in the workplace, or providing 
healthcare to staff as part of absence management (Irving, Chang, & Sparham, 2004).  It must 
also be acknowledged that VR has different meanings to different stakeholders (DWP, 2004).  
According to Irving et al. (2004) some individuals take a narrower definition of VR, separating 
VR from medical rehabilitation, and focusing solely on assisting individuals to return to 
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employment, following the accepted hierarchy of occupational outcomes.  The hierarchy of 
outcomes refers to placing the potential VR outcomes in a hierarchy of desirability, and they 
are pursued in sequence. The hierarchy of outcomes are:  
 
 The same job, with the same employer  
 A modified job with the same employer  
 A different job, with the same employer  
 The same job, with a different employer  
 A modified job, with a different employer  
 A different job, with a different employer 
 Vocational and/or academic retraining (Kendall & Thompson, 1998, cited in 
Waddell et al., 2008).  
 
The range of VR practitioners (considered below), and VR theoretical models further 
complicate the definition of VR. 
 
2.2.1.2 VR practitioners 
 
As VR uses a multidisciplinary approach (Gobelet, Luthi, Al-Khodairy, & Chamberlain, 2007), 
VR practitioners are drawn from a diverse range of professional and disciplinary backgrounds 
such as case managers, occupational therapists, employment retention officers, 
physiotherapists, and GP’s. Langman (2012) proposes that these can be viewed as ‘core’ and 
‘non-core’ practitioners. Core practitioners are defined by Langman (2012) as: ‘practitioners 
from a range of disciplinary backgrounds and in a variety of activities, spend the whole or 
substantial part of their time in working with disabled people, or with service delivery staff, 
with the aim of individuals securing or retaining employment or self-employment’ (p.10). 
Whereas non-core practitioners spend some time assisting employment or retention, this is only 
part of their work (Langman, 2012). This split in practitioners contributes to the wide spectrum 
of approaches falling under the umbrella of VR.  
 
Although there appear to be two strands of VR practitioners, there are commonalities across 
both: the goal of returning to or retaining employment, early person-centred intervention, the 
acceptance of the hierarchy of outcomes (Irving et al., 2004), and adopting a bio-psycho-social 
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approach to ensure the correct intervention or mixture of interventions are utilised to assist 
individuals to overcome identified barriers to work (Langman, 2012). 
 
2.2.1.3 Aims of VR 
 
The primary aim of VR is to improve individuals’ capability for work, and converting that into 
actually working, although it appreciates that this need not be paid employment but could 
consist of voluntary work or a meaningful activity (College of OH Therapists, 2008; Waddell 
et al., 2008). The improvement of the injury, illness and impairment that the individual has is 
not the main goal of VR, although through the process of VR, health may be improved (Waddell 
et al., 2008). VR is a service that is used with both employed and unemployed individuals, with 
an illness, impairment or injury. With regards to the unemployed population, VR seeks to assist 
these individuals to gain employment. For individuals who are employed, VR focuses on 
helping those who are off sick to RTW and assist those who are at work, but at risk of sickness 
absence, to SAW (VRA, 2013). Individuals will have varying reasons why they are struggling 
to RTW or SAW. Hence, VR aims to provide a bio-psychosocial approach i.e. considering the 
individual, their health problem and the social aspects (Bartys et al., 2017; Waddell, 2002), 
ensuring that the various influencing factors and reasons that the individuals are struggling to 
RTW or SAW are addressed (see section 1.1.4 for a critique of the bio-psychosocial model).  
 
2.2.1.4 VR approach 
 
VR is described as an approach, rather than a specific treatment or intervention. This 
demonstrates the understanding that there are a variety of different influences on individuals 
and their ability to RTW/SAW that need to be addressed. Traditionally VR was more concerned 
with unemployed individuals struggling to RTW and the models were clearly demarcated and 
defined as (1) traditional vocational assessment and counselling, (2) case management, (3) 
assertive community treatment and (4) supported employment, particularly the individual 
placement and support model (Cockburn & Kirsh, no date). Nowadays, the focus in VR has 
expanded to include enabling the employed population to SAW, recognising the benefits of 
preventing the downward spiral associated with long-term sickness absence (ACOEM, 2006; 
Varekamp, Verbeek, & van Dijk, 2006). Correspondingly, the spectrum of models has 
increased as individual VR organisations/services are using elements of these models to design 
their own unique model to address their specific target population and their unique barriers. 
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Thus, as VR has evolved it is now more appropriate to refer to VR as an approach. Waddell et 
al. (2008) state that 'there is a wide spectrum of VR approaches that vary by type and intensity' 
(p. 12). These range from the simple level intervention following basic principles of a VR 
approach which can be delivered within the workplace, or primary health care to help facilitate 
RTW, to the more complex cases requiring structured VR services (Waddell et al., 2008). This 
heterogeneity in the service provision of VR renders it difficult to compare the effectiveness of 
different services. Buys, Matthews & Randall (2015) conducted a transnational comparative 
analysis of VR knowledge and skill set, and identified the common knowledge and skill 
domains that can be attributed to VR, namely; vocational counselling, workplace disability case 
management, and workplace intervention and programme management. The VRA (2013) states 
that the process of VR requires input from a range of professionals from different disciplines, 
and provide the following list of examples of interventions that may be used within VR: 
 
 ‘assessment and appraisal 
 goal setting and intervention planning 
 provision of health advice and promotion, in support of returning to work 
 support for self-management of health conditions 
 career (vocational) counselling 
 individual and group counselling focused on facilitating adjustments to the medical and 
psychological impact of disability 
 case management, referral, and service co-ordination 
 programme evaluation and research 
 interventions to remove environmental, employment and attitudinal obstacles 
 consultation services among multiple parties and regulatory systems 
 job analysis, job development, and placement services, including assistance with 
employment and job accommodations 
 the provision of consultation about and access to rehabilitation technology’ (VRA, 
2013, no page). 
 
A VR approach is commonly accepted as following the key principles of early rehabilitation, 
work-focused health care and accommodating workplaces, which have been shown as effective 
strategies in RTW (Schaafsma et al., 2013; Higgins et al., 2012; Desiron et al., 2011; Accident 
Compensation Corporation (2004), cited in Ellis et al., 2010; Schaafsma et al., 2010; Lambeek 
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et al., 2010). Additionally, as discussed earlier, VR adopts a bio-psychosocial model, i.e. 
considering the individual, his or her health problem and the social aspects of disease (Waddell, 
2002), ensuring that the various influencing factors and causes of sickness absence are 
addressed. However, it is questioned whether this model is too patient centred, as opposed to 
considering the wider systemic influences on health (Bartys et al., 2017).  
 
2.2.1.5. Differences between VR and Occupational Health 
 
The differences between OH and VR are clear when looking at VR for the unemployed 
population looking to return to employment. However, when considering VR in the workplace 
for the SAW population, this distinction becomes less clear, in fact, this raises the question: is 
there a difference between OH and VR? Prior to discussing this question, it is important first to 
clearly define OH. 
 
OH is defined jointly by the International Labour Organisation and the World Health 
Committee on OH (1950) as 'the promotion and maintenance of the highest degree of physical, 
mental and social health of workers in all occupations by preventing departures from health, 
controlling risks and the adaptation of work to people, and people to their jobs' (Health 
Environment and Work Website (HEWW), 2013). To achieve this, OH is responsible for 
identifying health hazard risks within the workplace; advising on planning and organisation of 
work and working practices, providing advice and training on OH, safety and hygiene, and 
ergonomics; health surveillance, providing relevant vaccinations, organising first aid and 
emergency treatment, and occupational rehabilitation i.e. helping people stay in work and at 
times health promotion (HEWW, 2013; Wales Audit Office, no date; Bomel Limited, 2005).  
Thus, it is seen that OH has a multi-faceted role within the workplace, with only a component 
of its role focusing on sickness absence management. However, OH is recommended as an 
integral part of effective sickness absence management, and should be considered early in terms 
of long-term sickness absence (HSE, 2010; Electricity Industry OH Advisory Group, 2008; 
CBI, 2006 & CIPD, 2006, cited in Hayday, Broughton, & Tyers, 2007). 
 
As the demands and challenges facing the workforce in the UK have changed, health in the 
workplace has taken a prominent position in UK national agendas. In 2008, Dame Carol Black’s 
review challenged OH to meet the current workplace challenges; broaden its traditional remit, 
underpin its work with evidence and increase its capacity. The NHS Future Forum (2012) 
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summary report focused on four key themes, one of them being how to ensure that the public’s 
health stays at the heart of the NHS. One of the key challenges addressed was the management 
of long-term conditions. Harrison (2012) argues that the workplace is integral to addressing this 
challenge, and that providing optimal management of chronic conditions should be a core 
activity for OH professionals. Thus, there is an increasing demand on OH to change, widen its 
skill set through incorporating skills that were traditionally within the remit of HR, such as 
communication, negotiation skills, and adapt to the present challenges within the UK. 
Currently, within the UK, OH specialists are under threat, with fewer physician trainees and 
OH consultants being considered for the shortage occupation list; consequently there is a 
growing concern with the changes to work and the workforce (i.e. an increase in the ageing 
workforce, an increase in the number of long-term illnesses) of the ability of OH specialists to 
meet the future demand (Harrison, 2012; Harrison & Dawson, 2016; The Council for Work and 
Health, (2014); Centre for Workforce Intelligence, 2012; O’Donnell & Reymond, 2009).  
 
In order to meet these challenges, it is suggested that OH is provided by an integrated team 
comprising a variety of health professionals, e.g. occupational physiotherapists, occupational 
therapists, counsellors, psychologists and GP’s (The Council for Work and Health, 2014; 
Harrison, 2012). In response to Harrison’s editorial, Andrew Frank’s (2013) letter to the editor 
commented on the contribution that rehabilitation professionals provide to OH, recognised in 
the Council for Work and Health. Frank (2013) suggested that rehabilitation professionals can 
assist OH in ‘developing their knowledge of patients working life and the inter-relationships 
between health and work’ (p.306) as well as assisting with the use of case management and 
other strategies to improve job retention, which, Frank (2013) stated are currently used by the 
best OH departments. Moreover, O’Donnell & Reymond (2009), in a commentary article, 
suggest that VR services, although they may overlap with OH in some areas, if viewed as 
complementary to OH, and the strengths of each identified, could be used in combination with 
OH to bridge the gap. OH practitioners’ strengths are their medical knowledge, whereas the 
strengths of VR practitioners are identified as assisting with non-medical barriers to RTW, and 
having the time to work in the field with individuals, whereas OH practitioners are often 
constrained by time limitations (O’Donnell & Reymond, 2009). 
 
Thus, in answering the initial question posed as to the difference between OH and VR, it can 
be concluded that there is overlap between the two, with similar goals, however the skill sets of 
the practitioners differ, and in some cases the underpinning philosophies and models of 
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management also differ. It is hypothesised that rather than viewing the two as competitors, if 
viewed as complementary services, they could together meet the current demand facing the UK. 
This viewpoint is supported within the Improving Life’s: the future of Work, Health and 
Disability (DWP & DH, 2017) response paper. The paper, which outlines a strategy to increase 
the employment rate of disabled individuals, uses the term OH as an umbrella to term 
encompassing services such as vocational rehabilitation with the shared goal of protecting and 
promoting the safety, health and wellbeing of employed individuals.  
 
2.2.2 Sickness absence and presenteeism 
 
The following search strategy was used to identify articles to inform the discussion on the 
sickness absence and presenteeism both of which have been shown to have a negative impact 
on organisations.  
 
The following databases were searched: EBSCO host: including Medline, Business Source 
Premium, Academic Search Premier, Sports Discuss and Cinahl; Web of Science (core 
database), OVID host: including Psychinfo, HMIC, Ovid Medline; Cochrane. In addition, 
citation tracking was utilised.  Key terms: Sick, Sick absence, absenteeism, sick listed 
employee, sickness absence, ill-health, sick leave, work disability, presenteeism.  Limitations 
applied: publication year 2007 – 2017, academic journal article 
 
2.2.2.1 Patterns of sickness absence 
 
Sickness absence is commonly measured by frequency and duration. Long-term and short-term 
sickness absence are terms frequently used to describe patterns of sickness absence. There is 
no consensus on the definition of long-term sickness absence, within the UK it is commonly 
defined as 28 calendar days or 20 working days (CBI, 2011; NICE, 2009b), with short-term 
sickness absence being less than 20 working days.  
 
Current levels of sickness absence within the UK have been discussed in the introduction: 
however, historically it is seen that sickness absence patterns vary across countries, genders, 
ages, social class, employment type, public and private organisations, the size of organisations 
and geographical areas, indicating various influencing factors on whether individuals choose to 
take sickness absence (ONS, 2016).  Within the UK, women consistently have higher levels of 
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sickness absence (2.5%) than men (1.6%); an increase in sickness absence is seen with an 
increase in age (2.9% for ages 65 and over); public sector organisations report higher sickness 
absence levels (2.9%) than the private sector (1.7%) and self-employed sector (1.4%); larger 
organisations with large workforces report the highest sickness levels (2.5%); workers in 
elementary occupations have higher levels of sickness absence (2.7%) compared to managers 
and professionals (1.1%) and differences in geographical areas are seen with London having 
the lowest percentage sickness absence levels (1.4%) and Scotland and Wales showing a higher 
percentage (2.5% and 2.6% respectively) (ONS, 2016).  
 
The complexity of these variations may be due to factors such as differences in the occupation 
or organisation, public private sector differences, socio-economic factors, economic changes 
(either nationally or within an organisation), cultural changes/beliefs, labour market conditions 
and sickness absence insurances (Edge et al., 2017; Allebeck & Mastekaase, 2004; Yeomans, 
2011; Kristensen, 1991). Thus, the indications are that the influences on an individual’s decision 
to take sickness absence are multi-faceted. To further understand the reasons underlying 
sickness absence behaviour the causes of sickness absence need to be explored. 
 
2.2.2.2 Causes of sickness absence and presenteeism 
 
As identified when looking at the patterns of sickness absence, sickness absence is a complex 
issue. This complexity is again seen when examining its causes. Historically, long-term 
sickness absence, which accounts for approximately 32% of absenteeism, was most commonly 
caused by MSDs in manual workers and stress in non-manual workers (CIPD, 2010; Holmes, 
2008). However, in 2011 the CIPD Absence Management survey concluded, for the first time, 
that stress is the most common cause of sickness absence in both manual and non-manual 
employees. In 2014, stress continued to be the main cause of long-term sickness absence in 
public organisations (CIPD, 2014a), and in 2016/2017 12.5 million work days were lost due to 
work-related stress, anxiety or depression, accounting for 49% of all sickness absence days 
(HSE, 2017a). This impact of mental health conditions is further noted in Stevenson & Farmer’s 
(2017) report which states that 300,000 individuals with long-term mental health conditions 
lose their job every year, and 15% of people in work have symptoms of an existing mental 
health condition.  This can be hypothesised to be due to the economic climate and labour market 
within the UK at that time and presently, with large-scale public organisational change and 
restructuring, as well as job cuts, decreased pension benefits and pay freezes, and the 
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uncertainty surrounding Brexit contributing to increased employee stress levels. It is widely 
accepted that job insecurity and fear of finding alternative employment are associated with 
increased levels of stress (De Witte, Pienaar, & De Cuyper, 2016; Allebeck & Mastekaase, 
2004; Green, 2015). In 2014 MSDs accounted for the largest number of days off sick (ONS, 
2014), although this is no longer the case, MSDs resulted in 8.9 million sickness absence days 
in 2016/2017, and is in the top 5 causes of short and long-term sickness absence (HSE, 2017b; 
CIPD & Simply Health, 2016).  Thus, it is seen that both mental health disorders and MSDs are 
significant reasons for sickness absence. Other common causes of long-term absenteeism are 
acute medical conditions (for example stroke, heart attack and cancer), recurring medical 
conditions, mental ill health and injuries or accidents not related to work (Stevenson & Farmer, 
2017; CIPD & Simply Health, 2016; CIPD, 2011; CBI, 2011).  
 
Understanding the causes of sickness absence is further complicated by the inability of many 
absence measures to adequately verify the causes of sickness absence (Wegge, Schmidt, Parkes, 
& Van Dick, 2007).  Both the CIPD and CBI sickness absence surveys rely on an appropriate 
representative within the responding company to summarise sickness absence for the 
organisation and to complete the surveys. This, along with the relatively low number of 
respondents (CIPD respondents n = 592; CBI respondents n = 223), may affect the response 
rate and the accuracy of the data, both in terms of sickness absence record keeping, as well as 
accuracy of cause of sickness absence (Holmes, 2008). The Labour force survey (LFS is a 
survey of households) and includes questionnaires on workplace injuries and work-related 
illness. The results from this survey differ slightly from the results published by CBI and CIPD, 
with the LFS (2011) stating the most common cause of sickness absence in men is MSDs and 
in women is stress and mental health conditions. However, Holmes (2008) looked at the 
feasibility of comparing the results from the CBI and CIPD surveys to the LFS, and found that 
due to the differences in data collection, target population (organisations versus employees 
respectively), and question focus (work-related illnesses compared to general sickness 
absence), the results are not comparable. However, although the results differ slightly, the 
general finding is that stress and MSDs are common causes of sickness absence. 
 
Presenteeism and sickness absence are closely linked, and in exploring the causes of sickness 
absence it is also necessary to consider the reasons why individuals choose to SAW whilst 
feeling ill i.e. presenteeism (John, 2010; Aronsson et al., 2000; Dew, Keefe, & Small, 2005). 
With the recent trend of a decrease in the days of sickness absence both in the private and public 
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sector (CIPD, 2014a), there has been a corresponding increase in the number of people reporting 
that they are attending work whilst they are ill (Stevenson & Farmer, 2017; CIPD, 2015; CIPD, 
2012). This is highlighted in the CIPD and Simply Health 2016 Absence Management Survey, 
where 72% of respondents reported observing presenteeism within the workplace. Baker-
McClearn et al.’s (2010) research exploring absence management and presenteeism identified 
two categories influencing presenteeism - personal motivations and workplace pressures. 
Personal motivations to attend work whilst feeling ill included: beliefs such as no-one else could 
perform their job, loyalty to their own professional image, obligation and commitment to the 
organisation, colleagues, and clients, financial worries, and individual lifestyle factors (Garrow, 
2016; Baker-McClearn et al., 2010; John, 2010; Hansen & Anderson, 2008; Dew et al., 2005; 
McKevitt, Morgan, Dundas, & Holland, 1997). Workplace pressures identified influencing 
presenteeism were management style and management of absence, RTW interviews, triggers 
and sickness absence policies, loss of incentives, risk to promotion prospects/job insecurity, 
working time arrangements, job demands, peak pressures, pressure from manager or colleagues, 
job meets needs of others e.g. health care workers, organisational commitment, workplace 
culture and other unfavourable conditions e.g. poor working positions/postures, shift work 
(Garrow, 2016; John, 2010; Baker-McClearn et al., 2010; Chatterji & Tilley, 2002). Additional 
workplace pressures currently at play in the UK, possibly resulting in presenteeism, are the 
perceived threat of redundancies and job insecurity (Stevenson & Farmer, 2017; CIPD, 2015; 
CIPD, 2012). The interplay and impacts of personal motivation and workplace pressures, 
highlights the complex nature of presenteeism and sickness absence. 
 
Allebeck and Mastekaase (2004) encapsulate the complex nature of sickness absence behaviour 
through categorising the various theoretical approaches and explanatory models that have been 
used in sickness-absence research, namely, medical, sociological, psychological and 
economic/organisational. Although these categories are based on distinct theoretical 
approaches, it is evident through looking at each in turn, that they overlap and interlink. From 
a medical science perspective, biological factors are the primary explanation of the cause of 
sickness absence. However, using the medical theoretical perspective to explain sickness 
absence is limited, as is demonstrated by the fact that ranking in some organisations the top five 
reasons for short-term absenteeism are home/family responsibilities and absence not due to 
genuine ill health (CIPD & Simply Health, 2016; CIPD, 2015; CIPD, 2014a; CIPD, 2011). 
Moreover, when considering MSDs it is recognised that 12-weeks post injury the MSD is no 
longer the primary obstacle to the individual returning to work; at this point the wider 
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psychosocial influences have greater influence over the individuals returning to work (Sheppard 
& Frost, 2016). 
 
Using a sociological explanatory model to explain the causes of sickness absence encompasses 
investigating the influencing factors on individuals in terms of societal factors, living and work 
conditions (Allebeck & Mastekaasa, 2004). Marital status, relational problems, domestic 
responsibilities, number of dependants, social networks and personal social support have also 
been linked to reasons for sickness absence (Batt-Rawden & Tellnes, 2013; Melchior, 
Niedhammer, Berkman & Goldberg, 2003; Kristensen, 1991). Again, merely viewing sickness 
absence from a sociological perspective is limiting.  
 
Psychological research into sickness absence develops an alternative array of causes for 
sickness absence behaviour and its variation in individuals, encompassing individual 
personality factors and their interaction with the environment and risk factors. Individual 
factors, such as mental health, personal lifetime events, personality and personal coping styles, 
influence stress levels (Lee, Lee, Liao, & Chiang, 2009; Georgellis, Lange, & Tabvuma, 2012; 
Golbasi, Kelleci, & Dogan, 2008; Ilies & Judge, 2002). This theoretical perspective highlights 
the importance of examining psychological explanations when considering sickness absence 
behaviour.  
 
Additionally, organisational/workplace factors are shown to have an influence on job 
satisfaction and individual stress levels, which are both strongly linked to levels of sickness 
absence (Wegge et al., 2007; Fairbrother & Warn, 2003). Organisational factors which impact 
on job satisfaction and stress include the ethical morality of the company (Huhtala, Kaptein, & 
Feldt, 2016; De Tienne, Agle, Phillips, & Ingerson, 2012; Charles, 2001); job characteristics 
such as pay, security, type of work, hours of work, flexible job design, flexible work hours 
(Dionne & Dostie, 2007; Jose & Cabral, 2005); organisational communication (Lee et al., 
2009); trust in management (Baptiste, 2008); and career prospects (Theodossiou & Zangelidis, 
2009). Low levels of job satisfaction and high levels of stress have been linked to increased 
levels of sickness absence; conversely, high levels of job satisfaction have been shown to have 
a positive effect on organisational commitment and improved stock market performance where 
individuals value their co-workers and strongly identify with the organisational goals (Edmans, 
2011; Aghdasi, Kiamanesh & Ebrahim, 2011). Additionally, job satisfaction has been shown 
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to be an indicator of job quality and to positively impact on customer satisfaction (de Bustillo 
Llorente & Macias, 2005; Snipes, Oswald, Latour, & Armenakis, 2005). 
 
Thus, it is clear that individuals’ experiences of physical or mental health conditions can be 
influenced (either positively or negatively) by a variety of factors, such as medical, societal, 
organisation and psychological (CIPD & Simply Health, 2016; Batt-Rawden & Tellnes, 2013; 
Lee et al., 2009; Georgellis et al., 2012; Golbasi et al., 2008; Ilies & Judge, 2002; Wegge et al., 
2007; Aghdasi et al., 2011; Dionne & Dostie, 2007; Theodossiou & Zangelidis, 2009; Baptiste, 
2008; de Bustillo et al., 2005; Snipes et al., 2005). The influence of these factors needs to be 
considered and addressed when managing sickness absence and presenteeism, emphasising the 
need for a bio-psycho-social model.  
 
2.2.2.3 Consequences of sickness absence and presenteeism 
 
As identified when looking at the determinants of sickness absence and presenteeism, absence 
behaviour is multifaceted. This complexity is again highlighted when exploring the 
consequences of sickness absence and presenteeism. To fully appreciate the consequences, it is 
necessary to consider sickness absence and presenteeism from a variety of stakeholders’ 
perspectives; the employee, the employer/organisation, and society. The consequences of 
sickness absence and presenteeism for the various stakeholders will be discussed in turn below. 
 
As discussed in section 1.1.1, sickness absence results in a large economic cost, not only for 
organisations but for employees and the wider society too (Stevenson & Farmer, 2017; DWP 
& DH, 2016; Black & Frost, 2011; CIPD, 2011; Black, 2008; Bevan et al., 2007). Additionally, 
the costs outlined in section 1.1.1 do not include the ‘hidden’ costs of sickness absence for the 
individual, the organisation and society. Organisations may incur additional costs such as staff 
turnover, staff recruitment and retraining, loss of skill base, overtime, increased burden on 
colleagues, and time spent managing sickness absence (Baker-McClearn, 2010).  According to 
CIPD & Simply Health (2016), the median cost of sickness absence is £522 per employee per 
year. These costs differ according the business sector as well as the size of the organisation, 
with public sector organisations having a median of £835 per employee (CIPD & Simply 
Health, 2016).  Additionally, the costs will differ according to the actions taken by the 
individual. For example, if the individual retires due to ill-health, the organisation will have the 
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additional turnover costs. In 2014, non-genuine sickness absence is believed to account for one 
day in eight of all sickness absence in the UK (CIPD, 2014a). In 2016, non-genuine illness 
continues to be within the top 5 causes of sickness absence for some organisations, and thus it 
needs to considered as to why this is the case e.g. do the policies on flexible working, carer 
allowances need to be reconsidered in these cases? (CIPD & Simply Health, 2016). 
 
There is also an economic cost of sickness absence to the individual. Employees may incur a 
degree of economic hardship from extra costs such as transport to hospital visits, special diets 
and supplements, lost income, losing their home and ability to support their family (Taylor, 
Cunningham, Newsome, & Scholarios, 2010; NICE, 2004; Alter, 2009).  
 
From a humanitarian perspective, it is necessary to understand the wider impact of sickness 
absence on an individual, which is dependent on the length of sickness absence. Long-term 
sickness absence has been linked with various consequences, such as poor mental health, and 
there is a consensus that it is a strong predictor of claims for disability allowance and therefore 
welfare dependency (Black & Frost, 2011; Hultin, Lindholm & Moller, 2012, Waddell et al., 
2008). Floderus, Goransson, Alexanderson & Arronsson’s (2005) cross-sectional study, 
analysing the influence of long-term (12-18 months) sick leave on patients’ life situations, 
found that more than 60% of their participants reported negative effects related to leisure 
activities, sleep and psychological health. Gender, age and diagnosis influenced the experience 
of both positive and negative consequences of sickness absence, with women reportedly 
experiencing more positive consequences than men, which were attributed to their relationships 
with their partners and children (Floderus et al., 2005). On the other hand, Nyman, Andersson, 
Spak & Hensing’s (2009) longitudinal study found that women with long-term sick leave were 
more likely to report ill-health at a 5-year follow-up. However, these results need to be viewed 
with caution due to methodological limitations such as small sample size (Nyman et al., 2009). 
Furthermore, it is important to keep in mind when reviewing research into sickness absence, 
due to the complexity and interplay of sickness absence and the underlying illness, it is difficult 
to directly attribute outcomes specifically to sickness absence and results need to be viewed 
with caution. Bearing these limitations in mind, Waddell et al.’s (2008) literature review ‘VR: 
What works, for whom and When’ concluded that good work is positive for an individual’s 
health, with the negative aspects of sickness absence outweighing any positive consequences. 
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When considering the consequences of presenteeism from the perspective of the employer, 
presenteeism is viewed to have an impact on productivity (employee’s efficiency) and be a 
threat to workplace safety (Garrow, 2016; John, 2010; Baker-McClearn et al., 2010, Pilette, 
2005).  Although productivity is difficult to measure, studies have suggested that presenteeism 
results in greater productivity losses than absenteeism (Stevenson & Farmer, 2017; Garrow, 
2016; Dixon, 2005; Caverley et al.., 2007). These findings may refer to ‘unmanaged’ 
presenteeism, in other words, employers may not be aware that the employees are in work 
whilst they are feeling unwell, and the employees are not using work as part of a managed 
rehabilitation process, so as to ensure the period of presenteeism is short-lived. Presenteeism 
may be preferable to the employee and employer, as the structure of the workplace has been 
shown to assist recovery from certain ill-health conditions (Cocker et al., 2014). Studies suggest 
that if presenteeism is managed effectively, both the employer and the employee may reap long-
term benefits from short-term presenteeism (Baker-McClearn et al., 2010; Vingard et al., 2004; 
Aronsson & Gustafsson, 2005). The benefits for organisations may include reduced turnover 
costs, reduced training needs, and increased team stability. For employees, the effective 
management of presenteeism may reduce the risk of employees losing their confidence, skills, 
and social networks, as well as the decrease the risk of dropping out of the work market.  
 
Conversely, some studies suggest that presenteeism due to workplace pressures adversely 
impacts employee morale and increases absence (Taylor, Baldry, Bain, & Ellis, 2003; 
Bergstrom et al., 2009). Additionally, if the employee is not getting better due to being at work, 
this can lead to longer periods of lower productivity than if one were to take sick leave (Baker-
McClearn et al., 2010). This is supported by Dixon’s (2005) US Survey, which reported that 
employee burnout and lost productivity was 7.5 times greater with presenteeism than 
absenteeism. Additionally, according to analysis by Kivimaki et al. (2005), based on a cohort 
of 5,071 male British civil servants, without a previous history of myocardial infarction, 
unhealthy employees who do not take sick leave, compared to unhealthy employees who had 
moderate levels of sickness absence, had twice the incidence of serious coronary events. As 
within this cohort there was a small number of coronary events (n = 62), the findings do need 
to be further substantiated, however, it does highlight the need, for individuals, employers, 
organisations and healthcare practitioners to be aware of the potential harmful effects of 
presenteeism (Kivimaki et al., 2005).    
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As is seen from the potential positive and negative consequences of presenteeism, for both the 
organisation and the employee, it is imperative when implementing workplace rehabilitation 
strategies that they are well thought out and designed to support the individual. Thus, ensuring 
that sickness absence is not merely displaced, resulting in higher levels of long-term 
presenteeism, possibly resulting in ineffective and unproductive workforces.  With the 
consequences of sickness absence and presenteeism having far reaching economic, fiscal and 
social costs and impacts, and in the current economic climate within the UK, it is imperative 
that effective solutions to reducing these costs are found. 
 
2.2.2.4 The use of Vocational Rehabilitation in addressing sickness absence, 
presenteeism and turnover  
 
The wide variation within what is classified as VR creates difficulties in synthesising the 
evidence-base. The seminal report by Waddell et al. ‘VR, what works for whom and when’ 
(2008) synthesised the evidence into the following categories: health conditions (mental health, 
musculoskeletal and cardio-respiratory); delivery of VR (primary healthcare, workplace 
interventions, specialist rehabilitation services and social security interventions) and timing and 
co-ordination of interventions.  Although some approaches discussed in this report have 
evolved over the years, such as the stepped care approach (Burton, 2010; Kendall, Burton, 
Main, & Watson, 2010), the basic concepts remain the same. Dibben et al.’s (2012) rapid review 
of the evidence utilised the same categories. Dibben et al.’s (2012) and Coleman, Sykes & 
Groom’s (2013) critiques of the literature, echoed those of Waddell et al. (2008), highlighting 
that the studies lacked robust quantification of employment outcomes; evidence on CBA was 
limited and reliant on poor quality studies; and limited evidence for UK based intervention. 
 
Using these categories, identified originally by Waddel et al. (2008), enables the identification 
of common elements of the VR approach specific to the area of interest. This research is focused 
on VR workplace interventions for employees with ill-health who are trying to SAW or RTW, 
rather than on those who are trying to gain employment. The main causes of sickness absence 
are MSDs and mental health conditions. 
 
There is a consensus that VR is effective in the treatment of MSDs in the working age 
population (Alexander, Cooper & Mitchell, 2017; van Vilsteren et al., 2015; Dibben et al., 2012; 
Waddell et al., 2008). However, the type of modes and interventions under the VR umbrella 
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that are effective is less clear. There is a consensus that the following elements of VR have 
relatively moderate to strong evidence in their effectiveness in improving work outcomes and 
decreasing pain and disability in adults with MSDs: 
- Exercise and increasing activity (Alexander et al., 2017; Waddell et al., 2008) 
- Brief education (Alexander et al., 2017) 
- Cognitive Behavioural Therapy (Dibben et al., 2012; Waddell et al., 2008) 
- Workplace interventions such as modified work, changes to workplace or work design, 
early RTW (Alexander et al., 2017; van Vilsteren et al., 2015; Waddell et al., 2008; Dibben 
et al., 2012; Odeen et al., 2013) 
- Multidisciplinary rehabilitation including the liaison with all stakeholders (Alexander et 
al., 2017; Waddell et al., 2008; Dibben et al., 2012; National Spinal Taskforce, 2013) 
- Biopsychosocial rehabilitation (Alexander et al., 2017; Waddell et al., 2008; National 
Spinal Taskforce, 2013) 
- Work-focused health intervention (Odeen et al., 2013; Coleman et al., 2013) 
- Case management (Schandelmaier et al., 2012; Dibben et al., 2012; Hanson, Burton, 
Kendall, Lancaster, & Pilkington, 2006) 
 
The effectiveness of other elements of VR on MSDs, such as early intervention is less clear. 
Waddell et al. (2008) and Coleman et al. (2013) state that there is evidence of the benefits of 
early intervention on health. Contradicting this, Dibbin et al. (2012) concluded that there is 
insufficient evidence with regards to the impact of early interventions on work outcomes. There 
is agreement that further high-quality research is needed in this area due to heterogeneity of 
interventions (Alexander et al., 2017; van Vilsteren et al., 2015; Waddell et al., 2008; Dibben 
et al., 2012; Odeen et al., 2013; Lambeek et al., 2010). 
 
Considering the evidence-base in respect of mental health conditions and VR, Waddell et al. 
(2008) identified that there is limited focus of occupational outcomes within the mental health 
literature, with little or no evidence showing that VR is effective. However, 'there is general 
consensus that organisation-level interventions (disability management, improved 
communication, early contact with absent worker, an agreed rehabilitation plan, flexibility in 
work organisation and RTW arrangements) are applicable to mental health problems, and 
limited evidence that they improve work outcome' (Waddell, et al., 2008, p.22). These findings 
were supported by Dibben et al.’s (2012) review, which additionally concluded that there is 
strong evidence indicating positive effects of psychological and workplace-based interventions 
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for depression. Moreover, evidence indicates that employees with severe mental health 
conditions benefit from supported employment (Dibben et al., 2012).  A recent Cochrane review 
synthesising the evidence on interventions to improve RTW in people with depression, 
concluded that there is moderate quality evidence that work-directed interventions, such as 
work-modification and coaching, alongside clinical interventions reduce the number of sick 
days compared to the clinical intervention alone (Nieuwenhuijsen et al., 2014). However, this 
conclusion is based on 5 studies and further research is needed on work-directed interventions 
to improved RTW in employees with depression.  
 
With regards to the delivery of VR in the workplace, there is a consensus that proactive, 
approaches, workplace accommodations and modified work can be effective (Alexander et al., 
2017; Van Vilsteren et al., 2015; Dibben et al., 2012, Waddell et al., 2008). In addition, it is 
imperative to consider the timing of interventions. There is strong evidence that the longer the 
duration of sickness absence, the lower the chances of returning to work, with an increasing 
number of obstacles occurring (Black & Frost, 2011; Hultin et al., 2012; Waddell, et al., 2008). 
However, the majority of the evidence in support of VR is from Germany and Scandinavia, 
questioning the transferability of these findings to the UK context, which may differ in terms, 
of structural, social and cultural differences (Dibben et al., 2012). 
 
There is some evidence that early interventions decrease the length of sickness absence and 
associated risks of long-term incapacity (Gabbay et al., 2011; Hoefsmit, Houkes, Nijhuis, 2012; 
Waddell et al., 2008; Coleman et al., 2013). However, there is uncertainty over the best time to 
intervene, i.e. what is early, as many health conditions will improve within 3-6 weeks of onset, 
and to-date there is limited ability to effectively screen for those at risk of long-term disability 
(Waddell et al., 2008; Dubbin et al., 2012; Coleman et al., 2013). To overcome this uncertainty, 
Waddell et al. (2008) recommend the use of a stepped-care approach. Stepped care is an 
approach that guides care based on individual needs, starting with 'simple, low-intensity, low-
cost interventions and ‘stepping up’ to more intensive, complex and costly interventions for 
people who fail to respond' (p.40). This facilitates appropriate allocation of resources when 
managing ill-health. It is an approach that is widely used within health care professions 
(Cambridgeshire and Peterborough NHS Foundation Trust, 2013; Franx, Oud, Lange, Wensing, 
& Grol, 2012; Jakicic et al., 2012). This stepped care approach has evolved in regards to VR, 
and in 2010 Kendall et al. refined an evidence-based 3-phase stepped care approach for MSDs, 
using the onset of injury to provide a timeline. This bio-psycho-social stepped care approach, 
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recommends early access to evidence-based information, advice and early stage rehabilitation 
in the acute/early stage of injury. During the sub-acute/intermediate stage, the approach 
recommends facilitating RTW or SAW, through appropriate interventions such as case 
management, RTW planning or physiotherapy. And in the chronic/persistent stage where the 
focus is on preventing chronicity of the disease, it recommends exploring and resolving the 
obstacles to RTW, utilising a multi-disciplinary team (e.g. psychologists, occupational 
therapists, and physiotherapists) and evidence-based methods such as cognitive behavioural 
therapy to address these. 
 
Considering presenteeism, it is important to note that the evidence-base is young; however 
emerging findings indicate that workplace interventions and elements of VR may reduce 
presenteeism levels and increase productivity (Hammond et al., 2017; Cancelliere, Cassidy, 
Amendolia, & Cote, 2011; Knapp, McDaid, & Parsonage, 2011). However, as key elements of 
VR are early intervention and accommodating workplaces, which facilitate early RTW, there 
is an inherent risk of displacing the costs of sickness absence rather than reducing these costs. 
Thus, it is imperative that presenteeism is considered, both within individuals who do not take 
sickness absence and those that do. 
 
In summary, VR is advocated as an effective means of addressing sickness absence in the 
workplace and may assist with presenteeism and reducing turnover (Alexander et al., 2017: 
Black & Frost, 2011; Boorman, 2009; Cancelliere et al., 2011; Knapp et al., 2011) and through 
exploring the current evidence-base, it can be hypothesised that a best practice approach of VR 
within the workplace, for common health conditions, would consist of the following elements: 
 workplace based interventions 
 case management, ensuring timely liaison and co-ordination of rehabilitation with all 
stakeholders as required (e.g. management, HR, GP, specialist, health-care 
professionals (physiotherapist), and employee), 
 early intervention, using a stepped-care approach (i.e. intervention when and as needed), 
 multi-disciplinary work-focused rehabilitation  
 and accommodating workplaces, allowing for the implementation of early RTW and 
temporary modified work arrangements  
(Alexander et al., 2017; Van Vilsteren et al., 2015; Coleman et al., 2013; Dubbin et al., 
2012; Accident Compensation Corporation (2004), cited in Ellis et al., 2010; Schaafsma 
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et al., 2010; Lambeek et al., 2010; Boorman, 2009; Waddell et al., 2008, Irving et al., 
2004 ; Hanson et al., 2006). 
 
2.3 Cost effectiveness of VR interventions for employees who are either off 
sick or struggling to SAW 
 
2. 3.1 Outline of the comparative economic analyses models 
 
Although VR approaches are indicated to be effective interventions for sickness absence and 
presenteeism, in today’s economic climate it is necessary to explore the cost and benefits of any 
intervention so as to ensure the best use of scarce resources (Rabarison, Bish, Massoudi and 
Giles, 2015; NICE, 2013a; NICE, 2012; HM Treasury, 2011; MRC, no date). This is achieved 
through economic evaluations. Prior to discussing the evidence-base for the cost effectiveness 
of VR interventions it is necessary to understand what economic evaluations are and gain an 
understanding of the different economic analyses models.  
 
A widely accepted definition of an economic evaluation is ‘the comparative analysis of 
alternative courses of action in terms of both their costs and consequences’ (Drummond, 
Sculpher, Torrance, O’Brien, & Stoddart, 2005, p.9).  Whilst this definition is simple and 
concise, and currently used in a variety of academic papers (for examples, Shiell, Donalson, 
Mitten & Curry, 2002; Shemilt, et al., 2008; Brouwer & Georiou, 2012; Sutton et al., 2015; 
Gray & Wilkinson 2016), its relevance has recently been questioned, as it has not changed for 
decades and the comprehensiveness and usefulness in expanding areas, such as health 
economics is uncertain (Botchkarev, 2016). To address this uncertainty Botchkarev (2016) 
identified sixty non-identical definitions of economic evaluations, ascertained their common 
focus points and compared them to the commonly accepted definition by Michael Drummond. 
Botchkarev (2016) identified improvements to the commonly used Drummond definition, and 
proposed a new definition i.e. 
 
“Focusing on the optimal allocation of resources with the best value for money, Health 
Economic Evaluation is a data intensive analytic research process, based on a structured 
framework of methods for systematic identification, measurement, valuation, 
comparison, analysis and reporting of inputs (resources) and costs associated with them 
in relation to outcomes (benefits) and values associated with them, regarding healthcare 
goods and services (ranging across health programs, preventive, diagnostic and 
treatment interventions, medical devices, drugs), which is conducted with an objective 
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to provide economic evidence to inform decision and policy makers in order to improve 
investment efficiency” (p.6). 
 
However, this is specific to the field of health economics, which differs from organisational or 
business economics in terms of outcomes. For example, when considering interventions to 
reduce ill-health in employees, organisations are interested in productivity as opposed to 
utilisation of health care resources. Thus, currently, the Drummond definition is still accepted 
within the fields as a concise and generic overview. 
 
Economic analyses are used to prioritise and distribute resources.  They provide decision-
makers with a means to identify which services are more economically effective with regards 
to the outcomes that are of importance, for example, identifying services or interventions which 
have a greater health gain for the money spent (Botchkarev, 2016; Cox et al., 2011; Stone, no 
date). Klein, Day & Redmayne (1996) argue that without a formal rationing system such as the 
use of economic evaluations to inform decisions, informal rationing mechanisms for example, 
denial, selection, deflection, deterrence, delay, and termination will occur. Thus, using a formal 
rationing mechanism ensures that an informed decision is made. Although economic analyses 
provide information on the cost-effectiveness of a service, there are barriers to their use, such 
as methodological quality, possible conceptual and methodological inadequacies, the 
applicability of the research, generalisability of the research, difficulties in evaluating complex 
interventions, the priority of patient care over economic resources, the potential to over 
simplify, which may set up a project to fail by promoting unrealistic expectations, no standard 
way to assign monetary value to qualitative outcomes, and the ability of the decision makers to 
understand the analyses (Anderson & Hardwick, 2016; van Velden, Severens, & Novak, 2005; 
Williams, Bryan, McIver, Moore & Hendron, 2008). Moreover, the limitations of economic 
analyses include a risk of bias regarding assumptions and data selection, and the fact models 
often rely on non-experimental, observational data from time series or cross-sectional studies 
(Towse & Drummond, 1997). However, decisions do need to be made with limited data and 
thus, there is a need for economic analyses (Towse & Drummond, 1997). Therefore, it is useful 
to view them as decision aid tools, and take other sources of information, perspectives e.g. 
societal, and considerations e.g. ‘the feasibility of implementing an intervention, the 
acceptability of the intervention to a population, ethical and political concerns, and regulatory 
and legal issues’ (Stone, no date, p.458), into account prior to making a decision (Cox et al., 
2011; Snell, 2011; Sculpher, Claxton, Drummond & McCabe, 2006).  
45 
 
 
There are a number of broad economic evaluation approaches, namely; cost minimisation, cost 
effectiveness, cost utility, cost benefit, and cost consequence (van Dongen et al., 2014; Miller 
et al., 2013; Gray, 2011; Drummond et al., 2005). In order to determine the economic evaluation 
that will be most appropriate for evaluating VR it is first necessary to understand the differences 
between approaches to economic evaluation: 
 
 A cost minimisation evaluation is used to compare interventions with similar clinical 
effects. No value is placed on the health outcomes; it is only the costs that are explored. 
A cost minimisation evaluation is often used to find the intervention that achieved the 
desired outcome at the lowest possible cost (van Dongen et al., 2014; Drummond, 
Sculpher, Claxton, Stoddart, & Torrance, 2015; Gray, 2011; Walter et al., 2006; 
Drummond et al., 2005). It is a simple economic evaluation and easy to implement, 
however, it is limited to comparing interventions with the same outcomes and 
effectiveness is assumed to be similar (Phillips, Veenstra, Van Bebber, & Sakowski, 
2003; Briggs & O’Brien, 2001; Towse & Drummond, 1998) 
 
 A cost effectiveness analysis (CEA) is used to compare interventions that address the 
same health problem (Stone, no date).  A CEA is typically based on a single outcome 
and the outcome of the intervention is expressed in natural units, such as years of life 
saved, lives saved, and cases detected, or cases successfully treated (Miller et al., 2013). 
Thus, the results are expressed in terms of the ratio gain in health (related effect) to the 
monetary cost (resources used) of the health gain. The evaluations are made on the basis 
of this ratio across the different interventions (Drummond et al., 2015; van Dongen et 
al., 2014; Snell, 2011; Walter et al., 2006; Weinstein & Stanson, 1977). The results are 
easily understandable; however, the analysis is restricted to the same condition/disease 
(Phillips et al., 2003).  
 
 A cost utility analysis (CUA) is a type of CEA and is utilised when the outcome used to 
measure the impact of the intervention is expressed as a utility or quality of health 
outcome, a quality-adjusted-life-year (QALY) (Drummond et al., 2015; van Dongen et 
al., 2014; Gray, 2011). The US National Library of Medicine (2014) defines a QALY 
as:-  
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‘Units of measure of utility which combine life years gained as a result of health 
interventions health care programmes with a judgment about the quality of these 
life years.  A common measure of health improvement used in cost-utility 
analysis, it measures life expectancy adjusted for quality of life.’ (World Bank, 
2001, cited in The US National Library of Medicine, 2014, p1.). 
 
A QALY attempts to measure both mortality and morbidity i.e. a year of living in perfect 
health may be equated to 1 QALY, whereas as a year of living with a chronic condition 
might be equated to 0.7 QALY (Stone, no date). An advantage of a CUA is that they 
allow for comparison of different health effects, and consequently different health 
interventions (Drummond et al., 2015; Drummond, 2005; Stone, no date). However, on 
the flip side there is a debate over the monetary value placed on the QALY, moreover, 
it is accepted that the outcome measure, quality of life, may not fully capture the health 
gain from certain interventions (Gray, 2011). Moreover, this is reliant on patients’ 
preferences regarding quality of life and results can be difficult to interpret (Phillips et 
al., 2003). 
 
 A CBA is used when the outcomes are to be expressed in purely monetary terms 
(Drummond et al., 2015; Snell, 2011, Gray, 2011). This evaluation allows for the 
comparison of any health or non-health interventions, enabling the analysis to capture 
non-health effects, and the efficiency of interventions with different goals (Gray, 2011; 
House, 1998). A CBA is simply described as a tool to decide on the worth of an 
intervention through weighing up the advantages and disadvantages (McIntosh, Clarke, 
Frew, & Louviere, 2011) and determining whether the expected return is worth the 
effort (benefits greater than the costs) (van Dongen et al., 2014; McIntosh et al., 2011; 
Drummond, 2005; Treasury board of Canada Secretariat, 1998). However, the reduction 
of all costs and benefits to monetary terms, may lead to incorrect conclusions, if 
significant benefits cannot be monetised (House, 1998). Moreover, CBA’s run the risk 
of inaccuracies in quantifying/evaluating costs and benefits, subjectivity in underlying 
assumptions and inaccurate calculations, possibly resulting in inaccurate or skewed 
results (Phillips et al., 2003). 
 
 A cost consequence analysis (CCA) outlines all the outcomes and their units of 
measurement, allowing the decision makers to place their own weights on the various 
outcome measures (Gray, 2011; Mauskopf, 2017; Kelly, McDaid, Ludbrook & Powell, 
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2005). However, the lack of a ratio makes comparing interventions difficult (Phillips, et 
al., 2003). 
 
Table 2:  Summary of comparative economic analyses  
 
Method of 
analysis 
Comparison Measurement 
/assessment 
of costs 
Measurement 
/assessment 
of outcome 
Cost-outcome 
comparison 
Cost-
minimisation 
analysis 
Used to compare 
interventions with the same 
effectiveness or efficacy to 
establish the cheapest 
alternative 
Monetary  None None 
Cost-effectiveness 
analysis 
Used to compare 
interventions that produce a 
common health effect 
Monetary Natural units Costs per outcome 
unit 
Cost-utility 
analysis 
Used to compare 
interventions that have 
morbidity and mortality 
outcomes 
Monetary Utility values Costs per QALY 
Cost-benefit 
analysis 
Used to compare different 
programmes with different 
units of outcomes (health 
and non-health) 
Monetary Monetary Benefits/costs 
(BCR) 
Cost-consequence 
analysis 
Used to compare different 
programmes with a variety 
of economic and non-
economic outcomes 
Monetary Combination 
of all 
outcomes: 
Monetary/ 
natural units/ 
utility values 
None 
 
 
(Drummond et al., 2015; van Dongen et al., 2014; Gray, 2011; Walter et al., 2006; Drummond, 
2005; Stone, no date). 
 
When choosing an economic analysis model to utilise for research, the outcomes of interest and 
the perspective of the analysis influence the decision (van Dongen et al., 2014). Economic 
analyses can provide information on costs and benefits of interventions from different 
perspectives e.g. societal, organisational or individual (WHO, 2009).  Each of these 
perspectives includes different costs and benefits. An analysis from a societal perspective looks 
at costs and savings to society, such as a reduction in taxes; whereas an analysis from an 
organisational perspective will look at the costs and savings specific to the organisation such as 
a reduction in sickness absence rates; and an analysis from an individual’s perspective would 
include costs and benefits to the individual such as reduced medical care costs (WHO, 2009). 
All of these perspectives would be relevant when evaluating the cost benefits of VR as the costs 
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of sickness absence are wide reaching (see section 1.1).  When considering an economic 
analysis of VR in the context of this project the following are noted: 
 
 VR is a multi-faceted programme with an array of interventions. This results in a 
number of outcomes from a number of perspectives.  
 VR services differ in terms of VR interventions utilised, timings of interventions, target 
populations and VR practitioners.  
 The effects of VR are both health e.g. improved mental or physical health and non-
health related e.g. increased productivity. 
 The organisation purchasing the VR intervention is the main stakeholder; consequently 
most workplace interventions are evaluated from the organisations perspective (van 
Dongen et al., 2014; Tompa, Dolinschi, & de Oliveira, 2006; Uegaki et al., 2010; van 
Dongen et al., 2011; van Dongen et al., 2012; Verbeek, Pulliainen, & Kankaanpää, 
2009). Traditionally workplace health interventions to improve staff health and reduce 
sickness absence are purchased by the employer/organisation, thus generating research 
from an organisational perspective. Due to the growing awareness of the costs of 
sickness absence, effectively addressing sickness absence and helping employees with 
health conditions to stay in the workplace has become a national and international 
priority (DWP & DH, 2017, Black & Frost, 2011). This has resulted in a suggestion for 
the government to consider subsiding VR services (Black & Frost, 2011) and thus a 
need to explore the wider social/exchequer benefits too. This development is seen in 
more recent research (e.g. Wynne-Jones et al, 2018) where the costs and benefits of VR 
are considered from a variety of perspectives including the social/exchequer and the 
individual.  
 This research aims to provide an economic analysis tool that can be used by researchers 
and VR services, to evaluate the cost benefits of VR. As the current literature 
predominantly evaluates VR from an organisational perspective, and VR services are 
still currently providing their services to organisations, this perspective was considered 
an appropriate starting point for the economic analysis tool, and the focus of this 
research. However, in choosing the model it is important to consider the impact of this 
work moving forwards, and thus a model that allows adaptation in the future to 
incorporate wider social and individual benefits is needed.   
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Therefore, in order to capture all the outcomes, both health and non-health, of VR from an 
organisational perspective, and considering the models outlined above, a CBA would be the 
appropriate method of analysis to use.  In addition, employers are generally more interested in 
the results produced from a CBA i.e. how does the intervention impact on the company’s profit 
(van Dongen et al., 2014). Moreover, as a variety of perspectives may be of interest to the user, 
the CBA is useful as it allows the benefits to be measured to be determined by the user 
(Meijester et al., 2011). Thus, by utilising a CBA tool, future work incorporating different 
stakeholders’ perspectives can be easily added to the new CBA tool. Additionally, there is a 
need to monetise the impact in order to assist with decisions over resource allocation, again 
justifying the use of the CBA methodology. Another benefit of CBA models is that they enable 
the integration of a variety of outcomes into a single unit of measurement: pounds sterling 
(Kelly et al., 2005), which would allow for the model to be used to compare a number of 
different VR programmes. Moreover, Cagno, Micheli, Masi, & Jacinto (2013) advocate a CBA 
as opposed to CEA for OH and safety evaluations as it yields more meaningful results for the 
organisations.   Another benefit of using a CBA model is that they allow organisations to 
explore information at various stages of the implementation of interventions: 
 
- Pre-delivery (predictive) – CBA can inform ex-ante appraisals of what return on 
investments an intervention may be expected to deliver (HM Treasury, Public Service 
Transformation Network, New Economy, 2014).  
- During delivery – regular CBAs provide information on the performance of the 
intervention against desired outcomes, allowing for adjustments and improvements to 
the intervention throughout delivery (HM Treasury et al., 2014).  
- Post-delivery – allows the organisation to judge the worth of the intervention, as well 
as providing direction for improvements (HM Treasury et al., 2014). 
 
Lastly, for interventions where a control/comparator group is not feasible, a CBA model allows 
for the use of comparator groups to calculate the net effectiveness, enabling an estimation of 
what would have happened should the intervention not have been in place (HM Treasury et al., 
2014). 
 
There are limitations to using a CBA as the only method of economic analysis, as not all benefits 
or costs can be reduced to a monetary value. Kelly et al. (2005) acknowledge the practical 
difficulties in applying a CBA and suggest the use of CCA within a pragmatic framework to 
50 
 
capture various outcomes (Gray, 2011). A CCA does not restrict the type of outcome to a unit 
of measurement e.g. pounds, allowing all outcomes to be presented (Mauskopf, 2017; Kelly et 
al., 2005). Additionally, the inclusion of a CCA allows for more transparency in reporting the 
outcomes and may have greater resonance with the stakeholders involved with commissioning 
(Trueman & Anokye, 2012; Gray, 2011). However, the use of a CCA relies on the decision 
makers applying their own subjective weighting system to different outcomes (Gray, 2011), 
which may result in subjectivity and renders comparisons problematic (Keating & Keating, 
2014; Little, 2011). Thus, the use of a CBA would enable a more objective comparison.   
 
Although a CBA is not all-encompassing, with the economic pressures faced today, there is a 
demand for simple tools to be available for organisations to enable them to determine the costs 
and benefits of interventions (NICE, 2013b; Burton, 2010). Additionally, there is a need to be 
able to compare the effectiveness of interventions, to ensure the most cost-effective 
interventions become the focus of decision-making. Thus, it is important to examine the 
economic analyses used within VR, identify the limitations and gaps, and build on these to 
develop a practical economic analysis model, such as a CBA tool, specific to VR interventions. 
 
2.3.2 Current evidence-base on the costs and benefits within VR for the SAW 
population 
 
VR interventions target a wide and varied population, helping employed individuals to SAW, 
this includes employees who are off sick, or at risk of going off sick, and unemployed 
individuals to RTW. Within the RTW population there is a wealth of research exploring the 
costs and benefits of VR, with the overarching conclusion that VR programmes are cost-
effective when returning people to work (Khan, Ng, & Turner-Stokes, 2009; Van den Hout, De 
Bucj, & Vlieland, 2007; Murphy et al., 2006; Shepard & Reif, 2004; Dixon et al., 2002; 
Crowther, Marshall, Bond, & Huxley, 2001). However, the generalisability of these studies to 
the UK context is questionable as the research is mainly based in America, Canada and 
Scandinavian countries, all of which have different societal and economic structures to those 
found in the UK.  
 
There is a scarcity of evidence on the costs and benefits of VR interventions within the SAW 
population i.e. looking at preventing sickness absence, decreasing presenteeism, etc. This lack 
of evidence is listed, in a research study for the Association of British Insurers (2005), as one 
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of the barriers to the implementation of work focused rehabilitation within the UK (Wright, 
Beardswell, & Marsden, 2005). Thus, developing this evidence-base would be beneficial for 
the VR industry. Furthermore, Pruett, Swett, Chan, Rosenthal, & Lee (2008) highlighted that 
an additional difficulty in the evidence-base underpinning the cost effectiveness of VR is the 
expansive definition of VR, leading to a broad array of interventions being used, which need to 
be explored to understand the cost benefits of VR. Thus, the focus of this section of the literature 
review will be to explore the evidence-base of the costs and benefits of VR, and its various 
interventions, in the SAW population, identify limitations and gaps, and explore the reasons for 
the dearth of research in this area. Additionally, as the key aim of this research is to develop 
and utilise a practical CBA tool for VR, the evidence of the use of CBA in VR, in the SAW 
population, will be explored.  
 
As the use of a CBA tool for VR in the SAW population is the main focus of the research 
project, a comprehensive search (outlined below) of the literature for this section was 
conducted. 
 
Search strategy: the following databases where searched: Cinahl, Medline, Cochrane, Business 
Source Premier, Web of Knowledge and Health management information consortium.  The 
following key terms were exploded: CBA, VR, occupational rehabilitation, case management, 
sickness absence, sick leave, absenteeism, presenteeism, RTW, SAW, employment. The 
following limit was set: years 2000 – 2013. 
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Figure 3: Screening strategy with inclusion criteria i.e. SAW population, work-based intervention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. 3.3 Economic effectiveness of VR interventions for the SAW population 
 
Following the screening strategy outlined in Figure 3, thirty eight articles were identified for 
further reading. Whilst reviewing the literature on the economic effectiveness of VR 
interventions for the SAW population, it was found that relatively few studies had incorporated 
economic analyses (Busch, Bodin, Bergstrom, & Jensen, 2011; Van den Hout et al., 2007; 
Waddell et al., 2008; Karrholm et al., 2006). In addition, the analyses used different economic 
models, namely: CBAs and cost effectiveness analysis (CEA). 
 
CBA as a method of exploring the costs effectiveness of VR for the SAW population was 
utilised in two randomised controlled trials (RCT) conducted in Sweden and Holland, and case-
studies conducted in the UK (Busch et al., 2011; Van den Hout et al., 2007; Waddell et al., 
2008).  Busch et al.’s (2011) RCT, conducted in Sweden, compared the long-term effects of 
three different interventions on patients with chronic pain to a control group. All three of the 
interventions (physiotherapy, cognitive behavioural therapy and behavioral medicine 
rehabilitations, which was a full-time multidisciplinary programme including all aspects of the 
physiotherapy and cognitive behavioural therapy) included a vocational element: workplace 
visits, and invitations for work managers to attend the discharge session and agree a RTW plan. 
3829 records identified 
through database searching 
19 records identified through 
citation tracking 
3848 records screened on 
title 
89 records screened on 
abstract 
3759 records excluded 
51 records excluded 
38 records read 
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When comparing the sickness absence patterns 10 years after the intervention, it was found that 
on average the multidisciplinary group, which the authors refer to as the ‘Vocational 
Multidisciplinary group’, had 42.98 fewer days’ sickness absence days per year than the control 
group. The reduction in the other two groups (physiotherapy and cognitive behavioural therapy) 
when compared to the control group was not statistically significant. Correspondingly, the 
CBA, including all direct and indirect costs, over 10 years, showed substantial cost savings for 
the VR group with a decrease in costs by 53,382 EUR per individual compared to the other two 
groups. Costs of the interventions (booked expenses, salaries and taxes of the therapists), 
sickness absence, using the human capita approach, and disability pension were used to 
populate the CBA model. Sickness absence and disability pension data were obtained from the 
Swedish Social Insurance Agency. 
 
The strengths of Busch et al.’s (2011) research is that it is a longitudinal study with a 
randomised design, thus, it allows for an in-depth exploration of patterns of sickness absence 
over time. The economic evaluation was possible due to the comparator group, enabling the 
researchers to identify what would have happened had the intervention not been in situ. The use 
of the CBA model was comprehensive and transparent, within the analysis the time value of 
money was accounted for through discounting expenses by 3%, which is the percentage 
recommended by the WHO (Edejer et al., 2003).  Additionally, calculating the costs of 
disability pensions included a societal perspective. A possible limitation of the research was the 
use of a human capita approach to value production losses due to sickness absence. A reliance 
on this approach, although commonly used, is cautioned against by the WHO (2009) as ‘it is 
unrealistic in most settings (where a pool of underemployed or unemployed labour exists)’ (p. 
97). Additionally, various limitations to the study call into question the generalisability of the 
results to VR and the SAW population in a UK context. Firstly, the interchanging use of the 
terms ‘behavioural medicine rehabilitation group’ and ‘vocational multidisciplinary group’, as 
well as the inclusion of the vocational elements in the other two groups limit the ability to link 
the statistically significant findings to the VR aspect of the intervention. Secondly, as the data 
source only recorded absence periods of greater than 14 days, and frequent episodes of short-
term sickness absence were potentially excluded. Thirdly, accessing data from a database does 
not allow for the cross checking for human error in inputting the results. Lastly, the costs for 
the control group were set at 0, which as stated by the authors is probably an underestimation. 
Bearing these limitations in mind, Busch et al.’s (2011) economic analysis suggests that VR is 
cost-effective.  
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Conversely, Van den Hout et al.’s (2007) RCT, conducted in Holland, using both a CBA and 
CEA model to analyse the economic effectiveness of VR concluded, that VR for people with 
arthritis who perceived they were struggling to SAW, the programme costs were less than the 
total savings of other health care and non-health care costs (Van den Hout et al., 2007). 
However, the cost benefit findings were not statistically significant. The VR intervention used 
in Van den Hout et al.’s (2007) study comprised of a multidisciplinary team providing a basic, 
systematic assessment, followed by education, vocational counselling and guidance, and 
medical or non-medical treatment. The data collected for the CBA included healthcare, patient 
and productivity costs. These costs were based on questionnaires completed by the participants, 
which may have resulted in recall bias (Hassan, 2006). Another limitation to consider is that 
arthritis is a progressive disease, thus the follow-up time period of two years may not provide 
an accurate picture of the long-term effectiveness and cost benefit of the intervention. When 
calculating the costs, statistical analysis was used, and there was no formal CBA methodology 
utilised. With regards to job retention, no reduction in job loss was established, thus the authors 
concluded that from a societal perspective it was unclear whether the VR intervention 
programme reduces or increases total costs in respect of people with arthritis. From these two 
studies, it is seen that the results from using a CBA model to explore the cost-effectiveness of 
VR for the SAW population are inconclusive.  Busch et al.’s (2011) results indicated a positive 
cost-benefit ratio i.e. the economic benefits of the VR intervention were shown to be greater 
than the economic costs. However, Van den Hout’s (2007) conclusions remained unclear as to 
whether the VR intervention reduced societal costs. Although both studies used interventions 
that have similar components such as the multidisciplinary nature of the interventions, there 
were variations in the target populations and the definitions of VR used. Moreover, they both 
have limitations in the methodology and use of a CBA model. These limitations and variations 
confine the generalisability of the findings and indicate the need to interpret the results with 
caution. Furthermore, as the studies were conducted in Sweden and Holland respectively this 
potentially limits their applicability to the UK context.  
 
Looking at the UK context, best practice case studies of VR outlined in the UK Industrial 
Injuries Advisory Council report on the effectiveness of VR (Waddell et al., 2008). These case 
studies indicate that VR is effective and point towards VR being a cost-effective intervention. 
However, case studies are not considered good quality of evidence (Mann, 1996), thus 
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highlighting that further high-quality research into the cost and benefits of VR interventions 
within the UK is necessary (Waddell et al., 2008).  
 
A limitation of using a CBA as a method of exploring cost-effectiveness within VR and the 
SAW population is that it requires the monetisation of outcomes to provide a comparable cost-
benefit ratio, as well as needing a comparator/control group.  To overcome the difficulty of 
monetising all outcomes used, alternative economic analyses have been utilised to examine the 
cost effectiveness of VR interventions for the SAW population. Karrholm et al. (2006) used a 
CEA to explore the economic benefits of a multidisciplinary VR intervention focussing on 
enabling employees off sick to RTW. Sixty-four employers from a Swedish public co-operation 
project were rehabilitated, and their sickness absence rates for a year and a half post the 
intervention were compared to the previous year, as well as a matched pairs comparison group. 
Karrholm et al. (2006) estimated the economic benefit of the intervention to be 1,278 EUR per 
month and person, based on the whole group; and up to 2,405 EUR per month, per person for 
the sub group of employees who had more than 8.5 days sick leave per month. Moreover, 
Karrholm et al. (2006) noted that these economic benefits only provide a limited estimation of 
the economic benefits of improving the health of employees, highlighting likely additional 
economic benefits such as increased productivity. These findings are in line with the conclusion 
in Waddell et al.’s (2008) review, that there is strong evidence that VR interventions are 
effective, but limited evidence that they are cost-effective. Thus, reiterating the need for further 
research into the cost and benefits of VR interventions, specifically within the UK. 
 
As seen when examining the evidence-base of CBAs and VR, a difficulty in the usability of the 
research and findings is the wide variety of definitions of the VR intervention itself. This lack 
of heterogeneity creates difficulties when trying to compare outcomes and results. This lack of 
heterogeneity also generates the question, when reviewing the evidence on the use of CBAs 
within VR, of whether to narrow the included literature to interventions labelled as VR only, or 
to include a broader body of evidence by including economic analyses of interventions that VR 
includes? Pruett et al.’s (2008) literature review of the essential components of VR, found that 
although there is a lack of literature supporting the efficacy of VR, components of VR are 
supported by empirical evidence. This evidence of effectiveness of components of VR 
interventions is also observed in Burton’s (2010) review ‘Healthy Workplace Framework and 
Model’.  To gain a wider understanding of the cost benefits analysis of VR in the SAW 
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population, cost benefit analyses of interventions that come under the VR umbrella will be 
discussed. 
 
2. 3.4 Economic effectiveness of interventions or therapies used within VR 
services for the SAW population 
 
The definition of VR, i.e. “whatever helps someone with a health problem remain in or RTW” 
(Waddell et al., 2008, p.5) is all encompassing, thus, it is difficult to succinctly identify the 
various components that a VR intervention may comprise.  As discussed when defining VR, a 
widely accepted key component of the VR approach is work-focused health care and 
accommodating workplaces. Thus, economic evaluations of interventions conducted with a 
workplace component will be considered.  
 
Although workplace components are part of interventions, the varied nature of interventions 
used in VR, create limitations in the comparability of the results. Even when the same 
intervention is used, the results may vary due to differences in the research and economic 
evaluation methodology used.  
 
According to Waddell et al. (2008) there is ‘strong evidence that simple, inexpensive healthcare 
and workplace interventions in the early stages of sickness absence can be effective and cost-
effective for increasing RTW rates and reducing the number of people who go off sick’ (p.39). 
This finding is supported in Carroll et al.’s (2009) systematic review whose main findings were 
that early interventions (between 2-8 weeks sick leave) and direct work input are likely to be 
effective and cost effective. Additionally, there is a consensus in the evidence that improved 
communication between all stakeholders has been shown to lead to an increased RTW rate, 
decreased sickness absence and be cost-effective (van Vilsteren, et al., 2015; Dibben et al., 
2012; Carroll et al., 2009; Waddell et al., 2008).  
 
Loisel et al. (2002) and Bultman et al. (2009) both studied the economic impact of the 
Sherbrooke model, a Canadian intervention model that comprises of both occupational and 
clinical input as part of a coordinated and tailored work rehabilitation programme, whereby the 
interdisciplinary team works together to screen for work disability and develop RTW plans 
(Bultman, 2009). Loisel et al. (2002) found no significant cost-benefit; however, Bultman et al. 
(2009) found a positive cost-benefit ratio in favour of the intervention. The differences in these 
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results may be due to the fact the Loisel et al.’s (2002) sample consisted of patients with sub-
acute low back pain, whereas Bultman et al. (2009) included any MSD. Additionally, the two 
interventions were carried out in different countries, Canada and Denmark respectively, 
questioning the transferability of the intervention in different areas. Lastly, the economic 
analyses included different outcome measures and were conducted from different perspectives, 
reducing the comparability of the results. Loisel et al.’s (2002) CBA was populated with the 
costs borne by the insurers such as income replacement costs, health care costs, intervention 
costs, costs of work hours spent by the employees participating in the intervention, and the costs 
of sickness absence for low back pain. These costs differ to those from an employer or societal 
perspective. Bultman et al. (2009) performed the CBA from a societal perspective (considering 
the impact of the intervention on the welfare of the whole of the society), using productivity 
and health care costs as outcomes. The impact on the individual or employer was not determined 
as the different organisations employing the participants may have had differing sickness 
absence policies and practices.  
 
This lack of clarity over the cost-benefits of VR interventions for the SAW population is further 
complicated when the variety of mental and physical conditions that VR may address are 
considered. To date economic evaluations of workplace health have mainly been focused on 
physical conditions. According to NICE (2009a) no economic studies looking specifically at 
mental health at work have been published since 1990.  Graveling, Crawford, Cowie, Amati, & 
Vohra’s (2008) review of workplace interventions promoting mental wellbeing in the 
workplace, concluded that the evidence suggests that there are tangible benefits from mental 
wellbeing interventions; however, due to the low quality of the research an unequivocal 
statement on the effectiveness cannot be made.   
 
In the VR and mental health conditions research conducted since 2009, McDaid and Park 
(2011) found studies exploring the economic return on investment, and reporting positive 
economic findings from a number of workplace health promotion and stress management 
programmes. These programmes focused on those who had already been diagnosed as having 
a mental health condition, and the studies were largely in the USA, thus, questioning their 
generalisability to the UK context. In addition, they excluded a significant population of 
employees who may have had mental health needs.  Knapp et al.’s (2011) study targeted a wider 
population, exploring the cost-effectiveness of an intervention for depression and anxiety, 
which included screening all employees and offering those at risk cognitive behavioural 
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therapy. In the economic modelling to assess the cost-effectiveness of this intervention, they 
concluded that the intervention appeared to deliver cost savings through the reduction of 
sickness absence and improved levels of productivity, linked to decreased presenteeism (Knapp 
et al., 2011). These finding are supported by Kroger, Bode, Wunsch, & Kliem’s (2015) matched 
controlled study, where employees accessing work focused cognitive behavioural therapy as 
opposed to usual care cognitive behavioural therapy resulting in significantly less sickness 
absence at 12 months follow-up. However, these findings may not be generalisable due to the 
small sample size (n = 36), and the inclusion criteria of depressive disorder, which may have a 
different impact on sickness absence level compared to other mental health disorders such as 
anxiety. Moreover, the costs considered, such as health care insurance plans, may not be 
relevant to a UK context. 
 
Conversely, Van Oostrom et al.’s (2008) economic analyses of a workplace intervention for 
people with common mental health disorders (measured using the Four-Dimensional 
Symptoms Questionnaire (Terluin, 2006, cited in Van Oostrom et al., 2008), indicated no 
significant sustainability of results in both the CEA and CUA, and with regards to the CBA it 
demonstrated a higher cost of the intervention than the benefits. The intervention comprised of 
a stepwise approach to devising a RTW plan with the work supervisor. The outcomes used in 
the economic analysis were RTW, sickness absence (as a proxy measure of productivity), 
quality of life adjusted years (QALYs) and healthcare utilisation, with a follow-up period of 12 
months. The CBA was conducted from the employer’s perspective, whereas the CUA and CEA 
were from a societal perspective. Although these results, contradict other research, the 
intervention used within this study is a minimal input intervention and perhaps was not detailed 
enough to properly address the distress employees were experiencing. In addition, the studies 
demonstrating positive findings (Knapp et al., 2011 & Kroger et al., 2015) are not UK based 
studies and thus the generalisability of these results to the UK context is questionable.  The case 
studies displayed on the UK Health, Work and Wellbeing website (DWP, 2009), although low 
in the hierarchy of evidence, indicate positive economic results, with regards to decreased 
absenteeism and staff retention, for interventions focusing on mental health conditions.  
 
From the studies discussed above, there is some evidence that VR interventions for mental 
health conditions are cost-effective. However, there are question marks over the quality of 
research in this area, and limited availability of case studies presented in corporate literature 
(Mc Daid & Park, 2011).  Hamberg-van Reenen, Proper and van der Berg’s (2012) systematic 
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review of economic evaluations of worksite mental health interventions concluded that due to 
the limited number and poor methodological quality of studies in this area, further research is 
needed. Due to the far-reaching social, economic and individual costs of mental ill health, 
research into the effectiveness of VR interventions for mental health issues have been 
highlighted as a priority (Black, 2008; Lelliot et al., 2008, cited in Waddell et al., 2008). 
 
In respect of the cost benefits of VR for physical conditions, Palmer et al. (2012) carried out a 
high quality systematic review looking at the effectiveness of interventions in the community 
and workplace setting to reduce sickness absence and job loss in employees with MSDs. The 
review included thirty-four RCTs and eight cohort studies. Eight, out of the forty-two included 
studies had conducted a formal CBA. The results concluded that the cost-benefits of VR in 
physical conditions are uncertain. However, the majority of results did suggest overall net 
savings, although, in two reports (Hlobil et al., 2007 & Steenstra et al., 2009, both cited in 
Palmer et al., 2012) with 95% CI, the findings indicated substantial net losses. The typical 
outcomes used within the economic analyses were sickness absence and the cost of the 
intervention. Four studies (Bultman et al., 2009; Jensen, Bergstrom, Ljungquist, & Bodin, 2005; 
Loisel et al., 2002; Steenstra et al., 2006; all cited in Palmer et al., 2012), assessed benefits in 
terms of reduced health care costs, and one study included the cost of health care. Palmer et al. 
(2012) concluded that community and workplace interventions for MSDs do reduce job loss 
and sickness absence, however only weak recommendations could be put forward. 
Additionally, there is limited and inconclusive cost benefit data, thus the cost-effectiveness of 
the interventions are uncertain (Palmer et al., 2012). The included studies were mostly 
conducted in Europe and North America; covered a variety of anatomical sites of MSDs, 
although few differences were found by anatomical site; and the included interventions all 
varied, again highlighting the lack of homogeneity within this area of research, reducing the 
comparability and generalisability of the results.  
 
Conversely, Hanson et al.’s (2006) cost-effectiveness of case management for MSDs in the UK, 
showed a reduction in costs when exploring the following outcomes: healthcare costs, treatment 
duration, sick leave and time off work, productivity, compensation claims and litigation 
(number and length till closure).  Moreover, Tompa, de Oliveira, Dolinshic, & Irvin’s (2008) 
and Pruett et al.’s (2008) systematic reviews concluded that there is credible evidence 
supporting the financial benefits of disability management interventions for several intervention 
components and features, with moderate evidence for work/vocational interventions. Pruett et 
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al.’s (2008) review showed positive CBA results ranging from a 3 to 18 ratio, with a ratio over 
one indicating a positive return.  Although these findings apparently contradict Palmer et al.’s 
(2012) conclusion, the different focus of the systematic review may account for this 
discrepancy, with Tompa et al. (2008) and Pruett et al. (2008) focused on disability management 
interventions as opposed to workplace interventions. This extensive variability of VR 
interventions once more demonstrates the obstacles to research within the field of VR. Tompa 
et al. (2008) identified 17 economic evaluations, 8 of those were of a medium or high quality, 
and 3 of those 8 were identified as using CBAs as the method of economic evaluation (Loisel 
et al., 2002; Jensen et al., 2005; and Arnetz, Sjogren, Rydehn, & Meisel, 2003). However, on 
further examination, when using the definition of a CBA and a CEA provided in the 
introduction, Jensen et al.’s (2005) economic analysis fits the definition of a CEA as opposed 
to a CBA.  This lack of clarity amongst research studies of the differentiation between the 
various economic analyses available further complicates the picture when reviewing the cost-
effectiveness of VR interventions. 
 
In conclusion, when considering CBAs conducted for interventions with workplace 
components for physical health conditions, it is seen that the evidence is limited and 
inconclusive for the cost benefits of these interventions in the SAW population. This conclusion 
echoes that of the conclusions drawn earlier for mental health conditions.  
 
With regards to the sustainability of the interventions there are few studies that follow 
participants over the long-run, although, Jensen et al. (2009) conducted a simple cost-effective 
analysis of a multidisciplinary intervention for neck and back pain and showed a positive cost-
effectiveness over 7 years. Additionally, Squires, Rick, Carroll, & Hillage (2012) used the 
Markov mathematical model to synthesise evidence on workplace interventions for MSDs, and 
to analyse the long-term cost effectiveness through the extrapolation of data beyond the trial 
period. Squires et al.’s (2012) findings suggest that interventions resulting in small 
improvements in RTW are likely to be cost-effective when compared to other funded 
interventions within the NHS.   
 
Thus, the evidence-base on the cost-effectiveness of interventions used within VR, both for 
MSDs and mental health conditions, is limited and needs further development (Waddell et al., 
2008; Franche et al., 2005; Steenstra et al., 2006; Hanson et al., 2006).  
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2. 3.5 Summary of the economic effectiveness of VR services for the SAW 
population 
 
Throughout this section of the review it is seen that VR interventions are difficult to evaluate. 
The lack of homogeneity in the populations, conditions, interventions, and outcome measures 
used within VR, limit the ability to determine the effectiveness of VR (Johnston, Stineman & 
Velozo, 1997; cited in Pruett et al., 2008). The economic methods used in the studies looking 
at the cost benefits of VR, and the various interventions used within VR have a number of 
limitations. Overall, there was a lack of transparency, limited consensus on which model to use 
for an economic evaluation in the field of VR, questions surrounding the use of human capital 
as a measure of productivity, and limited clarity on terminology and differentiations between 
economic models. Additionally, when specifically considering the use of a CBA model within 
the field of VR, it is noted that it is seldom used, and when used the wider societal perspective 
is largely ignored, with few studies exploring the costs and benefits incurred by society and the 
individual in the SAW population. These limitations, however, are commonly found when 
evaluating workplace interventions, as the interventions attempt to change human behaviour, 
which is influenced by a wide variety of factors (Burton, 2010). Additionally, control groups 
are not always feasible, often relying on before and after data (Burton, 2010). 
 
Bearing these limitations in mind, through exploring the cost effectiveness evidence-base 
underpinning VR, in the SAW population, it can be concluded, that although studies suggest 
VR may be a cost-effective solution to enabling people to SAW, more research is needed to be 
able to draw robust conclusions (Noben, Nijhuis, de Rijk, & Evers, 2012; Black, 2008; Waddell 
et al., 2008). Additionally, research within the UK is limited and the quality of studies generally 
low, raising questions around the generalisability of findings in the UK context.  
 
2.4 Literature review conclusion 
 
Sickness absence and presenteeism result in poor outcomes for organisations, individuals and 
society as whole, not only with regards to economic outcomes, but from a health and wellbeing 
perspective (Dibben et al., 2012; CIPD, 2014a; CBI, 2013; Black, 2008; Bevan et al., 2007; 
Aronsson et al., 2000). Due to the multifaceted nature of sickness absence and presenteeism, 
and the array of influencing factors on individuals experiencing episodes of sickness absence 
or presenteeism (Allebeck and Mastekaase, 2004; Yeomans, 2011; Baker-McClearn et al., 
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2010), VR’s bio-psychosocial approach has been advocated as an effective intervention for the 
management of sickness absence (DWP & DH, 2017; Dibben et al., 2012; Black, 2008; Waddell 
et al., 2008; Carroll et al., 2009). However, the cost benefits of using VR to address sickness 
absence, although from initial results appears promising, are still to be determined, with a need 
for further robust research in this area. A variety of economic methodologies have been used 
within the field to examine the cost effectiveness of VR interventions (Parkin, 2009; Busch et 
al., 2011; Van den Hout et al., 2007; Karrholm et al., 2006; Bultman, 2009; Loisel et al., 2002; 
Van Oostrom et al., 2010). The use of CBAs, although recommended by the NHS Health 
Development Agency as the ideal method of economic analysis (Kelly et al., 2005), have 
seldom been used to evaluate VR in the SAW population. This could be explained by the fact 
that not all benefits can be assigned a monetary value (Kelly et al., 2005). Additionally, in the 
studies utilising CBA as a methodology to evaluate VR in the SAW population (Busch et al., 
2011; Van den Hout et al., 2007; Waddell et al., 2008; Loisel et al., 2002; Bultman et al., 2009; 
van Oostrom et al., 2010) there are number of limitations noted, both with regards to the studies 
and the limitations of CBA as a method of economic analysis. From this, it can be concluded 
that further research into a model to explore the costs and benefits of VR in the SAW population 
is needed. Additionally, according to Burton (2010) it is important that organisations are 
supported to determine the cost benefits of their investments without relying on academic 
support or costly research budgets, therefore ‘practical CBA tools’ are needed. Although there 
are limitations to using CBA’s, CBAs are useful as they allow outcomes to be monetised, 
provide insight into which intervention strategy will maximise the cost benefit, and enable the 
evaluation of costs and benefits from a variety of stakeholders’ viewpoints (van Dongen, 2014; 
Meijester et al., 2011). Moreover, within workplace/OH studies CBA’s have been widely used 
as they provide outputs that are of interest to organisations purchasing these services (van 
Dongen et al., 2014). In addition, CBA’s allow for the comparisons of different services.  As 
the service provision within VR is so varied this would facilitate identifying which VR services 
or elements of VR are effective.  Thus, with the current challenging economic circumstances in 
the UK and internationally, it is imperative that a user-friendly economic analysis tool, as a 
method of economic evaluation for VR interventions in the SAW population is developed. 
Considering the outlined economic models and their uses, and the stakeholders perspectives it 
is seen that a CBA model would be the most appropriate model for a VR intervention when 
conducted from an organisational perspective. The aim of this CBA tool would be to enable 
organisations and researchers to compare interventions and services from a variety of 
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perspectives, including the wider benefits of VR interventions, helping to assist decisions that 
are based not only on economics, but also from a welfare and utilitarian perspective.  
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3. Methodology 
 
3.1 Introduction 
 
This chapter discusses the methodology used to meet the aims of this study, namely: 
1. To develop economic outcomes, to be used within an existing CBA model, in order 
to ascertain the efficacy of the CBA tool in evaluating the costs and benefits of VR 
interventions and services. 
2. To implement and explore the practical application of the revised CBA tool, including 
the developed outcomes, using data from two VR services. 
 
The chapter begins with an overview of the methodological approaches, including a critical 
appraisal of mixed methods as the methodological approach underpinning this research. This is 
followed by a discussion of the rationale underpinning the use of the Greater Manchester (GM) 
New Economy CBA model within this study. In addition, an explanation of the economic 
workings of the GM New Economy model will be presented. The CBA model is described prior 
to discussing each phase of the research, to inform the reader of how the CBA model operates 
in order to conceptualise the methodology of each phase. Lastly, a discussion of the research 
designs used each stages of this research, with their respective strengths and limitations will be 
presented.  
 
3.2 Research methodology 
  
Prior to determining the methodological approach, it is recommended to firstly determine the 
underlying philosophical assumptions of the research, as this influences the choice of research 
philosophy/paradigm and ultimately the chosen methodology (Bashir, Syed and Quershi, 2017; 
Saunders, Lewis, and Thornhill, 2015; Scotland, 2012). The necessity of identifying the 
philosophical underpinnings has been debated, with suggestions that ignoring the underpinning 
philosophy and simply focusing on using methods appropriate to answering questions is 
sufficient (Holden & Lynch, 2004). With others asserting that reviewing the underpinning 
philosophy is good practice (Jackson, 2013) and may open the researcher to other possibilities, 
enrich their research skills and enhance their confidence in their methodological choices 
(Holden & Lynch, 2004; Sikes, 2004). The philosophical underpinning of the research is 
identified by discussing: epistemology, ontology and axiology, and identifying where along the 
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continuum of objectivism (i.e. there is a single truth) and subjectivism (i.e. there is no such 
thing as one objective truth, but rather a number of subjective truths) the research assumptions 
are situated (Jackson, 2013; Holden & Lynch, 2004). Ontology refers to the nature of reality, 
explaining the knowledge and assumptions about reality (Bashir et al., 2017; Saunders et al., 
2015; Scotland, 2012).   Epistemology, refers to the study of knowledge, how do you know 
something, how it knowledge acquired and interpreted (Basher et al., 2017; Saunders et al., 
2015; Scotland, 2012). Axiology concerns the values that the researcher places on the study 
(Denzin & Lincoln, 2005; Saunders et al., 2015).  
 
Contemplating each of these three assumptions in relation to the research subject of this thesis 
guides the choice of research paradigm and methodology.  Ontology, i.e. what is real, shapes 
the way in which the researcher sees and studies the research objects (Saunders et al., 2015; 
Scotland, 2012).  In this study the CBA model, the organisation purchasing VR, the VR 
provider and the employees, are the research subjects. The aim to develop economic outcomes 
to use in an existing model to ascertain the efficacy of the CBA tool in evaluating the costs and 
benefits of VR interventions indicate an objective/quantitative paradigm, as there is a single 
truth (Scotland, 2012), i.e. outcomes will be developed for the CBA tool. Quantitative 
approaches are based on ‘positivism’; all phenomena can be reduced to empirical indicators 
which represent the truth’ (Sale, Lohfeld & Brazil, 2002, p.44). Quantitative research, through 
robust methodology used, such as randomisation, blinding, control groups and large samples, 
intends to identify a casual or generalisable relationship between variables that is objective and 
uninfluenced by human perception (Watson, 2014; Sale et al., 2002; Creswell, 2002).  However, 
the second aim, to implement and explore the practical application of the revised CBA tool, 
indicates a more subjective / qualitative paradigm, as there may be a number of truths/views, 
influenced by a number of factors (Scotland, 2012), on the implementation and practical 
application of the CBA tool.  Qualitative methodology is based on ‘interpretivism’ and 
‘constructivism’, i.e. ‘there are multiple realities or truths, based on one’s construction of 
reality’ (Sale et al., 2002, p.45). As this construction of reality is widely influenced and fluid in 
nature, the ‘truth’ exists in the moment it is constructed, however, it is not generalisable or fixed 
(Sale et al., 2002). 
  
Epistemology considers what is acceptable and valid knowledge, and how we gain this 
knowledge (Jackson, 2013; Saunders et al., 2015; Scotland, 2012). This is influenced by what 
individuals think is real. In the multidisciplinary context of business there are a variety of 
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sources of knowledge such as numerical data, text data, and narratives, which are all considered 
legitimate sources of knowledge (Saunders et al., 2015). In this study, again the different aims 
have different underlying assumptions. Aim 1 takes a more objective stance, where the 
researcher and the subject (the CBA tool) and its efficacy in evaluating VR interventions are 
independent from each other. Whereas with aim 2, a more subjective viewpoint is adopted, as 
the implementation and practical application of the CBA tool by the researcher is by necessity 
interactive both during the implementation stage and whilst ascertaining the practical 
application of the CBA tool. Thus, when considering the ontology and epistemology, different 
research assumptions (objective/quantitative and subjective/qualitative) are seen to be 
underpinning the choice of methodologies needed to answer the different questions posed, 
indicating a need for a mixed methods approach. 
 
The axiology, i.e. the values of the researcher and the subjects, influences decisions with regard 
to the research methodology and data interpretation (Saunders et al., 2015; Dudovisky, 2018). 
Saunders et al. (2015) recommend that researchers outline their values regarding the subject 
area, which will heighten the researchers’ awareness of potential bias or ethical dilemmas. In 
this study, the researcher’s beliefs prior to starting the research were as follows: 
- VR is an effective intervention for enabling individuals with physical or mental health 
disorders returning to work. 
- Organisations purchasing VR are fundamentally interested in the economics/financial 
benefit of the intervention. 
- VR services are currently unable to adequately demonstrate their value. 
Paradigms are defined as a ‘set of interrelated assumptions about the social world which 
provides a philosophical and conceptual framework for the organized study of that world’ 
(Filstead, 1979, p. 34, cited in Ponterroto, 2005). There are a number of paradigms within 
research, the three most common ones being positivism (an objective approach to research 
which is based on the ideology that science is the essence to finding answers), interpretivism (a 
subjective approach to research which involves the researcher interpreting aspects of the study) 
and pragmatism (a mixed approach which is underpinned by the understanding that there are a 
number of ways to conduct research, and that a number of realities are needed to provide the 
full picture) (Dudovisky, 2018; Scotland, 2012).  Table 3 outlines these three paradigms, linking 
them to the ontology, research approach, axiology and research strategy. This illustrates that 
this research falls under a pragmatic paradigm. When taking both aims of the study into account 
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the ontology was objective and subjective, the research strategy was quantitative and 
qualitative, and the axiology may be biased.     
 
Table 3: Positivism, interpretivism, and epistemologies (Wilson, 2010, cited in Dudovisky, 2018) 
 
 Research 
approach 
Ontology Axiology Research strategy 
Positivism Deductive 
 
Objective Value-free Quantitative 
Interpretivism Inductive 
 
Subjective Biased Qualitative 
Pragmatism Deductive/ 
inductive 
Objective/ 
subjective 
Value free/biased Quantitative/ 
Qualitative 
 
Guided by the realisations from considering the underlying philosophical assumptions and 
paradigms, a mixed methods approach was the most apt research methodology to be utilised 
across the different stages within this research. A commonly accepted definition of mixed 
methods is an approach to research that involves the collection, analysis and interpretation of 
both quantitative and qualitative data in relation to the same subject; it may be in one study or 
in a series of studies (Leech & Onwuegbuzie, 2008). In 2011, a study into the acceptance of 
mixed methods in business and management indicated minimal acceptance (14%) (Cameron & 
Molina-Azorin, 2011). However, although there is no institutionalisation of mixed methods 
within this field, Molina-Azorin, Bergh, Corley and Ketchen (2017) propose that mixed 
methods are commonly used within organisational research although researchers have not 
necessarily characterised their work as such. 
 
The proposed strength of mixed methods is that it enables a complementary analysis of a 
question to be carried out, drawing on two different views of the same phenomenon (Molina-
Azorin et al., 2017; Sale et al., 2002) thereby allowing for a broader, in-depth analysis of a 
phenomenon (Molina-Azorin et al., 2017). Moreover, triangulating the results from various 
methods theoretically increases the results validity (Niglas, 2004, cited in Molina-Azorin et al., 
2017). Thus, mixed methodology is recommended as a useful tool to explore complex 
phenomenon (Creswell & Plano Clark, 2007; Sale et al., 2002). Moreover, mixed methods 
research provides the ability to use one method to elaborate or clarify the findings from another, 
and uses the results from one method to develop the use of the second method and expand the 
breadth of the topic area (Molina-Azorin et al., 2017). However, these advantages may be 
misnomers, as although it could be argued that ‘more is better’ with regards to research and that 
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the strengths of the two different paradigms offset the weaknesses of each other (Creswell and 
Plano Clark, 2007; Molina-Azorin et al., 2017), it may in practice result in diluting the 
important contributions of a single method (Hesse-Biber, 2015).  Moreover, there is a debate 
regarding whether quantitative and qualitative research methods can answer the same research 
question. If the two methods cannot answer the same question, yet the results from both 
methodologies agree, are they substantiating the findings or are the two methodologies merely 
researching different phenomena (Moffat, White, Mackintosh & Howel, 2006; Sale et al., 2002; 
Breakwell, Smith & Wright, 2012). However, in spite of this debate there is consistent 
agreement that qualitative and quantitative paradigms can be combined (Sale et al., 2002; 
Breakwell et al., 2012; Gelo, Braakmann, & Benetka, 2008). It is recommended that a solution 
to the quantitative-qualitative debate is to use the two methodologies to complement each other, 
using the strengths of each methodology to bolster the weaknesses in the other, allowing for a 
wider exploration of the complexities of the phenomenon under investigation (Molina-Azorin 
et al., 2017; Gelo et al., 2008; Moffat et al., 2006; Sale et al., 2002).  
 
The mixed methods approach used in this research is an explanatory sequential design, with 
two distinctly independently yet interactive phases (Creswell, Plano Clark, Gutmann, & 
Hanson, 2003; Gelo et al., 2008; Greene, 2007). The design gives priority to the quantitative 
methods, and implements the methods in a sequential timing, collecting quantitative data in the 
earlier stages, and qualitative in the later stage (Greene, 2007; Gelo et al., 2008).   
 
Creswell et al.’s (2003) framework ‘The Interconnection of Worldviews, Design and Research 
Methods’ (see Figure 4), focuses on the type of method, their relative importance, and in which 
sequence they will be used. However, a limitation in using this framework is that little 
consideration is given to how the question and the design of the methods intertwine (Hesse-
Biber, 2015).  Thus, this design becomes empirical in nature, focussing on getting the right 
design and working through set steps (Hesse-Biber, 2015). When overlaying the question as to 
how the methods and the research questions link, it is seen that it is the research question that 
determines the timing of the two methodologies, as well as the relative importance, addressing 
this limitation (Morse, 1991; cited in Hesse-Biber, 2015). Therefore, the question in relation to 
the timings of the two methodologies was considered when designing this research. A further 
advantage of the explanatory sequential design is that it allows for the distinct demarcation of 
the two methods, increasing the ease of implementation and write-up, as well as allowing for 
emergent approaches (Creswell & Plano Clark, 2007; Gelo et al., 2008). This is necessary for 
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this study, as the qualitative research question is reliant on the quantitative findings. However, 
the limitations of this design are the length of time it takes to implement, as well as the need for 
the researcher to decide which participants to select for the qualitative research (Ivankova, 
Creswell, & Stick, 2006; Creswell & Plano Clark, 2007). 
 
Figure 4: The interconnection of Worldviews, Design and Research Methods (Creswell et al., 2003) 
 
 
 
Through utilising the explanatory sequential mixed methods design, with two distinctly 
independently yet interactive phases, mixing the methods sequentially during data collection, 
and giving priority to the quantitative strand this enabled the research to answer the aims 
outlined above.  
 
The objectives of the research are divided into four phases, namely: 
 
Phase 1: 
 
1. To identify from the published literature the outcomes of VR interventions for 
organisations and employed individuals. 
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2. To revise the GM New Economy CBA model to ensure that the practical CBA tool 
developed is capable of analysing the costs and benefits of VR interventions. 
 
Phase 2: 
 
3. To collect the relevant data required to populate the revised practical CBA tool from 
two VR Services and the organisations to which VR is provided. 
 
Phase 3: 
 
4. To implement and test the revised practical CBA tool incorporating the developed 
outcomes to identify the cost-benefits of the VR interventions and services in a real-
world setting. 
 
Phase 4: 
 
5.  To appraise the value of the revised practical CBA tool to the VR provider and the 
organisation to which VR is provided. 
 
The methodology to address each phase will be discussed in turn. Prior to discussing each 
phase, an understanding the GM New Economy is necessary to contextualise each phase. 
 
3.3 Overview of and rationale for the use of the GM New Economy CBA to 
evaluate VR. 
 
The New Economy ‘is wholly-owned by the GM Combined Authority and provides policy, 
strategy and research support to the ten GM Local Authorities, the GM Local Enterprise 
Partnership (LEP) and other public and private sector bodies, with the aim of increasing GM’s 
Growth and Prosperity’ (HM Treasury et al., 2014, p.5). In 2011, the New Economy developed 
a user-friendly CBA tool to enable appraisal and evaluation of interventions focused on 
improving early years opportunities and offering better life chances within deprived 
neighbourhoods (Cox et al., 2011). This model allowed for the addition of outcomes of interest 
to users (e.g. hospital admissions, A&E attendance, incidents of crime, family wellbeing, 
unemployment, mental health etc.) and has subsequently been extended to include a variety of 
outcomes of interest to GM New Economy and the organisations that they work with. The CBA 
model’s processes and assumptions were developed in order to produce easily interpretable 
results, and are based on best practice and guidelines, where possible, ensuring that the lay 
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person and organisations have access to resources which will assist with the understanding of 
the cost benefits of particular interventions e.g. integrating employment and health care services 
(Cox et al., 2011). The CBA model enables both a return-on-investments (ROI) and a benefit 
cost ratio (BCR) to be determined. 
 
Figure 5: The GM New Economy Cost-benefit Analysis model (HM Treasury, Public Service 
Transformation Network, New Economy, 2014) 
 
A technical guide for the use of the CBA model has been developed and updated with ‘analysts 
from a number of central government departments including HM Treasury, DWP, Department 
for Business, Innovation and Skills (BIS), DH, Department for Communities and Local 
Government, Department for Education, Ministry of Justice, Home Office and the Cabinet 
Office (HM Treasury et al., 2014). These departments form ‘the Technical Advisory Group for 
the CBA methodology, along with local partners from the Whole Place Community Budget 
pilots and New Economy, local authorities and other public-sector agencies across GM’ (HM 
Treasury et al., 2014, p.5). Through the Whole Place Community Budget pilots version 1 of the 
guidance was tested, resulting in Version 2 of the guide being published in April 2014. Version 
2 incorporates changes due to recent evidence as well as further modelling on outcomes crime, 
alcohol and drug dependency (HM Treasury et al., 2014).  The CBA model is a working model 
and is updated as new outcomes are established. Allowing for the model to be easily adapted in 
the future and to include outcomes from a variety of stakeholders. The current version of the 
CBA model, which is used in this thesis, is version 4.2. This version includes the ability to 
incorporate cashability i.e. ‘the extent to which a change in an outcome or output (e.g. fewer 
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children in care) will result in a reduction in fiscal expenditure such that the expenditure 
released from that change can be reallocated elsewhere’ (HM Treasury et al., 2014, p.36). In 
the development of the CBA model the following key texts were used to inform the technical 
details; the HM treasury’s Green Book (2011); the DWP’s Social CBA Framework (Fujiwara, 
2010); the Business Innovation and Skills (BIS) Additionality Guidance (Department for BIS, 
2009); The Cabinet office/New Economics Foundation’s Guide to Social Return on Investment 
(Nicholls, Lawlor, Neitzert, Goodspeed, & Cupitt, 2009); and the Volunteering England’s 
Volunteer Investment and Value Audit (Gaskin, 2011).   
 
A unique feature of the GM new economy model is that it accounts for overly optimistic 
outcomes (optimism bias) by applying correction factors that account for the level of 
uncertainty in the data or assumptions made. These correction factors are based on the data 
source type, the age of the data/data analysis, the evidence-base for both the engagement/level 
of impact, the monetisation of outcomes, and any known data source error (Cox et al., 2011). 
Although optimism bias provides a greater level of robustness to the CBA model (HM Treasury, 
2011), the figures produced need to be viewed with an understanding of the limitations of CBAs 
and it is envisioned that CBA outputs will be ‘used as a decision support tool rather than a 
decision-making tool’ (Cox et al., 2011, p.13; Keating & Keating, 2014; Snell, 2011; Sculpher 
et al., 2006). 
 
Since the CBA model’s inception, it has been widely used within the public sector, social 
enterprises and third sector organisations, highlighting its applicability to a variety of 
populations and interventions. At the time of writing, to the best of my knowledge, and 
according to the New Economy, the CBA model has not been used within the private sector.  
The Citizens Advice Service 2015 report ‘The value of Citizens Advice service: our impact’, 
utilised the GM New Economy CBA model to demonstrate the financial and societal impact of 
their activities. Furthermore, the Department for Communities and Local Government (DCLG), 
comprising of 120 local authorities, incorporated the use of the GM New Economy CBA model 
into the bidding process for the Transformation Challenge Award (DCLG, 2014).  In 2017, the 
Work Foundation utilised the GM New Economy CBA model to evaluate ‘The Bridging the 
Gap Programme’, a programme aimed at supporting the integration of health care and 
employment services, to support people with health care conditions to ‘move towards 
employment and better manage their health care condition’ (Shehabi, 2017, p. i).  The Work 
Foundations programme indicates the usefulness of this model to interventions addressing 
73 
 
employment, further supporting the use of this model in this research. Although widely used, 
an organisation trialling the GM New Economy model identified limitations of the model, such 
as the limited number of factors/outcomes taken into consideration potentially skewing results, 
and missing the true value of the services, the lack of ability to attribute the results to the 
interventions/services, and the complexity and time demands of the data collection (Rose, 
2013). These identified limitations resulted in the organisation rejecting the findings from the 
CBA model (Rose, 2013).  This reiterates the necessity of transparency when conducting 
CBA’s and that the results produced are only part of the picture, thus CBAs should be viewed 
as  decision-making tools (Cox et al., 2011; Keating & Keating, 2014; Snell, 2011; Sculpher et 
al., 2006). 
 
There are many CBA models and instructions on how to conduct a CBA, all of these follow the 
same principles outlined in Cox et al. (2011) (Central Expenditure Evaluation Unit (CEEU), 
2011; Treasury Board of Canada Secretariat, 1998). However, the advantages of using the GM 
New Economy CBA for this research are: 
 
 The CBA model was developed for use within local authorities, thus there is a strong 
focus on the social costs and benefits as outcomes; 
 The CBA model is widely adaptable to a variety of agencies; 
 The CBA model is widely used within public and third sector organisations within GM, 
however, it has not been used within the private sector; 
 It was developed as a model to be shared within GM public agencies, therefore it is 
presented as an excel spreadsheet with the underlying calculations completed, 
increasing the usability of the CBA model;  
 It is an emerging model, which allows for the addition of outcomes of interest; 
 It allows for the sharing of the costs and benefits to be spread across different agencies, 
showing a true representation of where the costs and benefits are accrued, allowing for 
fairer distribution of budgets;  
 It has an inbuilt discount rate in line with national government recommendations: 
 It is developed locally, with local expert help available; 
 And it provides a ROI (measuring the cost of the programme versus the financial return 
for the organisation) (Cavallo, 2006)).  
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3.3.1 Existing economic models for evaluating workplace interventions in the 
public domain 
 
To my knowledge, at the commencement of this research there were no economic models in 
the UK, and within the public domain, suitable for exploring the economic impact of VR 
interventions. During the course of the research two economic models/frameworks in the UK 
for analysing interventions within the workplace emerged, the ‘British Heart Foundation Cost 
savings calculator’ (British Heart Foundation (BHF) & ERS Research and Consultancy, 2016) 
and the ‘Economic Modelling Framework’ (Levy, Hillage & Bevan, 2014), moreover, in 
Australia a similar model, the ‘Workplace Health Savings calculator’ was developed by Baxter 
et al. (2015), these will be briefly outlined below and contrasted to the CBA model used within 
this thesis.  
 
Levy et al. (2014) designed two models which allow organisations to explore the potential costs 
and benefits prior to implementation of new workplace policies and management practices. The 
first model estimates the level of effectiveness that would be needed by the implementation of 
new workplace polices and management practices in order to break even, and the second model 
estimates the maximum cost of the intervention in order to break even (Levy et al., 2014). The 
model is populated using benchmark data drawn from the evidence-base, as well as allowing 
organisations to input known data specific to their organisation (Levy et al., 2014). The 
outcomes or effects of the interventions are analysed in terms of sickness absence, turnover and 
productivity. When combined they provide the total impact of the intervention, however, there 
may be some overlap between these effects, and productivity needs to be focused on the direct 
outcomes of the intervention to minimise this overlap (Levy et al., 2014). The model is user-
friendly allowing for the organisation to input their own data where necessary, as well as adjust 
assumptions such as the discount rate (i.e. the interest rate used to determine the present value 
of future cash flows) in line with the discount rate used within their organisation (Levy et al., 
2014).  
 
BHF and ERS consultancy developed a model allowing organisations to see the potential cost 
savings of investing in health and wellbeing initiatives (BHF and ERS Research & Consultancy, 
2016). This model uses the outcomes of the interventions as sickness absence, presenteeism, 
and turnover. The model uses national averages and provides general guidelines to 
organisations. This differs from the Levy et al. (2014) model which allows organisations to 
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input their own data, consequently getting more focused results. As with Levy et al.’s (2014) 
model, the population of interest is the entire workforce, as the interventions of interest will be 
targeting all employees. Similarly, Baxter et al.’s (2015) model, enabling organisations to 
identify the potential annual savings of workplace health promotion interventions, also focuses 
on sickness absence and staff turnover rates as outcomes, using the entire workforce as the 
population.  
 
When comparing these models to the CBA tool that this research aims to develop, Levy et al. 
(2014), BHF & ERS Research & Consultancy (2016), and Baxter et al. (2015) all have their 
target population as the entire workforce. This differs from the CBA tool in this study which 
aims to only look at the VR intervention’s impact on those individuals with mental or physical 
health conditions. Moreover, these models (Levy et al., 2014; BHF & ERS Research & 
Consultancy, 2016; Baxter et al., 2015) allow organisations to consider alternative solutions to 
their identified need prior to implementation. Although this is a feature of GM New Economy 
CBA model, for the purposes of this research the CBA tool analyses the effects of the 
intervention post-implementation. All models use sickness absence and turnover as outcome 
measures, however, Levy et al.’s (2014) includes productivity and BHF & ERS Research and 
Consultancy (2016) includes presenteeism, whereas Baxter et al. (2015) state that in order to 
avoid over-estimating potential savings/benefits their model only includes sickness absence and 
turnover as outcomes. A unique feature of the GM New Economy model is that outcomes can 
easily be included or excluded, allowing a variety of outcomes to be in the model and adapted 
to individual organisations’ data collected and interest.  
 
From exploring the GM New Economy CBA model, it is seen that this model is easily adaptable 
and would allow for the addition of VR outcomes, and thus this model will be revised within 
this research. 
 
3.4 Workings of the Greater Manchester New Economy CBA 
 
The GM New Economy CBA model is in the form of an excel spread sheet which enables users 
to input data they have collected, on costs and benefits for already developed and calculated 
outcomes, resulting in the generation of the following outcomes: 
- Benefit Cost Ratio (BCR) = benefits/costs 
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- Net Present Values (NPV) = benefits – costs 
- Net Present Efficiency (NPE) = NPV of the benefits – NPV of the costs 
- Return on Investment (ROI) = (benefits – costs)/costs 
 
The BCR supplies information on the monetised value of the outcomes of an intervention, 
providing an indication of the level of return on investment achieved by the intervention (Cox 
et al., 2011). A BCR < 1 indicates that the costs outweigh the benefits, a BCR = 1 is breakeven 
point, and a BCR > 1 shows that the intervention has achieved more than it cost (Cox et al., 
2011).  Moreover, the CBA model produces a ROI; a profitability measure which evaluates the 
performance of a business (Cowen & Katten, 2009). However, ROI presents challenges when 
considering tax and inflation, as well as knowing what would be an adequate ROI (Cowen & 
Katten, 2009). Nevertheless, it still does aid decision making, and all things being equal, the 
higher ROI would be a more favourable investment (Cowen & Katten, 2009).  
  
In addition to calculating a BCR and ROI, the CBA model calculates the NPV. This is 
calculated, by discounting future benefits and costs, in order to provide a consistent measure of 
costs and benefits now and into the future. This criterion is simply based on whether the sum 
of discounted benefits exceeds the sum of discounted costs (Keating & Keating, 2014; Snell, 
2011; CEEU, 2011). The decision rule commonly accepted is that one should reject any project 
with a NPV of less than zero, unless there is a willingness to ‘lose money’ to achieve a non-
financial objective e.g. positive employer reputation, and when offered a choice amongst 
alternative projects to maximise the NPV (Keating and Keating, 2014; Lee & Lee, 2006; 
Treasury board of Canada Secretariat, 1998).  
 
In certain instances, BCR’s fail to produce meaningful results, for example, if a service reduces 
the level of costs through efficiency/streamlining, this would produce a negative BCR, 
suggesting that costs outweighed the benefits (HM Treasury et al., 2014). In these cases, NPE 
is an alternative way of assessing the worth of interventions. Interventions with a higher NPE 
should normally be chosen first (Keating & Keating, 2014; Cox et al., 2011). The NPV of the 
costs and benefits can then be used to determine the NPE. 
 
When populating the CBA model, two types of inputs are required; costs and benefits (Keating 
& Keating et al., 2017; Snell, 2011). The costs refer to all the costs associated with the 
intervention, these can be capital, revenue (total costs of managing or delivering a product or 
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service) or in-kind (volunteer costs) (HM Treasury et al., 2014). It is important to consider not 
only what the costs are, but also which agency bears the costs and when these costs are borne. 
Examples of costs include salaries of staff, travel costs, training costs, equipment etc. (as 
discussed in section 3.5.1). 
 
Benefits are looked at in terms of economic (economic benefits to the organisation and 
individuals), fiscal (savings to government agencies) and social benefits (non-economic 
benefits to individuals and society such as increased quality of life) (Keating & Keating, 2014; 
HM Treasury et al., 2014; Snell, 2011). The benefits are typically shaped by the objectives of 
the intervention. Possible economic benefits from a VR intervention in the SAW population are 
a decrease in sickness absence, a corresponding increase in productivity levels; fiscal benefits 
may include a decrease in the number of individuals moving out of employment and claiming 
social security benefits; and non-economic benefits may include an increase in worker morale, 
increased job satisfaction, increased job stability etc. (as discussed in section 3.5.1).  
 
Currently, the GM New Economy CBA spread sheet allows the inputting of data around 
specific outcomes that have been monetised i.e. the economic value of the benefits have been 
calculated, such as mental ill-health, A&E visits, worklessness and benefits payments etc. (HM 
Treasury et al., 2014). Once the data is inputted and the CBA model is implemented, sensitivity 
and scenario analyses are performed to determine which variables appear to have the most 
influence on the cost-benefit ratio (HM Treasury et al., 2014).  Sensitivity and scenario analysis 
is the method used to deal with uncertainty within the CBA model, i.e. assumptions employed 
during the modelling, discount rates used, quality of data, etc. (Keating & Keating, 2014; NICE, 
2013b). Utilising the best and worst-case scenario analysis enables the identification of the 
factors which have the greatest impact on the results, as well as the extent of this impact (NICE, 
2013b) thus enabling the evaluator to consider actions that may limit the uncertainty of these 
variables (Keating & Keating, 2014; NICE, 2013b; Treasury Board of Canada Secretariat, 
1998).  
 
The GM New Economy CBA model is a ‘living’ model, allowing for refinement and updating 
as new outcome measures are calculated.  
 
The data needed to apply the CBA model for a specific outcome is: 
 The target population: How many people could potentially access the intervention? 
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 The engaged population: How many people will access the intervention? 
 The impact: How many people will achieve the desired outcome? 
 The deadweight: What would have happened if the intervention had not been in place? 
 Value: What is the value of the desired outcome? 
 Predicted impact and lag: What is the predicted sustainability of the interventions 
impact? 
 
For each outcome, the above data is derived from different sources. Typically, in a CBA 
conducted following the implementation of an intervention, the organisation will collect data 
on the target population, the engaged population and the impact. They will then input this data 
into the CBA model against the appropriate outcome where the deadweight, value, impact and 
lag have been previously calculated and standardised, i.e. the outcome has been monetised. In 
a predictive CBA the engagement rates and impact rates need to be calculated prior to the 
implementing of the CBA model. One of the key considerations with CBA models is the risk 
of double counting benefits; this needs to be considered when choosing the outcomes to 
populate the model (Rebergen, Bruinvels, van Tulder, van der Beek, & van Mechelen, 2009; 
Messonnier & Meltzer, 2003).  
 
In order to monetise outcomes to be used within the CBA model it is necessary to calculate 
and/or obtain the deadweight value, impact and lag, as well as engagement rates. These are 
calculated using the existing evidence-base and expert opinion, as well as, if available, data 
from comparator organisations (Keating & Keating, 2014). In the initial stages of monetising 
outcomes, there may be insufficient data, requiring the use of assumptions within the CBA 
model; an inherent limitation of CBA models (Messonnier & Meltzer, 2003). To address this 
limitation ‘optimism bias’ correction is applied to the data collected. Additionally, it is 
important that any assumptions made are subject to sensitivity analysis (Keating & Keating, 
2014; Snell, 2011) and updated as appropriate.  
 
Optimism bias tables are a unique feature of the GM New Economy CBA model, to account 
for overly optimistic assessment of outcomes. These correction factors are based on the data 
source type, the age of the data/data analysis, the evidence-base for both the engagement/level 
of impact and the monetisation of outcomes, and any known data source error (Cox et al., 2011). 
The correction factors allow for percentage adjustments to be made based on the reliability, 
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source and age of the data. These correction factors will be applied to the revised CBA tool. 
Applying the correction factors provides a greater level of robustness to the CBA model (Cox 
et al., 2011; HM Treasury, 2013).  
 
Sensitivity analysis is a method whereby various parameters in the analysis are varied in order 
to test the impact of this variation on the overall result (the BCR or NPV) (Keating & Keating, 
2014; Snell, 2011, CEEU, 201; Pannell, 1997). Subjecting the CBA model to a range of 
sensitivity tests enables a greater understanding of the degree of confidence with which the 
outputs can be treated (Pannell, 1997; Keating & Keating, 2014; Snell, 2011, CEEU, 2011). It 
is necessary to conduct this analysis as in practice most variables estimated, which may impact 
on the results (Environmental Assessment Institute, 2006). There are a variety of approaches to 
sensitivity analysis, such as simple (only changing the value of the source of uncertainty), 
threshold (identifying a critical value for parameters in which conclusions may change), 
extreme scenario (best and worst case for all values) and probabilistic/risk analysis (attaching 
a distribution to the variables and running a Monte Carlo simulation) (Environmental 
Assessment Institute, 2006; Walker & Fox-Rushby, 2001; Briggs and Gray, 1999). When 
conducting an analysis, it is important to use the method most suited to aims of the analysis 
(Pannell, 1997). CEEU (2011) state that it is not sufficient to limit the sensitivity analysis to the 
assumed critical variables, therefore, a comprehensive approach to sensitivity analysis needs to 
be performed on all cost and benefit variables. It is recommended that only one parameter is 
changed at a time (Keating & Keating, 2014; Snell, 2011, CEEU, 2011). CEEU (2011) 
recommend that the variables are adjusted significantly during the testing (i.e. between +- 10% 
- 20%) to adequately assess the robustness of the CBA model. However, Snell (2011) 
concludes, that when a parameter is adjusted by an arbitrary percentage the result is 
meaningless, and recommends utilising a percentage that is ‘conceptually or physically 
meaningful’ (section A.3.2) to the decision maker. This view point is supported by Pannell 
(1997) who recommends that ‘the modeller needs to avoid conducting sensitivity analysis in an 
aimless or mechanical fashion’ (section 6). As this research aims to create a practical tool that 
is easily used by the lay person/organisations, a simple sensitivity analysis will be used, varying 
one parameter at a time, and changing the variables by a percentage that is conceptually 
meaningful for each variable.  
 
Scenario analysis is similar to sensitivity analysis, however, it accounts for the inter-dependence 
of variables, looking at a range of scenarios rather than the variable-by-variable approach used 
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in sensitivity analysis (Snell, 2011; CEEU, 2011; Pannell, 1997). To conduct a scenario analysis 
a number of scenarios are formulated, e.g. best case, worst case, and for each scenario a range 
of values are assigned to all the cost-benefit variables, these scenarios are then used to calculate 
the BCR and NPV (CEEU, 2011; Pannell, 1997).  An inherent weakness of sensitivity and 
scenario analysis, is that the analyst retains control over three aspects of the process; which 
variables to vary, the amount of variation that is considered clinically meaningful and what 
constitutes a robust finding (Walker & Fox-Rushby, 2001). Thus, it is essential to clearly outline 
the approach used.  
 
3.5 Methodology Phase 1  
 
Figure 6: Diagrammatic representation of the 4 phases of this research project highlighting phase 1 
 
 
 
 
 
 
 
 
 
Cost 
benefit 
analysis 
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Phase 1: revise the 
GM CBA tool  with 
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outcomes
Phase 2: collect 
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CBA tool, using 
data from Phase 2
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organisations
Using the 
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evaluate the value 
of the revised 
CBA to potential 
users 
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employees using 
the VR services – 
outcomes collected 
pre and post 
interventions. 
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collected by the VR 
services and 
organisations 
Researcher inputs 
data from phase 2, 
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tests the revised 
CBA model. 
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In order to meet the objectives of phase 1: 
 
1. To identify from the published literature the outcomes of VR interventions for organisations 
and employed individuals. 
2. To revise the GM New Economy CBA model to ensure that the practical CBA tool developed 
is capable of analysing the costs and benefits of VR interventions. 
 
This section outlines the methodology required to adapt the CBA tool so that it is capable of 
analysing the costs and benefits of VR outcomes. It firstly identifies the benefits (outcomes of 
VR) and the outcome measures to be used capture these benefits. Following this the 
methodology underpinning the identification of the reference and intervention case for each 
outcome is discussed. Lastly, it identifies the unit costs for each outcome, i.e. the cost of the 
benefit/outcome. 
 
3.5.1 Outcome measures: benefits and costs 
 
In order to meet the study aims (see section 3.1), it is imperative that the outcome measures are: 
appropriate for use within a practical CBA tool; of relevance to organisations that may be using 
this tool; and capture the effects of the intervention. The following outcome measures have 
been identified as measurements valued by decision makers within organisations (Van Dongen 
et al., 2013; Levy et al., 2014; BHF and ERS Research & Consultancy, 2016) and consequently 
a number of them have been included in economic evaluations of workplace health 
interventions (Van Holland, de Boer, Brouwer, Soer, & Reneman, 2012; IJzelenberg, 
Meerding, & Burdorf, 2007; Oxenburgh & Marlow, 2005; Uegaki, de Bruijne, van der Beek, 
van Mechelen, & van Tulder, 2011): 
 
 Sickness absence 
 Employee Turnover  
 Productivity 
 Injuries 
 Workers compensation-related costs  
 Presenteeism  
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In addition, there is a need to include the ‘hidden’ costs when exploring the economic costs and 
benefits of interventions in the workplace (Cagno, et al., 2013; Oxenburgh & Marlow, 2005; 
Barham & Begum, 2005; Bevan and Hayday, 2001). Previous studies have attempted to 
quantify these ‘hidden’ costs, but ratios and estimates have varied widely, thus Oxenburgh & 
Marlow (2005) recommend deriving the hidden costs for each organisation. The ‘hidden’ costs, 
in addition to decreased productivity, may include ‘overtime, over-employment (extra staffing), 
training, supervision, waste and rework, lost production time, warranty costs, maintenance, 
product and plant damage, and equipment down-time due to injury incidents’ (Oxenburgh & 
Marlow, 2005, p.209). 
 
When considering the above-mentioned outcomes to be used within an economic evaluation, it 
is important to ensure that the same effect is not measured twice (Zhang, Bansbak, & Anus, 
2011). Oxenburgh & Marlow (2005) define productive hours as ‘the total hours paid for by the 
employer less hours not actively producing, over a one-year period’ (p.211). The reasons cited 
for non-productive hours include absence (due to injury or illness or other reasons such as 
maternity leave), training, vacation and statutory holidays. This definition is limited as it does 
not consider the impact of presenteeism on productivity, and consequently does not highlight 
the reasons for this, such as poor management, inappropriate environment (e.g. too hot, poor 
ventilation), poor team dynamics (Noben, Evers, Nijhuis, de Rijk, 2014; Oxenburgh & Marlow, 
2005), and secondly, it does not address the quality of the productive hours (Oxenburgh & 
Marlow, 2005).  Brouwer, Koopmanschap, & Rutten’s (1999) Quality and Quantity 
questionnaire ‘addresses the quality and quantity of work during the previous work day with 
two questions, each to be answered with an 11-point Numeric Rating Scale’ (Van Holland et 
al., 2012, p. 5). However, this is over a limited time period and the results cannot necessarily 
be extrapolated to a longer time period. Measuring productivity is often difficult, thus proxies 
to estimate productivity are commonly used, such as absenteeism (Uegaki et al., 2011; van 
Dongen et al., 2014, van Oostrom et al., 2010), presenteeism (Spekle et al., 2010; van Dongen 
et al., 2014), and the impact of these on co-workers (Krol, Brouwer, & Rutten, 2013). 
Additionally, improvements in quality of life have been associated with increased productivity 
(Krol et al., 2013). However, the exact cost of sources of productivity other than absenteeism 
are debated, moreover there is an awareness that there is a risk of duplication of measurement 
of productivity if using a variety of measurements, thus there is a lack of consensus on whether 
to include these costs in an economic evaluation or not (van Dogen et al., 2014; Krol et al., 
2013; Zhang et al., 2011).  
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When considering productivity, although there is a debate on its true measurement, sickness 
absence is an accepted proxy measure (van Dogen et al., 2014; Krol et al., 2013; Zhang et al., 
2011; van Oostrom et al., 2010). Thus, to avoid duplication of the same effect, sickness absence 
will be the key indicator of productivity in this study and is measured in organisation 1 and 2 
(described in section 1.4). As identified in the literature review, the most common causes of 
sickness absence are MSDs and mental health disorders (CIPD, 2014a; ONS, 2014), thus, the 
sickness absence outcomes in this study will focus on MSDs and mental health issues.  
 
Additionally, it is necessary to capture the effects of ill-health on productivity when an 
individual does not take sick leave but has a physical or mental health condition i.e. 
presenteeism (van Dongen et al., 2014). When exploring the literature on measuring 
presenteeism, it is noted that currently there is no consensus on the best way to measure it 
(Garrow, 2016; Noben et al., 2014; Krol et al., 2013; Brooks et al., 2010; Terry & Min, 2010). 
This lack of consensus can be attributed to the fact that the evidence-base for presenteeism is 
an emerging evidence-base and consequently further research is needed prior to agreement 
being reached. Additionally, the complexities of the presenteeism phenomenon make its 
quantification difficult. One of the complexities is highlighted when different job characteristics 
are considered, for example, in a call centre, an employee’s productivity may be easily 
quantifiable by the number of calls made, whereas quantifying the productivity in a professional 
job such as a lawyer would be less clear cut (Mattke, Balakrishnan, Bergamo, & Newberry, 
2007; Braakman-Jansen, Taal, Kuper, & van de Laar, 2012). In an attempt to address the 
inherent limitations of using productivity as a measure of the quality and quantity of work an 
employee does on any given day, tools to measure presenteeism have been developed covering 
different facets of presenteeism, relying on self-reports of employees either reporting on their 
own estimation of their decrease in productivity, comparing their productivity to their 
colleagues, or estimating the amount of time that they are unproductive at work (Mattke et al., 
2007; Braakman-Jansen et al., 2012). Moreover, presenteeism does not always relate to a loss 
in quality and quantity of work produced, but may place individuals at increased risk of sickness 
absence at a later date or injury or accident (Halbesleben, Whitman & Crawford, 2014). Thus, 
when choosing an outcome measure for research into presenteeism, it is necessary to consider 
the variety of tools and choose the ‘best fit’ tool for the population at hand, question of interest, 
available evidence and the target country (Noben et al., 2014).  In order to explore this further, 
in organisation 2, presenteeism outcomes were collected. 
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As outlined above, turnover is commonly included in economic evaluations, exploring the 
impact of health interventions within the workplace (van Dongen et al., 2014; Bevan & Hayday, 
2001). Turnover will be further explored in organisation 2. 
 
As discussed in section 2.3.1 economic analyses are to be viewed as decision making aids, and 
it is important for purchasers of the VR services to consider the broader impacts of the service 
when making decisions (Cox et al., 2011; Snell, 2011; Sculpher et al., 2006). VR interventions 
aim to improve mental and physical health, patients’ quality of life, and their work-life/job 
satisfaction. Job satisfaction is an indicator of wellbeing (ONS, 2017), however, as wellbeing 
is a broad concept with a number of dimensions and is commonly used for assessing and 
informing national policies as opposed to being utilised at an organisational level (Alder & 
Seligman, 2016; La Placa & Knight, 2014), it was not included as an outcome in this research. 
Measures to assess mental and physical health, patients’ quality of life, and their work-life/job 
satisfaction are also included to allow decision makers to explore the wider impacts of VR; in 
organisation 1, general mental and physical health outcome data, as well as job satisfaction 
outcome data were collected, and in organisation 2, quality of life outcome data was collected. 
Different outcome measures were collected for each organisation.  
 
The above discussion outlines the benefits to be collected in this study. The costs of 
implementing and running the VR intervention are also needed to enable a CBA. These costs 
are commonly obtained from the VR services or the organisation purchasing the service (van 
Dongen et al., 2014; Tompa et al., 2006; Uegaki et al., 2010; van Dongen et al., 2011; van 
Dongen et al., 2012; Verbeek et al., 2009) and include costs such as salaries, travel costs, 
training costs, equipment, overhead activities etc. (van Dongen et al., 2014; Drummond et al., 
2005; Tompa, Verbeek, van Tulder, & de Boer, 2010).  
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3.5.2 Outcome measurement tools  
 
3.5.2.1 Economic benefits outcome measurements used within the new CBA tool 
 
3.5.2.1.1 Sickness absence 
 
Sickness absence is either collected from organisation’s electronic sickness absence records or 
self-report sickness absence from the employee participants (van Dongen et al., 2014). Johns & 
Miraglia (2015) used meta-analysis to explore the accuracy of self-reporting and concluded that 
self-reports of sickness absence have adequate test-retest reliability and converge reasonably 
well with organisational sickness absence records. However, participants do have a tendency to 
underreport their absenteeism. A commonly used self-report measurement of productivity loss 
is the Work Limitations Questionnaire Work Absence Module (a sickness absence self-report 
questionnaire) (Lerner et al., 2001; Lerner et al., 2010; Burton, Chen, Schultz, & Li, 2017; 
Amick et al., 2017; Keysor et al., 2017) (see Appendix 2). The questionnaire asks participants 
to provide the number of full and part work days lost due to ill-health, mental or physical, over 
the previous two weeks. By dividing the number of days of absence by the number of days 
normally worked within two-weeks, productivity loss due to absence is calculated (Lerner et 
al., 2010). Although there is no consensus of the period over which participant recall is accurate, 
Zhang et al.’s (2012; cited in Krol et al., 2013) systematic review concluded that a 3-month 
recall period for absence is the suggested limit. It can be assumed that the Work Limitations 
Questionnaire Work Absence Module will not be impacted by participant recall. However, 
accessing data from an electronic record negates participant recall concerns. Due to the 
tendency of participants to under report sickness absence, both measurements (i.e. electronic 
records and questionnaire data) will be used within this study. 
 
3.5.2.1.2 Presenteeism 
 
Although there is a broad understanding of the term presenteeism e.g. employees choosing to 
attend work, whilst they are not well enough to be at work, and working at reduced productivity 
(Hampson et al., 2017; Aronsson et al., 2000; Brown et al. 2014; Bergstrom et al., 2009; Claes 
et al., 2011), this definition does not adequately capture all interpretations of the term and limits 
understanding of presenteeism. When exploring the definition of presenteeism it is seen that 
there is no uniform definition, nor consistent measurement within research (Lohaus & 
Habermann, 2018).  Moreover, there are subtle differences in the interpretation of presenteeism 
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between countries, which results in different foci, for example the US focuses on work 
productivity loss due to health problems, whereas the UK and Europe tend to focus on why 
employees come to work when they are not well and the consequences of this on their health 
(Lohaus & Habermann, 2018). However, both perspectives are limiting in their views, with the 
US perspective focusing only on the consequence of presenteeism (John, 2010), and the UK 
and Europe’s interpretation not fully capturing the economic consequences of presenteeism to 
the workplace.   In addition, both of these perspectives tend to focus on the negative aspects of 
presenteeism (Lohaus & Habermann, 2018), which contradicts the premise of VR; namely, 
work-based rehabilitation, early RTW, enabling individuals with health conditions to SAW, 
and the acknowledgement that individuals attending work with health conditions may be 
beneficial for the organisation and individuals (Cocker et al., 2014; John, 2010). Indeed, many 
employees are fully productive in spite of having a health condition (Vingard, Alexanderson, 
& Norlund, 2004).  Before choosing an outcome measure it is important to clearly outline the 
interpretation of presenteeism used, as this will influence the choice of outcome measure. In 
this research, the focus is on the economic consequences of presenteeism, i.e. when an 
employee is at work how does the health condition impact on the employee’s productivity.  
 
There are a number of presenteeism outcome measurement tools (Garrow, 2016; Brown et al., 
2014). Brown et al.’s (2014) review of presenteeism measures used for workplace physical 
activity or sedentary behaviour research identified eight self-report measurement tools for 
presenteeism (see Table 4 below). This review excluded papers which used instruments that 
were designed for specific clinical populations and formulaic calculations of time ‘lost’ due to 
health conditions (using workplace statistics).  
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Table 4: Presenteeism instrument Characteristics 
 
Instrument 
 
Country 
of 
Origin 
Mode of 
delivery 
Response 
method 
 
Recall 
period 
(weeks) 
Length i.e. 
no, of 
questions 
Endicott Work 
Productivity 
Scale (EWPS) (Endicott, 
1997) 
USA 
 
Self-
administered 
Likert scale 
(0-4) 
1 25 
 
Health and Labour 
Questionnaire 
(HLQ) 
(Hakkaart-van Roijen, & 
Bouwmans, 2002) 
Nether-
lands 
Self-
administered 
Various 2 30 
The WHO  
Health and Work 
Performance 
Questionnaire (HPQ) 
(Kessler et al., 2003) 
USA Telephone 
interview 
Likert scale 
(1-10) 
1 clinical 
4 employers 
 
44 
 
Health and Work 
Questionnaire 
(HWQ) 
(Shikiar et al., 2004) 
USA Self-
administered 
Likert scale 
(1-10) 
1 24 
 
Stanford Presenteeism 
Scale 
(SPS-6) 
(Koopman, Pelletier, & 
Murray, 2002) 
USA Self-
administered 
Likert scale 
(1-5) 
4 6 
 
Work Ability Index 
(WAI) 
(Ilmarinen, 2007) 
Finland 
 
Self-
administered 
Likert scale 
(0-4) 
Unknown 14 
 
Work Limitations 
Questionnaire 
(WLQ) 
(Lerner et al., 2001) 
USA Self-
administered 
Likert scale 
(1-6) 
2 25 
 
Work Productivity Short 
Inventory (WPSI) 
(Goetzel, Ozminkowski 
& Long, 2003) 
USA Self-
administered 
Frequency 
and duration 
 
2, 12, 52 4 
 
(Brown et al., 2014, p. 244) 
 
The characteristics of the instruments varied in terms of administration (self or researcher), 
length (between 4 and 44 questions), response options (either Likert scale or open questions) 
and recall periods (one week to across the lifespan) (Brown et al., 2014). The majority of the 
measurements were developed in the USA, with one developed in Netherlands (Hakkaart-van 
Roijen, & Bouwmans, 2002) and one in Finland (Ilmarinen, 2007). It is questionable how 
generalisable these tools are to a UK population. 
 
Dennett & Thompson (2015) conducted a systematic review of measurement properties of 
instruments assessing presenteeism. Their review concluded that most presenteeism 
88 
 
instruments have had their validity studied, however, only one outcome measure, the Health 
and Work Questionnaire (HWQ) (Shikiar, Halpern, Rentz, & Khan, 2004), was assessed for 
criterion validity (Dennett & Thompson, 2015). Due to the weak validity of all presenteeism 
measurement tools further research into this area is recommended.  These weaknesses create 
difficulties in choosing a suitable outcome measure. Brown et al. (2014) recommended that 
when choosing appropriate measurement tools, the following be considered; scale sensitivity, 
participant burden and time cost, licencing of tools, research interests linked to the various 
constructs used in the tools, and time scale researchers are interested in.   
 
Taking Brown et al.’s (2014) guidance into account, when considering the outcome measure 
most suited to this research, the WLQ is the most appropriate. Whilst the following tools; Work 
Ability Index (WAI), Endicott Work Productivity Scale (EWPS), and WHQ had strengths 
(which will be discussed), their limitations resulted in them been discounted.  Looking at each 
tool in turn, the WAI (Ilmarinen, 2007) is a comprehensive measurement of employee 
presenteeism, as the questions cover all the constructs identified in the review; work 
performance, physical tolerance, psychosocial wellbeing, social/role functioning and 
absenteeism (Brown et al., 2014). It allows the researcher to explore longer reference periods 
i.e. a year to across a lifespan (Brown et al., 2014). Moreover, it is easy to administer (Coomer 
& Houdmount, 2013) and easily accessible as it is in the public domain (Brown et al., 2014). 
The WAI is useful in identifying groups or individuals who are struggling in work (Coomer & 
Houdmount, 2013). However, it is not recommended if the main area of interest is work 
performance (Mattke et al., 2007). As this is an area of interest when considering VR services, 
this tool was discounted for use in this research.  
 
The EWPS (Endicott, 1997), HWQ (Shikiar et al., 2004) and Work Limitations Questionnaire 
(WLQ) (Lerner et al., 2001) are the tools recommended to be considered when work 
performance is of interest, as these tools cover the following constructs: perceived impairment, 
comparative productivity and efficiency (identified in the Mattke et al. (2007) review). The 
EWPS scale quantifies productivity by exploring the frequency of work performance, and 
attitudes and behaviours (Beaton et al., 2010). The EWPS has been shown to have test-retest 
reliability and validity in employees with depression (Brown et al., 2014; Dennett & Thompson, 
2015). However, as VR is a service for employees with any condition, a tool that has reliability 
and validity in respect of a variety of conditions needs to be utilised, hence the EWPS is not 
considered suitable to be used for this research. Looking at the HWQ, this has been identified 
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in two reviews as measuring the above constructs (Mattke et al.., 2007; Brown et al., 2014); 
moreover, the Likert scale used in the HWQ has a greater range, therefore may be more 
sensitive to change after an intervention (Brown et al., 2014). The HWQ is a comprehensive 
measurement of employee presenteeism (Brown et al., 2014). It has been shown to have 
acceptable levels of construct and discriminant validity, and good convergent validity, although 
there is limited evidence on reliability and validity (Dennett & Thompson, 2015; Brown et al., 
2014). Therefore, it may be suitable as an outcome measure for this research.  
 
However, when comparing the HWQ to the WLQ. Noben et al.’s (2014) systematic review of 
self-reported instruments measuring ‘health related productivity changes’ concluded that the 
WLQ is the preferred choice of outcome as it has a strong evidence for content validity. The 
HWQ was discounted as an outcome measure.  This conclusion is not supported by Dennett & 
Thompson’s review (2015), which identifies EWPS, SPS-6 and the HWQ as the instruments 
with the best evidence in terms of their measurement properties. Although, interestingly the 
WLQ is not identified or discussed in Dennett & Thompson’s (2015) review, and therefore 
might have been an omission. Mattke et al.’s (2007) review highlights that the WLQ contains 
an additional construct: an estimation of unproductive time at work. The WLQ is a self-
administered questionnaire comprising of 25 questions. It takes 5 – 10 minutes to complete. 
The questions explore the limitations employees are experiencing at work due to their health 
problems, as well as looking at the productivity loss as a result (Lerner et al., 2003). The 
questions include work components that may be compromised by poor health, such as time 
management, physical demands, mental/interpersonal and output demands (Munir, 2008). The 
WLQ has been validated for, and used in research covering, a variety of chronic conditions and 
occupational groups (Munir, 2008; Tamminga, Verbeek, Frings-Dresen & de Boer, 2014; 
Lerner et al., 2017). Additionally, it has been shown to be sensitive to the effects of 
interventions (Shaw et al., 2014). Moreover, it can be used to provide a single Productivity 
Index score that can be used to estimate productivity loss, by comparing the percentage 
difference in output to a national database of normative data on healthy individuals (Lerner et 
al., 2009; Munir, 2008). Importantly, for this research the WLQ allows for presenteeism to be 
quantified as time, which enables presenteeism to be translated into a monetary value and used 
within an economic evaluation (Beaton et al., 2010). There is an additional component to the 
WLQ that can be used in conjunction with this tool that examines sickness absence, the WLQ 
Work Absence/time loss Module (Lerner et al., 2001) (see Appendix 3). Taking these factors 
into consideration the WLQ and the WLQ Work Absence Module were used within this study. 
90 
 
 
3.5.2.1.3 Turnover 
 
Most organisations routinely collect annual turnover figures (Oxenburg and Marlow, 2005; 
Campion, 1991). In this research turnover information will be provided by the organisations. 
 
3.5.2.2 Non-economic benefit outcome measurements used within the wider VR 
service evaluation 
 
3.5.2.2.1 Quality of Life 
 
There are a variety of instruments used to measure health states/quality of life (Joore et al., 
2010); namely, ‘EuroQol-5 dimension (EQ-5D), Health Utilities Index Mark 2 and 3, Quality 
of Well-being Scale, and the short form health measure (SF-6D) (Kim, Kim, Lee & Jo, 2014).  
These measures of health states have a value attached to them by converting them into estimates 
of quality-adjusted life-years (QALYs) (Joore et al., 2010). This value is subsequently used 
within cost-utility analysis and enables the broad effects of presenteeism and absenteeism on 
the health of individuals to be captured (Cocker et al., 2014).  The score and resulting QALY 
may differ according to the instrument of measurement, as the different measures vary in terms 
of the health descriptive states, and the ranges of ill-health and the scoring methodology (Joore 
et al., 2010). The EQ-5D and the SF-6D, both quality of life measurements, have different 
descriptive elements of quality of life, which in turn increases their sensitivity for different 
patient groups.  The SF-6D includes ‘vitality’ and ‘social functioning’ elements, which would 
increase its sensitivity for patients whose conditions impact on the social functioning of their 
lives and their levels of vitality, whereas the EQ-5D, looks at more functional elements such as 
mobility, self-care, usual activities, pain/discomfort and anxiety/depression (Joore et al., 2010). 
Additionally, the two tools differ in their description of ‘full health’ and ‘worse health’, with 
the EQ-5D reportedly having a ceiling effect (i.e. an increased proportion of respondents with 
best possible scores) when used within the general population and some patient groups. This 
ceiling effect rendered this tool more sensitive to patients with a severe health state at baseline 
(Oemar & Janssen, 2013; Joore et al., 2010). To address the ceiling effect the EuroQol tool wa 
amended to include 5 levels of severity within the existing 5 dimensions, and renamed the EQ-
5D, the EQ-5D-5L (Oemar & Janssen, 2013). 
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When considering the choice of quality of life measurement tool, a key consideration is the 
comparability of the results within the country of origin. Within the UK, the DH recommends 
that the EQ-5D-5L is used when evaluating their services; moreover, it is supported by the 
NICE and the Chartered Society of Physiotherapy (CSP, 2014). The EQ-5D-5L ‘is a 
standardised measure of health status developed by the EuroQol Group in order to provide a 
simple, generic measure of health for clinical and economic appraisal’ (Oemar & Janssen, 2013, 
p. 4). The EQ-5D-5L is a self-reported outcome measure that is used for a variety of health 
conditions and treatments/services. It is a simple quality of life measurement tool that takes a 
few minutes to complete (Oemar & Janssen, 2013). It comprises of 5 dimensions of health: 
mobility, ability to self-care, ability to undertake usual activities, pain and discomfort, and 
anxiety and depression (CSP, 2014). The strengths of the EQ-5D-5L are that it is a short 
questionnaire that takes the participant approximately one minute to complete, has good test-
retest reliability and validity, (Ijzelenberg et al., 2007), has been validated across a variety of 
conditions, including eight chronic conditions, and across six countries (Oemar & Janssen, 
2013), it allows comparability across a variety of conditions (CSP, 2014) and is widely used 
within the UK (Ijzelenberg et al., 2007). For this study, the EQ-5D-5L (EuroQol Group, 1990) 
was utilised (see Appendix 1). Although, as discussed above, the EQ-5D results can be 
converted to QALY’S and used within a cost-utility analysis, in this research, quality of life is 
measured to explore the non-economic benefits of VR as opposed to the economic benefits and 
thus is not used within the CBA tool. This ensures that the measurement of productivity is not 
duplicated (Krol et al., 2013). 
 
3.5.2.2.2 General mental health 
 
To capture psychological changes, sources of stress and predisposing factors of stress, there are 
a number of mental health measurements available such as the patient health questionnaire 
(PHQ) (Spitzer, Kroenke & Williams, 1999), WHO-5 (WHO, 1998) and the self-report tool 
General Health Questionnaire (GHQ) (Goldberg, 1972). The GHQ is commonly utilised in OH 
studies and workplace settings (Guidi, Bagnara, & Fichera, 2012; Jackson, 2007). This is 
illustrated in a review of self-reported illness at work (Lenderink et al.’s, 2012), where 33 
studies reported GHQ outcomes, compared to the two studies reporting PHQ outcomes.  
Moreover, since its inception in 1972, it has been translated into 38 different languages 
indicating its widespread use (Jackson, 2007). Using this tool enables valid comparison of 
results.  The validity of the GHQ has been determined by a number of studies (De Witte et al., 
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2010; Makowska, Merecz, Moscicka, & Kolasa, 2002; Goldberg et al., 1997), with reliability 
coefficients ranging from 0.78 to 0.95 in the various studies (Jackson, 2007). Additionally, it 
has been validated within occupational settings (Stride, Wall, & Catley, 2007). The GHQ is 
available in different versions, the 12, 28, 30 or 60 items, all of which have been shown to have 
good reliability and validity (Wang & Lin, 2011). 
 
The GHQ is easy to administer, complete and score (Jackson, 2007), and can be used to compare 
changes in individual pre-and post an intervention, as well as identify ‘cases’, i.e. individuals 
who are showing signs and symptoms of minor psychological distress (Stride et al., 2007; 
Weinberg & Creed, 2000; Goldberg, 1972). In order to identify individuals with minor 
psychological distress Goldberg (1972) specified a cut off score of greater than 3 or 4 is used 
(Stride et al., 2007; Weinberg & Creed, 2000; Goldberg, 1972). However, when people are 
physically ill, a higher threshold is recommended for optimal discrimination, hence a score of 
4 or more is recommended to be used to identify ‘cases’ (GL Assessment, 2011). The GHQ-12, 
is the shortest and most commonly used version, moreover, findings from studies indicate that 
it is as effective as the longer version in both screening and detecting cases (Wang & Lin, 2011). 
In this research, the GHQ-12 (i.e. 12 items) was utilised (see Appendix 4), and when identifying 
‘cases’ a cut off score of 4 was implemented. 
 
3.5.2.2.3 General Physical health 
 
To capture improvements in individual’s physical health there are over a hundred generic and 
condition specific outcome measures that could be used (Nelson et al., 2015; Suk, Hanson, 
Norvell, & Helfet, 2005). As the outcome measure is within a study considering work outcomes, 
it is appropriate to focus on physical function outcome measures. A previous systematic review 
identified 12 outcome measures capturing physical function (Barten, Pisters, Huisman, Takken, 
& Veenhof, 2012), of which nine were different versions of the Patient Specific Function Scale 
(PSFS) (Stratford, Gill, Westaway, & Binkley, 1995). The PSFS is a subjective scale that allows 
for measured change in identified functional limitations or goals in relation to work and life 
settings. The patient identifies up to five activities, including work related activities, that they 
have difficulties completing due to their condition and then the patient rates the functional 
limitation of these (Stratford et al., 1995) (see Appendix 4). The PSFS is a valid and reliable 
outcome measure with MSDs such as neck pain, lower back pain, and knee pain (Kowalchuk 
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et al., 2012; Fields, 2002; Cleland, Fritz, Whitman, & Palmer, 2006; Pengel, Refshauge, and 
Maher, 2004; Chatman et al., 1997). It is user-friendly, averaging four minutes to complete 
compared to other functional scales which take between eight and forty minutes (Nicholas, 
Hefford & Tumilty, 2012). Moreover, out of the twelve outcome measures identified by Barten 
et al., (2012), the PSFS was ranked the highest for construct validity, reliability and 
responsiveness. However, this result was based on Cleland et al.’s (2006) study, which only 
included 38 participants, questioning its generalisability. Considering the working population, 
Gross, Battie and Asante’s (2008) results provided ‘construct and predicative validity evidence 
for the PSFS as an indicator of functional limitation in workers’ compensations’ (p. 1294). 
Supporting the use of the PSFS to explore work outcomes in research.  
 
3.5.2.2.4 Job Satisfaction Scale 
 
The Job Satisfaction Scale (JSS) (Warr, Cook, & Wall, 1979) (see Appendix 4), is a self-report 
scale to identify satisfaction at work, widely used in organisational psychology research and 
practice (Heritage, Pollocks and Roberts, 2015). The items are rated on a seven-point Likert-
type scale, with a high score indicating high job satisfaction (Rout & Rourt, 1997).  It is a valid 
and reliable outcome measure for organisational research (Fields, 2002). 
 
3.5.2.2.5 Summary of outcome measures to be utilised in the study 
 
In summary, following a review of the literature on benefit outcome measurement tools the 
following outcome measures are used within this research: 
 
1) Economic benefit outcome measures: 
 Sickness absence, both from organisational data and self-reported, using the 
Work Limitations Questionnaire Work Absence/Time loss Module (Lerner et 
al., 2001). 
 Presenteeism/productivity, using the Work Limitations Questionnaire (Lerner et 
al., 2001). 
 Turnover 
 
2) Non-economic benefit outcome measures 
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 Quality of life, using EQ-5D-5L (Oemar & Janssen, 2013). 
 Psychological distress, using the General Health Questionnaire (GHQ-12) 
(Goldberg, 1972). 
 Patient Specific Function Scale (PSFS) (Stratford et al., 1995). 
 Job Satisfaction Scale (JSS) (Warr et al., 1979). 
 
The outcomes used for the two organisations differed. Table 5 summarises the outcomes 
considered for each organisation, the outcome measurement tools used, where the data was 
gathered from, whether the outcome data was used within the new CBA tool or as part of the 
wider VR service evaluation, and the justification for the use or exclusion of considered 
outcomes.  
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Table 5: Summary of outcomes considered and used within this research for organisation 1 and 2 
 
Outcome 
 
Used or 
considered 
for use? 
Outcome 
measurement 
tools used. 
Where the data 
was obtained 
from? 
Was the data used within 
the CBA tool or as part of 
the wider service 
evaluation?  
Justification for use or exclusion. 
Organisation 1 
Costs 
Cost of the VR 
Service 
Used n/a Organisation 1  CBA tool  
Benefits  
Economic benefits 
Sickness absence 
due to 
musculoskeletal 
disorders 
Used 
Electronic 
sickness absence 
records  
Organisation 1  CBA tool 
Common method of collecting sickness absence. 
Sickness absence is commonly used as a proxy 
for productivity (van Dogen et al., 2014; Krol et 
al., 2013; Zhang et al., 2011; van Oostrom et al., 
2010). 
Sickness absence 
due to mental 
health 
Used 
Electronic 
sickness absence 
records  
Organisation 1  CBA tool 
Common method of collecting sickness absence. 
Sickness absence is commonly used as a proxy 
for productivity (van Dogen et al., 2014; Krol et 
al., 2013; Zhang et al., 2011; van Oostrom et al., 
2010). 
Sickness absence 
due to other causes 
Considered 
Electronic 
sickness absence 
records 
Organisation 1  n/a 
At the start of the research project MSDs and 
mental health conditions were the two most 
common causes of sickness absence (CIPD, 
2014a; ONS, 2014). Thus, these conditions were 
focused on.  
Turnover Considered  
Organisational 
turnover data 
n/a n/a 
The organisation was undergoing major 
restructuring, resulting in a high number of 
redundancies during the project. The turnover rate 
would not be a true reflection 
Hidden costs  
 
Considered  n/a n/a n/a 
Although multipliers are used in some instances 
to estimate hidden costs, these have been varied 
and it is recommended that organisations 
calculate their own hidden costs (Oxenburgh & 
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Marlow, 2005). No appropriate data was supplied 
by the organisation to allow for this.    
Non-economic benefits 
Job satisfaction Used 
Job Satisfaction 
Scale (Warr et al., 
1979) 
Participants  Service evaluation 
It is a widely used (Heritage et al., 2015), valid 
and reliable outcome measure for organisational 
research (Fields, 2002). 
General mental 
health 
Used 
General Health 
Questionnaire 
(Goldberg, 1972) 
Participants Service evaluation 
It is commonly used in OH settings (Guidi et al., 
2012; Jackson, 2007). It has good validity and 
reliability (Stride et al, 2007; Wang & Lin, 2011). 
It enables the identification of participants with 
psychological distress (Weinberg & Creed, 2000; 
Goldberg, 1972). 
General physical 
health 
Used 
Patient Specific 
Function Scale 
(Stratford, Gill, 
Westaway, & 
Binkley, 1995) 
Participants Service evaluation 
User friendly (Nicholas et al., 2012) and has high 
construct validity, reliability and responsiveness 
when compared to other similar measures (Barten 
et al., 2012). 
 
Organisation 2 
Costs 
Specific costs of the 
VR service 
Considered n/a VR service  n/a 
The costs provided were incomplete. The costs 
provided were just under the annual budget 
supplied for the organisation so it was decided to 
use the annual budget. 
Annual budget of 
the VR service 
Used n/a Organisation 2 CBA tool  
Benefits 
Economic benefits 
Sickness absence 
due to 
musculoskeletal 
disorders and 
mental health 
conditions 
Used 
Electronic 
sickness absence 
records  
Organisation 2 CBA tool 
Common method of collecting sickness absence. 
Sickness absence is commonly used as a proxy 
for productivity (van Dogen et al., 2014; Krol et 
al., 2013; Zhang et al., 2011; van Oostrom et al., 
2010). 
Used 
Work limitations 
questionnaire 
work absence 
Participants 
n/a due to low number of 
participants (n=3)  
Some VR services may not have access to the 
organisations sickness absence data. This 
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module (Lerner et 
al, 2001) 
outcome measurement tool would allow them to 
collect sickness absence data.  
Sickness absence 
due to other causes 
Considered 
Electronic 
sickness absence 
records 
Organisation 2  n/a 
At the start of the research project MSDs and 
mental health conditions were the two most 
common causes of sickness absence (CIPD, 
2014a; ONS, 2014). Thus, these conditions were 
focused on.  
Turnover Used 
Organisations 
electronic records 
Organisation 2 CBA tool  
Presenteeism Used 
Work limitations 
questionnaire 
(Lerner et al, 
2001) 
Participants 
n/a due to low number of 
participants (n=3) 
It has strong evidence for content validity (Noben 
et al., 2014) and is validated in occupational 
groups (Munir, 2008; Tamminga, Verbeek, 
Frings-Dresen & de Boer, 2014; Lerner et al., 
2017). It considers unproductive time at work and 
explores work limitations due to participants 
health condition (Mattke et al., 2007). It allows 
for presenteeism to be quantified as time, which 
enables presenteeism to be translated into a 
monetary value and used within an economic 
evaluation (Beaton et al., 2010) 
Hidden costs  
 
Considered  n/a n/a n/a 
Although multipliers are used in some instances 
to estimate hidden costs, these have been varied 
and it is recommended that organisations 
calculate their own hidden costs (Oxenburgh & 
Marlow, 2005). No appropriate data was supplied 
by the organisation to allow for this.    
Non-economic benefits 
Quality of life 
Used 
 
Quality of life, 
using EQ-5D-5L 
(Oemar & 
Janssen, 2013). 
 
Participants 
n/a due to low number of 
participants (n=3) 
Validated in 8 conditions and across 6 countries 
(Oemar & Janssen, 2013). It is advocated to be 
used and widely used within the UK (CSP, 2014). 
It can be converted to a monetary value and used 
within a cost-utility evaluation (Joore et al., 2007; 
Cocker et al., 2014). In this research it was not 
considered as an economic benefit so as to ensure 
that the measurement of productivity was not 
duplicated (Krol et al, 2013). 
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3.5.3 Methodology for determining the reference case, the intervention case and 
the net effectiveness percentage for each outcome 
 
In order to add the outcomes/benefits, of relevance to organisations purchasing or providing 
VR, to the GM new economy model namely: sickness absence due to musculoskeletal 
disorders, sickness absence due to mental ill-health, presenteeism and turnover; the intervention 
case (i.e. what happens when the intervention is put in place), the reference case (i.e. what 
would happen without the intervention been in place), the deadweight estimation (i.e. what 
percentage outcome would have occurred without the intervention), and unit cost for each 
outcome of interest, need to be calculated (McPherson & Inglis, 2008; HM Treasury, 2011; Cox 
et al., 2011).  The HM Treasury Green Book (2011) defines deadweight as: 
 
‘Outcomes which would have occurred without the intervention. Its scale can be 
estimated by assessing what would have happened in the ‘do minimum’ case, ensuring 
that due allowance is made for other impacts which impact on the net additionality’ 
(p.57).  
 
The methodologies for identifying the reference and intervention case, deadweight, and unit 
costs will be discussed in turn. 
 
The reference and intervention case are calculated from data extracted from current literature. 
There are a number of methodologies that could be used to identify the relevant data, such as 
meta-analysis ‘a formal statistical framework with which we can rigorously combine and 
compare the results of these experiments’ (Harrison, 2011, p.1), a review of the published 
literature, a review of the grey literature and expert opinion (Cox et al., 2011; Henrichson & 
Rinaldi, 2014). The gold standard when developing CBA models is to use the data from RCTs 
(Henrichson & Rinaldi, 2014; Glick, Polsky, & Shulman, 2001; Johnston, Buxton, Jones & 
Fitzpatrick, 1999). However, in cases where it is not possible to evaluate an investment with an 
RCT, such as in the organisations presented in this research, or where there are data or resource 
limitations, the values of benefits, deadweight, impact and lag can be difficult to source (CEEU, 
2011; Cox et al., 2011). The CEEU (2011) suggest that reference values may be found in sector 
specific models, previously conducted research studies and Value for Money reviews. Cox et 
al. (2011) support this view, additionally suggesting consultation with experts in cases where 
no values can be found. Research in any discipline is rarely uniform, with a variety of research 
designs, outcomes and participant variabilities present, rendering the synthesis of the results to 
confirm or refute a hypothesis difficult (Cochrane, no date; Harrison, 2011). Moreover, as 
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discussed in the literature review (see section 2) the evidence-base for VR is not homogenous 
in terms of interventions, and the quality of the evidence is limited.  Although a meta-analysis 
is one of the recommended procedures, it is not an appropriate methodology for this study as it 
relies on the underpinning studies been homogenous, valid and robust (Cooper, 2009). For this 
research, a review/synthesis of the published literature was conducted, the results analysed and 
general trends were identified in order to identify the reference and intervention case and 
subsequently deadweight. The limitations of using the evidence-base to develop outcomes are 
that suitable studies may not be found/published, studies may not have the same dependent 
variable, and different studies may not be comparable (Liberati et al., 2009).  To account for 
any limitations in the data used to identify the reference and intervention case, and subsequently 
deadweight, optimism bias corrections was applied to the data (as discussed in section 3.3 and 
3.4). Moreover, to further address the limitations mentioned, sensitivity and scenario analysis 
will be performed (as discussed in section 3.4).  
 
For this research, the following framework and definitions of terms were used. Firstly, the 
baseline, which is defined as a starting point within economic evaluations, needs to be clarified 
(Dritsaki, Achana, Mason & Petrou, 2017; McPherson & Inglis, 2008; National Centre for 
Environmental Economics Office of Policy U.S., 2010). In this research, the starting point is a 
set time period prior to the employee’s first appointment with the VR service. In addition, it is 
necessary to specify the end point (National Centre for Environmental Economics Office of 
Policy U.S., 2010), which for this scenario is one year later. When evaluating health outcomes, 
it is important to note that the individual’s health will most likely change from the baseline 
measurement with or without an intervention. The intervention and the reference case need to 
be determined in order to calculate the deadweight (McPherson & Inglis, 2008) (Refer to Figure 
7).  
 
Moreover, it is necessary to clearly outline the assumptions underlying the reference and 
intervention cases for each outcome (National Centre for Environmental Economics Office of 
Policy U.S., 2010), refer to Table 6 for the assumptions underpinning each outcome. 
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Table 6: Assumptions underpinning the reference and intervention case for each outcome 
 
Assumptions common to all outcomes (i.e. sickness absence due to MSDs, sickness absence due to mental health conditions, presenteeism and turnover):  
- 100% of the impact of the intervention will be realised within one year. 
- Usual care has similar influences on all outcomes across the different studies and countries. 
- The outcome (i.e. number of sickness absence days per MSDs and per mental health condition, presenteeism levels and turnover rates) is similar across different 
countries. 
- The starting point of the reference case and intervention case is a set time period prior to the intervention, and the end point in this scenario is one year later. 
Assumptions specific to individual outcomes: 
Sickness absence due to MSDs Sickness absence due to mental health 
conditions 
Presenteeism Turnover 
The mean number of sickness 
absence days per year is a true 
representation of sickness 
absence for employees 
accessing usual care, and 
accounts for relapses employees 
may experience.  
 
The mean number of sickness absence days per 
year is a true representation of sickness absence 
for employees accessing usual care.  
The mean percentage of presenteeism 
per year is a true representation of 
presenteeism for employees 
accessing usual care 
The turnover rate per year, up until the 
implementation of the VR service, is a true 
representation of turnover for employees 
accessing usual care.  
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Table 6 outlines the assumptions made by the researcher. These assumptions guide the 
researcher in identifying the reference and intervention. Outlining these assumptions provides 
clarity and transparency to the analysis (National Centre for Environmental Economics Office 
of Policy U.S., 2010). In addition, outlining the assumptions provides detail on whether 
adjustments, such as compounding, discounting, or inflation are necessary. As the VR 
intervention is introduced over a short period and the CBA model assumes that 100% of the 
impact of the intervention will be realised within one year, no adjustments such as 
compounding, discounting or inflation are necessary (Cowen & Katten, 2009). 
 
A unique aspect of this research project is that in order to determine the reference case, 
intervention case and deadweight, the usual CBA model (refer to Figure 7) has been flipped 
(refer to Figure 8), in other words a mirror image of a usual CBA model has been created. This 
flipped model was created to illustrate that the intervention outcome i.e. sickness absence from 
an organisational perspective has a finite benefit, once the employee is healthy and back in work 
the benefit of the intervention ceases. This differs from a typical CBA intervention benefit for 
example getting people back into work from a societal perspective where one may expect 
benefits to continue infinitely due to an individual starting in the job market (refer to Figure 7). 
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Figure 7: Graphical representation of deadweight (calculating additionality) (employment example) 
(adapted from Source: Adapted from European Commission (2003) The Evaluation of Socio-Economic 
Development, The Guide, December European Commission, Directorate General for Regional Policy: 
Brussels, cited in McPherson & Inglis (2008)) 
 
 
 
Figure 8: Graphical representation of deadweight (sickness absence example) (adapted from Source: 
Adapted from European Commission (2003) The Evaluation of Socio-Economic Development, The Guide, 
December European Commission, Directorate General for Regional Policy: Brussels, cited in McPherson 
& Inglis (2008)) 
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To further explain Figure 8, and define the key terms underpinning this model, the downward 
sloping red and blue lines illustrate a percentage reduction in sickness absence days, from the 
baseline/starting point (total number of sickness absence days prior to the intervention) to the 
outcome (total number of sickness absence days post the intervention).  If the intervention 
resulted in no (zero) sickness absence days, there would be a 100% reduction in sickness 
absence. The blue line (the reference case) indicates what would happen if there was no 
intervention and the red line (the intervention case) indicates what would happen if there was 
an intervention. The reference case (blue line) is not observed during the research and thus 
needs to be estimated (see below). The additional benefit/net effect is the difference in the 
percentage reduction of sickness absence days due to the intervention, compared to percentage 
reduction of sickness absence days from no intervention (the counter-factual). The net effect is 
determined by the review of the literature. The counter factual (the assumed outcome without 
an intervention) is not known, and thus needs to be calculated. The following calculation will 
be used to calculate the counterfactual: 
 
Counterfactual = outcome 
     1-net effect % 
 
For example, if the intervention outcome is 10 and the consensus within the literature is that the 
net effect of an intervention is 20%. Then the counterfactual is 1/(1-0.2) = 12.5. Without the 
intervention, the estimated outcome (reference case) is 12.5 and so the intervention outcome is 
20% lower. 
 
Once the counterfactual is calculated, the deadweight percentage can be determined using the 
following calculation: 
 
Deadweight % = starting point - counterfactual 
                starting point 
 
As the CBA model for this research has been flipped (see Figure 7 and 8), the definition of 
deadweight changes. It is no longer what percentage of the outcome that would have occurred 
without the intervention, but what percentage of the employee’s recovery would have occurred 
without the intervention.  
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To summarise, in order to add the outcomes/benefits to the GM new economy model, the 
reference case, intervention case, deadweight and cost need to be determined. The intervention 
case, the starting point and the outcome are determined from the organisations sickness absence 
data provided in phase 2 of this research, the reference case and deadweight are determined by 
calculating the counterfactual based on the estimated net effectiveness of the interventions 
(which is determined by a review of the literature, see section 3.5.4). The methodology for 
determining the costs is discussed in section 3.5.5. 
 
3.5.4 Literature review search strategy 
 
As discussed in section 3.5.3, a literature review is the first step in determining the reference 
and intervention case for each outcome. In order to conduct a thorough literature, a search 
strategy and inclusion and exclusion criteria need to be determined and outlined for each 
outcome (Greenhalgh, 1997; Staples & Niazi, 2007; Egger, Smith & Phillips, 1997). In order 
to determine a reference case, it is necessary for the outcome data (in this case sickness absence 
data), to be presented in a consistent, comparable manner, enabling the extraction of a mean 
difference; moreover, a homogenous intervention and population group enable comparison 
(Stroup et al., 2000; Egger et al., 1997).  Too stringent inclusion and exclusion criteria, 
restricting heterogeneity may lead to selection bias (Stroup et al., 2000). Conversely, when 
heterogeneity is too great, a single summary measure may not be appropriate (Stroup et al., 
2000). As a single summary measure is needed to determine a reference case, the inclusion and 
exclusion criteria need to ensure homogeneity of the included articles. In order to ensure 
homogeneity of the outcome data, inclusion and exclusion criteria were outlined regarding the 
type of study, the presentation of the data, the age of the data and the population and intervention 
(see Table 7, below).   
 
Sickness absence is a complex subject, and further consideration is needed when identifying 
inclusion and exclusion criteria related to this. Examining the sickness absence data over a year 
allows for the impact on reoccurrence of sickness absence to be included. This is particularly 
pertinent when considering mental health conditions. It is widely known that employees absent 
from work with common mental health conditions have an increased risk of reoccurrence 
(Knudsen, Harvey, Mykletun, & Overland, 2012; Koopmans, Bultman, Roelen, Hoedeman, van 
der Klink & Groothoff, 2011; Nielsen et al., 2010; Roelen, Koopmans, Anema & van der Beek, 
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2010). In fact, Koopmans et al. (2011) looked at 9,904 employees with first time sickness 
absence due to mental health conditions, and found that 19% of employees had a reoccurrence 
of sickness absence, and 90% of these were within the first 3 years. Considering the known 
reoccurrence rate, it would be appropriate to use ‘mean annual sickness absence days’ per year 
as an outcome, as opposed to ‘time to RTW’ which is commonly used an outcome within 
research into mental health and sickness absence (Fleten & Johnsen, 2006; Lander, Friche, 
Tornemand, Andersen, & Kirkeskov, 2009; Dewa, Hoch, Carmen, Guscott, & Anderson, 2009; 
Sogaard & Bech, 2009). The use of the outcome ‘time to RTW’ may be due to the fact that 
sickness absence due to mental health disorders is commonly long-term (Nielsen et al., 2010), 
and consequently this outcome is of importance when considering the efficacy of interventions. 
Moreover, considering 90% of reoccurrences happen within the first 3 years following the 
initial episode (Koopmans et al., 2011), there is limited long-term research as is evidenced by 
NICE (2009b) ‘Workplace health: long-term sickness absence and incapacity to work 
guidelines’, which recommend that evaluations ensure a long-term follow-up enabling all work 
outcomes to be adequately evaluated.  These guidelines were reviewed in 2014 and no changes 
to this recommendation were implemented.  
 
Outlining a search strategy prior to conducting research helps reduce the bias that surrounds 
literature reviews, such as citation bias (only including studies that are supportive of the 
published results), database bias (using common databases which may have limited 
publications from developing countries) and biased inclusion criteria (authors selecting papers 
that support their viewpoint) (Stroup et al., 2000; Egger & Smith, 1998). Literature reviews are 
also at risk of publication bias, as it has been found that the chances of publishing are three 
times higher if the results are significant (Duval & Tweedie, 2000; Easterbrook, Berlin, Gopalan 
& Matthews, 1991), thus it is good practice to explore the grey literature.  The literature search 
and data extraction were conducted by the researcher, which may have introduced error, as it is 
best practice to have two blinded researchers to complete this element of the research process 
(Egger et al., 1997). See Table 7 for an outline of the inclusion/exclusion criteria in the search 
strategy, the databases searched, key terms, and limitations. The date limitations vary, as the 
searches for different outcomes were conducted at different stages of the research process.  
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Table 7: Methodology for determining the reference and intervention case for each economic outcome 
 
Outcome Sickness absence due to MSDs Sickness absence due to mental 
health conditions 
Presenteeism Turnover 
Search Strategy:  As the evidence-base for VR is an emerging field, workplace interventions were used as a proxy for VR 
Databases searched Cinahl, Medline (EBSCO, OVID, 
Web of Science (WoS)), Cochrane 
and Business Source Premium 
(BSP). 
In addition, citation tracking was 
utilised. 
EBSCO host: including Medline, 
Business Source Premium, 
Academic Search Premier, Sports 
Discuss and Cinahl; Web of Science 
(core database), OVID host: 
including Psychinfo, HMIC, Ovid 
Medline; Cochrane. In addition, 
citation tracking was utilised. 
Cinahl, Medline (EBSCO, 
OVID, Web of Science 
(WoS)), Cochrane and 
Business Source Premium 
(BSP). In addition, citation 
tracking was utilised. 
Cinahl; EBSCO host: including 
Medline, Business Source Premium, 
Academic Search Premier, Sports 
Discuss; Web of Science (core 
database), OVID host: including 
Psychinfo, HMIC; Cochrane. In 
addition, citation tracking was 
utilised.  
  
Limitations 2000 - 2015 
Academic journal article. 
2007 – 2017 
Academic journal article. 
2000 – 2015, RCT’s, English 
language, Academic journal 
article. 
 
2007 – 2017 
Academic journal article. 
 
Key terms See Appendix 5.1 for search terms. See Appendix5.2 for search terms. See Appendix 5.5 for search 
terms. 
 
See Appendix 5.4 for search terms. 
Inclusion/Exclusion 
criteria 
- Employed individuals who are off 
work due to MSDs. 
-  The inclusion of a control or 
comparator group. 
-  The data on sickness absence days 
presented as a mean over a year.  
- The sickness absence data is less 
than 20 years old.  
 
- Employed individuals who are off 
work due to mental health 
conditions.  
- The inclusion of a control or 
comparator group. 
- The data on sickness absence days 
presented as a mean over a year.  
- The sickness absence data is less 
than 20 years old.  
- Employed individuals.  
- The inclusion of a control or 
comparator group.  
- The data on presenteeism 
presented as a mean change 
between pre and post. 
- The presenteeism data is 
less than 20 years old.  
- Employed individuals who are off 
work due to mental health conditions 
or MSDs.  
- The inclusion of a control or 
comparator group. 
- The data presented as turnover 
rates. 
 - The turnover data is less than 20 
years old. 
Last searched 21 March 2015 18 April 2017. 
 
21 March 2015 25 March 2017 
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3.5.5 Calculating costs to be used in the CBA tool 
 
3.5.5.1 Sickness absence costs (MSDs and Mental ill-health) 
 
When looking at the sickness absence data, the methods used to calculate the cost of sickness 
absence needs to be clearly stated, as do the inclusion and exclusion criteria. Currently, there is 
inconsistency within the literature, with economic evaluations using various methods of calculating 
sickness absence (Kigozi, Jowett, Lewis, Barton, & Coast, 2016; Krol et al., 2013; Uegaki et al., 
2011). For the purposes of this study, absence due to maternity/paternity leave, compassionate 
leave, bereavement and ‘no-reason provided’ are excluded. In organisation 1, the VR intervention 
(described in section 1.4.1) was aimed at MSDs, hence only sickness absence due to MSDs was 
included. In organisation 2, the VR intervention (described in section 1.4.2), was aimed at all 
sickness absence causes, thus, all reasons of sickness absence are included, but separated into 
different conditions, mental health disorder, MSD and other, to allow for sickness absence due to 
MSDs and mental health disorder to be further explored in the CBA. Additionally, absence was 
separated into less than and > 6-months. This is due to the fact that when individuals are off work 
for longer than 6-months the RTW rate drops with Squires et al.’s (2012) synthesis suggesting that 
the RTW percentage in this group may be as low as 2.3. With regards to calculating the cost, in 
organisation 1, the cumulative net work days lost (including part and whole) were converted into 
work hours, based on the average work week consisting of 37.5 hours, i.e. 7.5 hours per day. This 
was based on information provided by the organisations as to the average number of hours worked 
per week. In terms of part days, it was assumed that participants were 100% productive during 
work hours. The same procedure and assumptions are applied to the data from organisation 2. 
 
There is a debate in the literature around which methods are most appropriate to measure 
productivity, with no consensus within existing national guidelines (Kigozi et al., 2016). It is 
commonly accepted that sickness absence is a measure of productivity (Kigozi et al., 2016; Uegaki 
et al., 2011; Krol et al., 2013). However, when calculating the costs of sickness absence, there is a 
debate within the economic health field as to whether one should use the human capita (HC) or 
friction costs (FC) approach, discussed in more detail below (Kigozi et al., 2016; van Dongen et 
al., 2014; Krol et al., 2013, Rost, Meng, & Xu, 2014). The most commonly used approach is the 
human capita approach (Kigozi et al., 2016; Stromberg, Aboagye, Hagberg, Bergstrom, Lohela-
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Karlsson, 2017; Rost et al., 2014). The HC approach estimates the loss of production due to 
absence, and the expected or potential earnings lost (Rost et al., 2014; van Asselt, Dirksen, Arnt, 
& Severns, 2008). The cost of sickness absence is calculated using the following calculation: 
 
 Time lost units (full time equivalent work days) * price weight per time unit (population mean) 
 (Gold, Siegel, Russel, & Weinstein, 1996). 
 
The WHO (2009) cautions against the reliance on the HC approach as ‘it is unrealistic in most 
settings (where a pool of underemployed or unemployed labour exists)’ (p. 97). In addition, it is 
unclear as to whether this approach under or over-estimates the cost of absence, as it does not take 
into account the impact of sickness absence on production, nor the work that the colleagues, agency 
staff or newly hired staff may do to compensate for their absence (van Dongen et al., 2014; Jo, 
2014; Rost et al., 2014). The FC approach assumes that costs of sickness absence are ‘limited to a 
friction period (i.e. the time it takes to find a replacement), and that the decrease in productivity is 
less than 100% of the time lost at work (i.e. elasticity)’ (Koopmanschap et al., 1995 cited in: Spekle 
et al., 2010, p. 4). The FC approach attempts to quantify actual loss of production, and varies 
according to the wider labour market, as the labour market determines how long it takes to find a 
replacement (Kigozi et al., 2016; Jo, 2014; van Asselt et al., 2008). Additionally, FC includes costs 
such as recruitment and training (Kigozi, et al., 2016; Jo, 2014; van Asselt et al., 2008). However, 
the FC is rarely used, outside of the Netherlands (Kigozi et al., 2016), as it requires a large amount 
of data to accurately calculate the friction period, and when organisations use their own labour 
supply through mechanisms such as over-time, it is harder to accurately capture and quantify, 
compared to the HC approach which requires a simple wage calculation as a proxy for employee 
productivity (Jo, 2014; Lensberg, Drummond, Danchenko, Despiegel, & Francois, 2013). To my 
knowledge, there is no UK national database with a friction period for sickness absence. The 
disruption correction or multiplier effect considers that the cost of sickness absence may be 
underestimated as the disruption on productivity is not accounted for (Rost et al., 2014; Lensberg 
et al., 2013).   
 
Rost et al. (2014) explored the results of a return on investment analysis using these different 
methods of calculating costs of absence and presenteeism. Upward adjustments (disruption 
correction) were used to compensate for under estimating costs and friction downward adjustments 
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were used to compensate for co-workers and replacement workers compensating for the absence, 
as well as, in the case of presenteeism, co-workers or the employee (when feeling better) 
completing the workload assigned to them. Rost et al. (2014) concluded that when conducting a 
return on investment, three methods of calculating the cost of absence are utilised to provide a 
range of estimates. In addition, from the employer’s perspective it is recommended that when 
labour substitutions are regularly used the FC method is utilised. Within this research project, the 
three methods identified by Rost et al. (2014), namely: HC approach; disruption correction, which 
is adjusting the HC result to account for co-worker disruption; and the FC which accounts for 
labour substitution, were considered, but due to the lack of data collected by the organisations, both 
the FC and disruption cost could not be calculated. Thus, productivity in organisation 1 and 2 was 
calculated using the HC approach. 
 
Hours of absence were used as a proxy for productivity loss in organisation 1. In organisation 2, 
hours of absence are also used as a proxy for productivity loss and the following costs relating to 
sickness absence are included; Occupational Sick Pay (OSP) and National Insurance (NI) 
contributions.   
 
3.5.5.2 Presenteeism costs 
 
The overall costs of presenteeism to the economy, organisations and society are discussed in 
section 1.1.2 and 2.2.2. This section considers the cost of presenteeism per employee. There is 
currently no established and validated method of determining the costs of presenteeism, and there 
are a wide range of assumptions surrounding costing presenteeism (Hampson et al., 2017; Garrow, 
2016). There are two commonly used methods to determine the costs of presenteeism, the first 
method is to apply an absenteeism-presenteeism multiplier. The costs of presenteeism have been 
estimated at between 1.8 and 10 times the cost of absenteeism (Virgin Pulse, 2017, cited in 
Hampson et al., 2017; Brown et al., 2014; Sainsbury Centre for Mental Health, 2007). The choice 
of the multiplier will influence the results either towards higher or lower costs. The second 
approach considers the number of presenteeism days and calculating a cost of this considering the 
industry and absence cost (Hampson et al., 2017). Sainsbury Centre for Mental Health (2007), 
using data from US research, calculated, for the UK, the cost of presenteeism per employee is £605 
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per year. At the time of populating the CBA tool for organisation 1, these were the figures available, 
and it was recommended that if an organisation does not have data to estimate productivity loss 
due to ill-health within the workplace that the figure of £605 per employee is used as a national 
estimate (CIPD, 2008). 
 
In organisation 2, the Work Limitation Questionnaire (WLQ) (Lerner et al., 2001) (discussed in 
section 3.4.1.1.2) is used as a measure of presenteeism. The productivity loss score from this 
questionnaire is derived from weighting the score from the four scales; time management, physical, 
mental-interpersonal, and output. This score represents a percentage reduction in productivity in 
the 2-weeks prior to answering the questionnaire compared to normal productivity (Lensberg et al., 
2013). Using the HC approach, this percentage, is then converted into a percentage loss of average 
weekly hours worked, and the cost is the hourly wage of an individual. However, Schultz et al. 
(2009) raise the question as to whether those individuals are 0% productive during those hours. 
Currently, there is no consensus of how to calculate presenteeism using a FC approach, and 
according to Kigozi et al. (2016), of the 46 studies they found that used the FC method of 
calculating productivity loss only one study included presenteeism costs. Thus, presenteeism costs 
were planned to be calculated from the WLQ scores, using the HC approach. However, as there 
was insufficient data collected in this research project to facilitate this, the CIPD recommendation 
of a cost of £605 per employee was utilised within the CBA tool.   
 
3.5.5.3 Turnover costs 
 
When considering costs of sickness absence, it is important to consider the indirect costs of ill 
health, which extend beyond the lost productivity of the individual (Pugner, Scott, Holmes, & 
Hieke, 2000). Indirect costs include agency costs/over-time costs, turnover rates and costs, loss of 
working skills of individuals, business reputation, cost of care lost earnings and lost opportunities 
of earnings of family members (Cagno et al., 2013; WHO, 2003; Scottish Intercollegiate Guidelines 
Network (SIGN), 2000) (see section 3.5.1). These costs are difficult to quantify (Cagno et al., 
2013). It is acceptable practice to use a multiplier, which is dependent on the direct costs, to 
estimate the indirect costs (Cagno et al., 2013; Uegaki et al., 2010). However, in a review of 
publications using this method, it was found that the multiplier varied between and 2 and 50 (most 
common was 3x and 4x), indicating difficulties in choosing the multiplier number (Barra, 2010, 
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cited in Cagno et al., 2013). Oxenburgh and Marlow (2005) propose deriving the hidden costs for 
each organisation, as opposed to applying a blind multiplier. Ideally, indirect costs such as turnover 
costs would be included (van Asselt et al., 2008; Pilgrim, Carroll, Rick, Jagger, & Hillage, 2008). 
These costs are included in organisation 2, however, organisation 1 (see section 1.4.1) had major 
organisational restructuring during the time of data collection, with high levels of staff 
redundancies and turnover, rendering the inclusion of turnover inappropriate.   
 
According to the CIPD (2014b) the majority of employers do not record or calculate the costs of 
absence such as turnover. For the purposes of the CBA tool, providing a benchmark turnover cost 
is necessary. The CIPD (2013; 2014b) calculated the average costs of turnover and recruitment to 
be £7750 per employee.  The Sainsbury Centre for Mental Health (2007) calculated an average 
cost of turnover, recruitment and training per employee as £11,625, 40% of the average salary.  
This is significantly higher than the CIPD estimate, Levy et al. (2014) concluded that the CIPD 
figure seems to be a low estimate when comparing “to the US evidence which puts the full cost of 
staff turnover at 50% of the salary” (p. 27).  Interestingly, a national study by Oxford Economics 
in 2014, cited in ERS Research and Consultancy (2016), estimated the average cost of replacing 
an employee as £30,614. This figure was based on the logistical costs of finding a new employee 
as well as the wage costs until the new employee is working at full productivity (ERS Research 
and Consultancy, 2016).  It is seen from these three sources cited that there is a large variability in 
the estimates of the costs of turnover. This may be explained by considering the variability in the 
costs to organisations of different sizes, the differences across business sectors and the poor data 
keeping/monitoring of costs by organisations within the UK (Black & Frost, 2011). For the 
purposes of this model, if organisations do not have turnover costs, the average between the three 
estimates was used, i.e. £16,663.  
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3.6 Methodology Phase 2:  
 
Figure 9: Diagrammatic representation of the 4 phases of this research project highlighting phase 2 
 
 
 
 
 
 
 
 
 
This section firstly outlines the research design used for both organisations (described in section 
1.4), describing its strengths and limitations. And then provides further details on the research 
methods specific to each of the two organisations, illustrating the differences between these for 
both organisations, such as the aims, data collection methods, outcome measures used and 
populations. 
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In order to meet the objective for phase 2, namely; 
 
3. To collect the relevant data required to populate the revised practical CBA tool from two VR 
Services and the organisations to which VR is provided. 
 
The research design used for both organisations is a pre-experimental, single factor (one way) 
repeated-measures, within-group (time series) (pre-intervention, post-intervention and 3-6-month 
post-intervention), i.e. participants are measured on more than one occasion, the independent 
variable is ordinal (e.g. repeated observations over a time period) and the dependent variable is 
interval and continuous (Frost, 2015; Jupp, 2014; Ellis, 1999). The simplest version of this is a pre 
– post-test (Ellis, 1999), and this design is used for this project.   
 
Although using control groups is considered methodologically robust when looking for casual 
inference (Grant & Wall, 2009; Shadish, Cook & Campbell, 2002), this is not always practical or 
possible. The difficulties in including a control group within studies in organisations are well 
documented (Edmondson & McManus, 2007; Mitchie & Williams, 2003). In this research, in both 
organisations the VR service is offered to all employees, and therefore it is not possible to include 
a control group. To overcome the lack of a control group the repeated-measures time series design 
was used. The strength of the time series design is that is allows for the identification of shifts over 
time in participants knowledge, attitudes or behaviour that are influenced by the intervention 
(Colosi & Dunifon, 2006; Sutton, Baum & Johnston, 2005; Coyle, Boruch & Turner, 1991). 
However, the pragmatic use of one group, with no control/comparator group, limits the external 
validity/generalisability of the research, as well as the ability to determine causality (Shadish et al., 
2002; Mitchie & Williams, 2003). Additionally, a weaknesses of this study design is the risk of 
participant bias, specifically, response shift bias, i.e. a ‘change in the participant’s metric for 
answering questions from the pre-test to the post-test due to a new understanding of a concept being 
taught’ (Klatt & Taylor-Powell, 2005, cited in Colosi & Dunifon, 2006, p. 2).  
 
To overcome the limitations of no comparator group, the GM CBA model outlined in the literature 
review incorporates a deadweight figure i.e. what would have happened had the intervention not 
been in place, allowing the intervention to be compared to the standard/norm. This value will be 
identified in phase 1. Additionally, normative data from the organisation has been collected, i.e. 
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overall sickness absence data trends, attrition rate etc. By including the follow-up time periods of 
3-months (in organisation 2) and 6-months (in organisation 1), this will allow for the sustainability 
of the change to be explored, i.e. the extent to which the health benefits are maintained after the 
support from the VR service has been removed (Stirman, et al., 2012). According to Breakwell et 
al. (2012) it is unlikely that changes will be maintained if the treatment does not have an effect, 
however, this is not entirely accurate, as it could be argued that extraneous variables influenced the 
results in the follow-up, even though the initial intervention had been effective (Stirman et al., 
2012). All results need to be interpreted bearing these limitations in mind. 
 
3.6.1 Organisation 1 
 
Organisation 1 (as described in section 1.4.1) is an in-house VR service for employees with MSDs 
within a NHS Primary Care Trust. This section outlines the specific methodology used for the 
evaluation of organisation 1.  
 
3.6.1.1 Aims: 
 
The overall research project aims are: 
1. To develop economic outcomes, to be used within an existing CBA model, in order to ascertain 
the efficacy of a practical CBA tool in evaluating the costs and benefits of VR interventions and 
services. 
2. To implement and explore the practical application of the revised CBA tool, including the 
developed outcomes, using data from two VR services. 
 
In order to achieve this relevant data need to be collected to populate the revised CBA tool (Phase 
2: collect primary and secondary data from 2 VR services to populate the costs and outcomes of 
the CBA tool). This data was collected through conducting evaluations of two VR 
organisations/services. Each evaluation had specific aims to ensure that the relevant data was 
collected.  
 
Looking at organisation 1’s aims (the focus of this section) these were: 
a) To assess the impact of the VR service on the health of employees with MSDs. 
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b) To assess the impact of the VR service on employees with MSDs sickness absence and 
the associated costs. 
c) To determine the costs and benefits of the VR service. 
 
3.6.1.2 Methodology: 
 
The methodology reported here, relates to the quantitative section of the mixed methodology 
approach (see section 3.2 for further discussion). The evaluation was a pre-experimental repeated-
measures within-group (time series) (pre-intervention, post-intervention, 3 and 6-month post-
intervention follow-up (see section 3.6 for further discussion).  
 
When deciding on a service evaluation model, a common question is whether to use an internal 
(using an individual or group directly involved with the service) or external model (using an 
external evaluator who is independent to the model) (Menestrel, Walahoski, & Mielke, 2014; Owen 
& Rogers, 1999, cited in Conley-Tyler, 2005). There are a number of key factors which influence 
the choice of model. Considering the benefits of an internal evaluation model, it may be cheaper, 
depending on the time utilisation of the internal evaluator, the internal evaluator may be more 
readily available than an external evaluator, and the internal evaluator will have an inherent 
knowledge of the programme, operations and context (Volkov & Baron, 2011; Conley-Tyler, 
2005). By implication, the reverse of these benefits are the weaknesses of the external evaluation 
model. Likewise, the benefits of an external evaluator models such as the evaluator having expert 
skills and expertise, perceived objectivity, willingness to criticise and ability to collect information 
from participants, are the weaknesses of an internal model (Volkov & Baron, 2011; Conley-Tyler, 
2005). These strengths and limitations of internal and external evaluators are debated, for example 
although external evaluators are seen to be unbiased, all individuals bring their own bias/personal 
values (Conley-Tyler, 2005; Menestrel et al., 2014). It has been proposed to overcome the inherent 
weaknesses in both models, a third/hybrid model may be utilised, creating a functional relationship 
between internal and external evaluators (Menestrel et al., 2014; Conley-Tyler, 2005; Patton, 1987; 
Shapiro & Blackwell, 1987). In this model the evaluators’ role and tasks are divided, this lowers 
the cost and allows for the transfer of skills from the external evaluator to the internal evaluator 
(Conley-Tyler, 2005).  Due to the practical implications of collecting data, an internal evaluation 
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team was needed with an in-depth knowledge of the processes, as well as availability to collect the 
data. And an external evaluation team was needed to provide the research knowledge and skills. 
Thus, an internal/external evaluation model was used, with an external evaluation team responsible 
for analysing the quantitative data, and an internal evaluation team responsible for collecting the 
quantitative data via questionnaires, extracting the sickness absence records, and providing the 
costs of the VR service.  
 
3.6.1.3 Ethical approval  
 
Prior to commencing the study ethical approval was gained from the University of Salford Ethics 
Committee (Ref no: REP 10/039. 7/4/2010 & 20/07/2011. See Appendix 7.1). In addition, the 
appropriate NHS Research and Development office was contacted to enquire whether NHS 
Research ethics was needed. The NHS Research and Development office informed the research 
team that as this case study was a service evaluation, NHS ethical clearance was not required 
(Health Research Authority NHS, 2014) (see Appendix 7.1).  Prior to participating all participants 
were provided with an invitation and participant information sheet, which clearly outlined the 
reason for the research, any potential benefits or risks of participation, data handling and storage, 
dissemination of findings, the voluntary nature of the study and the right to withdraw at any point. 
Contact details were provided for the lead investigator should any potential participants require 
additional information or wish to lodge a complaint.  
 
3.6.1.4 Sampling technique: 
 
When randomisation of the participants is not required for the research design, non-probability 
sampling is commonly used (Etikan, Musa & Alkassim, 2016; Doloros & Tonco, 2007). Non-
probability sampling is convenient, especially when there are limited resources, however, due to 
the subjective nature of choosing participants, and not giving all participants the equal chance of 
been included the research loses its generalisability to the wider population (Etikan et al., 2016). 
There are two common non-probability sampling methods, convenience and purposive (Etikan et 
al., 2016, Laerd Dissertation, 2012). Convenience sampling is where participants who meet the 
practical criteria such as easily accessible, available at a given time, willingness to partake, are 
included for the purpose of the study (Etikan et al., 2016; Suri, 2011; Laerd Dissertation, 2012). 
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Convenience sampling can be used for both quantitative and qualitative research; however, it is 
most commonly used in quantitative research (Etikan et al., 2016). With convenience sampling 
although participants may be selected on the basis of ease of access, the samples used are rarely 
convenient to draw and this method is more often referred to, to distinguish them from random 
samples (Price, 2013). The advantages of convenience sampling are that it is easy to identify the 
sample, it is less time consuming, and it may be the only practical form of sampling when working 
with organisations and needing access to formal lists of employees for probability sampling 
techniques (Etikan et al., 2016).  However, this form of sampling has limitations, such as it may 
result in a biased sample limiting the generalisability of the results; it is not possible from this non-
probabilistic sampling technique to describe the relationship between the sample and the population 
of interest; it is not possible to understand why some people agreed to participate whilst others did 
not; and statistical inference is not possible (Etikan et al., 2016; Price, 2013; Suri, 2011; Laerd 
Dissertation, 2012).  With purposive sampling or judgement sampling participants are chosen based 
on pre-determined characteristics or criteria to increase the probability of the research question 
being answered (Etikan et al., 2016; Doloros & Tonco, 2007; Laerd Dissertation, 2012). Purposive 
sampling is commonly used in qualitative research (Laerd Dissertation, 2012; Doloros & Tonco, 
2007). This method of sampling best enables the researcher to answer the question, increasing 
internal validity, but limiting the generalisability of the results (Doloros & Tonco, 2007). The 
nature and type of research guide the choice of sampling method (Etikan et al., 2016).  In this phase 
of the research, for organisation 1, convenience sampling was used as the methodology is 
quantitative and the subjects were selected due to their accessibility and willingness to take part. 
All clients who had their first appointment with the VR service during the time period of 
recruitment were invited to take part. 
 
3.6.1.5 Procedure primary data collection. 
 
The case manager/physiotherapist, as part of the internal evaluation team was responsible for 
recruiting participants, gaining informed consent and collecting the pre-data and post data, at the 
patients first and last appointment. A follow-up questionnaire (3 and 6-months) was sent to the 
participants via the internal evaluation team administrative assistance, with a stamped addressed 
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return envelope. A reminder was sent to participants one week later if they did not return their 
follow-up questionnaire. 
 
3.6.1.6 Primary data outcome measures 
 
The following reliable and valid outcome measures were used to evaluate the impact of the service 
on the health of the staff (see section 3.4 and 3.4.1 for further information on the outcome 
measures): 
 
1) The General Health Questionnaire (GHQ-12) (Goldberg, 1972), a self-report of general 
health to identify psychological distress. 
2) The Job Satisfaction Scale (JSS) (Warr et al., 1979), a self-report to identify satisfaction 
at work. 
3) Patient Specific Function Scale (PSFS) (Stratford et al., 1995), a subjective scale which 
allows for measured change in identified functional limitations or goals in relation to work 
and life settings. 
 
3.6.1.7 Procedure secondary data collection  
 
Sickness absence within the Primary Care Trust was recorded on an Electronic Staff Record. 12 
months pre and post-intervention sickness absence data, of employees attending the VR service, 
was extracted and anonymised by the Primary Care Trust. This data, along with the costs of 
sickness absence and of the VR service, were provided to the evaluation team. 
 
3.6.1.8 Data analysis 
 
SPSS 16 (SPSS Inc., Chicago IL) was used to conduct the statistical analysis. Non-parametric 
analysis was used to analyse the primary data, as the data failed to satisfy the criteria for parametric 
analysis, due to: the data not having a normal distribution; the outcome measures consisting of 
Likert scales with subjective wording; and convenience sampling being used (Hicks, 2004).  
Friedman’s test was used to identify significant differences between the groups, at the three 
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different time points, and Wilcoxon’s test was then used to highlight where these differences 
occurred, i.e. compare the different time points (Rumsey, 2011).  
 
GHQ-12 was scored using both the Likert and Binary method. The Binary method was used to 
identify ‘cases’, a score greater than 4, subjects showing minor psychological distress (Goldberg, 
1972) (see section 3.4.1.2.2).  
 
A paired-samples t-test was conducted to evaluate the impact of the VR service on the number of 
sickness absence days taken by staff during this time period.  A paired-samples T-test determines 
whether the average (i.e. mean) score for the pre-sickness absence data significantly differs from 
the average score of the post-sickness absence data (Rumsey, 2011).  
 
3.6.2 Organisation 2 
 
Organisation 2 (as described in section 1.4.2) is an in-house VR service for employees with 
physical or mental ill-health within a public organisation in the UK. This section outlines the 
specific methodology used for the evaluation of organisation 2.  
 
3.6.2.1 Aims: 
 
In order to achieved the overarching research aims i.e. develop and implement a practical CBA 
tool, relevant data to populate the CBA tool needs to be collected (Phase 2: collect primary and 
secondary data from 2 VR services to populate the costs and outcomes of the CBA tool). This data 
was collected through conducting evaluations of two VR organisations/services. Each evaluation 
had specific aims to ensure that the relevant data was collected.  
 
Organisation 2 aims: 
a) To assess the impact of the VR service on the sickness absence levels, presenteeism 
levels and quality of life of employees attending the service. 
b) To assess the impact of the VR service on employees attending the service and the 
associated costs. 
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c) To determine the costs and benefits of the VR service. 
 
3.6.2.2 Methodology: 
 
The study was a pre-experimental repeated-measures within-group (time series) (pre-intervention, 
2-weeks post-intervention, 3-months and 6-months post - intervention) (see section 3.6.1.2 for 
further discussion). 
 
3.6.2.3 Ethical approval 
 
The same ethical procedure as was conducted with organisation 1 was undertaken with organisation 
2 (see section 3.6.1.3 above). University of Salford Ethics Committee (Ref no. HSCR14/79. Ethical 
approval granted 9/10/2014. Amendment approved 12/12/2014. See Appendix 7.2).  
 
3.6.2.4 Sampling technique: 
 
Convenience sampling was used, all clients who have their first appointment with the VR service 
during the time period of recruitment (October 2014 – October 2015), were invited (See section 
3.6.1.4 for further discussion on convenience sampling). 
 
3.6.2.5 Procedure primary data collection. 
 
The VR case managers (VRCM) informed the potential participants about the research project. If 
the participants agreed to receiving information about the project, they were telephoned by the lead 
investigator to explain the project, and emailed an invitation and information sheet. On verbally 
consenting to take part, participants were emailed a consent form and the questionnaire. 
Participants were requested to complete both and return via email to the lead investigator. At 2-
weeks post their first appointment at the VR service, participants were emailed their 2-week follow-
up questionnaire, which they were requested to complete and return via email, and the same at 3-
months and 6-months post.  If the participant did not return the questionnaires a reminder email 
was sent one week later. All participants were able to receive or return the forms electronically or 
via the postal system if they wished. 
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3.6.2.6 Primary data outcome measures: 
 
The following outcome measures were collected to evaluate the impact of the VR service on the 
employees in terms of sickness absence, productivity/presenteeism and quality of life (see section 
3.4 and 3.4.1 for further information on the outcome measures): 
- Sickness absence using the Work Limitations Questionnaire Work Absence Module 
(WLQ-work absence module) (Lerner et al., 2001). 
- Presenteeism/productivity questionnaire using the Work Limitations Questionnaire 
(WLQ) (Lerner et al., 2001).  
- Quality of life, using the EQ-5D-5L (EuroQol group, 2009).  
 
In addition, sickness absence within the organisation was recorded electronically; 3 months pre-
intervention and 3-month post intervention data was extracted and anonymised by the organisation, 
prior to sending to the researcher.  
 
3.6.2.7 Procedure secondary data collection 
 
The secondary data was provided by the VR service provider and the host organisation. All data 
provided was anonymised and aggregated. The VR service provider and organisation provided 
sickness absence data, average salary, annual turnover, VR service data such as number of referrals, 
and an overall budget for the VR service with a breakdown of the service costs.  
 
3.6.2.8 Data analysis 
 
The sample sizes were small (n = 3), thus no statistical analysis could be conducted. Should the 
data have been sufficient it was planned that SPSS 22 (SPSS Inc., Chicago IL) would be used to 
analyse the data. The questionnaire data would have been analysed using either the one-way 
repeated ANOVA if the data had met the underlying assumptions of parametric data, i.e. it was 
normally distributed, the groups were independent and the variances of the group were equal, or 
the Friedman and Wilcoxon tests would have been used to detect whether there was a difference 
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between the groups, at the three different time points, and to compare the results at two different 
time points (Rumsey, 2011).  
 
3.7 Methodology Phase 3 
 
Figure 10: Diagrammatic representation of the 4 phases of this research project highlighting phase 3 
 
 
 
 
 
 
 
 
 
In order to meet the objectives of phase 3, namely; 
 
4. To implement and test the revised practical CBA tool incorporating the developed outcomes to 
identify the cost-benefits of the VR interventions and services in a real-world setting. 
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The data from phase 2 was used to populate the revised CBA tool (revised in phase 1). The CBA 
tool was implemented, producing the following outputs: Benefits Cost Ratio, Net Present Value 
and Return on Investment.  The inherent limitation of using a CBA is the uncertainty and risks with 
estimating the values to be used within the CBA tool and the structural uncertainty of the CBA tool 
i.e. the assumptions and decisions that you based the CBA tool on (Salling & Banister, 2010; 
Keating & Keating, 2014; Snell, 2011; Sculpher et al., 2006). To account for these limitations an 
optimism bias correction factor was inputted into the CBA tool. After applying optimism bias, a 
probabilistic sensitivity analysis and scenario analysis was conducted as outlined in section 3.4.  In 
addition, a break-even scenario was added to the CBA tool, providing information on what the 
changes would be to the key variables to allow for the NPV (Benefits) to exactly equal the NPV 
(Costs) (CEEU, 2011). 
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3.8 Methodology Phase 4 
 
Figure 11: Diagrammatic representation of the 4 phases of this research project highlighting phase 4 
 
 
 
 
 
 
 
 
 
 
In order to meet the objective of phase 4, namely; 
 
5. To appraise the value of the revised practical CBA tool to the VR provider and the organisation 
to which VR is provided. 
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This methodology is the qualitative element of the mixed methodology approach used in this 
research project (see section 3.5 for further discussion). A focus group was used as a standalone 
qualitative method to explore the value of the revised CBA tool to the VR provider and the 
organisation. A focus group is structured group of selected participants, facilitated by a moderator 
that allows a combination of interviewing, participant observation and data collection through 
group interactions, with a specific topic focus (Massey, 2010; Litosseliti, 2003; Morgan, 1997). 
One reason focus groups are used is to generate information on individuals’ perceptions and 
attitudes on particular topics (Massey, 2010; Litosseliti, 2003). The choice in this methodology is 
due to the strength of focus groups in that the group dynamics may result in the elicitation of more 
detailed information than would be possible in one-to-one interviews (Smith, 2008; Litosseliti, 
2003; Morgan, 1996; Kitzinger, 1999; Merton et al., 1990 cited in McLafferty, 2004).  Statements 
may be ‘challenged, extended, developed, undermined or qualified in ways that generate rich data 
for the researcher’ (Willig, 2001, p.29; Litosseliti, 2003). It is important to be aware of this 
phenomenon when conducting focus groups to ensure that it does not evolve into a group interview, 
diminishing the group interaction (Liamputtong, 2011; Morgan, 1996). However, these group 
dynamics can also be a limitation as members may censor their speech, and have their opinions 
influenced or moderated in a group setting i.e. false consensus (Smith, 2008; Parker & Tritter, 
2006; Litosseliti, 2003). Moreover, it is important to consider the ethical concerns, as 
confidentiality from the other participants cannot be assured in these scenarios (Parker & Tritter, 
2006). Further limitations of focus groups include possible bias through the researcher guiding 
participants to say what the researcher wants to hear, difficulties in distinguishing between the 
group view and individuals’ views, and the inability to generalise the results due to small sample 
groups and the inability to ensure the sample is representative of the wider population (Litosseliti, 
2003; Morgan, 1997). A number of these limitations, such as confidentiality can be moderated 
through the setting of ground rules at the beginning of the focus group, as well as awareness of the 
moderator of the potential pitfalls (Smith, 2008; Litosseliti, 2003).  
 
3.8.1 Sampling 
 
Purposive sampling (discussed in section 3.6.1.4) was used in this phase of the research. The 
researcher identified the major stakeholders who were directly involved or affected by the research 
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(Given, 2008), thus increasing the probability of the research question being answered (Etikan et 
al., 2016; Doloros & Tonco, 2007; Laerd Dissertation, 2012). In this study, it is the individuals 
from the organisations who were responsible for collecting the secondary data, and the individuals 
reading the CBA reports and making decisions with the aid of the CBA reports, i.e. those who can 
provide insight into the value of the CBA tool, who were invited by email to take part in the study. 
The email invite, including information sheet, was sent from the main contact within the VR service 
on behalf of the researcher. 
 
3.8.2 Sample size 
 
Sample size is a contentious issue with focus groups, there is little consensus in the literature as to 
the ideal number of participants, with authors (Howard, et al., 1989; Twin, 1998, both cited in 
McLafferty, 2004; Kitzinger, 1999) recommending between four and twenty (Massey, 2010; 
Litosseliti, 2003; McLafferty, 2004). The key consideration is to ensure that the group is not too 
large to prevent adequate interaction from all participants, nor too small that it fails to provide 
sufficient breadth (Merton et al., 1990, cited in McLafferty, 1990). In this research, there was one 
focus group with four participants due to the small number of potential participants. 
 
3.8.3 Focus group procedure 
 
Prior to the focus group, the researcher conducted a brief presentation explaining the CBA model, 
and the participants had the chance to input data into the new CBA tool to generate cost/benefits 
results (see Appendix 9), using a case study as an example and a glossary page (see Appendix 9). 
The in-person focus group was audio recorded. A spare recorder was taken in case of a fault with 
the primary recorder.  An audio recorder rather than a video recorder was used, as it is often more 
acceptable to participants, although they may still censor their responses knowing they are been 
recorded (McLafferty, 2004; Newcomer, Hatry & Wholey; 2015). A limitation of an audio recorder 
is that is cannot record non-verbal communication (McLafferty, 2004). Ground rules were 
developed to address the potential risks of lack of confidentiality (Smith, 2008; Parker & Tritter, 
2006), and the process was provided in writing and articulated to the participants. Written consent 
was obtained from the participants prior to the focus group, participants were informed that they 
could withdraw at any stage from the research (see Appendix 10). They were informed of the 
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purpose of the research, the handling and storage of their data. The focus group took place in a 
private room on the organisations premises. The researcher facilitated the discussion based around 
a series of questions. These questions were designed, based on the aims of the research project, to 
prompt the participants to expand on their views on using the CBA tool; it’s perceived use within 
their organisation and the limitations or areas of development within the CBA tool (Litosseliti, 
2003). These questions were open questions with probing questions to elicit further information if 
needed (Liamputtong, 2011; Litosseliti, 2003) (see Appendix 6).  Although the facilitator is meant 
be neutral in the focus group, merely keeping the groups focused (Newcomer et al., 2015; 
Litosseliti, 2003), due to the nature of this focus group following a presentation and a practical 
session applying the CBA tool to a case study scenario, questions were directed at the researcher, 
drawing the researcher into the conversation. 
 
3.8.4 Focus group analysis 
 
The audio recordings of the focus groups were transcribed. When analysing focus group data it is 
important to bear in mind that the outcome is as a result of the interaction between the agenda, the 
facilitator and with and between the members of the focus group (Merton & Kendall, 1956, cited 
in Parker & Tritter, 2006; Litosseliti, 2003). Difficulties in analysing focus group data arise as they 
provide both individual and group level data, which can be hard to differentiate between (Massey, 
2010; Hyden & Bulow, 2003, cited in Parker & Tritter, 2006; Litosseliti, 2003). Members of focus 
groups may shift their perceptions or change their mind through the focus group, highlighting the 
unpredictability of the group dynamics, as well as the risk of false consensus (Parker & Tritter, 
2006; Litosseliti, 2003). It is suggested that to overcome the group dynamics that ‘researchers 
should pay particular attention to the more ‘sensitive moments’ in focus group interaction’ 
(Kitzinger & Farquhar, 1999, cited in Parker & Tritter, 2006, p. 32).  
 
A common critique of focus groups is that the analysis process is poorly defined (Flores & Alonso, 
1995; Hurwoth, 2003; Myers & McNaghten, 2001; Webb & Kerven, 2001; all cited in Massey, 
2010). The reasons for this are debated with some authors proposing that the analysis can vary 
according to the topic and purpose, others argue that the methods are not scientific enough and rest 
solely on the researcher’s choice (Massey, 2010). This has led to three general methods of analysis 
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that are loosely defined, without any limitations proffered, namely: grounded theory, 
phenomenological approaches and thematic analysis (Massey, 2010). Grounded theory is 
‘inductive and iterative with analysis occurring with reflexive data collection for the purpose of 
theory generation’ (Bernard & Ryan, 2010; Charmaz, 2008; Dick, no date, cited in Massey, 2010, 
p.22; Cho & Lee, 2014). When using phenomenological analysis, the participants are viewed as 
co-researchers as they ‘search for essential meaning found in their shared experiences’ (Bernand 
& Ryan, 2010; Creswell, 2007; Wilkinson, 1998, cited in Massey, 2010, p.22). The last analysis 
methodology, thematic/content analysis aims to identify common themes and categories such as 
individuals’ attitudes, opinions and beliefs, under which to group the written or oral data (Cho & 
Lee, 2014; Massey, 2010). The purpose underpinning content analysis is to gain an understanding 
of the impact or process of the topic of interest (Massey, 2010).  This purpose most closely aligns 
with the aim of the focus group. Moreover, Parker & Tritter (2006) recommend content analysis 
for focus groups as it takes the nature of the group and context into account. The transcripts were 
analysed using thematic/content analysis. There are limited descriptions on how to conduct 
qualitative content analysis, it often merely involves grouping comments under categories, and then 
linking these to core themes (Cho & Lee, 2014; Elo et al., 2014; Massey, 2010). This lack of 
standardised process impacts on the validity, reliability and trustworthiness of content analysis (Elo 
et al., 2014). Following the basic outlined steps of content analysis (Cho & Lee, 2004; Massey, 
2010; Elo et al., 2014) the following procedure was followed. NVIVO was used to organise the 
data. The complete transcript was retained to ensure the context was not lost. The transcript was 
read for general impressions, it was then coded, identifying substantive parts in the transcription 
relating to the research question, and these were then categorised (Litosseliti, 2003). From the 
categories overarching themes were identified.  Due to the looseness of the analysis methodology 
bias is a risk at this stage, and constant awareness of this by the researcher was necessary 
(Litosseliti, 2003). 
 
3.9 Summary of the research methodology used in each phase 
 
The following visual model (Figure 12) for mixed-methods sequential explanatory design 
procedures, adapted from Ivankova et al. (2006), summarises the research methodologies used 
across the different phases, as well as illustrating the overarching mixed methods methodology. 
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Figure 12: Visual model for mixed-methods sequential explanatory design procedures. (Adapted from 
Ivankova et al., 2006) 
Phase Procedure Product 
 
 
 
 
 
 Literature review 
 Mathematical 
calculations 
1) Reference and intervention case,  
2) 2)   And costs for outcomes relevant to 
VR, namely: 
- Reducing sickness absence due to 
MSDs and mental ill-health 
- Reducing presenteeism 
- Reducing Turnover 
 
 
 
 
 
 
 Convenience sampling 
 Pre-experimental 
repeated-measures 
within-group (time 
series). 
 Pragmatic internal/ 
external evaluation 
Numeric data: 
1)  For identified outcome measures: 
- GHQ-12; JSS; PSF; WLQ- work 
absence module; WLQ; EQ-5D-5L 
2) Sickness absence data  
3) Costs of sickness absence data 
4) Costs of the VR services 
 
  Data screening, 
parametric or non-
parametric 
 Statistical test 
 SPSS 16 (SPSS Inc., 
Chicago IL) 
 
1) Descriptive statistics 
       Statistical significance 
 
 
 
 
 
 
 Implement the CBA 
tool using the data 
determined in phase 1 
and collected in phase 2 
 
1) Economic outcomes: 
BCR/ROI/NPV 
 
 
 
 
 
 
 Purposive sampling of 
individuals from 
organisation 2 (n=4) 
(used in phase 2) 
 Formulating focus 
group questions 
 
1) Focus group members (n=4) 
2) Focus group procedure 
 
 
 
 
 Focus group – 4 
participants 
 Audio recorded 
 
 
1) Focus group audio recording 
2) Focus group transcript 
 
 
 
 
 
 Coding and thematic 
analysis 
 NVIVO qualitative 
software 
1) Codes, categories and themes 
 
 
 
 Interpretation and 
explanation of the 
quantitative and 
qualitative results 
 
1) Discussion 
2) Implications 
3) Future research 
        Phase 1 
        Phase 2: 
Quantitative data 
collection for the 2 
organisations 
       Phase 2: 
Quantitative data analysis 
for the 2 organisations 
        Phase 4: 
Qualitative data collection 
Connecting 
quantitative and 
qualitative phases 
        Phase 4: 
Qualitative data analysis 
Integration of 
qualitative and 
quantitative results 
       Phase 3: 
Implement and test the 
new CBA tool 
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4. Results 
 
4.1 Introduction 
 
This chapter presents the results for the objectives of each phase of this study, namely: 
Phase 1: 
 
1. To identify from the published literature the outcomes of VR interventions for 
organisations and employed individuals. 
2. To revise the GM New Economy CBA model to ensure that the practical CBA tool 
developed is capable of analysing the costs and benefits of VR interventions. 
Phase 2: 
 
3. To collect the relevant data required to populate the revised practical CBA tool from two 
VR Services and the organisations to which VR is provided. 
Phase 3: 
 
4. To implement and test the revised practical CBA tool incorporating the developed 
outcomes to identify the cost-benefits of the VR interventions and services in a real-world 
setting. 
Phase 4: 
 
5. To appraise the value of the revised practical CBA tool to the VR provider and the 
organisation to which VR is provided. 
 
The results for each phase are discussed sequentially, as each phase is dependent on the completion 
of the previous phase.  
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4.2 Phase 1 results  
 
 
 
 
 
 
 
 
Figure 13: Diagrammatic representation of the 4 phases of this research project highlighting phase 1 
 
This chapter outlines the results from phase 1 they are described separately for each outcome. 
Firstly, the results addressing Phase 1, objective 1, are presented.   
 
1. To identify from the published literature the outcomes of VR interventions for 
organisations and employed individuals. 
 
To meet this objective for each outcome the reference and intervention cases have been determined, 
allowing the calculation of the deadweight and the estimated ‘net effectiveness percentage’ i.e. the 
Cost 
benefit 
analysis 
tool
Phase 1: revise the 
GM CBA tool  with 
VR apporpriate 
outcomes
Phase 2: collect 
primary and 
secondary data 
from 2 VR services 
to populate the 
costs and outcomes 
of the CBA model
Phase 3: Implement 
and test the revised 
CBA tool, using 
data from Phase 2
Phase 4: Explore 
the value of the 
revised CBA to VR 
services and 
organisations
Using the 
literature base 
Focus groups to 
evaluate the value 
of the revised 
CBA to potential 
users 
Primary data – 
employees using 
the VR services – 
outcomes collected 
pre and post 
interventions. 
Secondary data – 
collected by the VR 
services and 
organisations 
Researcher inputs 
data from phase 2, 
implements and 
tests the revised 
CBA model. 
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percentage improvement between the two cases.  To determine the reference and intervention 
cases, a systematic literature search was conducted and the results for each outcome are presented 
below, to include: 
 a summary of the articles included in the identification of the deadweight and the 
estimated net effectiveness calculation, 
 a review of the included literature, outlining the assumptions of the CBA tool,  
 and a calculation the deadweight to be used within the revised GM New Economy CBA.  
 
Secondly, the results addressing Phase 1, objective 2, are outlined. 
2. To revise the GM New Economy CBA model to ensure that the practical CBA tool 
developed is capable of analysing the costs and benefits of VR interventions. 
 
To meet this objective, the unit costs, i.e. the cost of the benefit such as the cost of sickness 
absence per employee per day, for each outcome are also presented in turn. 
 
4.2.1 Identifying the reference and intervention cases in order to determine the 
deadweight and estimated net effectiveness percentage of each outcome to be used 
within the practical CBA tool 
 
As outlined in section 3.5.3 and 3.5.4 a systematic literature search was conducted to determine the 
reference and intervention case. The purpose of the literature search is to identify the reference and 
intervention cases, allowing for the determination of the net effectiveness of VR interventions. 
Consequently, the key element of included articles is the inclusion of a control or comparator 
group.  
 
4.2.1.1 Sickness absence due to MSDS: reference and intervention case results 
 
The inclusion and exclusion criteria for this literature search are: 
 Employed individuals who are off work due to MSDs. 
 The inclusion of a control or comparator group. 
 The data on sickness absence days presented as a mean over a year.  
 The sickness absence data is less than 20 years old.  
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Refer to section 3.5.4 for a detailed search strategy. 
 
Figure 14: Flow chart of study selection process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Titles identified and screened   
N = 45  
 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 3.5.4)   
  N = 28 
 
Full copies retrieved and assessed for 
eligibility 
    N = 14 
Number of studies reviewed 
N = 4 
 
Abstracts screened   
N = 17 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 3.5.4)   
   
N = 3 
 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 3.5.4)   
    N = 10 
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Table 8: Summary of included articles, with sickness absence findings reported in terms of days sick leave per year or percentage difference over a 
year. 
 
Authors & 
Country 
 
Research 
study 
Population 
(including 
condition) 
 
 
Intervention 
(n = x) 
Usual care 
(n = x) 
Total mean no. 
of sickness 
absence days 
(intervention 
group) 
Total mean no. 
of sickness 
absence 
(control group) 
Difference 
between 
intervention 
and control 
means 
Significance Percentage 
difference 
between 
intervention 
and control 
V1 = 
intervention 
V2 = control 
(net additional 
benefit) ((V1-
V2)/V1 *100) 
Arnetz et al. 
(2003) 
Sweden 
Prospective 
controlled 
trial 
Patients with 
physician 
diagnosed 
MSDs.  
Selected from a 
roster of all sick 
leave cases at 
the Swedish 
National 
Insurance 
agency. All 
cases are 
referred by 
employees 
between 4 and 8 
weeks sick 
leave. 
N = 65 
Proactive 
insurance case 
managers 
combined 
with 
workplace 
ergonomic 
interventions 
N = 72 
Traditional 
case 
managemen
t 
Total mean 
number of sick 
days (from the 
1st day of 
absence):  
0-6-months = 
110 (6.5 SEM; 
52.4 SD) 
6-12 months = 
95.8 (13.1 
SEM;105.6 SD) 
0-12 months = 
144.9 (11.8 
SEM; 95.14 
SD) 
Total mean 
number of sick 
days (from the 
1st day of 
absence): 
0-6-months = 
131.1 (5.9 SEM; 
50.06 SD) 
6-12 months = 
150.3 (8.8 SEM; 
74.70 SD) 
0-12 months = 
197.9 (14.0 
SEM; 118.8 
SD). 
0-6 months =  
-21.1 
 
6-12 months = 
-54.5 
 
0-12 months = 
-53 
0-6-months p 
<0.05 
 
6-12 months p 
<0.01 
 
0-12 months 
p <0.01 
0-6-months 
19% 
 
6-12 months 
56.89% 
 
0-12 months 
27% 
Du Bois & 
Donceel 
(2012) 
Belgium 
Single 
blinded 
RCT 
Claimants with 
LBP. 
Claiming for 
allowances 
following 
minimum 1 
month sickness 
absence. 
N = 252. 
Proactive 
service aimed 
at quick 
RTW. 
Provided 
counselling, 
information 
and advice 
N = 257. 
Disability 
evaluation 
Total mean 
number of days 
of sick leave per 
year: 
63.9 
(54.8–73.0) 
Total mean 
number of days 
of sick leave per 
year: 
75.9 
(65.4–86.56) 
-12 P = 0.16 
This is not 
significant.  
16% 
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and disability 
evaluation 
Karjalainen 
et al. (2003) 
Finland 
RCT Sub-acute lower 
back pain. 
Employees had 
LBP which 
made working 
difficult for 
more than 4 
weeks but less 
than 3 months.  
a) N = 55 – 
mini 
intervention 
with a 
physician and 
a 
physiotherapis
t 
b) N = 46 – 
same as a) + a 
work site visit 
N = 51. 
Treated in 
municipal 
primary 
health care 
Total mean 
number of days 
of sick leave: 
a) 19 (median = 
0 days) 
b) 28 (median 
=1) 
Total mean 
number of days 
of sick leave: 
41 (median = 7) 
a)-22 
b)-13 
a) vs control 
P = 0.019 
b) vs control 
P = 0.071 
a) 54% 
b) 32% 
Bultman et 
al. (2009) 
Denmark 
RCT Employees on 
sick leave 
between 4-12 
weeks due to 
MSDs 
N = 68 Co-
ordinated and 
tailored work 
rehabilitation. 
This consists 
of a work 
disability 
screening by 
an inter-
disciplinary 
team, 
identification 
of barriers to 
RTW and a 
collaborative 
development 
of a RTW 
plan. 
N = 51 
Traditional 
case 
managemen
t 
Total mean 
numbers of 
hours sickness 
absence (mean 
days calculated 
as 7.5 hours per 
day):  
0-3 months 
278.3 (SD 
165.9; median 
262) 
3-6-months 
187.6 (SD 
183.1; median 
134) 
6-12 months 
190.4 (SD 
312.1; median 
2.5) 
0-6-months 
190.4 (SD 
319.3; median 
419) 
0-12 months 
656.6 (SD 
565.2; median 
476) = 87.6 
days  
Total mean 
numbers of 
hours sickness 
absence (mean 
days calculated 
as 7.5 hours per 
day):  
0-3 months 
331.1 (SD 
152.9; median 
335) 
3-6-months 
254.5 (SD 199; 
median 234) 
6-12 months 
411.7 (SD 
423.1; median 
254) 
0-6-months 
585.6 (SD 
322.6; median 
537)0-12 
months 997.3 
(SD 668.8; 
median 892) 
(using a 7.5 
hour day) = 133 
days 
0-3months 
= -52.8 
3-6 months 
= -66.9 
6-12 months 
= -221.3 
0-6-months 
= -395.2 
0-12 months 
= -340.7 
0-3months 
P = 0.060 
3-6 months 
P = 0.096 
6-12 months 
P = 0.009 
0-6-months 
P = 0.034 
0-12 months 
P = 0.006 
34% 
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Through reviewing the included articles it was noted that the reporting of the impact on sickness 
absence was not consistent, with some studies reporting the mean number of days per sickness 
absence episode (Lindstrom et al., 1992; Abasolo et al., 2005; Fleten & Johnsen, 2006; Leon et al., 
2009; Nystuen & Hagen, 2003; Lambeek et al., 2010; Meyer, Fransen, Huwiler, Uebelhart, & 
Klipstein, 2005) or the mean number of sickness absence days over a year (Du Bois & Donceel, 
2012; Arnetz et al., 2003; Hultberg, Lonnroth, Allebeck, Hensing, 2006; Jorgensen, Faber, Hansen, 
Holtermann, & Sogaard, 2011; Bultman et al., 2009; Karjalainen et al., 2003), whereas others 
reported only the median for number of sickness absence days per episode or per year (Staal et al., 
2004; Lindstrom et al., 1992), or the percentage returning to work over a year (Norrefalk, Ekholm, 
Linder, Borg, & Ekholm, 2008; Meyer et al., 2005). Additionally, the inclusion and exclusion 
criteria described within the articles clearly distinguished between long-term sickness absence 
(Loisel et al., 1997; Lambeek et al., 2010; Bultman et al., 2009; Meyer et al., 2005; Nystuen & 
Hagen, 2003), with the minimum long-term sickness absence being defined as longer than 28 days, 
and short-term sickness absence, less than 28 days (Du Bois & Donceel, 2012; Steenstra et al., 
2006; Lindstrom et al., 1992; Karjalainen et al., 2003; Staal et al., 2004; Abasolo et al., 2005; Fleten 
& Johnse, 2006; Arnetz et al., 2003; Hultberg et al., 2006; Jorgensen et al., 2011; Leon et al., 2009; 
Norrefalk et al., 2008).  
 
Considering the inclusion criteria outlined in the methodology, a total of 4 articles were included 
to determine the reference and intervention case (Arnetz et al., 2003; Bultman et al., 2009; Du Bois 
& Doncell, 2012; Karjalainen et al., 2003). Looking at the reference and intervention case in the 
identified studies, the percentage improvement between the two cases (the net additional 
benefit/net effectiveness) for short-term sickness absence was on average 32.6%, with percentage 
changes ranging from 16% - 54% (See Table 8).  
 
It is also important to consider sickness absence that lasts longer than 6-months. No studies meeting 
the inclusion criteria considered employees referred to the service post 6-months sickness absence.  
Considering the grey literature, Linaker, Harris, Cooper, Coggon, & Palmer’s (2011) review of the 
sickness absence figures for MSDs within the UK concluded that the UK national figures for MSDs 
are incomplete and inconsistent, thus it was not possible to calculate an accurate UK reference case 
for long-term sickness absence due to MSDs. The only cautious conclusion that can be made is that 
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previous literature has not demonstrated an effect on long-term sickness absence. Thus, in this 
study, for long-term sickness absence due to MSDs deadweight will equal the impact of the 
intervention.  
 
4.2.1.2 Sickness absence due to mental health conditions: reference and intervention 
case results 
 
The inclusion and exclusion criteria for this literature search are: 
 Employed individuals who are off work due to mental health conditions. 
 The inclusion of a control or comparator group. 
 The data on sickness absence days presented as a mean over a year.  
 The sickness absence data is less than 20 years old.  
 
Refer to section 3.5.4 for a detailed search strategy. 
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Figure 15: Flow chart of study selection process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Titles identified and screened   
N = 5042  
 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 3.5.4)   
  N = 4923 
 
Full copies retrieved and assessed for 
eligibility 
    N = 39 
Number of potential studies to be 
included  
N = 5 
 
Abstracts screened   
N = 119 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 3.5.4)   
     
N = 80 
 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 
3.5.4)   
   
 N = 34 
 
Number of studies to reviewed 
N = 5 
 
Excluded (did not meet 
the revised inclusion 
criteria (see discussion 
below))   
   
 N = 1 
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Table 9: Summary of included articles for mental ill-health, with sickness absence findings reported in terms of mean number of days to full return to 
work. 
 
Authors &  
Country 
Research 
study 
Population 
(including 
condition) 
Intervention 
(n = x) 
Usual care 
(n = x) 
Total mean no. 
of sickness 
absence days 
(intervention 
group) 
Total mean 
no. of 
sickness 
absence days 
(control 
group) 
Difference 
between 
intervention 
and control 
means 
Significance Percentage 
difference 
between 
intervention and 
control 
V1 = intervention 
V2 = control 
(net additional 
benefit) ((V2-
V1)/V2 *100) 
Rebergen et 
al. (2009) 
Netherlands 
Economic 
evaluation 
(from 
societal and 
employers 
perspective) 
alongside a 
RCT 
Police workers 
on sick leave 
due to mental 
health 
conditions 
N = 125 
Trained 
occupational 
physicians 
providing 
guideline 
based care  
N = 115 
Easy access 
to 
counselling 
Net sick leave 
over a year 
Human Capital 
Approach 
(HCA) 113 
(Standard 
deviation (SD) 
= 83 Gross sick 
leave HCA 151 
(SD = 97);  
Net sick 
leave over a 
year HCA 
114 (SD = 
87)); 
Gross sick 
leave HCA 
146 (SD = 
103 
Net sick 
leave = - 1 
Gross sick 
leave = 5 
No 
significant 
differences in 
days of sick 
leave 
N/a as not included 
in the deadweight 
calculations. 
Van 
Oostrom et 
al. (2010)  
Netherlands 
Economic  
evaluation 
from a 
societal and 
employer 
perspective, 
alongside a 
RCT 
Employees of 
three large 
Dutch 
organisations on 
sick leave with 
distress 
N = 73 
Treatment by 
an 
Occupational 
Physician and 
a workplace 
intervention. 
Workplace 
intervention 
consisted of a 
stepwise 
communication 
process to 
identify and 
overcome 
barriers to 
RTW, liaising 
N = 72 
Treatment 
by an 
Occupational 
Physician 
Mean duration 
of sick leave 
until lasting 
RTW  
133 (SD 109) 
days  
 
 
Mean 
duration of 
sick leave 
until lasting 
RTW  
134 (SD 108) 
days 
-1 No 
significant 
differences 
between 
groups 
(no p value 
provided in 
the article) 
0.75%  
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between RTW 
co-ordinator, 
supervisor and 
employee 
Noordik et 
al. 2013  
Netherlands 
Cluster 
RCT 
Employees off 
work due to 
common mental 
disorders 
N = 75 
Exposure 
based RTW 
intervention 
N = 85 Care 
as usual 
Medium time to 
RTW = 209 
days 
The mean 
number 
of recurrences 
of sick leave 
within a one-
year follow-up 
did not differ 
between both 
interventions (P 
= 0.96). 
The mean time-
to-full RTW 
was 277 (95% 
CI 222–332) 
days. 
Medium time 
to RTW = 
153 
The mean 
time-to-full 
RTW was 
191 (95% CI 
151–230)   
86 Median time 
to- 
full RTW 
differed 
significantly 
between the 
groups 
(P = 0.02). 
More likely 
to RTW with 
care as usual. 
- 45%  
Schene et al. 
(2007)  
Netherlands 
RCT Adults with 
major 
depression, with 
a work 
reduction of at 
least 50% due to 
their mental 
health disorder 
N = 30 
Outpatient 
psychiatric 
treatment + 
Occupational 
Therapy - 
diagnostic 
phase with 
occupational 
history and 
work 
reintegration 
plan, and (ii) 
therapeutic 
phase with 
individual 
sessions and 
group sessions 
N = 32 
Outpatient 
psychiatric 
treatment 
Calculated total 
work hours 
worked in 6-
months. 
Medians 
presented; 
Month 1-6: 
20.45 
Month 7-12: 
261.75 
 
For patients off 
work – 
calculated time 
to RTW. Mean 
= 207 days  
Calculated 
total work 
hours worked 
in 6-months. 
Medians 
presented; 
Month 1-6: 0 
Month 7-12: 
0.85 
For pts off 
work – 
calculated 
time to RTW. 
Mean = 299 
days 
-92  
Month 1-6 p 
= 0.022 
Month 7-12 p 
= 0.042 
30.77%  
Blonk et al. 
(2006) 
Netherlands 
RCT Self-employed 
individuals 
insured for 
work disability 
2 groups: 
N = 35 
Combined 
intervention 
N = 34 
 no 
treatment 
Mean number 
of days to 
RTW (full) 
CI = 177 
Mean 
number of 
days to 
RTW (full) 
CI = -75 
 
CBT = -2 
Significant 
difference: 
P<0.1, CI 
group had 
29.76% 
improvement 
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at a private 
insurance 
company. 
Participants 
were unable to 
work due to 
psychological 
complaints. 
(CI) – 
individual 
and work 
focused CBT, 
conducted by 
a labour 
expert 
N = 36 
CBT 
CBT group = 
256 
= 252 significantly 
lower 
number of 
days until 
RTW than 
the CBT 
and control 
group 
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Through reviewing the included articles, it was noted that the reporting of the impact on 
sickness absence for mental health conditions was not consistent. From the studies reviewed, 
only one study (Rebergen et al., 2009) met all the inclusion criteria. Four studies (van Oostrom 
et al., 2010; Hees, de Vries, Koeter, & Schene, 2013; Noordick et al., 2013 and Schene, Koeter, 
Kikkert, Swinkels, & McCrone, 2007) met all the inclusion criteria, except the criterion that 
annual mean sickness absence days were reported.  In order to address this, the authors van 
Oostrom, Noordick and Schene were emailed and the raw data or the data presented as a mean 
over a year was requested. The author Hees was not emailed as no email address could be found. 
The author Noordick responded to the email and provided raw data, enabling the calculation of 
the average days to RTW. Van Oostrom et al. (2010) and Schene et al. (2007) presented their 
sickness absence data as the mean time to full RTW. Thus, in order to form an evidence-based 
conclusion for the reference and intervention case, the inclusion criteria “the data on sickness 
absence days presented as a mean over a year” was changed to “the data on sickness absence 
days presented as the mean time to full RTW”. It is acknowledged that this may introduce 
limitations to the CBA tool, as it does not account for sustainability of the intervention on 
sickness absence. However, considering that Noordik et al. (2013) reported that the number of 
reoccurrences did not differ between the group (p = 0.96), and Rebergen et al. (2009) concluded 
no significant differences in the mean sickness absence over one year between groups, this 
provides support for the validity of mean time to full RTW as an outcome measure. Considering 
this adaptation, a total of 4 articles were included to determine the reference and intervention 
case, namely: van Oostrom et al., 2010; Noordick et al., 2013; Schene et al., 2007; Blonk, 
Brenninkmeijer, Lagerveld, & Houtman, 2006.  All four studies were conducted in the 
Netherlands, raising questions as to the generalisability of their findings to the United Kingdom.  
 
When considering the results of the studies, two studies concluded that there was no significant 
decrease in sickness absence due to mental health conditions with the introduction of a 
workplace intervention, (Van Oostrom et al., 2010; Noordik et al., 2013). Interestingly, Noordik 
et al. (2013) reported a significant difference (p = 0.02) between the control and intervention 
group, in favour of the control group, with there been a 45% improvement in the control group. 
The other two included studies (Blonk et al., 2006; Schene et al., 2007) found a significant 
difference in the mean number of days till RTW in the intervention group compared to the 
control group. From the results in these studies no firm conclusion on the impact of workplace 
health interventions on sickness absence due to mental health conditions can be made.  
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Studies not included to inform the reference and intervention case, due to way in which they 
presented the data, again demonstrate this inconsistency in results. Kroger et al. (2013) found 
significant decreases in the days of incapacity in the intervention group, whereas, Rebergen et 
al. (2009) and Hees et al. (2013), indicated no significant difference between the control and 
intervention group. Again, these studies are not based in the UK, and have limitations such as 
small sample numbers. These findings are supported by a Cochrane review (Van Vilsteren et 
al., 2015) exploring workplace health interventions and sickness absence, with the inclusion of 
subgroups, one being mental health. Van Vilsteren et al. (2015) concluded that although 
workplace interventions may reduce the length of the first episode of sickness absence due to 
mental health conditions, the sustainability of RTW is variable, and there is “no evidence of a 
considerable effect of workplace interventions on time to RTW in workers with mental health 
problems (p.2)”. Van Vilsteren et al. (2015) concluded that the quality of evidence on the 
effectiveness of workplace interventions for workers with mental health disorders is low, and 
currently do not indicate that workplace interventions have an effect on employees with mental 
health conditions. Van Vilsteren et al. (2015) advised that further high-quality research is 
needed into a range of conditions.  
 
This highlighted need for further research into a range of conditions may explain why Van 
Vilsteren et al.’s (2015) review at first glance appears to contradict Nieuwenhuijsen et al.’s 
(2014) Cochrane review: ‘Interventions to improve RTW in depressed people’. This review 
concluded that there is moderate evidence that the addition of a workplace intervention 
alongside a clinical intervention improved work outcomes, reducing sickness absence in a 
specific sub category of mental health condition i.e. depression. Thus, indicating that when sub-
categorising mental health conditions this may result in different conclusions, further 
highlighting a need to further differentiate between the different mental health conditions when 
evaluating the impact of workplace interventions.  
 
Moreover, the results may be inconclusive as a variety of workplace interventions are 
considered in the various reviews. Considering a specific workplace intervention, Vogel et al.’s 
(2017) Cochrane review explored the effectiveness of RTW coordination programmes, which 
are a key component of many VR interventions. The review included three studies that looked 
at sickness absence due to mental health conditions. Vogel et al. (2017) found no significant 
difference in work outcomes, either in the short-term, long-term or very long-term. However, 
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the evidence included was of very low quality, with small sample numbers, and thus further 
high-quality research may change the current findings.  
 
Wagner et al.’s (2016) synthesis of systematic reviews concluded that there is moderate 
evidence that workplace health interventions for mental health conditions improve work 
outcomes, however, the evidence-base is limited and they recommend further research 
including outcomes seldom included in mental health intervention literature such as sickness 
absence, presenteeism, costs and productivity. 
 
From this it may be hypothesised that due to the variety of mental health conditions, and 
possible work place interventions, the current evidence-base does not allow for a conclusive 
answer to be drawn as to whether workplace interventions, and in effect, VR, decrease sickness 
absence due to mental health conditions. Thus, highlighting the need for a structured approach 
in researching/evaluating VR as discussed in section (2.2.1.1). 
 
Considering the reference and intervention case, it is acknowledged that the effectiveness of 
VR in reducing sickness absence due to mental health conditions is inconclusive, thus the only 
cautious conclusion that can be made for the purpose of the CBA tool being developed is that 
the intervention will not have an effect. Thus, deadweight will equal the impact of the 
intervention.  
 
4.2.1.3 Turnover reference and intervention case results 
 
The inclusion and exclusion criteria for this literature search are: 
 Employed individuals who are off work due to mental health conditions or MSDs,  
 The inclusion of a control or comparator group,  
 The data presented as turnover rates 
 The turnover data is less than 20 years old. 
 
Refer to section 3.5.4 for a detailed search strategy. 
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Figure 16: Flow chart of study selection process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
On screening the articles, none met the inclusion criteria.  When considering the evidence-base 
for VR impacting on turnover, there is a consensus that workplace interventions aimed at 
individual’s health may lead to a decrease in turnover rates/job loss (Alexander et al., 2017: 
Black & Frost, 2011; Boorman, 2009; Cancelliere et al., 2011; Knapp et al., 2011). However, 
the underpinning evidence-base is of a low quality, due to the limited number of studies and 
small sample sizes, therefore further research is needed to form a robust conclusion (Oakman, 
Keegel, Kinsman, & Briggs, 2016; Palmer et al., 2012). From reviewing the articles identified 
in the search, it is found that there is limited evidence on turnover rates following VR and 
workplace health interventions. This finding is supported by a literature review conducted by 
Baxter et al. (2015) during the development of the Workplace Health Savings calculator, an 
adaptation of the NICE (2008) model. Baxter et al. (2015) concluded that in light of the large 
variability in both estimates and methodological quality of the evidence-base on turnover rates, 
the Price Waterhouse Coopera (PwC) review was the most appropriate for their needs. 
Additionally, the Health at Work: Economic Evidence Report 2016 (ERS Research and 
Consultancy, 2016), used the PwC 2008 review as a basis for their conclusions on the impact 
of wellness programmes on turnover. It is widely recognised that there is a need for further 
high-quality studies to be conducted on work directed interventions and the impacts such as 
Titles identified and screened   
N = 7873 
 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 3.5.4)   
   
  N = 7575 
 
Full copies retrieved and assessed for 
eligibility 
    N = 60 
Number of studies reviewed 
N = 0 
 
Abstracts screened   
N = 298 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 3.5.4)   
     
N = 211 
 
Excluded (did not meet 
inclusion and exclusion 
criteria see section 3.5.4)   
    
N = 60 
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turnover/job retention (Dewa, Loong, Bonato, & Joosen, 2015; van Vilsteren et al., 2015; 
Nieuwenhuijsen et al., 2014; Schaafsma et al., 2013). ERS Research and Consultancy (2016) 
state that when considering mental health in the workplace the research suggests that 
interventions to “improve the management of mental wellbeing in the workplace should enable 
employers to save at least 30% of lost production and staff turnover” (p. 11). However, no 
evidence was referenced against this statement, questioning the reliability of the conclusion.  
 
When considering the reference and intervention case, it is seen in papers exploring turnover, 
that it is implicitly assumed that without the interventions there will be no change to the turnover 
rate (PwC, 2008). Therefore, for the purposes of this CBA tool, the assumption will be made 
that any changes in the turnover rates are due to the VR intervention. The deadweight that will 
be used for turnover is 0%. In other words, all changes to the turnover rate are assumed to be 
due to the implementation of the VR service. This may introduce bias, as contextual factors are 
known to influence employee turnover (Horn & Griffith, 1995, cited in Ahuja, Chudoba, 
Kacmar, McKnight, & George, 2007). A few examples of contextual factors influencing 
turnover behaviour include, workplace attributes (Oldham & Rotchford, 1983), perceived 
organisational and supervisor support (Maertz, Griffeth, Campbell, & Allen, 2007), and job 
satisfaction (Egan, Yang, & Bartlett, 2004), and the wider labour market conditions (CIPD, 
2014). Due to an awareness of a potential bias being introduced with a deadweight of 0%, a 
sensitivity analysis has been conducted on turnover rates following the implementation of the 
CBA tool (see section 4.6.7).  
 
4.2.1.4 Presenteeism reference and intervention case results 
 
The inclusion and exclusion criteria for this literature search are: 
 Employed individuals,  
 The inclusion of a control or comparator group,  
 The data on presenteeism presented as a mean change between pre and post 
 The presenteeism data is less than 20 years old. 
 
Refer to section 3.5.4 for a detailed search strategy. 
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Figure 17: Flow chart of study selection process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenteeism is closely linked to sickness absence and ill-health. The evidence-base for 
presenteeism is recent; however emerging findings indicate that workplace interventions and 
elements of VR may reduce presenteeism levels and increase productivity (Cancelliere et al., 
2011; Knapp et al., 2011) (see section 2.2.2). With a key element of VR being early intervention 
and accommodating workplaces, allowing for early RTW, it runs the risk of displacing the costs 
of sickness absence rather than reducing these costs. It is imperative that the costs of 
presenteeism are accounted for, both within individuals who do not take sickness absence and 
those that do. 
 
Due to the emerging field of literature on VR, workplace interventions were used as a proxy 
for VR. On screening the articles, 3 RCT’s (IJzelenberg et al., 2007; Nurminen et al., 2002; 
Von Thiele, Lindfors, & Lundberg, 2008) and a systematic review (Cancelliere et al. 2011), 
exploring presenteeism in the workplace were identified. However, the data produced in the 
results was insufficient for the purposes of identifying a reference and intervention case, the 
presenteeism outcomes were not heterogeneous, limiting comparability; the studies primary 
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aims were mainly to promote health as opposed to reducing presenteeism; workability, work 
performance and working role function were interpreted as a measure of presenteeism (Baker 
& Aas, 2012); and results were presented as a combination of lost time due to absenteeism and 
presenteeism, limiting the ability to distinguish presenteeism levels in the control and 
intervention groups. These limitations are partly due to the fact that presenteeism is a relatively 
new concept (Baker & Aas, 2012) as well as the fact that there is presently no consensus on the 
best way to measure presenteeism (Krol et al., 2013; Brooks et al., 2010; Terry & Min, 2010).  
 
Bearing the measurement and emerging field limitations in mind, the prevalence of 
presenteeism, using self-reports as measurement, is well supported, with 30% - 53% of the 
Swedish workforce and more than 70% of the Danish workforce reporting presenteeism 
(Jarpsten, 1998; Vingard et al., 2004; Aronsson & Gustafsson, 2005; Hansen & Anderson; all 
cited in Claes, 2011).  Additionally, research in New Zealand and Canada report evidence of 
the prevalence of presenteeism (Keefe & Small, 2005; Caverly, et al., 2007; all cited in Claes, 
2011). 
 
The impacts of presenteeism, have been linked both to decreased productivity within work 
hours, as well as future sickness absence (Bergstrom et al.., 2009; Caverly et al.., 2007; Hansen 
& Andersen, 2009; Hansson et al., 2006; Kivimaki et al.., 2005; Schultz, Chen, & Edington, 
2009; Schultz & Edington, 2007; all cited in Claus, 2011). These impacts are more pronounced 
when comorbidities are present (Holden et al., 2011). Bergstrom et al.’s (2009) research, 
compromising of a sample of 3757 employees from the public sector and 2485 employees from 
the private sector in Sweden, indicated that if individuals had 5 or more episodes of 
presenteeism within a year they were more likely subsequently to have sickness absence of 
more than 30 days. This result stayed consistent even with adjustments for confounding 
variables, such as previous episodes of absence, reported health status, and work factors. De 
Graaf et al. (2012) using a face-to-face survey and the WHO Disability Assessment Schedule 
(n = 6646) in the Netherlands, estimated the number of days lost to sickness absence and 
sickness presenteeism associated with common mental and physical disorders. De Graaf et al. 
(2012) concluded that in addition to sickness absence, on average, an individual with a mental 
health disorder would have an additional 8.0 days of reduced-qualitative functioning, and those 
with physical disorders an additional 3.5 days of reduced-qualitative functioning. These days 
of reduced-qualitative functioning, could then be costed on hourly wages, and is a method of 
quantifying presenteeism that is commonly used, however, Schultz et al. (2009) raises the 
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question as to whether those individuals are 0% productive during those hours. Additionally, 
Vingard et al. (2004), cautions the conclusion that presenteeism is necessarily negative for 
employees and employers, stating that there is insufficient evidence to demonstrate decreased 
work performance. Additionally, presenteeism may be preferable to the employee and 
employer, as the structure of the workplace has been shown to assist recovery from certain ill-
health conditions (Cocker et al., 2014).  
 
From reviewing the literature related to presenteeism, there is limited evidence to enable robust 
conclusions to be made on reference and intervention cases. Thus, no conclusion can be drawn, 
and the only cautious conclusion that can be made is that the intervention will not have an 
effect. Deadweight will equal the impact of the intervention, i.e. it can be assumed that as the 
intervention has no effect. This assumption will be utilised and explored within the sensitivity 
analysis.  
 
Having identified the reference and intervention cases, and subsequently the net effectiveness 
of the VR interventions for the different outcomes, deadweight can now be calculated.  
 
4.2.1.5 Deadweight calculations based on the net effectiveness of the 
interventions determined from the literature searches 
 
In order to calculate the deadweight for each outcome (which is necessary to ensure that the 
benefits of the VR intervention are not over estimated) the following information is needed for 
each outcome for each organisation: 
 
 Starting point (number of sickness absence days pre) 
 Outcome (number of sickness absence days post) 
 Net effectiveness (percentage calculated from the literature) 
 
This data can then be inputted into the following formula to calculate the deadweight (see 
section 3.5.3 for explanation): 
Counterfactual = outcome / (1-net effect) 
 
Deadweight % = (Starting point – Counterfactual) /starting point 
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4.2.2 Unit costs to be used in the CBA mode 
 
Unit costs are the costs of the benefit/outcome e.g. the cost of sickness absence per employee 
per day. These are used within the CBA tool to calculate the financial benefits of each outcome.  
 
4.2.2.1 Sickness absence due to MSDs and Mental ill-health: unit costs 
 
The following tables outline the sickness absence costs that will be used in the CBA tool for 
organisation 1 and 2. 
 
Table 10: Sickness absence costs for organisation 1 (NHS employer, year 2010 – 2011, average salary 
£71.18 per day, £25,980.70 per annum). 
 Average cost per person Source 
Weekly salary £499.63 
Sickness absence costs 
provided by 
organisation 
Wage cost to employer during first 6-months of 
sickness absence (within this organisation the length of 
sick pay is determined by the length of service e.g. 
1year service = 1 month full, pay and 2 months half 
pay, 6 years of service = 6-months full pay and 6-
months half pay).  
This data was not provided, nor the length of episodes 
of sickness absence. Therefore, it is assumed that 
sickness absence that was < 6-months was paid in full.  
£71.18 per day  
Sickness absence data 
provided by 
organisation 
Wage cost to employer during 6‐12 months of sickness 
absence. For the reasons mentioned above this will be 
assumed to be half of full pay for the time post 6-
months. 
£35.59 per day 
Sickness absence data 
provided by 
organisation 
Cost of employers’ national insurance contribution for 
first 6-months of occupational sick pay (OSP) per day 
£9.82 per day (13.8% of 6-
months full salary)  
Gov.UK website 
(2015) 
Cost of employers’ national insurance contribution for 
6‐12 months of OSP per day 
£4.91 per day (13.8% of 6-
months half salary) 
Gov.UK website 
(2015) 
 
Table 11: Sickness absence costs for organisation 2 (Public organisation employer, year 2014 – 2015; 
average salary £22,942.75.00 per annum). 
 Average cost per person Source 
Weekly salary £441.21 
Provided by the 
organisation 
Cost of OSP to employer during first 6-months of 
sickness absence  
£88.24 
Provided by the 
organisation 
Cost of OSP to employer during 6‐12 months of 
sickness absence. For the reasons mentioned above this 
will be assumed to be half of full pay for the time post 
6-months. 
 
£44.12 
 
Provided by the 
organisation 
Cost of employers’ national insurance contribution for 
first 6-months of OSP  
 £12.18 (13.8%) 
Gov.UK website 
(2015)  
Cost of employers’ national insurance contribution for 
6‐12 months of OSP  
 £6.09 (13.8%) 
Gov.UK website 
(2015)  
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4.2.2.2 Presenteeism: unit costs 
 
Presenteeism costs will be estimated at £605 per employee attending the VR service (see 
section 3.5.5.2). 
 
4.2.2.3 Turnover: unit costs 
 
Turnover costs will be estimated at £16,663 per employee (see section 3.5.5.3).  
 
4.2.2.4 Benefits/outcomes of VR service that are not in the CBA tool but could be 
added if data was available 
 
To ensure that a CBA tool is user-friendly it needed to incorporate information that is easily 
accessible by organisations using the CBA tool. Ideally, to get a complete picture of the 
economic impact of an intervention one would want to include the indirect costs and benefits 
such as: 
a. Co-worker overtime 
b. Salary cost of replacement workers 
c. Light duties cost, if these were not in the original role of the employee 
d. Reimbursement for sickness absence to the organisation, via their insurance. 
e. Increased work load and pressure on co-workers 
f. Decreased productivity of co-workers 
g. Time spent facilitating the RTW of the chronically ill employee 
h. Attrition and turnover costs (Rail Safety and Standards Board, 2014; Uegaki, de Bruijne, 
van Tulder, & van Mechelen, 2007). 
 
However, organisations 1 and 2 were unable to provide this information, thus these costs and 
benefits are not included in the study. However, organisations need to be aware of these 
additional indirect costs and benefits when using the CBA tool as a decision-making tool. 
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4.3 Phase 2 results  
 
Figure 18: Diagrammatic representation of the 4 phases of this research project highlighting phase 2 
 
 
 
 
 
 
 
 
 
The objective of phase 2 was to collect the relevant data required to populate the practical CBA 
tool from two VR Services and the organisations to which VR is provided. This chapter presents 
the data collected for organisation 1 and 2 as part of the evaluation of their VR services. 
 
4.4 Organisation 1 
 
This section presents the data collected for organisation 1 (see 1.4.1) as part of an evaluation of 
their VR service. In organisation 1 an in-house VR service for employees with MSDs within 
an NHS organisation in the North-West England, UK was evaluated. 
 
Cost 
benefit 
analysis 
tool
Phase 1: revise the 
GM CBA tool  with 
VR apporpriate 
outcomes
Phase 2: collect 
primary and 
secondary data 
from 2 VR services 
to populate the 
costs and outcomes 
of the CBA model
Phase 3: Implement 
and test the revised 
CBA tool, using 
data from Phase 2
Phase 4: Explore 
the value of the 
revised CBA to VR 
services and 
organisations
Using the 
literature base 
Focus groups to 
evaluate the value 
of the revised 
CBA to potential 
users 
Primary data – 
employees using 
the VR services – 
outcomes collected 
pre and post 
interventions. 
Secondary data – 
collected by the VR 
services and 
organisations 
Researcher inputs 
data from phase 2, 
implements and 
tests the revised 
CBA model. 
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The aims of organisation 1’s evaluation were: 
 
a) To assess the impact of the VR service on the health of employees with MSDs. 
b) To assess the impact of the VR service on employees with MSDs sickness absence 
and the associated costs. 
c) To determine the costs and benefits of the VR service. 
 
Primary and secondary data was collected. Primary data was collected from the service users’ 
pre-intervention, post intervention and 3 and 6-months post intervention. The primary data was 
collected to assess the impact of the VR service on job satisfaction levels, mental health status, 
and the physical function of employees attending the service i.e. aim a) of organisation 1 
evaluation.  The secondary data was collated by the organisation, with the aim to evaluate the 
impact of the VR service on sickness absence levels and costs within the organisation i.e. aim 
b) of organisation 1 evaluation. Both the secondary and primary data collected was used to 
populate the revised CBA tool, to determine the costs and benefits of the VR service i.e. aim c) 
of organisation 1’s evaluation.  
 
This section will firstly present the results of the primary data, which has not been used to 
populate the CBA tool. Then the secondary data, which is used within the CBA tool, will also 
be presented. These results will then be used to populate the CBA model and the results of the 
populated CBA tool will be presented in chapter 4.6 (Phase 3 results). 
 
4.4.1 Participants: organisation 1 
 
304 employees were referred to the VR service from 1st March 2010 to 31st January 2011. Of 
these 285 employees attended the service and were assessed for eligibility. No participants were 
excluded, however 65 employees declined to partake in the research. Pre-questionnaire data 
was collected for 220 employees.  89 data observations were collected post intervention, with 
131 data observations lost to follow-up. As the duration of the intervention varied in length, 
according to patients needs and the time limitation of the study being restricted to 12 months, 
the 3-month (n = 40) and 6-month (n = 11) post data observations collected were limited (See 
Figure 19). In addition, participants had missing data at a number of points, as they did not all 
complete the full questionnaire pack. Although loss to follow-up/attrition is common, it may 
introduce bias and limit the statistical power (Kristman, Manno, & Cote, 2004). A common rule 
of thumb is that less than 5% loss to follow-up results is minimal bias, whilst above 20% brings 
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the validity of the results into question (Dettori, 2011; Dumville, Torgerson, & Hewitt, 2006). 
However, this threshold is not universally accepted, as rates of loss to follow-up vary widely 
(Guyatt et al, 2011) and differ between different study types, for example in cohort studies it is 
acceptable to have a loss of 60%-80% (Kristman et al., 2004). As a general rule of thumb, the 
higher the proportion of loss to follow-up the greater the risk of bias (Guyatt et al., 2011). This 
risk increases when the loss of follow-up can be associated with the likelihood of the outcome 
of events for example, the patient may fail to return to their physiotherapy appointment because 
of a deterioration in their medical condition (Akl et al, 2012). To assist in determining the risk 
of attrition bias, it is recommended that the baseline characteristics of the groups are compared 
and should the characteristics substantially change this indicates a higher level of risk (Dumville 
et al., 2006).  This evaluation had a large pre-post loss to follow-up (68%), and the nature of 
the intervention may mean that the loss to follow-up is associated with the outcome of events, 
therefore indicating a high likelihood of bias. This will be explored further through the 
comparison of the baseline characteristics.   
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Figure 19: Patient Cohort organisation 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*The duration of the intervention was not standardised, it varied according to patient needs. 
 
4.4.2 Primary data and results: organisation 1: 
 
Socio-demographic data of the participants (n=219) was collected pre-intervention, 1 
participant did not complete the demographic data. As there was a large loss to follow-up, the 
baseline characteristics of the participants lost to follow-up from pre- to post-VR intervention 
were compared (see Table 12). This provides a clearer picture of the sub-sample lost to follow-
up and may provide an indication of attrition bias (Dumville et al., 2006). 
 
 
 
 
 
 
Assessed for eligibility (n= 285) 
Excluded (n= 65) 
 
   Declined to participate or did not 
attend or missing data 
 
 Completed 3-month follow-up questionnaire data 
(n = 40) 
 Lost to follow-up or lost due to time constraints 
(n = 58) 
 
 Received VR intervention and provided pre-
questionnaire data (n = 220) 
 
 Completed 6-month follow-up questionnaire data 
(n = 11) 
 Lost to follow-up or lost due to time constraints 
(n = 29) 
 
 Completed post questionnaire data (n = 89) 
 Lost to follow-up (n = 131) 
 
 
 
 
Pre-intervention 
Post intervention * 
3-month follow-up 
6-month follow-up 
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Table 12: Baseline socio-demographic data of all participants in organisation 1, those lost to follow-up 
and those remaining in the trial at post- and 3-months post-VR intervention measurement 
 
  All 
participants 
No of 
patients 
(percentage) 
(n = 219) 
Participants lost 
to follow-up at 
post- VR 
intervention 
(n = 130) 
Remaining 
participants at 
post-VR 
intervention 
(n = 89) 
Remaining 
participants at 
3-months post-
VR 
intervention 
(n = 35) 
Gender 
 
Male  
Female  
No response 
37 (16.9%) 
181 (82.6%) 
1 (0.5%) 
24 (18.5%) 
105 (80.8%) 
1 (0/8%) 
12 (13.5%) 
77 (86.5%) 
 
4 (11.4%) 
31 (88.6%) 
Age 
16-25 years 
26-35 years 
36-45 years 
46-55 years 
56-65 years 
No response 
10 (4.6%) 
47 (21.4%) 
59 (26.8%) 
73 (33.2%) 
27 (12.3%) 
4 (1.8%) 
6 (4.6%) 
32 (24.6%) 
32 (24.6%) 
39 (30%) 
18 (13.8%) 
3 (2.3%) 
4 (4.5%) 
15 (16.9%) 
36 (29.2%) 
34 (38.2%) 
9 (10.1%) 
1 (1.1%) 
2 (5.7%) 
5 (14.3%) 
10 (28.6%)  
15 (42.9%) 
3 (8.6%) 
Patients 
employment 
status: 
At work 
Off sick 
No response 
201 (91.8%) 
15 (6.8%) 
3 (1.4%) 
118 (90.8%) 
9 (6.9%) 
3 (2.3%) 
83 (93.3%) 
6 (6.7%) 
33 (94.3%) 
2 (5.7%) 
Work 
hours: 
Full-time 
Part-time 
No response 
176 (80.4%) 
42 (19.2%) 
1 (0.8%) 
98 (75.4%) 
23.8 (31%) 
1 (0.8%) 
78 (87.6%) 
11 (12.4%) 
31 (88.6%) 
4 (11.4%) 
Staff group 
 
Administrative 
Allied Health 
Professional 
Nursing 
Estates 
Senior 
Management 
Medical 
Other  
No response 
75 (34.2%) 
63 (28.8) 
 
51 (23.3%) 
5 (2.3%) 
14 (6.4%) 
 
2 (0.9%) 
4 (1.8%) 
5 (2.3%) 
41 (31.5%) 
39 (30%) 
 
30 (23.1%) 
5 (3.8%) 
8 (6.2%) 
 
1 (0.8%) 
3 (2.3%) 
3 (2.3%) 
35 (39.3%) 
23 (25.8%) 
 
21 (23.6%) 
0 (0%) 
6 (6.7%) 
 
1 (1.1%) 
1 (1.1%) 
2 (2.2%) 
15 (42.9%0 
9 (25.7%) 
 
7 (20%) 
0 (0%) 
2 (5.7%) 
 
0 (0%) 
1 (2.9%) 
1 (2.9%) 
NHS Staff 
Grade 
 
1 
2 
3 
4 
5 
6 
7 
8 
No response 
1 (0.5%) 
13 (5.9%) 
22 (10%) 
20 (9.1%) 
27 (12.3%) 
27 (12.3%) 
33 (15.1%) 
24 (11%) 
52 (23.7%) 
1 (0.8%) 
8 (6.2%) 
11 (8.5%) 
13 (10%) 
17 (13.1%) 
17 (13.1%) 
15 (11.5%) 
13 (10%) 
35 (26.9%) 
0 (0%) 
5 (5.6%) 
11 (12.4%) 
8 (9%) 
10 (11.2%) 
10 (11.2%) 
18 (20.2%) 
11 (12.4%) 
16 (18%) 
0 (0%) 
2 (5.7%) 
6 (17.1%) 
4 (11.4%) 
3 (8.6%) 
3 (8.6%) 
9 (25.7%) 
3 (8.6%) 
5 (14.3%) 
Ethnic 
group 
 
White 
Black 
Asian 
Mixed 
Other 
No response 
208 (95%) 
1 (0.5%) 
4 (1.8%) 
1 (0.5%) 
1 (0.5%) 
4 (1.8%) 
123 (94.6%) 
0 (0%) 
2 (1.5%) 
1 (0.8%) 
0 (0%) 
4 (3.1%) 
85 (95.5%) 
1 (1.1%) 
2 (2.2%) 
0 (0%) 
1 (1.1%) 
 
34 (97.1%) 
1 (2.9%) 
 
 
As is seen in Table 12, the baseline characteristics of the three groups i.e. lost to follow-up, 
remaining participants at post- and 3-months post-VR intervention are largely similar. The only 
characteristic with a difference of more than 10% was the work hours, the participant group 
post and post-3 months had a larger percentage of full time workers (87.6% and 88.6% 
respectively) compared to the lost to follow-up group (75.4%).  Although there is a similarity 
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in the baseline characteristics noted between these three groups, when looking at the 3-months 
post-VR intervention data observations there is a further loss to follow-up of 86%. This is a 
very high loss to follow-up and introduces a high risk of bias and decreased validity of the 
results. Therefore, the primary data results must be interpreted with this risk in mind.  
 
4.4.2.1 Primary outcome data analysis: organisation 1 
 
The pre-intervention, post intervention and 3-month post intervention data observations were 
analysed. To detect whether there was a difference between the same group, at the three 
different time points, and to compare the results of the same group at two different time points 
Friedman and Wilcoxen tests were used (Rumsey, 2011). In addition, with regards to the GHQ-
12, it can be analysed used a binary score, where participants scoring greater than 4 are 
purported to be subjects showing minor psychological distress (Goldberg, 1972) (see Section 
3.5.2.2.2). For individuals who are physically ill, it is recommended that a higher threshold cut-
off score of 4 is needed for optimal discrimination (GL Assessment, 2011). The 6-month ‘post 
intervention’ data set (n = 11) was excluded from the analysis, as it was too small. A number 
of participants did not complete all the questionnaires within the questionnaire pack, resulting 
in different data observation numbers for the different questionnaires.  
 
4.4.2.2 Primary outcome data results: organisation 1 
 
Table 13: Initial Outcome Descriptive Statistics pre-VR intervention 
 
Scores pre-VR intervention N Mean 
GHQ-12 pre (Likert scale) 209 1.0750 
Job Satisfaction Scale (JSS) pre  211 5.0559 
Patient Specific Function Scale (PSFS) pre  187 5.3681 
 
The benchmark scores for NHS General Mental Health (Likert scoring method) are: mean = 
1.01; standard deviation (s.d.) = 0.46; n = 20549 (Stride et al., 2007). Thus, for GHQ-12 pre-
intervention, the employees in organisation 1 displayed a marginally higher GHQ-12 score, 
with a mean of 1.08. 
 
The benchmark scores for NHS hospital staff in respect of job satisfaction are:  mean = 4.51; 
s.d. = 0.86; n = 20694 (Stride et al., 2007).  Thus, pre-intervention the employees in organisation 
1 displayed higher levels of job satisfaction than the norm (mean = 5.06).  
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On searching the literature no published norms on the PSFS were found.  
 
Table 14, provides a summary of the JSS scores for 34 participants, pre-VR intervention, at 
discharge and at 3-months. Out of the 211 participants providing pre-VR JSS scores (see Table 
12) only 34 participants provided JSS scores at both discharge and 3-months post discharge.    
 
 
Table 14: Job Satisfaction Scale (Warr et al., 1979) pre-VR intervention, at discharge and at 3-months post 
discharge 
 
Scores pre- VR intervention, discharge and 3-months 
post intervention 
N Mean 
JSS Pre  34 5.1074 
JSS at discharge 34 5.3100 
JSS 3 months post discharge 34 5.2621 
 
Using Friedman test the results (Table 14) indicate that there is no significant difference in the 
JSS scores across three points in time, pre, at discharge and 3-months post discharge, ² (2, n = 
34) = 0.582, p< 0.005.  However, there is a significant increase in the JSS score between pre-
intervention and discharge in the predicted direction (Wilcoxon, n = 88, z = -2.302, two-tailed 
p = 0.021). There is no significant difference in the JSS score between discharge and 3-months 
post discharge (Wilcoxon, n =34, z = -0.832, two-tailed p = 0.405). 
 
Tables 15, 16 and 17 present the results for the GHQ-12 scores. At pre-intervention 62 
participants scored greater than 4 on the GHQ-12 and were identified as ‘cases’ i.e. showing 
minor psychological distress (Goldberg, 1972). Table 15 presents the pre-GHQ-12 scores on a 
binary scale. This allows the exploration of the percentage of participants scoring the varied 
results.  
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Table 15: GHQ-12 Pre-VR intervention – Binary Scale 
 
 
Score pre-VR intervention 
(Binary scale) 
Frequency (number of 
individuals scoring the 
corresponding score on the 
GHQ-12) 
 
Cumulative percent 
0 54 25.8 
1 45 47.4 
2 30 61.7 
3 18 70.3 
4 17 78.5 
5 8 82.3 
6 10 87.1 
7 5 89.5 
8 10 94.3 
9 4 96.2 
10 4 98.1 
11 2 99.0 
12 2 100 
Total : 209  
 
Table 15 illustrates that 29.7% (n = 62) of participants showed signs of minor psychological 
distress (i.e. a GHQ-12 score of 4 or above) pre-VR intervention.  
 
Table 16 reports the pre and post GHQ-12 scores of the participants identified as ‘cases’. At 
pre-intervention 62 ‘cases’ were identified. At post-intervention 19 ‘cases’ were identified. The 
62 participants who scored 4 or above on the GHQ-12 at pre-intervention all completed post-
intervention questionnaires and were explored further as a subgroup within the 89 participants 
who completed the post-questionnaires. This sub-groups (62 participants identified as ‘cases’ 
pre-intervention) mean pre- and post GHQ-12 scores are presented in Table 16.  
 
Table 16:  GHQ-12 pre-VR and at discharge mean scores for the ‘Cases’ identified pre-VR intervention  
 
Scores pre-VR intervention and at 
discharge for participants identified as 
‘cases’ 
N Mean GHQ-12 score 
 
GHQ-12 pre   62 6.5323 
GHQ-12 at discharge 62 2.6316 
 
There is a significant reduction in the mean scores of the 62 participants identified as ‘cases’ 
between pre and discharge (Wilcoxon, n = 19, z = -3.380, two-tailed p = 0.001). 
 
Table 17 below, provides a summary of the GHQ-12 scores for 35 participants, pre-VR 
intervention, at discharge and at 3-months. Out of the 209 participants providing pre-VR GHQ-
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12 scores (see Table 13) only 35 participants provided GHQ-12 scores at both discharge and 3-
months post discharge.    
 
Table 17: GHQ-12 (Likert Scale) (Goldberg, 1972) pre-VR intervention, at discharge and at 3-months post 
discharge 
 
Scores pre-VR intervention, discharge and 3-months 
post intervention (Likert scale) 
N Mean 
GHQ-12 pre  35 1.0400 
GHQ-12 at discharge  35 0.7814 
GHQ-12 3 months post discharge  35 0.8189 
 
Using a Friedman test, the results indicated that there was a significant reduction in the GHQ-
12 scores (indicating better mental health) across two points in time, pre- (Md = 2.53) and 
discharge (Md = 1.69), although at 3-months post discharge the GHQ-12 score had increased 
slightly (Md = 1.79), ² (2, n = 35) = 16.894, p< 0.005.  There was a significant reduction in 
the GHQ-12 score between pre- and discharge (Wilcoxon, n = 88, z = -3.280, two-tailed p = 
0.001).  There was no significant difference in the GHQ-12 score between discharge and 3-
month post discharge (Wilcoxon, n = 35, z = -0.884, two-tailed p = 0.377). 
 
Table 18, provides a summary of the PSFS scores for 27 participants, pre-VR intervention, at 
discharge and at 3-months. Out of the 187 participants providing pre-VR PSFS scores (see 
Table 13) only 27 participants provided PSFS scores at both discharge and 3-months post 
discharge.    
 
Table 18:Patient Specific Function Scale (Stratford et al., 1995) pre-VR intervention, at discharge and at 3-
months post discharge 
 
Scores pre- VR intervention, discharge and 3-months 
post intervention 
N Mean 
PSFS Pre  27 5.5644 
PSFS at discharge 27 8.1770 
PSFS 3 months post discharge 27 8.3148 
 
Using Friedman test the results indicated that there was a significant increase in the PSFS scores 
(indicating improved function) across three points in time, pre- (Md = 1.09), at discharge (Md 
= 2.33) and 3-months post discharge (Md = 2.57), ² (2, n = 27) = 38.800, p< 0.005. There was 
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a significant increase in the PSFS score between pre and discharge (Wilcoxon, n = 78, z = -
7.090, two-tailed p = 0.000).  There was no significant difference in the PSFS score between 
discharge and 3-months post discharge (Wilcoxon, n = 27, z = -0.961, two-tailed p = 0.337). 
 
In summary: 
 
These results indicate that participants who attended the VR service showed a reduction in 
sickness absence; an improvement of mental health, job satisfaction and identified functional 
limitations. These results were sustained over three months. However, due to the large loss to 
follow-up these results have a high risk of bias, which may impact on their validity. While these 
findings inform the VR service evaluation, they are not used within the CBA tool 
 
4.4.3 Secondary data results: organisation 1: 
 
4.4.3.1 Sickness absence results: organisation 1 
 
The secondary data in respect of sickness absence was provided by organisation 1. This data is 
used to populate the CBA tool in phase 3. 12-month pre and post sickness absence data on 127 
staff members who had attended the VR service and agreed to participate in the research study 
was provided (see Table 19). In addition, the salary costs of each employee’s sickness absence 
were provided. During the research study the PCT was integrated into a wider hospital trust, 
this resulted in a number of redundancies. Due to this integration, a number of employees who 
had consented to taking part in the study were longer working for the PCT. Thus, sickness 
absence data with 12-months pre and post was only available for 127 employees from the 
original cohort of 220. As the data was randomly missing, i.e. it is likely that the missing data 
is not due to participants’ referral to the VR service, this decreases bias (Kristman et al., 2004; 
Soley-Bori, 2003). When missing data is missing at random it is acceptable to ignore this in 
your estimations (Soley-Bori, 2003). Thus, this data is assumed to be representative of the wider 
population.  
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Table 19: Total cost of sickness absence12 months pre and post VR intervention 
 
Individual sickness absence for 
participants (n= 127) 
Total sickness absence cost MSD sickness absence cost 
12 months pre  £139,344.80 
 
£40,223.13  
(28.87% of total sickness absence 
cost pre) 
12 months post  £113,897.55 
 
£6,453.88  
(5.67% of total sickness absence 
cost post) 
Difference in cost pre and post  £25,447.25 £33,769.25 
 
A paired-samples t-test was conducted to evaluate the impact of the VR service on the number 
of sickness absence days taken by staff during this time period.  The mean number of sickness 
absence days, 12 months pre-intervention (mean = 17.0546, s.d. = 29.95369) and 12 months 
post intervention (mean = 10.9578, s.d. = 26.05643) did not differ significantly (t = 1.841, df = 
126, one-tailed p = 0.68). However, the mean number of MSD sickness absence days, 12 
months pre-intervention (mean = 6.3890, s.d. = 24.29677) and 12 months post intervention 
(mean = 0.6016, s.d. = 2.69008) differed significantly in the predicted direction (t = 2.654, df 
= 126, one-tailed p = 0.009).   
 
Table 20 outlines the number of sickness absence days, the mean and the standard deviation, 
12 months pre and post discharge from the intervention, for both sickness absence due to all 
conditions and MSDs. 
 
Table 20:12-month pre and post VR intervention sickness absence data 
 
Individual sickness absence (n=127) No. of 
days 
Mean Standard deviation 
Sickness absence in days (all conditions) 
12 months pre  2166 17.0546 29.95369 
12 months post discharge 1391.64 10.9578 26.05643 
Sickness absence in days (MSDs) 
12 months pre  811.4 6.3890 24.29677 
12 months post discharge 76.4 0.6016 2.69008 
 
Table 20, shows a decrease in general sickness absence 12 months post attending the VR 
service, although not statistically significant. In organisation 1 the mean number of sickness 
absence days, 12 months pre-VR intervention (mean = 17.0546, s.d. = 29.95369) and 12 months 
post-VR intervention (mean = 10.9578, s.d. = 26.05643) did not differ significantly (t = 1.841, 
df = 126, one-tailed p = 0.68). However, the mean number of MSD absence days, 12 months 
pre- VR intervention (mean = 6.3890, s.d. = 24.29677) and 12 months post-VR intervention 
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(mean = 0.6016, s.d. = 2.69008) differed significantly in the predicted direction (t = 2.654, df 
= 126, one-tailed p = 0.009). 
 
Table 21 depicts the sickness absence data pre and post-VR intervention for employees with 
sickness absence < and > 6-months.  
 
Table 21: Sickness absence data pre- and post-VR intervention for employees with sickness absence < 
and > 6-months 
 
Individual sickness absence 12 months pre- 
referral to the VR service (n=127) 
No of employees No. of days Mean 
Sickness absence < 6-months Pre 125 615.4 4.92 
Sickness absence < 6-months Post discharge 125 76.4 0.61 
Sickness absence > 6-months Pre 1 196 196 
Sickness absence > 6-months Post discharge 1 0 0 
 
Using the sickness absence data and costs provided, it was possible to work out an average cost 
of sickness absence per day, as follows: 
 
Total cost of sickness absence 12 months pre and post = £ 253,242.35  
      Total number of sickness absence days 12 months pre and post = 3557.64 
 
= £71.18 per day 
 
4.4.3.2 Turnover: organisation 1 
 
Organisation 1 had major organisational restructuring during the times of data collection, with 
high levels of staff redundancies and turnovers, rendering the inclusion of organisation 1 
turnover rates inappropriate. 
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4.4.3.3 Costs: organisation 1 
 
 
Table 22: Costs of the VR service provided by the NHS Primary Care Trust. 
 
Type of cost Spend(total) £ 
Marketing and Advertising of Project      1,000.00 
Dedicated time to lead and undertake the project    66,940.00 
Clinical involvement, as appropriate         333.00 
Supply of technical skills    10,000.00 
Travel         485.00 
*Workplace assessments       -7,800.00 
Total    70,958.00 
 
*Prior to the implementation of the VR service, workplace assessments were purchased from 
an external company. The money spent on workplace assessments for the year prior to VR 
service was £7,800. This figure was provided by finance procurement, following an audit trail. 
With the advent of an in-house VR service, the workplace assessments were incorporated into 
the service, replacing the external companies. 
 
The total cost of the VR service for employees attending the service with MSDs conditions (n 
= 285) was £70,958.00. 
 
In summary: 
 
The costs of the VR service are £70,958.00. The sickness absence figures provided indicate that 
sickness absence due to MSDs decreased significantly 12 months post attending the VR service, 
with an associated reduction in costs.  The costs and sickness absence data in this section will 
be used within the CBA tool (see section 4.6). 
 
4.5 Organisation 2 
 
This section presents the data collected for organisation 2 (see section 1.4.2) as part of an 
evaluation of their VR service. In organisation 2 (a UK public organisation) an in-house VR 
service for employees with physical or mental ill-health was evaluated. 
 
The aims of organisation 2’s evaluation were: 
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a) To assess the impact of the VR service on the sickness absence levels, presenteeism 
levels and quality of life of employees attending the service, and the associated costs. 
b) To determine the costs and benefits of the VR service. 
 
Primary and secondary data was collected. Primary data was collected from the service users’ 
pre-intervention, 2-weeks post intervention and 3 and 6-months post intervention. The primary 
data was collected to assess the impact of the VR service on self-reported sickness absence 
levels, presenteeism levels and quality of life of employees attending the service i.e. aim a) of 
organisation 2 evaluation.  The secondary data was collated by the organisation to evaluate the 
impact of the VR service on sickness absence and turnover levels within the organisation i.e. 
aim a) of organisation 2’s evaluation. The secondary data collected was used to populate the 
revised CBA tool, to determine the costs and benefits of the VR service i.e. aim b) of 
organisation 2’s evaluation.  
 
This section will firstly present the results of analysis of the primary data. Analysis of the 
secondary data to be used within the CBA tool will then be examined. These results will then 
be used to populate the CBA tool and the results of the populated CBA tool will be presented 
in chapter 4.6 (Phase 3 results). 
 
4.5.1 Participants: organisation 2 
 
To preserve client confidentiality, participants were recruited through the VR service. Although 
requested, no data was provided on the number of individuals invited to take part in the 
intervention.  12 participants consented to having information sent to them. No participants 
were excluded, however 9 employees declined to partake in the research. As a result, pre-
questionnaire data and 2-week post intervention data was collected for 3 participants only. 1 
participant was lost to follow-up; thus 3-month and 6-month follow-up data was collected for 
2 participants only (See Figure 20). Due to the small sample no statistical analysis of the data 
was conducted. 
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Figure 20: Patient Cohort organisation 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.5.2 Primary data and results: organisation 2 
 
4.5.2.1 Primary outcome measure results: organisation 2 
 
There are differences in the outcome measurements used and the data collection timings 
between the two organisations. The reasons for this are threefold; firstly, the organisations 
expressed an interest in specific outcome measures. Organisation 1 expressed an interest in job 
satisfaction and mental health. Moreover, as the VR intervention was focused on MSDs, the 
PSFS was utilised to explore the effectiveness of the intervention on this further. Organisation 
2 expressed an interest on the effect of the VR service on quality of life.  Secondly, learnings 
from the research conducted in organisation 1 were introduced into the evaluation of 
Invited to take part (n=unknown) 
Expressed interest and sent pre-participant pack (n=12) 
 
 Declined to participate (n = 9) 
 
 
 Completed 3-month follow-up questionnaire 
data (n = 2) 
 Lost to follow-up (n = 1) 
 
 Received VR intervention and provided pre-
questionnaire data (n = 3) 
 
 Completed 2 –week post questionnaire data 
(n = 3) 
 Lost to follow-up (n = 0) 
 
 
 
 
Pre-intervention 
2-week post 
intervention  
3-month follow-up 
 Completed 6-month follow-up questionnaire 
data (n = 2) 
 Lost to follow-up (n = 1) 
 
6-month follow-up 
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organisation 2. Errors noted in the sickness absence data collected during organisation 1’s 
evaluation were addressed by including a self-report of sickness absence outcome measure.  
Varied discharge dates of participants noted in organisation 1’s results, resulted in changing the 
timings of data collection for organisation 2 from pre, at discharge, 3-months and 6-months (as 
collected in organisation 1) to pre, 2-weeks post, 3 and 6-months post. Thirdly the development 
of the CBA tool informed the outcome measures used in organisation 2. As the CBA tool is to 
be used by VR services, they may not have access to organisations sickness absence data, so an 
alternative means of collecting this information is needed i.e. self-report. Moreover, as the 
research on the CBA tool developed a need to measure presenteeism was identified and 
included in the outcome measures in organisation 2.  
 
The following outcome measures were used in organisation 2: 
 
- Sickness absence using the Work Limitations Questionnaire Work Absence Module 
(WLQ-4) (Lerner et al., 2001), a self –report of sickness absence. 
 
- Presenteeism/productivity questionnaire using the Work Limitations Questionnaire 
(WLQ) (Lerner et al., 2001). The questions used in the questionnaire explore the 
limitations employees are experiencing at work due to their health problems, as well as 
looking at the productivity loss as a result, allowing for presenteeism to be quantified 
as a monetary value (Lerner et al., 2003).  
 
- Quality of life, using the EQ-5D-5L (EuroQol Group, 2009). The EQ-5D-5L ‘is a 
standardised measure of health status developed by the EuroQol Group in order to 
provide a simple, generic measure of health for clinical and economic appraisal’ (Oemar 
& Janssen, 2013, p. 4). 
 
Due to the low number of participants, no statistical analysis was conducted and no summary 
statistics are presented. The three individuals who did take part in the service reported an 
improvement in quality of life, pain, presenteeism and levels of sickness absence. However, no 
conclusions can be drawn from this finding. The quality of life outcome measure was collected 
to inform the VR service evaluation, whereas presenteeism and self-reported sickness absence 
were intended to be used within the new CBA tool.  
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4.5.3 Secondary data results: organisation 2 
 
Secondary data was supplied by the VR provider and the organisation the VR service was 
situated within. The data was anonymised and aggregated by the organisation. This data has 
been used in phase 3 to populate the CBA tool. The sickness absence data was for all individuals 
who attended the VR service (n = 138). 
The secondary data comprised of:  
 VR service costs 
 Sickness absence costs of participants attending the VR service. 
 Turnover rates 
 
4.5.3.1 VR service costs: organisation 2 
 
 
The VR service had a budget of £88,000. As part of the evaluation, a breakdown of costs was 
calculated (see Table 23). These costs are approximations based on information provided by 
the organisation both verbally and within documentation. The information provided covered 
different time periods, thus are used as approximates of annual costs. Moreover, the service 
provides internal and external contracts, with no data provided on proportioning costs e.g. 
department overheads, VR platform, car allowance. Thus, the costs are not exact but rather 
provide an overview of the costs of the VR service.  For the purposes of the CBA tool, as no 
underspending was reported, it is assumed that the full budget was spent and that the budget 
represents the total cost.  
 
The VR service provided different levels of interventions according to the case needs namely; 
telephone, intermediate, basic, and complex. In order to calculate the costs of the different levels 
of interventions (see Table 23 below) an average salary was used. Internal VR case managers 
have a salary of between £23,000 - £26,000, and associate salaries are approximately £30,000. 
Therefore, calculations have been worked on the average salary between £23,000 - £30,000 i.e. 
£26,500. As the VR service provides internal and external services, a cost per case based on the 
average salary of a VR case manager was calculated. The breakdown for the costs per case was 
calculated as follows: 
 Admin: 20 mins = £4.53 
 Travel: 3 hours = £40.77 
 Assessment: 1.5 hours = £20.39 
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 Report writing: 3 hours = £40.77 
 Case management 1 hour per week.  
- Basic = 8 weeks case management = £108.72    
- Intermediate = 12 weeks = £163.08    
- Complex = 16 - 26 weeks (average 21 weeks) = £285.39 
Total costs per level of intervention: 
 Telephone triage = £65.67 
 Basic = £215.18 
 Intermediate = £269.54 
 Complex (taking an average between 16 and 26 weeks case management) = £391.85 
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Table 23: VR service costs 
 
Type of cost Cost 
Approximate Total Spend per 
annum 
Triage cases 
£65.67  
(28 telephone triages between 
06/01/2014 – 24/11/2014) 
Therefore: approx. 30.5 per 
annum 
                                        £2002.94 
Basic referral cases 
£215.18  
(51 basic cases between 
06/01/2014 – 24/11/2014) 
Therefore: approx. 56 per annum 
                                     £12,050.08 
Intermediate referral cases  
£269.54  
(29 intermediate cases between 
06/01/2014 – 24/11/2014) 
Therefore: approx. 32 per annum 
                                        £8625.28 
Complex referral cases  
£391.85  
(30 complex cases between 
06/01/2014 – 24/11/2014) 
Therefore: approx. 33 per annum 
                                     £12,931.05 
Department overheads 
Not provided (internal service not 
cross charged against entire 
department) 
                                           No data 
VR Platform  
£2100  
per month (Cost covered by 
internal service although used for 
external contracts) 
                                     £25,200.00 
Car allowance 
£3300  
per year – not all VC’s 
Further information needed on 
number of VC’s provided with 
this allowance 
Mileage 25-40p per mile No data 
Mobile phones No data No data 
Account management fee 
 
1 day per week (used average 
VRC salary to calculate) 
 
£5300.00 
EAP (Employee Assistance 
Programme)  
£4189.65  
per 6-months 
(£7.95 per employee per year 
(PEPY) 1054 employees.) 
                                        £8379.30 
OH Provider  
£300 
 per referral (approx. 3 a year) 
£900.00 
GP reports  
£125  
per report (approx. 4 every 6-
months) 
£1000.00 
POHQ (Post Offer Health 
Questionnaires) 
£45  
(approx. 58 every 6-months) 
£5220.00 
Ad hoc MI information and 
reports requests 
£75  
per hour (approx. 4 every 6-
months) 
£600 
Total cost 
Not including missing 
information 
£82,208.65 
Budget provided / Assumed 
total cost 
 £88,000.00 
 
As seen from the above calculations, the fixed budget for the VR service covers the costs 
provided, however not all costs have been included e.g. department overheads, mileage, and 
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mobile phone costs. These costs were requested however the organisation did not provide them.  
Moreover, these calculations do not include the cost of the employees’ time for attending the 
service should they be in work. Therefore, the actual cost of the service may be greater than the 
fixed budget provided. However, for the purposes of this model the budget will be assumed to 
be representative of the total cost of the VR service.  
 
Between 06/01/2014 – 24/11/2014 138 employees were referred to VR service, indicating 
approximately 152 referrals per annum. No data on the number of referrals per sickness absence 
case was provided. For the purposes of this model, it is assumed that the data provided is 
representative of the entire cohort. The data to be used in the CBA tool is limited to the 
individuals whose sickness absence data was provided by the organisation with at least three 
months pre and post VR referral (n= 68). Moreover, as this model is limited to mental ill-health 
and musculoskeletal disorders, only employees attending the VR service for a mental health 
condition (n=34) or musculoskeletal (n=9) condition are included. This limitation in the data is 
not necessarily random, as the incomplete data was provided by the organisation. Thus, this 
loss of cases may introduce bias and decrease the validity of the estimations. The annual budget 
cost of £88,000 can be assumed to be for 152 referrals, thus within the CBA tool a percentage 
of this cost will be used to represent a cost of the VR for 43 employees. Therefore for 43 
employees the service costs £24,894.74. Thus, for the purposes of implementing the CBA 
considering MSD and mental health conditions only, the total cost that will be used is 
£24,894.74. When considering different scenario’s, the CBA tool will be implemented 
approximating and differentiating the costs for the different causes of sickness absence, 
consequently, the cost for MSDS (n= 9) equals £5,210.53 and the cost for mental health 
disorders (n=34) equals £19,684.21. 
 
4.5.3.2 Sickness absence costs: organisation 2 
 
The organisation provided an overview of sickness absence data for all employees during the 
time period March 2013 – March 2015 (see Table 24). In addition, they provided sickness 
absence data for the individuals attending the VR service during the time period 1st September 
2014 – 29th March 2015 (n = 81). 
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Table 24: Sickness absence data for all employees from March 2013 – March 2015 
 
  Number of episodes duration of days days per episode 
Mental health 
sickness absence 
Long-term 58 1927 33.22 
Short-term 315 2324 7.38 
MSDs  
sickness absence 
Long-term 18 789 43.83 
Short-term 199 953 4.79 
*OTHER 
sickness absence  
Long-term 69 1928 27.94 
Short-term 1916 5487 2.86 
 
*Other – reasons given = cancer; cold, flu and infections; surgery; ear, eye, nose, mouth and 
dental; cardiovascular (e.g. stroke); chest and respiratory; stomach, liver, kidney and digestion; 
genito-urinary or gynaecological; road traffic accident; neurological 
 
Looking at the sickness absence figures in Table 24, it is seen that over a two-year period 45% 
of sickness absence days due to mental health conditions is from 58 episodes (15% of the total 
number of episodes). No figures were provided on the number of individuals with the various 
categories of sickness absence data provided. This is a similar figure when looking at the 
number of sickness absence days due to MSDs over a two-year period, with 45% of the sickness 
absence days accounted for in 18 episodes (8% of the total number of episodes). When 
considering ‘Other’ causes of sickness absence 26% of the sickness absence days are due to 
long-term sickness over two years (n = 69 episodes - 3% of the total number of episodes).   
 
The data provided by the different sectors of the organisation did not align in respect of dates. 
Thus, for the purposes of using this secondary data in the CBA tool, it was necessary to make 
assumptions on the average referral number per annum and set date limitations to ensure 
sufficient pre and post VR referral sickness absence data was available for employees referred 
to the service in 1 year. 
 
Between 06/01/2014 – 24/11/2014 138 employees were referred to the VR service. From this 
it can be assumed that there are approximately 152 referrals per annum. No data on the number 
of referrals per sickness absence cause was provided. For the purposes of the CBA tool the 
sickness absence data used will be assumed to be representative of the wider cohort.   
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From1/09/2014 – 29/04/2015 there were 101 referrals to the VR service. The organisation 
provided sickness absence data for 81 of these referred employees. To ensure sufficient data 
was included the date limits set were 30/05/2014 – 28/07/2015. This allowed for 65 employees’ 
sickness absence data to be included in the CBA tool. For employees’ data to be included, 3 
months of sickness absence data for MSDs or mental health conditions was needed pre and post 
VR referral between the dates 30/05/2014 – 28/07/2015. The employees included were all 
referred to the service within a 1-year time period.  This data is presented in Table 25. The cost 
of sickness absence is calculated using the average salary i.e. average employee salary at 
17/07/2015 = £22,942.75, therefore £88.24 daily rate. 
 
Table 25: 3-months pre and post referral sickness absence data of employees attending the VR service n 
= 65 
 
 
Total No of 
sickness 
absence 
days 3-
months 
pre-
referral 
Total No 
of sickness 
absence 
days 3- 
months 
post-
referral 
Difference 
in sickness 
absence 
days pre 
and post 
Cost of 
sickness 
absence pre –
referral 
Cost of 
sickness 
absence 3 
months post 
–referral 
Difference in 
sickness 
absence cost 
between pre 
and post 
referral 
MSD (n= 
9) 
261 
(mean = 
28.77) 
87 
(mean = 
9.66) 
174 £23,030.64 £7,676.88 £15,353.76 
Mental 
health 
condition
s (n = 34) 
406 
(mean = 
11.94, 
truncated 
mean (with 
25% 
trim)*** = 
10.84) 
521 
(mean = 
15.32, 
truncated 
mean (with 
25% trim) 
= 12.08) 
-115 
Difference in 
mean = 3.38 
Difference in 
truncated 
mean -1.24 
£35,825.44 £45,973.04 -£10,147.60 
*Other 
(n= 40) 
297 226 71 £26,207.28 £19,942.24 £6,265.04 
No 
reason 
(n= 7) 
10 59 -49 £882.40 £5206.16 -£4,323.76 
**All (n 
= 65 ) 
974 893 81 £85,945.76 £78,798.32 £7,147.44 
*Other – reasons given = cancer; cold, flu and infections; surgery; ear, eye, nose, mouth and 
dental; cardiovascular (e.g. stroke); chest and respiratory; stomach, liver, kidney and digestion; 
genito-urinary or gynaecological; road traffic accident; neurological. 
** N = 65, as some employees had sickness absence for more than one reason.  
*** truncated mean with trim = a statistical measure of central tendency i.e. calculating the 
mean after discarding an equal percentage of the sample at the high and low end (this is explored 
when data is not normally distributed). 
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Table 25 indicates that costs in respect of sickness absence, sickness absence due to mental 
health conditions and ‘no reasons’ were greater following the VR referral than before. Whereas 
the costs of sickness absence due to MSDs and other health conditions was less post VR referral 
than before. However, due to the loss of data these results are at risk of bias, which may impact 
on their validity. 
 
4.5.3.3 Turnover rates: organisation 2 
 
 
The organisation provided turnover rates for the time period 1st March 2013 to 28th February 
2015 (see Table 26). During this time period the organisation was undergoing a restructure, 
thus not all employees who left were replaced, therefore the percentage provided is a 
combination of attrition and turnover. 
 
Table 26: Turnover rates 
 
Date from Date to 
Employees at 
start of year 
Leavers over the time 
period 
Turnover/Attrition 
01/03/2013 28/02/2014 1115 182 16% 
01/03/2014 28/02/2015 1107 249 22% 
 
Looking at the data from 2013 – 2014, only 8 employees were not replaced, indicating that 16% 
is a turnover rate as opposed to an attrition rate (i.e. number of individuals leaving the 
organisation and not being replaced). For the purposes of the CBA tool, a turnover rate of 16% 
will be used.  
 
The turnover rate is not linked to the introduction of VR intervention. The evidence-base on the 
impact of VR on turnover is limited, as discussed in section 2.2.2.4. There is some evidence 
that early interventions decrease the length of sickness absence and associated risks of long-
term incapacity (Waddell et al., 2008; Coleman et al., 2013; Hammond, 2008), however, it is 
accepted that further research is needed to enable robust conclusions (Van Vilsteren et al., 
2015).  
 
As the data from the organisations render an estimate of the effect of the VR services on 
turnover impossible to calculate, an estimate from the literature was obtained. This is to be used 
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in the absence of a pre and post turnover rate. The literature used to estimate the effectiveness 
of VR on organisational turnover, differs from the literature used to identify the reference case, 
intervention case and deadweight. The articles identified below do not meet the inclusion and 
exclusion criteria needed for the identification of the intervention and reference case. However, 
for the purposes of implementing the CBA tool, an estimate of the impact of VR on turnover, 
can be inferred through considering the results from the available evidence reviews and studies: 
- PwC (2008) 
- ERS Research and Consultancy (2016) 
- Palmer et al. (2012) 
- Van Den Hout, Vlaeyen, Heuts, Zijlema, & Wijnen (2003) 
 
Looking at these in turn, the PwC (2008) report “Building the Case for Wellness” reported a 
positive reduction in turnover in companies introducing wellness interventions. PwC (2008) 
addressed the lack of a clear definition for wellness interventions by proposing a conceptual 
model, which includes the three main types of wellness interventions, namely; health and safety, 
management of ill health, prevention and promotion. Examining 55 case studies, PwC (2008) 
reported that 18 of these firms had a reduction in turnover ranging from 10% to 25% with an 
average around 20-25%. However, these case studies do not include control or comparison 
groups, and are at risk of bias as there was reliance on self-report (PwC, 2008, cited in Levy et 
al., 2014). Moreover, the PwC review is focused on musculoskeletal health, limiting the 
applicability to services addressing mental health conditions. Additionally, the review focuses 
on workplace health promotion, which differs from VR both in the type of interventions applied, 
the target population and the realisation of benefits. Workplace health promotion benefits are 
typically realised within 2-5 years (Baxter et al., 2015), whereas the impact of VR interventions 
are shorter term. Similarly, the Health at Work economic evidence review (ERS Research and 
Consultancy, 2016) cited a case study of a health advisor intervention that reduced turnover by 
10%. They concluded that investments in the management of mental health of employees may 
reduce turnover by 30%, although the supporting evidence was not clearly linked to this 
statement.  Palmer et al.’s (2012) review on the effectiveness of community and workplace 
interventions to reduce sickness absence and job loss for employees with MSDs identified 5 
studies (from the 42 included studies) that included job loss as an outcome. On reviewing these 
studies, Palmer et al. (2012) concluded that there is a small beneficial effect with regards to 
preventing job loss. Of these 5 studies, none of the interventions were conducted within the 
workplace and they were all conducted in Scandinavian and European countries, questioning 
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their generalisability to the UK context and VR interventions. Van den Hout et al.’s (2003) 
randomised control trial examined whether problem-solving therapy assisted with preventing 
work disability in patient with lower back pain, they found that the intervention group (n = 44) 
had 22% less job loss compared to the control group (n = 39). Gard et al. (1999, cited in Palmer 
et al. 2012) did not provide results on turnover or job loss, Jensen et al. (1998) & Torstensen et 
al. (1998, cited in Palmer et al., 2012) and Lindh et al. (1997, cited in Palmer et al., 2012) did 
not include interventions that related to VR.    
 
As is seen there is limited evidence on the impact of VR on turnover. Moreover, the 
generalisability of this research to the UK VR context is limited. However, for the purposes of 
using and implementing the CBA tool, a conservative estimate based on the studies discussed 
above will be used as an estimate of the impact of VR on turnover rates for organisation 1 and 
2 i.e. a reduction of 20% in turnover will be assumed to be as a result of the VR intervention. 
This is in line with Baxter et al.’s (2015) estimate of turnover reduction due to workplace health 
interventions of 10-25%. This estimate will be explored further within the sensitivity and 
scenario analysis.  
 
In summary: 
 
The approximate costs of the VR service fall within the budget set of £88,000. The sickness 
absence figures provided indicate that over a two-year period a small number of episodes 
(MSDs = 18 episodes; mental health conditions = 58 episodes; other = 69 episodes) of long-
term sickness absence result in a large proportion of sickness absence days for the different 
categories of conditions (MSDs = 45%; mental health conditions = 45%; other = 26%). The 
data provided was limited, restricting the amount of data that could be included in the evaluation 
(n=65), and possibly introducing bias. Looking at the costs of sickness absence 3 months’ pre 
and post referral, the results indicated that overall the cost of sickness absence was less in the 
three months post referral. However, mental health conditions had greater sickness absence 
costs post referral as opposed to pre-referral.  A turnover rate of 16% was calculated and will 
be used in the CBA tool. 
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4.6 Results Phase 3 results  
 
Figure 21: Diagrammatic representation of the 4 phases of this research project highlighting phase 3 
 
 
 
 
 
 
 
 
 
Phase 3’s objective was to implement and test the revised practical CBA tool incorporating the 
developed outcomes to identify the cost-benefits of the VR interventions/services in a real-
world setting. In order to implement the CBA tool, the secondary data collected in phases 1 and 
2 need to be synthesised. This section pulls together the data that has been collected in phase 1 
and 2, and describes where/how the data will be utilised within the CBA tool. It then presents 
the results from implementing the CBA tool and the sensitivity analysis and scenario analysis 
for each organisation in turn. 
 
Cost 
benefit 
analysis 
tool
Phase 1: revise the 
GM CBA tool  with 
VR apporpriate 
outcomes
Phase 2: collect 
primary and 
secondary data 
from 2 VR services 
to populate the 
costs and outcomes 
of the CBA model
Phase 3: Implement 
and test the revised 
CBA tool, using 
data from Phase 2
Phase 4: Explore 
the value of the 
revised CBA to VR 
services and 
organisations
Using the 
literature base 
Focus groups to 
evaluate the value 
of the revised 
CBA to potential 
users 
Primary data – 
employees using 
the VR services – 
outcomes collected 
pre and post 
interventions. 
Secondary data – 
collected by the VR 
services and 
organisations 
Researcher inputs 
data from phase 2, 
implements and 
tests the revised 
CBA model. 
178 
 
4.6.1 Organisation 1 – synthesis of data to be used in the CBA tool from phase 1 
and 2 for the revised outcomes. 
 
4.6.1.1 Organisation 1: costs 
 
The total cost of VR service for employees attending the service with MSDs conditions (n = 
285) was £70,958.00. The CBA tool was generated, with the assumption that 100% of the costs 
would be realised within 1 year.  Following the GM New Economy guidelines (HM Treasury 
et al., 2014) optimism bias was calculated at +25%, because the data source was provided by 
the service, and was 4-5 years old.  The optimism bias that aligns with the lowest confidence 
grade in any of the criteria is the optimism bias correction used (see Table 27). Thus, when 
accounting for optimism bias, the total cost to be used within the CBA tool = £88,698.00. See 
Figure 23 for a screen shot of the costs within the CBA tool. 
 
Table 27: Confidence grade definitions and rationale for selected optimism bias corrections for 
organisation 1 cost (HM Treasury et al., 2014). 
 
Confidence 
grade 
Colour 
coding 
Data source Age of data 
Known 
Data error 
  
Optimism 
bias 
correction 
1   
Independently 
audited cost 
data 
Current 
Data (<1 
year old) 
+-2% 
 
0% 
2   
Formal service 
delivery 
contract costs 
1-2  years 
old 
+-5% 
 
+5% 
3   
Practitioner 
monitored 
costs 
2-3 years 
old 
+-10% 
 
+10% 
4   
Costs 
developed from 
ready 
reckoners 
3-4 years 
old 
+-15% 
 
+15% 
5     
4-5 years 
old 
+-20% 
 
+25% 
6   
Uncorroborated 
expert 
judgement 
>5 years old +-25% 
 
+40% 
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Figure 22: Screenshot of CBA tool Costs tab for organisation 1 
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4.6.1.2 Organisation 1: benefits 
 
 
As discussed when describing the CBA tool (see section 3.4 and Figure 24), the following data is 
needed to implement the CBA tool: 
 
The data needed to apply the CBA tool for a specific outcome is: 
 The target population: How many people could potentially access the intervention? 
 The engaged population: How many people will have accessed the intervention? 
 The impact: How many people will achieve the desired outcome? 
 The level of retention: the percentage of individuals who continue to be engaged until 
the intervention is complete. 
 The deadweight: What would have happened if the intervention had not been in place? 
 Value: What is the value of the desired outcome? 
 Predicted impact and lag: What is the predicted sustainability of the interventions 
impact? 
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Figure 23: Implementing the CBA tool (Adjusted from HM Treasury et al., 2014). 
 
 
 
 
%Engaged Value 
How many 
potential 
beneficiaries? 
How many  
will we  
reach? 
How many 
will achieve 
desired 
outcome? 
What would 
have 
occurred 
anyway? 
What is the 
value of the 
desired 
outcome? 
1 - %optimism bias 
How confident 
are we in the 
evidence? 
%Retained 
How many  
will complete 
the 
programme? 
At risk /  
affected 
populati
on 
 
%Impact %Deadweight 
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4.6.1.2.1 Benefit 1: MSD sickness absence < 6-months 
 
Following the research study, there was an organisational restructure that resulted in limited access 
to employees’ sickness absence data, thus sickness absence data was only provided for a limited 
number of employees (n = 127). For the purposes of the CBA, it is assumed that this cohort is 
representative of the wider population attending the VR service, and a percentage impact for the 
entire cohort will be used within the CBA tool. 
 
Using the data gathered for organisation 1, the following figures and assumptions were used to 
populate the CBA tool for sickness absence < 6-months: 
 
 The target population: n = 304, employees who were referred to the VR service in one 
year. 
 
 The affected population/predicted incidents: n = 1465.77, the predicted total number of 
full time equivalent (FTE) working days for sickness absence for employees with < 6-
months sickness absence due to MSDs. From the sickness absence data provided, the mean 
number of days of sickness absence < 6-months due to MSDs = 4.92, for 98% of employees 
referred to the VR service (125 employees out of 127 had sickness absence < 6 month). 
98% of 304 = 297.92. Thus, the predicted total number is 4.92 *297.92 = 1465.77.  
 
 The level of engagement: = 94%, sickness absence data was provided for 127 employees 
who attended VR, 125 staff members (99%) attending the VR service had sickness absence 
due to MSDs for < 6-months. From the 304 employees referred to VR, 285 attended, thus 
engagement = 94%.  
 
 The level of retention: = 92.5%. No data was collected during the study on the retention 
rate. The UK national average did not attend (DNA) rate for physiotherapy musculoskeletal 
outpatients is 7.5% (Health and Social Care Information Centre, 2012). Although 
organisation 1 was not an outpatients’ physiotherapy service, the service was similar in 
nature and the MSDs that patients attending the service with are similar to the MSDs 
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patients would attend a physiotherapy outpatients department with. Thus, the physiotherapy 
outpatients’ service is used as a proxy for the VR service. 
 
 Impact: = 88%. Post intervention there was an 87.59% reduction in the number of FTE 
work days sickness absence, calculated as follows: 
(615.4 (total number of days sickness absence < 6-months pre-attending VR service) - 76.4 
(total number of sickness absence < 6-months post attending VR service)/615.4) * 100 
 
 % Deadweight:  = 81.74% (see section 3.5.3 for an explanation of the calculation) 
Starting point = 615.4 
Outcome = 76.4 
Net effect = 32.25% 
 
Counterfactual = 76.4/(1-0.32) 
= 76.4/0.68 
= 112.35 
 
Deadweight% = 615.4 -112.35/615.4 * 100 
= 81.74% 
 
 Value:  = £81.00  
The mean cost of sickness absence per day (n = £71.18) was calculated using the human 
capital approach: 
 
Time lost units (FTE work days) * price weight per time unit (mean of study population). 
 
Within this organisation the level of sick pay is determined by the length of service e.g. 1-
year service = 1 months full pay and 2 months half pay, 6 years of service = 6-months full 
pay and 6-months half pay. This data was not provided, nor was the length of episodes of 
sickness absence. Therefore, it was assumed that sickness absence of < 6-months was paid 
in full. Additional costs included were the employers’ national insurance payments, 
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calculated at 13.8% of the wage (Gov.UK, 2015), thus, 13.8% of £71.18 = £9.82. Thus, 
total value per day of sickness absence = £81.00 
 
 Predicted impact: It was assumed that 100% of the benefits will be realised within a year. 
 
 % Optimism bias: = - 25%. An optimism bias of -25% was applied using the correction 
tables in the CBA tool, this correction is due to the fact that the data is 4-5 years old, and 
there is known data error within the sickness absence data collected. This optimism bias 
applies for all benefits (see Table 28). 
 
Table 28: Confidence grade definitions and rationale for selected optimism bias corrections for organisation 1 
benefits. (HM Treasury et al., 2014). 
 
Confidence 
grade 
Colour 
coding 
Population/ 
Cohort Data 
Evidence-
base 
(engagement/ 
impact) 
Age of 
data/ 
analysis 
Known 
data 
error 
  
Optimism 
bias 
correction 
1   
Figures taken 
from agency 
data systems 
Randomised 
Control Trial in 
UK 
Current 
Data (<1 
year old) 
+-2% 
 
0% 
2   
Figures derived 
from local stats 
International 
Randomised 
Control Trial 
1-2  years 
old 
+-5% 
 
-5% 
3   
Figures based 
on national 
analysis in 
similar areas 
Independent 
monitoring of 
outcomes with 
a robust 
evaluation plan 
2-3 years 
old 
+-10% 
 
-10% 
4   
Figures based 
on generic 
national 
analysis 
Practitioner 
monitoring of 
outcomes with 
a robust 
evaluation plan 
3-4 years 
old 
+-15% 
 
-15% 
5   
Figures based 
on international 
analysis 
Secondary 
evidence from 
a similar type 
of intervention 
4-5 years 
old 
+-20% 
 
-25% 
6   
Uncorroborated 
expert 
judgement 
Uncorroborated 
expert 
judgement 
>5 years 
old 
+-25% 
 
-40% 
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4.6.1.2.2 Benefit 2: MSD sickness absence > 6-months 
 
Using the data gathered for organisation 1, the following figures and assumptions were used to 
populate the CBA tool for sickness absence > 6-months: 
 
 The target population: n = 304, employees who were referred to the VR service. 
 
 The affected population/predicted incidents: n = 595.84, the predicted total number of 
FTE working days for sickness absence for employees with more than 6-months sickness 
absence due to MSDs. From the sickness absence data provided, the mean number of days 
of sickness absence more than 6-months due to MSDs = 196, for 1% of employees referred 
to the VR service (1 employee out of 127 had sickness absence more than 6 month). 1% of 
304 = 3.04. Thus, the predicted total number is 196 *3.04 = 595.84. 
 
 The level of engagement: = 94%, sickness absence data was provided for 127 employees 
who attended VR, 125 staff members (99%) had sickness absence due to MSDs for < 6-
months. From the 304 employees referred to VR, 285 attended, thus engagement = 94%. 
 
 The level of retention: = 92.5%. See section 4.6.1.1.1 for explanation. 
 
 Impact: = 100%. Post intervention there was a 100% reduction in the number of FTE work 
days sickness absence, calculated as follows: 
(196 (total number of days sickness absence < 6-months pre-attending VR service) - 0 (total 
number of sickness absence < 6-months post attending VR service)/196) * 100 
 
 % Deadweight: = 100% (see section 4.2.1.1) 
 
 Value:  = £40.50  
Using the human capital approach discussed above, the mean cost of sickness absence per 
day (n = £35.59) was calculated. Additional costs included were the employers’ national 
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insurance payments, which are calculated at 13.8% of the wage (Gov.UK, 2015), thus, 
13.8% of £71.18 = £4.91. Thus, total value per day of sickness absence = £40.50 
 
 Predicted impact: It was assumed that 100% of the benefits will be realised within a year. 
 
 % Optimism bias: = - 25%. An optimism bias of -25% was applied using the correction 
tables in the CBA tool, this correction is due to the fact that the data is 4-5 years old, and 
there is known data error within the sickness absence data collected (see Table 28). 
 
 
See Figure 25 and 26 for screen shot of benefit 1 and benefit 2. 
 
 
 
 
 
187 
 
 
Figure 24: Section of the CBA tool demonstrating the inputted figures for outcome: sickness absence < 6-months 
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Figure 25: Continued Section of the CBA tool demonstrating the inputted figures for outcome: sickness absence < 6-months 
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4.6.2 Organisation 1 CBA results 
 
Various scenarios and perspectives of the data available were analysed within the CBA to 
provide BCRs by exploring the impact of organisation 1’s VR service on sickness absence due 
to MSDs, taking into account sickness absence for < and > 6-month outcomes. 
 
The BCR = benefits/costs. A ratio less than 1 indicates the costs are higher than the benefits. 
 
As seen in Table 29 and Figure 27, the BCR = 0.05. An economic BCR = 0.05, indicates that 
the economic costs of organisation 1 VR service are greater than the economic benefits.  For 
every £100 the organisation spends on the VR service, it gets £5 back, therefore is losing £95 
for every £100 spent.  
 
Table 29: Outcomes and benefits incorporated into the GM New Economy Manchester CBA tool 
 
Outcomes Benefits 
Who does the 
benefit accrue 
to 
Costs Benefits 
Net present 
value 
BCR 
Sickness 
absence due 
to MSDS < 6-
months 
Reduced 
sickness 
absence due 
to MSDs  
Organisation 1 £88,698.00 £4575.49 -£84,122.01 
0.05  
(-95%) 
Sickness 
absence due 
to MSDS >6-
months 
Reduced 
sickness 
absence due 
to MSDs 
Organisation 1 £88,698.00 0 -£88,698.00 0 (0%) 
Combined all 
outcomes 
Reduced 
sickness 
absence due 
to MSDS  
Organisation 1 £88,698.00 £4575.49 -£84,122.01 
0.05  
(-95%) 
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Figure 26: Screenshot of the CBA output metrics for combined outcomes organisation 1 
 
 
 
Table 29 indicates that there was no economic benefit from the VR service for long-term 
sickness absence due to MSDs, although a small benefit of £4,575.49 in reduced short-term 
sickness was noted. When looking at Figure 27, the results appear to indicate a BCR of -1.00 
and a ROI of 0.05. However, this appears to be inconsistent with the financial terms in the 
literature, as the calculation underpinning the ROI is in fact a BCR calculation: =AB22/AB21 
i.e. benefits (AB22)/costs (AB21) (Keating and Keating, 2014; Phillips, 2011; McIntosh et al., 
2011; Investopedia, 2018) (see Figure 28 below).  
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Figure 27: Screenshot indicating the underlying calculation of the ROI results box 
 
 
 
Looking at the results presented in Figure 28, the number/result (0.05) alongside the label 
‘Public Value Return on Investment’ is in fact a BCR for the organisation.   
 
The following formula is used to calculate the ROI (Phillips, 2011; Investopedia, 2018):  
   
ROI = (benefit -cost)  
  cost  
In the scenario, the  
ROI = (£4,575.49 – £88,697.50)  X 100% 
  £88,697.50 
ROI = -95% 
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As seen on Figure 28, this result of a ROI of - 95% is not reflected on the CBA tool, in either 
the BCR or the ROI results box. This suggests that there is an inconsistency in the use of 
financial terms between the GM New Economy model and the financial literature.   
 
As the BCR is 0.05, the costs are greater than the benefits. Thus, the intervention would not be 
recommended. 
 
4.6.3 Organisation 1 CBA: Sensitivity analysis results 
 
Sensitivity analysis – is a method whereby various parameters in the analysis are varied in order 
to test the impact on the overall result –assisting with decisions of allocating scarce resources 
(HM Treasury, 2011). 
 
A simple sensitivity analysis was conducted (see Section 3.4) varying each parameter/project 
variable where there was uncertainty.  
 
a) Outcome: Sickness absence < 6-months. 
 
The variable ‘level of engagement and impact’ was not subjected to a sensitivity analysis as 
there was no uncertainty surrounding the data provided by the organisation (see section 
4.6.1.1.1). However, the variables, predicted incidents, deadweight and retention rate were 
subject to sensitivity analysis.  
 
Looking at these results in turn, the variable predicted incidents was altered by 5% and 10% as 
it was possible that the predicted incidents might fluctuate between 0% and 10% in either 
direction (see Table 30). 
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Table 30: Sensitivity analysis for sickness absence < 6-months of variable: predicted incidents 
 
Change in 
variable: Predicted 
incidents n = 
1465.77 
 
 
10% 
 
 
+5% 
 
 
0% 
 
 
-5% 
 
 
-10% 
Overall Cost £88,697.50 £88,697.50 £88,697.50 £88,697.50 £88,697.50 
Overall Benefit £5,033.05 £4,804.30 £4,575.49 £4,346.71 £4,117.94 
Net Benefit -£83,664.45 -£83,893.20 -£84,122.01 -£84,350.79 -£84,579.56 
BCR 0.06 0.05 0.05 0.05 0.05 
 
Through adjusting the number of predicted incidents, up and down 5% and 10%, the BCR 
ranges between 0.06 and 0.05. This indicates that the predicted incidents variable has a limited 
influence on the results.  
 
The variable deadweight is changed by varying the net effectiveness (32.35%), which was 
determined from the literature (see section 4.2.1.1). Results of the included studies ranged from 
16% to 54% improvement between the intervention and control group. Thus, the sensitivity 
analysis was varied with 16% as the minimum and 54% as the maximum, with the mid points 
between these ranges and calculated net effectiveness (32.35) i.e. 16%, 24.18%, 32.35%, 
43.18% 54% (see Table 31). 
 
Table 31: Sensitivity analysis for sickness absence < 6-months of variable: deadweight 
 
% net 
effectiveness 
inputted and the 
resultant 
deadweight 
Net 
effectiveness = 
54% 
Deadweight 
= 73% 
Net 
effectiveness = 
43.18% 
Deadweight 
= 78% 
Net 
effectiveness = 
32.35% 
Deadweight 
= 82% 
Net 
effectiveness = 
24.18% 
Deadweight 
= 84% 
Net 
effectiveness = 
16% 
Deadweight 
= 85% 
Overall Cost £88,697.50 £88,697.50 £88,697.50 £88,697.50 £88,697.50 
Overall Benefit £10,719.55 £6,939.40 £4,575.49 £2,912.15 £1,739.33 
Net Benefit -£77,977.95 -£81,758.10 -£84,122.01 -£85,785.35 -£86,958.17 
BCR 0.12 0.08 0.05 0.03 0.02 
 
Through adjusting the net effectiveness within a range of 16%-54%, deadweight varied from 
73% to 85%. This resulted in the BCR ranging between 0.12 and 0.02, indicating that the 
deadweight variable has an influence on the estimates but not the substantive findings.  
 
The retention rate (92.5%) was estimated from the evidence-base indicating that on average 
7.5% of individuals attending out patients’ physiotherapy do not attend their follow-up 
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appointment (see section 4.6.1.1.1). The retention rate was varied between 85% and 100% i.e. 
100%, 96.25%, 92.5%, 88.25%, and 85%. Using the 7.5% estimated non-attendance rate as a 
guide for the variance that could be reasonably assumed, this varied the retention rate by 7.5% 
in either direction. 
 
Table 32: Sensitivity analysis for sickness absence < 6-months of variable: retention rate 
 
 
Retention rate 
figures used 
 
100% 
 
96.25% 
 
92.5% 
 
88.25% 
 
85% 
Overall Cost £88,697.50 £88,697.50 £88,697.50 £88,697.50 £88,697.50 
Overall Benefit £4,946.48 £4,760.99 £4,575.49 £4,365.27 £4,204.51 
Net Benefit -£83,751.02 -£83,936.51 -£84,122.01 -£84,332.32 -£84,492.99 
BCR 0.06 0.05 0.05 0.05 0.05 
 
Through adjusting the retention rate up and down by 7.5% the BCR ranges between 0.06 and 
0.05, indicating that the retention rate has a limited influence on the results.  
 
When changing the variables predicted incidents, deadweight and retention rate, a set 
percentage (based on what could be reasonably assumed), the BCR ranged between 0.12 and 
0.05. The greatest variation was due to the variation in deadweight, however, the estimates do 
not vary greatly. At no point does the BCR = 1, i.e. breakeven point.  
 
b) Outcome: Sickness absence > 6-months. 
 
As in outcome a) only the variables, level of engagement and impact were subject to sensitivity 
analysis (see section 4.6.1.1.2).  
 
The variable, predicted incidents was altered by 5% and 10%, as it is possible that the predicted 
incidents might fluctuate between 0% and 10% in either direction (see Table 33). 
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Table 33: Sensitivity analysis for sickness absence > 6-months variable: predicted incidence 
 
Change in 
variable: 
Predicted 
incidents n = 
595.84 
 
 
10% 
 
 
+5% 
 
 
0% 
 
 
-5% 
 
 
-10% 
Overall Cost £88,697.50 £88,697.50 £88,697.50 £88,697.50 £88,697.50 
Overall Benefit £4,575.49 £4,575.49 £4,575.49 £4,575.49 £4,575.49 
Net Benefit -£84,122.01 -£84,122.01 -£84,122.01 -£84,122.01 -£84,122.01 
BCR 0.05 0.05 0.05 0.05 0.05 
 
Through adjusting the number of predicted incidents up and down 5% and 10% the output 
metrics did not change, indicating that the predicted incidence had no change on this outcome. 
 
The variable deadweight was changed by varying the net effectiveness (0%), which was 
determined from the literature (see section 4.2.1.2). The only study meeting the inclusion 
criteria reported 34% improvement between the intervention and control group. Thus, the 
sensitivity analysis was varied with 0% as the minimum and 34% as the maximum, with the 
mid points between these ranges and determined net effectiveness (0%) i.e. 0%, 17%, 34% (see 
Table 34). 
 
Table 34: Sensitivity analysis for sickness absence > 6-months of variable: deadweight 
 
% net effectiveness inputted 
and the resultant deadweight 
Net effectiveness = 
0% 
Deadweight 
=100% 
Net effectiveness = 
17% 
Deadweight 
= 100% 
Net effectiveness = 
34% 
Deadweight 
= 100% 
Overall Cost £88,697.50 £88,697.50 £88,697.50 
Overall Benefit £4,575.49 £4,575.49 £4,575.49 
Net Benefit -£84,122.01 -£84,122.01 -£84,122.01 
BCR 0.05 0.05 0.05 
 
Adjusting the net effectiveness does not alter the deadweight or the results. However, sensitivity 
analysis is neither relevant nor instructive in this case as the sample size is only one. 
 
As for the outcome: sickness absence < 6-months (see above) the retention rate was varied 
between 85% and 100% i.e. 100%, 96.25%, 92.5%, 88.25%, 85% (See Table 35). This varied 
the retention rate by 7.5 % either direction, using the 7.5% estimated non-attendance as a guide 
for the variance that could be reasonably assumed. 
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Table 35: Sensitivity analysis for sickness absence > 6-months of variable: retention rate 
 
Retention rate 
figures used 
 
100% 
 
96.25% 
 
92.5% 
 
88.25% 
 
85% 
Overall Cost £88,697.50 £88,697.50 £88,697.50 £88,697.50 £88,697.50 
Overall Benefit £4,575.49 £4,575.49 £4,575.49 £4,575.49 £4,575.49 
Net Benefit -£84,122.01 -£84,122.01 -£84,122.01 -£84,122.01 -£84,122.01 
BCR 0.05 0.05 0.05 0.05 0.05 
 
Through adjusting the number of predicted incidents up and down 7.5% the output metrics did 
not change, indicating that the retention rate has a no influence on the results for the outcome 
sickness absence > 6-months.  
 
When changing the variables with a level of uncertainty (i.e. predicted incidents, deadweight 
and retention rate) by a set percentage (based on what could be reasonably assumed) the BCR 
did not change and at no point did it breakeven (i.e. BCR = 1). Thus, the VR intervention would 
not be recommended. 
 
From the sensitivity analysis, it can be hypothesised that the uncertainties within the CBA tool 
with regards to sickness absence due to MSDs, both > and < 6-months, do not impact on the 
overall findings. 
 
4.6.4 Organisation 1 CBA: Scenario analysis results 
 
In addition to varying single variables (section 4.6.3) a scenario analysis was conducted for 
each outcome. The worst case and best-case scenarios were looked at, and a breakeven scenario 
explored (see Table 36).  
 
a) Scenario analysis for sickness absence < 6-months: 
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Table 36: Scenario analysis for sickness absence < 6-months 
 
 Best case scenario Worst case scenario Break even 
Predicted incidents = 
1465.77 
1612.35 1319.19 2000 
Level of engagement n = 
94% 
100% 88% 100% 
Retention rate n = 92.5% 100% 85% 100% 
Deadweight 
N =82% 
73% 85% 11% 
Overall Cost £88,697.50 £88,697.50 £88,697.50 
Overall Benefit £14,275.04 £1,417.18 £88,942.69 
Net Benefit -£74,422.46 -£87,280.18 £254.19 
BCR 0.16 0.02 1 
 
The scenario analysis demonstrates that in the best and worst case the BCR does not reach 1, 
therefore, the intervention would not be recommended. The breakeven point demonstrates that 
a large variation in the deadweight (from 82% to 11%) would be required to breakeven, which 
is not realistic based on the literature reviewed.  
 
b) Scenario analysis for sickness absence > 6-months: 
 
This scenario analysis was not conducted because the variable analysis demonstrated no change 
to the output metrics through varying single variables and subsequently multiple variables. 
Consequently, there is no best- and worst-case scenario that differs from the results found above 
for sickness absence > 6 months. 
 
In summary, the findings that the intervention costs are greater than the benefits are maintained 
when comparing the best and worst-case scenario. Therefore, based on these results, in 
organisation 1 the VR intervention would not be recommended. 
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4.6.5 Organisation 2 – synthesis of data to be used in the CBA tool from phase 1 
and 2 for the revised outcomes. 
 
4.6.5.1 Organisation 2: costs 
 
The total cost of VR service per annum for employees attending the service with mental health 
and MSDs conditions (n = 43) is £24,894.74. This was calculated based on 152 employees 
attending the VR service at a cost of £88,000.00 per annum. Therefore, the cost for 9 employees 
attending with MSDs = £5210.53, and the cost for 34 employees attending with mental health 
conditions = £19,684.21. The CBA tool was applied, with the assumption that 100% of the 
costs will be realised within 1 year.  Optimism bias was calculated at 15%, this is because the 
data source was provided by the service, and is 3-4 years old.  A confidence grade between 1 
and 6 is allocated based on the data source, age of data and known data error. The highest 
confidence grade is used to determine  the optimism bias which  is the optimism bias correction 
used in the CBA tool (see Table 37). Thus, when accounting for optimism bias, the total cost 
to be used within the CBA tool = £28,628.95. See Figure 29 for a screen shot of the costs within 
the CBA tool. 
 
Table 37: Confidence grade definitions and rationale for selected optimism bias corrections for 
organisation 2 cost. (HM Treasury et al., 2014). 
 
Confidence 
grade 
Colour 
coding 
Data source Age of data 
Known 
Data error 
  
Optimism 
bias 
correction 
1   
Independently 
audited cost 
data 
Current 
Data (<1 
year old) 
+-2% 
 
0% 
2   
Formal service 
delivery 
contract costs 
1-2  years 
old 
+-5% 
 
+5% 
3   
Practitioner 
monitored 
costs 
2-3 years 
old 
+-10% 
 
+10% 
4   
Costs 
developed from 
ready 
reckoners 
3-4 years 
old 
+-15% 
 
+15% 
5     
4-5 years 
old 
+-20% 
 
+25% 
6   
Uncorroborated 
expert 
judgement 
>5 years old +-25% 
 
+40% 
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Figure 28: Screenshot of CBA tool Costs tab for organisation 2 
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4.6.5.2 Organisation 2: benefits 
 
See section 4.6.1.2 for a discussion on the data needed for each benefit. 
 
 
4.6.5.2.1 Benefit 1: MSD sickness absence < 6-months. 
 
Using the data gathered for organisation 2, the following figures and assumptions were used to 
populate the CBA tool for MSD sickness absence < 6-months: 
 
 At risk affected population: n = 9  
152 employees were referred the VR service. Sickness absence data was provided for 
65 members of staff attending. It is assumed that this is representative of the entire 
cohort. Data was available for 9 employees with MSDs with 3 months sickness absence 
data. 
 
 Predicted incidents: n = 1044 
Predicted total number full-time equivalent working days sickness absence for 
employees with < 6-months sickness absence due to MSDs in the 3 months prior to 
having been referred to the VR service. From the sickness absence data for 65 staff 
members, 9 had sickness absence < 6-months due to MSDs, with a total number of 
sickness absence days of 261. The CBA tool represents a year, thus the data used is 
assumed to be representative of a year. Therefore, 261 days of sickness absence were 
recorded in the 3 months prior to the intervention, and over a year it is assumed that this 
number multiplied by 4 will provide a predicted number of incidents per year.  
 
 % Engaged:  = 100% 
No data on engagement was provided. Thus, it is assumed that all employees engaged 
with the service. 
 
 % Retained:  = 100% 
No data on retention was provided. Thus, it is assumed for the 9 employees attending 
the service for MSD's that retention is 100%. 
 
 % Impact: = 66.67%  
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Post intervention there was a 66.67% reduction in FTE work days sickness absence (261 
(sickness absence days pre) - 87 (sickness absence days post)/ 261 * 100 = 66.67%). 
 
 % Deadweight: = 51% (see section 3.5.3 for an explanation of the calculation). 
Starting point = 261 
Outcome = 87 
Net effect = 32.25% 
 
 Counterfactual = 87/(1-0.32) 
= 87/0.68 
= 128 
 
Deadweight% = 261-128/261 * 100 
= 50.96% 
 
 Value:  = £100.42 
The mean cost of sickness absence per day was calculated using the human capital 
approach. The data on sickness absence pay was not provided. Therefore, it is assumed 
that sickness absence that was < 6-months was paid in full. Additional costs included 
are the employers national insurance payments, which are calculated at 13.8% of the 
wage (Gov.UK, 2015), thus, 13.8% of £88.24 = £12.18. 
Thus, total value per day of sickness absence = £100.42 
 
 % Optimism bias: = - 15% 
Optimism bias was calculated at -15%, as the data was provided by the service, the 
outcomes were monitored independently to the organisation, there is no known data 
error, however the data for the benefits is 3-4 years old.  Thus, the optimism bias that 
aligns with the lowest confidence grade in any of the criteria is -15% (see Table 38). 
This applies for all the benefits.  
 
See Figure 30 & 31 for screen shot of all benefits. 
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Table 38: Confidence grade definitions and rationale for selected optimism bias corrections for Case 
study 2 benefit 1 (HM Treasury et al., 2014). 
 
Confidence 
grade 
Colour 
coding 
Population/ 
Cohort Data 
Evidence-
base 
(engagement/ 
impact) 
Age of 
data/ 
analysis 
Known 
data 
error 
  
Optimism 
bias 
correction 
1   
Figures taken 
from agency 
data systems 
Randomised 
Control Trial in 
UK 
Current 
Data (<1 
year old) 
+-2% 
 
0% 
2   
Figures derived 
from local stats 
International 
Randomised 
Control Trial 
1-2  years 
old 
+-5% 
 
-5% 
3   
Figures based 
on national 
analysis in 
similar areas 
Independent 
monitoring of 
outcomes with 
a robust 
evaluation plan 
2-3 years 
old 
+-10% 
 
-10% 
4   
Figures based 
on generic 
national 
analysis 
Practitioner 
monitoring of 
outcomes with 
a robust 
evaluation plan 
3-4 years 
old 
+-15% 
 
-15% 
5   
Figures based 
on international 
analysis 
Secondary 
evidence from 
a similar type 
of intervention 
4-5 years 
old 
+-20% 
 
-25% 
6   
Uncorroborated 
expert 
judgement 
Uncorroborated 
expert 
judgement 
>5 years 
old 
+-25% 
 
-40% 
 
4.6.5.2.2 Benefit 2: MSD sickness absence > 6-months. 
 
Due to the limitations of the sickness absence data provided and the need to limit it to include 
only individuals who had three months pre and post VR referral, this outcome could not be 
included in the CBA tool (see Figure 30 & 31). 
 
4.6.5.2.3 Benefit 3: Mental health conditions sickness absence < 6-months 
 
Using the data gathered for organisation 2, the following figures and assumptions were used to 
populate the CBA tool for sickness absence relating to mental health conditions < 6-months: 
 
 At risk affected population: n = 34 
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152 employees were referred the VR service. Sickness absence data was provided for 
65 members of staff attending, assumed to be representative of the entire cohort. Data 
was available for 34 employees with mental health conditions with 3 months sickness 
absence data.  
 
 Predicted incidents: n = 1984 
Predicted incidents refers to the predicted total number full-time equivalent working 
days sickness absence for employees with < 6-months sickness absence due to mental 
health conditions in the 3 months prior to been referred to the VR service. From the 
sickness absence data for 65 staff members, 34 had sickness absence < 6-months due to 
mental health conditions, with a total number of sickness absence days of 496. The CBA 
tool represents a year, thus the data used is assumed to be representative of a year. 496 
days of sickness absence were recorded in the 3 months prior to the intervention, over 
a year it is assumed that this number multiplied by 4 will provide a predicted number of 
incidents per year.  
 
 % Engaged: = 100% 
No data on engagement was provided; therefore it is assumed that all employees 
engaged with the service. 
 
 % Retained: = 100% 
No data on retention was provided. Thus, it is assumed for the 34 employees attending 
the service for mental health conditions that retention is 100%. 
 
 % Impact: = -28.33%  
The pre and post sickness absence data for mental health conditions were tested for 
normal distribution using SPSS v.24. See Table 39 for the results of the normal 
distribution testing. 
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Table 39:  Results of the normal distribution testing of the sickness absence data for mental health 
conditions 
 
N = 34 Pre Post Normal values 
Skewness value  
0.451 (std error 0.403) 
Z = 1.119 (0.451/0.403) 
1.023 (std error 0.403) 
Z = 2.54 
Z value between -
1.96 to +1.96 
Kurtosis value 
-0.904 (std error 0.788) 
Z = -1.147 (-0.904/0.788) 
-0.387 (std error 0.788) 
Z = 0.491 
Z value between -
1.96 to +1.96 
Shapiro-Wilk test p-
value 
0.12 0.000 Above 0.05 
Histograms 
Does not have the shape of a 
normal curve.  
Not normally distributed 
Visually indicate 
data is normally 
distributed 
Normal Q-Q plots 
The dots are approximately 
along the line.  
The dots are approximately 
along the line. 
Visually indicate 
data is normally 
distributed 
 
A Shapiro-Wilk test (p>0.5) (Shapiro & Wilk, 1965; Razali & Wah, 2011) and a visual 
inspection of the histograms and normal Q-Q plot (see Appendix 8) showed that the number of 
mental health conditions sickness absence days were approximately normally distributed pre-
VR intervention, with a skewness of 0.451 (SE 0.403) and a kurtosis of -0.904 (SE 0.788). For 
the post sickness absence days, the data does not appear to be normally distributed, with the 
Shapiro-Wilk test (P<0.5) and a visual inspection of the histograms and normal Q-Q plot (see 
Appendix 8) indicating a non-normal distribution, with a skewness of 1.023 (SE 0.403) and a 
kurtosis of -0.387 (SE 0.788) (Cramer, 1988; Cramer & Howitt, 2004; Doane & Sweard, 2011).  
 
It can be concluded that the post sickness absence data for mental health conditions is not 
normally distributed; therefore the truncated mean was explored. Looking at both the means 
and the truncated means, which accounted for outliers it is seen that there was still an increase 
in FTE work days. Post intervention there was a -28.33 % increase in FTE work days sickness 
absence; (406 (sickness absence days pre) - 521 (sickness absence days post)/406) * 100 = -
28.33%).   
 
 % Deadweight: n = -28.33% (see section 4.2.1.2) 
 
 Value: = £100.42 
The mean cost of sickness absence per day was calculated as discussed in Section 
4.6.5.2.1. 
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 % Optimism bias: = - 15% 
Optimism bias was calculated at -15% (see benefit 1, section 4.6.5.2.1) 
 
See Figures 30 & 31 for screen shots of all benefits 
 
4.6.5.2.4 Benefit 4: Mental health conditions sickness absence > 6-months 
 
Due to the limitations of the sickness absence data provided and the need to limit it to only 
include individuals who had three months pre and post VR referral data this outcome could not 
be included in the CBA tool (see Figures 30 & 31). 
 
4.6.5.2.5 Benefit 5: Turnover 
 
 At risk affected population: n = 43 
152 employees were referred to the VR service within one year. Sickness absence data 
was provided for 65 members of staff attending. 43 employees were referred with 
mental health conditions or MSDs.  
 
 Predicted incidents: n = 43 
 
 % Engaged: = 100 
Total number of employees with mental health conditions or MSDs attending the VR 
service.  
 
 % Retained: = 100% 
No data on retention was provided. Thus, it is assumed all employees attending the 
service for MSDs or mental health conditions that retention is 100%. 
 
 % Impact: = 3.2% 
Yearly turnover rate for the organisation is approximately 16%. No information on the 
reasons for turnover was provided. For the purposes of this model it will be assumed 
that all employees contribute equally to the turnover rate.  From the literature (see 
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section 4.2.1.3) it is assumed that the introduction of a VR service will reduce the overall 
turnover by 20%.  
 
In one year, 152 out of 1107 employees attended the VR service, 43 due to MSDs or 
mental health conditions. It is assumed that the employees attending the VR service 
were more likely to leave the company due to ill-health, however, due to the lack of data 
this assumption will not be included within the CBA tool. It is assumed that if these 
employees did not attend the VR service (i.e. no intervention) 16% of them would leave 
the company within a year. For employees attending the VR service it is assumed that 
12.8% (i.e. 16% less 3.2% (20% of 16%)) will leave the organisation. In other words, 
of the 43 employees attending the VR service for MSDs and mental health conditions it 
will be assumed that 12.8% (n = 5.5) of these will leave the organisation within a year, 
whereas had these 43 employees not attended the VR service, 16% (n = 6.88) would 
have left the organisation within a year. Therefore, 5.5 employees attending the VR 
service with MSDs and mental health conditions would leave the organisation as 
opposed to 6.88, saving the organisation the cost of replacing 1.38 employees. 
 
 % Deadweight: = 0% (see section 4.2.1.3 for explanation) 
 
 Value: = £16,663.00 (see section 4.2.2.3 for explanation) 
 
 % Optimism bias: = - 15% 
Optimism bias was calculated at -15%, see benefit 1 for calculation of optimism bias. 
 
See Figures 30 & 31 for all benefits.  
 
4.6.5.2.6 Benefit 6: Presenteeism 
 
There were insufficient participants to facilitate the use of presenteeism as an outcome for 
organisation 2 (see Figure 30 & 31). 
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Figure 29: Screenshot of benefits 1,2,3,4, 5 and 6 for organisation 2. 
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Figure 30: Screenshot of benefits 1,2,3,4 and 5 for organisation 2 continued. 
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4.6.6 Organisation 2: CBA results 
 
 
Various scenarios and perspectives of the data available were analysed with the CBA to provide 
BCRs. These explored the impact of organisation 2’s VR service on sickness absence and turnover 
due to MSDs and mental health conditions. 
 
The BCR = benefits/costs. A ratio less than 1 indicates the costs are higher than the benefits. 
 
As seen in Table 40 and Figure 32, the BCR = 1.17, which indicates that the economic costs of 
organisation 2’s VR service are less than the economic benefits.  For every £100 the organisation 
spends on the VR service, it gets £117 back, therefore is gaining £17 for every £100 spent.  
 
Table 40: Outcomes and benefits incorporated into the GM New Economy Manchester CBA tool 
 
Outcomes Benefits 
Who does the 
benefit accrue 
to 
Costs Benefits 
Net present 
value 
BCR 
Sickness 
absence due 
to MSDS < 
6-months 
Reduced 
sickness absence 
due to MSDs 
Organisation 2 £5,992.11 £14,080.52 £8.088.41 2.35 (135%) 
Sickness 
absence due 
to mental 
health 
conditions < 
6-months 
Reduced 
sickness absence 
due to mental 
health 
conditions 
Organisation 2 £22,636.84 0 £22,636.84 0 (0%) 
Turnover 
Reduced 
turnover due to 
MSDs and 
mental health 
conditions 
Organisation 2 £28,628.95 £19,489.04 -£9,139.91 0.68 (-32%) 
Combined all 
outcomes 
Reduced 
sickness absence 
and turnover due 
to MSDS and 
mental health 
conditions 
Organisation 2 £28,628.95 £33,569.56 £4,940.61 1.17 (17%) 
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Figure 31: Screenshot of the CBA output metrics for combined outcomes organisation 2 
 
 
 
 
 
Table 40 and Figure 32 indicate that there was no economic benefit from the VR service in respect 
of sickness absence due to mental health conditions, whereas a modest benefit was realised for 
short-term sickness absence due to MSDs. The biggest economic benefit accrued due to the VR 
service is the reduction of turnover. As discussed in section 4.6.2, Figure 32 ROI results are in fact 
BCR results (this cannot be changed as Figure 32 is extracted from the GM New Economy model 
and the label boxes were locked). 
 
4.6.7 Organisation 2: sensitivity analysis results 
 
As outlined in section 3.4 a simple sensitivity analysis was conducted. Varying each 
parameter/project variable where there was uncertainty by a conceptually logical percentage.  
 
a) Outcome: Sickness absence < 6-months. 
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Only the variables, predicted incidents, level of engagement, deadweight and retention rate were 
subject to sensitivity analysis (see Section 4.6.5.2.1).  
 
The variable, predicted incidents, was altered by 5% and 10% as it is possible that the predicted 
incidents might fluctuate between 0% and 10% in either direction (see Table 41). 
 
Table 41: Sensitivity analysis for sickness absence due to MSDs < 6-months of variable: predicted incidence 
 
Change in variable: 
predicted 
incidences 1044 
 
 
+10% 
 
 
+5% 
 
 
0% 
 
 
-5% 
 
 
-10% 
Net present value 
cost 
£5,992.11 £5,992.11 £5,992.11 £5,992.11 £5,992.11 
Net present value 
benefit 
£15,488.57 £14,784.54 £14,080.52 £13,376.49 £12,672.46 
Net present budget 
impact 
£9,496.46 £8,792.43 £8,088.41 £7,384.38 £6,680.36 
BCR 2.58 2.47 2.35 2.23 2.11 
 
Through adjusting the number of predicted incidents up and down 5% and 10%, the BCR ranges 
between 2.58 and 2.11, indicating that the predicted incidents variable has a limited influence on 
the results. However, the results are not changed to the extent where the intervention would no 
longer be recommended (i.e. a BCR less than 1). 
 
Data was not provided on the level of engagement. To explore this further, the variable was 
adjusted by 10% and 20% respectively, as it can be reasonably assumed that 80% of the referred 
employees will attend (see Table 42). 
 
Table 42: Sensitivity analysis for sickness absence due to MSDs < 6-months of variable: level of engagement 
 
Change in variable: level of 
engagement 100% 
 
0% 
 
-10% 
 
-20% 
Net present value cost £5,992.11 £5,992.11 £5,992.11 
Net present value benefit £14,080.52 £12,672.47 £11,264.41 
Net present budget impact £8,088.41 £6,680.36 £5,272.30 
BCR 2.35 2.11 1.88 
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When adjusting the level of engagement by 10% and 20% the BCR ranges between 2.35 and 1.88, 
indicating that the level of engagement variable has a limited influence on the results. However, 
the results are not changed to the extent that the intervention would no longer be recommended.  
 
The retention rate (100%) was estimated as no data was provided by the organisation.  No data was 
found on the retention rate of VR services. Thus, the retention rate was adjusted by 10% and 20% 
respectively, as it can be reasonably assumed that 80% of the referred employees will continue to 
attend the service until discharged (see Table 43). 
 
Table 43: Sensitivity analysis for sickness absence due to MSDs < 6-months of variable: retention rate 
 
Change in variable: retention 
rate n = 100% 
 
0% 
 
-10% 
 
-20% 
Net present value cost £5,992.11 £5,992.11 £5,992.11 
Net present value benefit £14,080.52 £12,672.46 £11,264.41 
Net present budget impact £8,088.41 £6,680.36 £5,272.30 
BCR 2.35 2.11 1.88 
 
When adjusting the retention rate by 10% and 20% the BCR ranges between 2.35 and 1.88, 
indicating that the retention rate variable has a limited influence on the results. However, the results 
are not changed to the extent where the intervention would no longer be recommended.  
 
 
The variable deadweight was changed by fluctuating the net effectiveness (32.35%) determined 
from the literature (see section 4.2.1.1). The included studies results ranged between 16% and 54% 
improvement between the intervention and the control group. Thus, the sensitivity analysis will be 
varied with 16% as the minimum and 54% as the maximum, with the mid points between these 
ranges and calculated net effectiveness (32.35) i.e. 16%, 24.18%, 32.35%, 43.18% 54% (see Table 
44). 
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Table 44: Sensitivity analysis for sickness absence due to MSDs < 6-months of variable: deadweight 
 
% net effectiveness 
inputted and the 
resultant 
deadweight 
Net 
effectiveness = 
54% 
Deadweight 
= 28% 
Net 
effectiveness = 
43.18% 
Deadweight 
= 41% 
Net 
effectiveness = 
32.35% 
Deadweight 
= 51% 
Net 
effectiveness = 
24.18% 
Deadweight 
= 56% 
Net 
effectiveness = 
16% 
Deadweight 
= 60% 
Overall Cost £5,992.11 £5,992.11 £5,992.11 £5,992.11 £5,992.11 
Overall Benefit £34,724.35 £22,479.13 £14,080.52 £9,443.45 £5,634.29 
Net Benefit -£28,732.24 £16,487.02 £8,088.41 £3,441.34 -£357,82 
BCR 5.80 3.75 2.35 1.57 0.94 
 
Through adjusting the net effectiveness within a range of 16%-54%, deadweight varied from, 28% 
to 60% this resulted in the BCR ranging between 5.80 and 0.94. This indicates that the deadweight 
variable has a large influence on the results. If deadweight is adjusted to 60% the BCR is slightly 
below 1 (0.94), indicating that the costs outweigh the benefits.  
 
Thus, from the sensitivity analysis it can be hypothesised that the uncertainties within the CBA 
tool with regards to sickness absence < 6-months due to MSDs for the variables predicted incidents, 
retention rate and level of engagement do not impact on the overall findings. However, should the 
net effectiveness estimated from the literature be incorrect, it will influence the deadweight 
percentage and consequently impact on the results.  
 
a) Outcome: Sickness absence due to mental health conditions < 6-months. 
The only variable for the outcome sickness absence due to mental health conditions < 6-months 
subjected to sensitivity analysis was deadweight. As the net effectiveness for this outcome was 
calculated to be zero, unless the net effectiveness changes, the net benefits will be zero not matter 
which variable is adjusted. Therefore, the key variable explored was deadweight, as this is 
determined from the net effectiveness. To explore this, a range of net effectiveness values were 
inputted. These, in turn changed the calculated deadweight (see Table 45). The values of net 
effectiveness ranged between 0 and 31% (see Table 45) and were determined from the literature 
(see section 4.2.1.2). 
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Table 45: Sensitivity analysis for sickness absence due to mental health conditions < 6-months of variable: 
deadweight 
 
% net effectiveness 
inputted and the 
resultant 
deadweight 
Net 
effectiveness = 
0% 
Deadweight 
= -28% 
Net 
effectiveness = 
8% 
Deadweight 
= -39% 
Net 
effectiveness = 
15% 
Deadweight 
= -51% 
Net 
effectiveness = 
23% 
Deadweight 
= -67% 
Net 
effectiveness = 
31% 
Deadweight 
= -86% 
Overall Cost £22,636.84 £22,636.84 £22,636.84 £22,636.84 £22,636.84 
Overall Benefit £- £18,818.04 £38,189.56 £64,641.20 £97,226.55 
Net Benefit -£22,636.84 -£3,818.80 £15,552.72 £42,004.36 £74,589.71 
BCR 0.00 0.83 1.69 2.86 4.30 
 
Through adjusting the net effectiveness within a range of 0%-31% deadweight varied from -28% 
to -86%, resulting in the BCR ranging between 0 and 4.30 thereby indicating that estimates of the 
deadweight variable in this outcome have a substantial influence on the results. If net effectiveness 
is changed to 15% the BCR is 1.69 indicating that the benefits outweigh the costs.  
 
From the sensitivity analysis, it can be hypothesised that should the net effectiveness estimated 
from the literature be incorrect, it will influence the deadweight percentage and consequently 
impact on the results.  
 
b) Outcome: Turnover. 
The variable impact and predicted incidents were not subjected to a sensitivity analysis (see section 
4.6.5.2.5), however the variables deadweight, level of engagement and retention rate were. 
 
The variable deadweight was estimated to be 0% (see section 4.2.1.3). Due to the uncertainty 
surrounding the underlying assumption, this variable will be adjusted by 5% and 10% respectively 
(see Table 46). 
 
Table 46: Sensitivity analysis for turnover: deadweight 
 
Change in deadweight 
variable n = 0% 
Deadweight 
= 0% 
Deadweight 
= 5% 
Deadweight 
= 10% 
Overall cost £28,628.95 £28,628.95 £28,628.95 
Overall benefit £19,489.04 -£10,962.59 - £41,414.22 
Net benefit -£9,139.91 -£39,591.54 -£70,043.17 
BCR 0.68  -0.38 -1.45 
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When the deadweight was varied between 0% and 10%, a large variation in the BCR was noted 
(0.68 - -1.45) indicating that the deadweight variable has an influence on the results. 
 
Data was not provided on the level of engagement and retention rate. To explore this further, the 
variable was adjusted by 10% and 20% respectively, as it can be reasonably assumed that 80% of 
the referred employees will attend the service and continue to attend until discharged (see Tables 
47 and 48). 
 
Table 47: Sensitivity analysis for turnover variable: level of engagement 
 
Change in variable: level of 
engagement n = 100% 
0% -10% -20% 
Net present value cost £28,628.95 £28,628.95 £28,628.95 
Net present value benefit £19,489.04 £17,540.14 £15,591.24 
Net present budget impact -£9,139.91 -£11,088.81 -£13,037.72 
BCR 0.68  0.61 0.54  
 
 
Table 48: Sensitivity analysis for turnover variable: retention rate 
 
Change in variable: retention 
rate n = 100% 
 
0% 
 
-10% 
 
-20% 
Net present value cost £28,628.95 £28,628.95 £28,628.95 
Net present value benefit £19,489.04 £17,540.14 £15,591.24 
Net present budget impact £9,139.91 £11,088.81 £13,037.72 
BCR 0.68  0.61  0.54  
 
When the retention and engagement rate are adjusted by 10% and 20% the BCR ranges between 
0.68 and 0.54; indicating that the retention rate and engagement rate has a limited influence on the 
results.  
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4.6.8 Organisation 2 CBA: Scenario analysis results 
 
In addition to varying single variables (section 4.6.7) a scenario analysis was conducted for each 
outcome. The worst- and best-case scenarios were looked at, and a breakeven scenario was 
explored (see Tables 49 and 50).  
 
c) Scenario analysis for sickness absence due to MSDS < 6-months: 
 
Table 49: Scenario analysis for sickness absence due to MSDS < 6-months 
 
N = 9 Current Scenario Best case scenario Worst case scenario 
Break even 
scenario 
Predicted incidents  1044 1148.4 939.60 1044 
Level of engagement  100% 100% 80% 100% 
Retention rate  100% 100% 80% 100% 
Impact 67% 67% 67% 67% 
Deadweight 51% 28% 60% 16.9% 
Net present value 
cost 
£5,992.11 £5,992.11 £5,992.11 £5,992.11 
Net present value 
benefit 
£14,080.52 £38,196.78 £3,245.35 £6,015.67 
Net present budget 
impact 
£8,088.41 £32,204.67 -£2,746.76 £23.56 
BCR 2.71  6.37 0.54 1  
 
The scenario analysis for MSDS shows that to break even the deadweight needs to be 16.9%. In 
the best-case scenario, there would be a BCR of 6.37 whereas in the worst-case scenario there 
would be a BCR of 0.54.  
 
d) Scenario analysis for sickness absence due to mental health conditions less than 6-months: 
 
As the deadweight for sickness absence will always be equal to the impact, the result will not 
change when variables, except deadweight, are adjusted (see section 4.6.6). Therefore, no scenario 
analysis on mental health conditions was conducted. 
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e) Scenario analysis for turnover 
 
Table 50: Scenario analysis for turnover 
 
N = 43 Current scenario Best case scenario Worst case scenario Break even 
Predicted incidents 43 51.6 34.4 64 
Level of engagement  100% 100% 80% 100% 
Retention rate  100% 100% 80% 100% 
Effectiveness 
 
3.2 3.2 3.2 3.2 
Deadweight 
 
0% 0% 10% 0% 
Net present value 
cost 
£28,628.95 £28,628.95 £28,628.95 £28,628.95 
Net present value 
benefit 
£19,489.04 £23,386.85 -£21,204.08 £29,006.95 
Net present budget 
impact 
-£9,139.91 -£5,242.10 -£49,833.03 £378.00 
BCR 0.68  0.82  -0.74  1.01  
 
As is noted in the turnover scenario analysis the BCR ranges from 0.68 to -0.74. To break even the 
number of individuals seen by the VR service with MSDs or mental health conditions needs to 
increase to 64 per annum.  
 
In summary, the results that the interventions costs are greater than the benefits are maintained 
when comparing the best and worst-case scenario for the outcome turnover. However, for the 
outcome sickness absence < 6-months due to MSDs, the results vary from a BCR in the best-case 
scenario of 6.37, to a BCR in the worst-case scenario of 0.54. Therefore, based on these results, 
and the finding of a ROI of 17%, the VR intervention would be recommended.  
 
In summary:  
 
Organisation 1’s total costs equalled £88,698.00. The total benefits for the included outcomes (i.e. 
sickness absence due to MSDs < and > 6-months) equalled -£84,122.00 thereby generating an 
economic BCR of 0.05 and a ROI of -95%.  For every £100 organisation 1 spends on the VR 
service, it gets £5 back, therefore is losing £95 for every £100 spent.  
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Organisation 2’s total costs equalled £28,628.95. The total benefits for included outcomes (i.e. 
sickness absence due to MSDs and mental health conditions < 6-months, and turnover) equalled 
£33,569.56, generating an economic BCR of 1.17 and a ROI of 17%. This indicates that for every 
£100 organisation 2 spends on the VR service it gets £117 back.   
 
The variables needed to generate the benefits (i.e. impact, predicted incidents, deadweight, level of 
engagement and retention rate) were subject to sensitivity and scenario analysis for both 
organisations. Considering the scenario analysis, in organisation 1, no scenario generated a BCR 
greater than 1 thereby indicating that the VR intervention in organisation 1 would not be 
recommended. In organisation 2 the best-case scenario for sickness absence due to MSDs < 6-
months resulted in a BCR of 6.37 whereas in the worst-case scenario there would be a BCR of 
0.54. The VR intervention in organisation 2 would be recommended with caution. It was noted that 
the variation of deadweight (calculated from the net effectiveness which is determined from the 
literature) had the biggest influence on the results during the sensitivity and scenario analysis. 
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4.7 Phase 4 results 
 
Figure 32: Diagrammatic representation of the 4 phases of this research project 
 
 
 
 
 
 
 
 
Phase 4’s objective was to appraise the value of the revised practical CBA tool to the VR provider 
and the organisation to which VR is provided. This section discusses the key themes that emerged 
from the analysis of the data retrieved from the focus group. The focus group comprised of 
individuals from organisation 2 who were during the research, and moving forwards would be 
responsible for collecting the data for the CBA tool, generating and reading the CBA reports, and 
making decisions with the aid of the CBA reports.   
Cost 
benefit 
analysis 
tool
Phase 1: revise the 
GM CBA tool  with 
VR apporpriate 
outcomes
Phase 2: collect 
primary and 
secondary data 
from 2 VR services 
to populate the 
costs and outcomes 
of the CBA model
Phase 3: Implement 
and test the revised 
CBA tool, using 
data from Phase 2
Phase 4: Explore 
the value of the 
revised CBA to VR 
services and 
organisations
Using the 
literature base 
Focus groups to 
evaluate the value 
of the revised 
CBA to potential 
users 
Primary data – 
employees using 
the VR services – 
outcomes collected 
pre and post 
interventions. 
Secondary data – 
collected by the VR 
services and 
organisations 
Researcher inputs 
data from phase 2, 
implements and 
tests the revised 
CBA model. 
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4.7.1 Focus group  
 
Four individuals from the in-house VR service in organisation 2 took part in the focus group. These 
were the service director (P3), the national VR services manager (P1), the senior operations 
manager for the VR service (P2), and an intern (P4).  
 
From the analysis the following key themes emerged: 
 The usefulness of the CBA tool 
 The usefulness of the report produced 
 The ease of using the CBA tool 
 Suggestions for development of the CBA tool 
 
4.7.1.1 The usefulness of the CBA tool 
 
The participants agreed that the CBA tool is a useful tool and that they do not have anything similar 
at this point in time.  They were enthusiastic about the potential of the tool to be even more effective 
as it develops further, for example by having further outcomes included.  
 
P2: “I think, like we said this morning, it’s always something that we’ve not had, and would 
be very, very useful. It looks like it will be a really good tool.”  
 
P3: “I mean, there is nothing in this space, at the moment. Yes, and as it progresses and 
develops then yes, absolutely. But, as what it does now, it’s really useful.” 
 
P1: “It’s still useful as it is.” 
 
One participant felt that the CBA tool would be useful as part of a package of measures that 
incorporates other factors, such as findings from employee satisfaction surveys, or data about 
employee engagement, as opposed to it being the only aspect to decision making. 
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P1: “It’s a good tool to have. I suppose it’s part of the package, isn’t it, because a lot of 
organisations now are also looking at, “How does it work in terms of employee 
engagement?” So, it’s less pounds and pence, and more employee satisfaction surveys, how 
do people feel valued? Would they work for the company?”  
 
The participants identified that the CBA tool would benefit their VR service in a number of ways. 
They felt that the CBA tool would be a useful adjunct to their marketing strategy, enabling them 
to demonstrate the potential savings to an organisation purchasing VR. Moreover, it would 
facilitate their conversations with existing and future clients, in identifying the organisations health 
needs and the potential cost savings should the organisation use VR to address the identified needs.  
Another potential use of the CBA tool would be within service design. The CBA tool would enable 
the VR service to explore their expenditure and the related benefits, and determine where they 
should be allocating their resources.  
 
P3: “I think, in time, if you were to do that with some companies you’d worked with, it 
would be amazing to say, “Actually, we’ve worked with so-and-so for six months, and on 
the basis of that we’ve saved them X amount of money.” You could use that to work out 
what you’ve saved them over a period of time, and say, “In a year that would be such-and-
such. So, we’ve come to speak to you about saving you…”” 
 
P3: “Yes, sell, sell, sell. We’re all out speaking to companies and we’ve got a business 
development team as well.” 
 
P2: “Service design as well, I think.” 
 
4.7.1.2 The usefulness of the report 
 
The participants agreed that the report generated from the CBA tool would be helpful in decision 
making within the VR service demonstrating the value of implementing VR. However, they felt 
the usefulness of the report produced for their VR service was limited as the data used was from a 
small sample sizes.   
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P3: “I think the biggest challenges are with the sample sizes and stuff like that, wasn’t it? 
Casting my mind back, I think when I did read it you could see the indications of where it 
could help with further decision making and driving some of that activity. But, I think, for 
the actual data that was used, within our service, it wasn’t very statistically impactful, in 
that sense.” 
 
Participants recognised the challenges in collecting data needed for the CBA tool such as recruiting 
participants, and organisations not collecting or measuring the relevant data. To overcome the 
difficulties of data collection and collating data retrospectively, it was suggested that VR services 
build data measurement and collection process into the service design.  
 
P2: “I think it’s being aware of the data that you want to collect prior to running… Do you 
know what I mean? So, doing something retrospectively, here is a cost/benefit and trying 
to apply retrospectively to data can be a bit of a challenge, either because you haven’t got 
people coming forward or because it hasn’t been measured properly, or any of that sort of 
stuff.  
 
I think, going forward, I would be looking at it so that you would have the sorts of data that 
you would want to collect, with a forward view of, “This is what we want it to tell us.” 
Then, either build that into your service design, in our case, or build that in as an employer, 
that they’re the metrics you’re measuring.” 
 
4.7.1.3 The ease of using the CBA tool 
 
When discussing the ease of using the CBA tool, there was a consensus that the CBA tool was 
user-friendly and easy to populate. The CBA tool is colour coded to assist the users to identify 
which columns to complete.  The participants found when using the case study, the colour coding 
of the boxes enhanced the user-friendliness of the CBA tools.  
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P1: “Although it’s quite a simple thing, literally saying, “Fill in the blue boxes,” is great. 
You know what I mean? Particularly when you work in business and you haven’t got time 
to work out that it’s column A, B and then you’ve also got to do AM. So, just colour-coding 
and stuff like that really helps.” 
 
P2: “I think so, I think it would just be walking through the data and making sure you’re 
drawing on the right sources. It’s easy to populate.” 
 
When the participants considered using the model at a later stage, they were in agreement that they 
might have difficulties recalling where the data should go in the CBA tool.  There was a consensus 
that for future use aide memoirs, such as a little module booklet, or instruction tabs built into the 
model, would be useful. 
 
P2: “I think if you were to go away and then say, ‘Here, you can use the model now’, we’d 
probably need to sit down and try and work out what it all was again. But, if there’s 
something that accompanies it, that explains it, like a little module or something you do 
first, like you said a booklet or anything like that, I think it will be pretty straight forward.” 
 
P1: “You could even do, on the sheet itself, tabs that are other pre-populated documents, 
so people could see how it’s filled in, or an instruction per tab. So, when you get into it 
you’ve got access to the instructions on that tab.” 
 
Although the participants agreed populating the CBA tool was easy, they felt that collecting the 
data to be used within the CBA tool could be problematic. They expressed concerns with regards 
to knowing what data to collect as well as ensuring the accuracy of this data. They felt this could 
be addressed within an aide memoir. 
 
P3: “I think it is just the nature of the data that you’re collecting and the knowledge. I know 
you’ve done the crib sheet, and stuff like that, but, I think, being able to understand 
collecting the data that you’ve put together in the case study, if you like, and pulling that 
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together accurately, notwithstanding how accurate the data is itself. But, do you know what 
I mean, just inputting that, understanding all the measures and metrics…” 
 
4.7.1.4 Further development of the CBA tool 
 
A number of ideas to further develop the CBA tool were identified during the focus group. It was 
suggested that the CBA tool be expanded to enable organisations to assess the cost/benefits of a 
variety of interventions as opposed to an intervention that is specific to VR. 
 
P1: “Would it capture something more like an overarching umbrella of services that may 
include more digital type interventions? Would you just capture the costs in the same way?” 
 
One participant felt another way to expand the model would be to include outcomes (costs and 
benefits) for a wider range of mental and physical health conditions. Incorporating all conditions 
addressed by VR would provide the complete picture to organisation. Moreover, it would assist 
with service redesign, for example it might identify costly interventions with small gains that the 
VR service could decide to no longer offer. However, this viewpoint was not unanimous, with 
another participant arguing that organisations would not be interested in that level of detail, but 
were more interested in the overall outcome i.e. is sickness absence across the organisation reduced 
and what are the costs/benefits of this result.  
 
P1: “I suppose, my question mark would be around when you have other disability types 
coming in, which may, or may not, be harder to… There are quite a lot of stats there about 
mental health, and quite a of stats there about MSDs, when you get your diverse conditions 
there is less. There’s a business case there but there are less stats around absence levels 
and… Then that gives you the complete business case, in some respects.” 
 
P3: “I think, overall, for a programme, if it wasn’t disability specific, you’d want to know 
the cost of the intervention against the cost saving. So, isn’t it better to do it [unclear audio 
0:06:08] in an organisation anyway? I suppose, if you were buying a service, and you were 
saying, “Right, I’m spending this amount, say £70,000 on a VR service,” you’re not going 
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to be looking at one particular condition at a time, are you, because it’s the effectiveness 
of what you’re spending on that service, as a whole, that you’re measuring, and what you’re 
getting back from it.” 
 
A further potential development suggested by one participant was to tailor the CBA tool to the 
different industry sectors. The costs, causes, and duration of sickness absence, as well as the VR 
interventions that can be offered, differ for each industry sector. For example, an individual with a 
sprained ankle would be able to return to a desk-based job with adjustments, however, there are no 
adjustments suitable to allow a builder to return to a construction site. 
 
P1: “The thing is, also, if you then talk to organisations about just getting the data off them, 
and in some respects, you don’t have to provide the service to them, because you can put 
your assumptions in and then put it for an industry, in construction, for example, “This is 
how a VR model would benefit you.” So, you could do your next PhD in different sectors.” 
 
During the focus group, it was recognised that there are a number of hidden/soft costs and benefits 
of VR services, such as improved job satisfaction, quality of life, team working etc., that cannot be 
captured in the CBA tool. It was identified that highlighting this to individuals using the CBA tool 
or reading the report would be necessary to allow an informed decision.  
 
P1: “Sometimes, I think some of the hidden costs around sickness absence are the extra 
costs on employees, who work longer hours and that kind of thing, where there’s not a value 
to it but, obviously, there is more of an impact on other people. I know it’s __[unclear audio 
0:18:04] and you can’t really capture that in this kind of model, but…” 
 
P:1 “You could almost say, “This is almost like a minimum cost/benefit model, and bear in 
mind you’d have loads of hidden costs as well,” which is quite powerful.” 
 
Lastly, participants recommended structural changes to the CBA tool. One participant felt that the 
inclusion of a front-end template, as opposed to populating the underpinning excel spreadsheet, 
would improve the presentation and ease of use of the CBA tool.  
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P1: “I’d also say, maybe a front-end template. So, when you sit down with a company you 
can say, “How many employees do you have? What’s their average salary?” so you can 
just fill in all that stuff, nice and neat.” 
 
An additional structural change suggested was to include the ability on the excel spreadsheet to 
enable the inclusion/exclusion of the different costs. This feature is available for the outcomes, 
allowing the impact of different outcomes on the BCR to be explored. By including this feature for 
the costs, it would enable the exploration of the different costs for different outcomes.  
 
P4: “Then whether it would be possible to have an equivalent of the including outcome 
column on the costs page, so you don’t have to delete the data.” 
 
In summary: 
 
The participants agreed that the CBA tool is a useful, practical tool and that they do not have 
anything similar at this point in time.  They were enthusiastic about the potential of the tool to be 
even more effective as it develops further. The participants felt that the CBA tool would benefit 
their VR service in terms of marketing, service development/design and assisting organisations to 
identify health needs that VR could address.  The participants agreed that the report generated as a 
result of the CBA tool would be helpful in decision making within the VR service and 
demonstrating the value of implementing VR. However, they felt the usefulness of the report 
produced for their VR service was limited as the data used was from a small sample sizes.  
Participants discussed ways of overcoming the identified data collection challenges, such as 
building the outcome measures and data collection into the service design. The participants felt that 
the CBA tool was user-friendly; however, they expressed concerns on remembering how to use it 
at a later date. They suggested the provision of aide memoires would assist when revisiting the 
CBA tool. Further suggestions for improving the CBA tool were discussed, namely: enabling the 
model to be used for any health intervention, as opposed to a VR specific intervention, including 
the costs and benefits of a wider range of causes of sickness absence, tailoring the CBA tool to the 
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different industry sectors, highlighting the hidden benefits and costs, and structural changes to the 
CBA tool such as including a front-end template and allowing the easy inclusion/exclusion of costs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
228 
 
5. Discussion 
 
In order to address the aims and objectives, outlined below, the research was completed in stages, 
with each stage addressing specific objectives and consequently used to inform the subsequent 
stage. Following a brief rationale for undertaking this research, the discussion section will address 
each objective in turn. 
 
5.1 Aims 
 
1. To develop economic outcomes, to be used within an existing CBA model, in order to ascertain 
the efficacy of a practical CBA tool in evaluating the costs and benefits of VR interventions and 
services. 
2. To implement and explore the practical application of the revised CBA tool, including the 
developed outcomes, using data from two VR services. 
 
5.2 Objectives: 
 
1. To identify from the published literature the outcomes of VR interventions for organisations and 
employed individuals. 
2. To revise the GM New Economy CBA model to ensure that the practical CBA tool developed 
is capable of analysing the costs and benefits of VR interventions. 
3. To collect the relevant data required to populate the revised practical CBA tool from two VR 
Services and the organisations that they provide the VR to. 
4. To implement and test the revised practical CBA tool incorporating the developed outcomes to 
identify the cost-benefits of the VR interventions and services in a real-world setting. 
5. To appraise the value of the revised practical CBA tool to the VR provider and organisation VR 
is provided to. 
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5.3 Research Rationale 
 
The cost of sickness absence and presenteeism has far reaching economic and social consequences. 
Within the UK ill-health among working age individuals costs the economy £100 billion a year; 
moreover, employers face an annual bill of around £9 billion for sickness absence costs and 
turnover due to ill-health (DWP & DH, 2016; Black & Frost, 2011). This appears to be a 
conservative apportion of costs to employers as Stevenson & Farmer (2016) estimated the cost of 
mental health to employers to be between £33 billion and £42 billion, this calculation included 
presenteeism, sickness absence and turnover costs.  Similar costs could be inferred for MSDs as 
they are, along with mental health conditions, one of top five causes of short and long-term sickness 
absence, and a leading cause of disability (CIPD & Simply Health, 2016; Joyce et al, 2015; Hoy et 
al, 2014). It is imperative that effective means of addressing sickness absence and presenteeism are 
identified. VR is widely advocated internationally and nationally as an intervention to help 
employed individuals SAW (DWP & DH, 2017; Black & Frost, 2011; Boorman, 2009; Carroll, 
Rick, Pilgim, Cameron, & Hillage, 2009; Waddell et al., 2008). Although, the evidence points 
towards VR being effective, further research conducted in the UK is needed to firmly establish its 
effectiveness within the UK. Moreover, the evidence-base on the cost-effectiveness of VR is 
limited (Dibben et al., 2012; Waddell et al., 2008). With the current economic climate, globally 
and within the UK, it is imperative that scarce resources are used effectively. Therefore, there is a 
pressing need to develop the evidence-base on the cost effectiveness of VR, as well as enable the 
lay person to assess the costs and benefits of VR. Currently, there is no user-friendly practical 
economic tool available in the public arena for VR services and researchers to use. This research 
outlines the development of such a tool, envisioning that the practical CBA tool developed will lay 
the foundation for future work and practice. Moreover, during the development of the model a 
further two case studies within the UK were conducted adding to the evidence-base for VR within 
the UK.  
 
5.4 Objective 1: To identify from the published literature the outcomes of VR 
interventions for organisations and employed individuals. 
 
A number of potential direct benefits of VR aimed at assisting the employed population to SAW 
or RTW were identified, such as improving employees physical and mental health, decreased 
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sickness absence, decreased presenteeism, and reducing employee turnover (Hammond et al., 
2017; Alexander et al., 2017: Black & Frost, 2011; Boorman, 2009; Cancelliere et al., 2011; Knapp 
et al., 2011; Van Holland et al., 2012; Oxenburgh & Marlow, 2005; Uegaki et al., 2011). In 
addition, a number of indirect benefits for both the employee and employer were identified, such 
as improved quality of life, decreased agency costs, decreased costs of care and increased earning 
potential of both employee and family (Cagno, et al., 2013; Oxenburgh & Marlow, 2005; Barham 
& Begum, 2005; Bevan and Hayday, 2001; WHO, 2003; SIGN, 2000). When considering which 
outcomes or benefits of VR to include in this research, specifically within the CBA tool, 
consideration was given to the ease of monetisation of the outcomes, the relative importance placed 
on the outcomes by the organisations that would be utilising the CBA tool and the economic value 
of including an outcome. Although, conducting a CBA from an organisational perspective limits 
the potential benefits included, at the start of this research organisations were the main purchasers 
of VR, and consequently the main stakeholders therefore most workplace interventions were 
evaluated from an organisational perspective (van Dongen et al., 2014; Tompa, Dolinschi, de 
Oliveira, 2006; Uegaki et al., 2010; van Dongen et al., 2011; van Dongen et al., 2012; Verbeek, 
Pulliainen, & Kankaanpää, 2009). Bearing this in mind, this research focused on an organisational 
perspective so as to ensure the tool was useful for the current VR providers.  However, this picture 
is changing, both in terms of considering the funding of VR and where VR services are best placed 
(DWP & DH, 2017). These changes generate the need to consider the costs and benefits of VR 
from wider social and individual perspectives. A recent RCT explored the costs and benefits of a 
VR advice service for employees with musculoskeletal pain within a GP practices (Wynne-Jones 
et al, 2018), and considered a number of perspectives in the economic analysis. When deciding on 
the economic analysis tool for this research a tool was chosen that would facilitate further 
development incorporating a variety of outcomes from different perspective.  For this research, an 
organisational perspective was taken and the outcomes identified to be included in the CBA tool 
were: sickness absence due to MSD and mental health conditions, presenteeism, and turnover. Each 
of these outcomes will be discussed in turn: 
 
Sickness absence was included as it is commonly used in cost effectiveness studies for workplace 
interventions (Carrol et al., 2009; Bultman et al., 2009; Dibben et al., 2012; Dixon et al., 2002; 
Lambeek et al., 2010; Noben, 2012) and there are UK norms of sickness absence levels (CIPD & 
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Simply Health, 2016; ONS, 2014; CBI, 2013).  The inclusion of sickness absence improves the 
comparability of the CBA tool to the evidence-base, moreover, sickness absence is easily 
monetised, the costs are of interest to organisations and this type of data is routinely collected (van 
Dongen et al., 2014). However, the health conditions resulting in sickness absence are wide ranging 
(HSE, 2017a; CIPD & Simply Health, 2016; CIPD, 2014a; CIPD, 2011; CBI, 2011; Wegge et al., 
2007), which in turn impact differently on the expected length of sick leave. Due to the variety of 
causes of sickness absence the two most common causes, namely, MSDs and mental health 
conditions were the focus (HSE, 2017b; CIPD & Simply Health, 2016). Although it is recognised 
that by narrowing the CBA tools’ capability to only include MSDs and mental health conditions, 
potential benefits of VR on other health conditions may be missed. If significant benefits cannot 
be monetised this may lead to incorrect conclusions (House, 1998), thus this limitation of the CBA 
model needs to be borne in mind when interpreting the results.   Another factor considered when 
using sickness absence as an outcome was that the probability of an employee returning to work 
following sickness absence is substantially decreased after 6-months of absence, highlighting the 
importance of identifying cost effective interventions to prevent employees moving out of 
employment due to ill-health (Squires et al., 2012; NICE, 2009b; Waddell et al., 2008), moreover, 
the sickness absence pay in a number of public organisations, such as organisation 1, decreases to 
half pay at 6 months.  Therefore, the cost of absence would differ before and after 6-months 
sickness absence.  Two sickness absence outcomes, for both MSDs and mental health conditions, 
were developed i.e. sickness absence due to MSDs < and > 6-months, and sickness absence due to 
mental health conditions < and > 6-months. 
 
Presenteeism was included as an outcome in this research study, as despite being a relatively new 
concept, the differing interpretations across countries, and the ongoing debate as how to measure 
and define presenteeism (Lohaus & Habermann, 2018; Garrow, 2016; Noben et al., 2014; Krol, et 
al., 2013; Brooks et al., 2010; Terry & Min, 2010), it has been increasingly considered when 
evaluating impacts of workplace interventions (Uegaki et al., 2011; Ijzelenberg et al. 2007; 
Cancelliere et al., 2011; Knapp et al., 2011). The costs of presenteeism have been identified as 
ranging between 1.8 and 10 times the cost of absenteeism (Virgin Pulse, 2017, cited in Hampson 
et al., 2017; Brown et al., 2014; Sainsbury Centre for Mental Health, 2007).  This variation in the 
costs may be due to the lack of homogeneity in the outcome measures used in research (Lohaus & 
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Habermann, 2018). Additionally, there is a concern that decreases in sickness absence levels may 
be masking increases in presenteeism levels (CIPD, 2012).  Presenteeism has been linked to 
productivity levels (Lohaus & Habermann, 2018; Bergstrom et al.., 2009; Caverly et al.., 2007; 
Hansen & Andersen, 2009; Hansson et al.., 2006; Kivimaki et al.., 2005; Schultz et al., 2009; 
Schultz & Edington, 2007; all cited in Claus, 2011), and if taken as a proxy of hours not worked, 
as was done in this research, is relatively easy to monetise. However, presenteeism effects are not 
always negative and may in fact be viewed favorably when individuals are using work as part of 
rehabilitation (Cocker et al., 2014). Taking into account the variations in defining, interpreting and 
measuring presenteeism, when considering economic evaluations perhaps the ‘term’ presenteeism 
is a misnomer. Lohaus and Habermann (2018) argue that the definition ‘attending work while ill’ 
is an open and all-encompassing definition, allowing exploration into a number of facets of 
presenteeism such as the consequences, the costs, why people exhibit the behaviour. All though 
this definition is broad, it still has limitations as would an individual with a long-term disability 
consider themselves ill? And when using this definition for research, it would necessitate the 
outlining and clarification of the position of the research. Thus, posing the question of why use the 
term presenteeism. It may be clearer to simply define the research question, as opposed to clearly 
outlining ones’ interpretation of presenteeism as was done in this research.  In fact, stepping away 
from the term presenteeism to reduced productivity due to a health condition may enable the 
research goal to be more clearly articulated.  Inherent difficulties noted in using an emerging topic 
such as presenteeism in economic evaluations are the limited evidence-base (Baxter et al., 2015; 
Baker & Aas, 2012).  The findings from this research further illustrate this, as the limited evidence-
base prevented robust conclusions being drawn, weakening the assumptions within the CBA tool. 
In order to ensure the CBA tool does not falsely attribute benefits, a cautious conclusion that the 
intervention will not have an effect was drawn. As a result, some users of the CBA tool may decide 
to exclude this outcome from the economic analysis. A useful feature of the CBA tool is that it 
allows for outcomes to be easily included or excluded.  
 
The last outcome included in the CBA tool was turnover. Although the need for further high-quality 
evidence is recognised (Oakman et al., 2016; Palmer et al., 2012; Dewa et al., 2015; van Vilsteren 
et al., 2015; Nieuwenhuijsen et al., 2014; Schaafsma et al., 2013), there is a consensus in the 
literature that workplace interventions may reduce employee turnover, decreasing costs to 
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organisations, assisting individuals in avoiding unemployment, and reducing the knock on societal 
and economic costs of unemployment (Alexander et al., 2017: Black & Frost, 2011; Boorman, 
2009; Cancelliere et al., 2011; Knapp et al., 2011). Turnover has a monetary value and is easily 
used within a CBA tool. Although costs of turnover are not regularly collected by organisations 
(Black & Frost, 2011; Oxenburg and Marlow, 2005; Campion, 1991) there is sufficient literature 
(ERS Research and Consultancy, 2016; CIPD, 2013; CIPD, 2014b; Sainsbury Centre for Mental 
Health, 2007; Levy et al., 2014) to allow for an approximate cost to be calculated. 
 
Indirect costs and benefits were not included in this model. It is acceptable practice to use a 
multiplier, dependent on the direct costs, to estimate the indirect costs, however, there is no 
consensus on the multiplier to use, with the multiplier used in studies ranging between 2 and 50 
(Barra, 2010, cited in Cagno et al., 2013; Uegaki et al., 2011). Moreover, it is difficult to estimate 
some indirect costs such as increased workload on colleagues, and many organisations do not 
routinely collect these costs, decreasing the functionality of including them in the CBA tool. It is 
important when calculating costs and benefits of an intervention that benefits are not double 
counted (Krol et al., 2013; CEEU, 2011; Rebergen et al., 2009). Quality of life is an outcome that 
is increasingly being encouraged to be used in all health care interventions (CSP, 2014), so as to 
increase the comparability of outcomes of varied interventions and to enable economic analyses to 
be conducted.  Although quality of life has been linked to productivity (McDonald, DiBonaventura, 
& Ullman, 2011; Pare et al., 2006; Dean et al., 2005), this relationship is not supported in all the 
literature (Lamer, Meerding, Severens, & Brouwer, 2005), and it is questionable as to whether 
including this in a CBA would merely be duplicating the impacts noted in decreased sickness 
absence and/or presenteeism (Krol et al., 2013).  In this research, in order to provide a cautious 
indication of the cost effectiveness of VR when addressing sickness absence due to MSDs and 
mental health conditions, the outcomes included are: sickness absence due to mental health 
conditions and MSDs < and > 6-months; presenteeism; and turnover. Establishing the most cost-
effective means to support individuals with these specific conditions to SAW has far reaching 
potential positive impacts for individuals, organisations and society, given the costs for sickness 
absence related to mental health conditions and MSDs (discussed in section 5.3). 
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5.5 Objective 2: To revise the GM New Economy CBA tool to ensure that the 
practical CBA tool developed is capable of analysing the costs and benefits of 
VR interventions. 
 
To address objective 2, the intervention case (i.e. what happens when the intervention is put in 
place), the reference case (i.e. what would happen without the intervention been in place), the 
deadweight estimation (i.e. what percentage outcome would have occurred without the 
intervention), and unit cost for each outcome of interest, needed to be calculated (McPherson & 
Inglis, 2008; HM Treasury, 2011; Cox et al., 2011). The reference and intervention cases need to 
be synthesised from the existing evidence-base for each potential outcome/benefit, in order to 
ensure that the CBA tool is capable of analysing the net effectiveness of VR.  The reference and 
intervention cases enable the researcher to determine what would have happened should the 
individual have not attended the VR service, allowing for an inference of the net effectiveness of 
VR to be established (McPherson & Inglis, 2008). From this net effectiveness deadweight can be 
calculated. A unique aspect of this research project is that the model is focused on VR, therefore 
in order to determine the reference case, intervention case and deadweight, the usual CBA tool was 
flipped; in other words a mirror image of a usual CBA tool was created. This flipped model was 
created to illustrate that the intervention outcome i.e. sickness absence from an organisational 
perspective has a finite benefit, once the employee is healthy and back in work the benefit of the 
intervention ceases. This differs from a typical CBA intervention benefit for example getting 
people back into work from a societal perspective where one may expect benefits to continue 
indefinitely due to an individual starting in the job market.  
 
This research has added to the literature by determining new intervention and reference cases for 
sickness absence < 6-months due to MSDs, using four studies (Arnetz et al., 2003; Du Bois & 
Doncell, 2012; Karjalainen et al., 2003; Bultman et al., 2009). Using these four studies the net 
effectiveness of VR (32.6%) for MSDS was identified. The net effectiveness was used within the 
CBA tool to calculate the deadweight (i.e. what % of people would RTW without the intervention) 
for each VR organisation. Deadweight was calculated as 81.74% in organisation 1 and 50.96% in 
organisation 2. A strength of calculating deadweight from the estimated net effectiveness of the 
VR services is that it limits the effect of different populations on the result. An alternative method 
of calculating the net effectiveness would be to look at the expected probability of returning to 
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work within a set time period for MSDs accessing usual care. Squires et al. (2012) using this 
method developed a Markov model to explore long-term sickness absence due to MSDs. The data 
calculated for the Markov model utilised synthesised evidence from a systematic review informing 
NICE Public Health Guidance 19: Managing Long-Term Sickness and Incapacity for Work 
(2009b). The review examined the effectiveness of interventions for MSDs compared to usual care, 
using RTW as an outcome. Squires et al., (2012) calculated the probability of being on sick leave 
with usual care and going back to work (0-6-months) as 64.8%, using a weighted average of 
effectiveness studies. Squires et al.’s (2012) calculations and the calculations presented in this 
research have limitations due to the evidence-base from which they are constructed. The quality of 
the research in this field is generally poor (Squires et al., 2012); none of the included studies are 
based within the UK; and due to the lack of long-term follow-up data, assumptions were made by 
Squires et al. (2012). Both methodologies relied on a limited evidence-base. This research’s 
findings (81.74% and 50.96%) are in line with those of Squires et al. (2012) (64.8%). Although 
these initial findings are positive, and add to the evidence-base, there is a still a need for further 
empirical research to confirm the existing findings within the literature.     
 
Looking at the sickness absence data for > 6-months, there was insufficient data available to 
calculate the net effectiveness of VR interventions. Squires et al. (2012) used a mean estimate of 
2.3% likelihood of returning to work between 6 – 12 months due to MSDs (DWP, 2005, cited in 
Squires et al., 2012). This mean however, was not from a meta-analysis of the research, it was 
based on the DWP’s (2005) statistics for incapacity benefit and severe disablement allowance, 
which is a different population to the population of this study i.e. employed individuals. Moreover, 
the data are from 2005, making their generalisability to the UK today questionable. The only 
cautious conclusion that can be made is that previous literature has not demonstrated an effect on 
long-term sickness absence. As a result, in this study, for long-term sickness absence due to MSDs 
deadweight was calculated as equal to the impact of the intervention.  
 
In reviewing the literature for the outcome ‘sickness absence due to mental health conditions < and 
> 6-months’, the lack of homogeneity in reporting outcomes resulted in the inclusion/exclusion 
criteria being revised. With this revision four studies were examined in detail (van Oostrom et al., 
2010; Noordick et al., 2013; Schene et al., 2007; Blonk et al., 2006). From the included studies, 
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two studies (Blonk et al., 2006; Schene et al., 2007) reported significant improvement with the 
addition of VR elements, whereas the other two studies (Van Oostrom et al., 2010; Noordik et al., 
2013) had no significant differences in favour of the VR intervention. This inconsistency is evident 
throughout the literature on mental health and workplace interventions (Vogel et al., 2017; 
Nieuwenhuijsen et al., 2014; Kroger et al., 2013; Rebergen et al., 2009; Hees et al., 2013) with a 
Cochrane review concluding that although workplace interventions may reduce the length of the 
first episode of sickness absence due to mental health conditions, the sustainability of this RTW is 
variable, and there is “no evidence of a considerable effect of workplace interventions on time to 
RTW in workers with mental health problems” (Van Vilsteren et al., 2015, p.2). This lack of 
consensus in the literature could be due to the variety of conditions falling under the mental health 
umbrella, as well as the variety of workplace interventions considered within reviews. This 
highlights the need for a structured approach when evaluating the impact of VR interventions. 
Considering the reference and intervention cases, it is acknowledged that the effectiveness of VR 
in reducing sickness absence due to mental health conditions is inconclusive. Furthermore, a recent 
RCT with an economic evaluation alongside indicated that a participatory, supportive work 
programme for employees with mental health conditions was not economically viable (Lammerts, 
Van Dongen, Schaafsma, van Mechlen & Anema, 2017). Although there is a body of evidence 
supporting the concept of good work being good for your health (Taylor et al., 2017; Waddell et 
al., 2008), which would lead one to conclude that VR would have positive benefits on employees 
mental health, at this point the only cautious conclusion that could be made for the development of 
the CBA tool was that the intervention will not have an effect. This may change as the evidence-
base expands. The CBA tool in this study assumes that the deadweight equals the impact of the 
intervention. When this assumption was subjected to a sensitivity analysis it highlighted that this 
assumed assumption is very cautious. The findings from the literature show values of -45%, 0%, 
30% and 31%.  As the evidence-base develops these results will be refined, allowing for further 
development of the CBA tool.  
 
The literature review for turnover produced similar results with no studies meeting the inclusion 
criteria. Although there is a consensus that workplace interventions aimed at improving health of 
individuals may decrease turnover (Alexander et al., 2017: Black & Frost, 2011; Boorman, 2009; 
Cancelliere et al., 2011; Knapp et al., 2011) the studies exploring this topic are of low 
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methodological quality and further research is needed to form robust conclusions (Oakman et al., 
2016; Baxter et al., 2015; Palmer et al., 2012; Dewa et al., 2015; van Vilsteren et al., 2015; 
Nieuwenhuijsen et al., 2014; Schaafsma et al., 2013).  Although, the evidence for the net 
effectiveness of VR is inconclusive, for the purposes of this CBA tool, it was deemed reasonable 
to assume a net positive effect. In this CBA tool, deadweight equals zero. This may introduce bias 
and was further explored by running a sensitivity analysis on the CBA tool results. The sensitivity 
analysis indicated that the deadweight percentage for turnover influenced the overall results and 
needs to be explored in scenario analysis when using the CBA tool to ensure that the robustness of 
the results. 
 
Considering presenteeism, the results of the literature search were insufficient for the purposes of 
identifying a reference and intervention case. The presenteeism outcomes were heterogeneous, 
limiting comparability; the studies primary aims were mainly to promote health as opposed to 
reducing presenteeism; workability, work performance and working role function were interpreted 
as a measure of presenteeism (Baker & Aas, 2012); and results were presented as a combination of 
lost time due to absenteeism and presenteeism, limiting the ability to distinguish presenteeism 
levels in the control and intervention. These limitations are partly due to the fact that presenteeism 
is a relatively new concept (Baker & Aas, 2012) as well as the fact that there is presently no 
consensus on the best way to measure it (Krol et al., 2013; Brooks et al., 2010; Terry & Min, 2010). 
De Graaf et al. (2012) using a face-to-face survey and the WHO Disability Assessment Schedule 
(n = 6646) in the Netherlands, estimated the number of days lost to sickness absence and sickness 
presenteeism associated with common mental and physical disorders. De Graaf et al. (2012) 
concluded that in addition to sickness absence, on average, an individual with a mental health 
condition would have an additional 8.0 days of reduced-qualitative functioning, and those with 
physical disorders an additional 3.5 days of reduced-qualitative functioning. These days of 
reduced-qualitative functioning, could then be costed on hourly wages, a method of quantifying 
presenteeism that is commonly used, and used within this research. However, Schultz et al. (2009) 
raise the question as to whether those individuals are 0% productive during those hours. 
Additionally, Vingard et al. (2004), cautions the conclusion that presenteeism is necessarily 
negative for employees and employers, stating that there is insufficient evidence to demonstrate 
decreased work performance, additionally, presenteeism may be preferable to the employee and 
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employer, as the structure of the workplace has been shown to assist recovery from certain ill-
health conditions (Cocker et al., 2014). Bearing this debate in mind, there was limited evidence to 
enable robust conclusions to be made on reference and intervention cases. The only cautious 
conclusion that could be made was that the intervention will not have an effect. As the evidence-
base develops these results will be refined, further developing the CBA tool.  
 
In addition to identifying the intervention and reference case, the net effectiveness and calculating 
the deadweight, the unit costs of each outcome needed to be ascertained. Considering sickness 
absence costs, it is commonly accepted that sickness absence is a measure of productivity (Kigozi 
et al., 2016; Uegaki et al., 2011; Krol et al., 2013). However, there is inconsistency within the 
literature with economic evaluations using various methods of calculating sickness absence 
(Kigozi, et al., 2016; Krol et al., 2013; Uegaki et al., 2011). The most commonly used approach is 
the human capita (HC) approach which estimates the loss of production due to absence, and the 
expected or potential earnings lost (Kigozi et al., 2016; Stromberg et al., 2017; Rost et al., 2014). 
The HC approach may over or underestimate the cost of sickness absence (van Dongen et al., 2014; 
Jo, 2014; Rost et al., 2014), however compared to the friction costs (FC) approach, an approach 
attempting to quantify the loss of production over time, requiring a large amount of data, it is a 
simple wage calculation (Jo, 2014; Lensberg et al., 2013). The HC approach was used within this 
research. Presenteeism costs were estimated to cost between 1.8 and 5.1 times the cost of 
absenteeism (Brown et al., 2014; Sainsbury Centre for Mental Health, 2007), with the cost per 
employee estimated at £605 (Sainsbury Centre for Mental Health, 20017; CIPD, 2008). The HC 
and FC debate identified when considering the measurement of sickness absence pertains to the 
measurement of presenteeism (Schultz et al., 2009; Kigozi et al., 2016). The FC approach is seldom 
used in the calculation of presenteeism costs (Kigozi et al., 2016). As turnover costs are seldom 
recorded by organisations (CIPD, 2014b) an estimate was necessary for the CBA tool. The 
estimates in the literature ranged from £7750 (CIPD, 2013; CIPD, 2014b) to £30,614 (ERS 
Research and Consultancy, 2016) per employee. An average of the estimates in the literature was 
calculated and used as an estimate of turnover costs per employee, estimated to be £16,663. 
 
As is seen from the reference and intervention cases, and unit costs, developed for sickness absence 
due to MSDs and mental health conditions, turnover and presenteeism, the evidence-base in this 
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field is limited. This necessitated assumptions on variables within the CBA tool to be made, which 
are described in the methodology. Moreover, these limitations resulted in the cautious conclusion 
being drawn that VR interventions will not have an effect on presenteeism and sickness absence 
due to mental health. The limited evidence is to be expected in a newly emerging field, and as the 
literature develops, these conclusions will be refined. Although the CBA tool has constraints due 
to the limited evidence, if data had been readily available there would have been no need for the 
tool (Pilgrim et al., 2008). In order for the cost effectiveness of VR to be studied there needs to be 
a suitable model, and this research is forming the ground work for future analyses of VR cost 
benefits. 
 
5.6 Objective 3: To collect the relevant data required to populate the revised 
practical CBA tool, from two VR services and the organisations to which VR is 
provided. 
 
As objective 3 sought to collect data for the first VR specific CBA tool, it was necessary to initially 
establish that the services evaluated in the two organisations were incorporating VR approaches. 
From the literature discussed in chapter 1, it was seen that VR is a term commonly misunderstood 
(Langman, 2012).  There are a range of: definitions of VR (DWP, 2004; VRA, 2013; Waddel et 
al., 2008; Langman, 2012; Fadyl, McPherson, Nicholls, 2015; Nice, 2009b); practitioners of VR 
(Langman, 2012); and a debate as to the similarities and differences between VR and OH (Frank, 
2013; O’Donnell & Reymond, 2009). This diversity creates difficulties in establishing whether a 
service is actually a VR service. From synthesising the evidence-base for VR, it was hypothesised 
in this research that a best practice approach of VR within the workplace, for common health 
conditions, would consist of the following elements: workplace based interventions, case 
management, early intervention, a stepped-care approach, multi-disciplinary work-focused 
rehabilitation and accommodating workplaces, allowing for the implementation of early RTW and 
temporary modified work arrangements (Coleman et al., 2013; Dubbin et al., 2012; Accident 
Compensation Corporation, 2004, cited in Ellis et al., 2010; Schaafsma et al., 2010; Lambeek et 
al., 2010; Boorman, 2009; Waddell et al., 2008, Irving et al., 2004). When comparing organisation 
1 to the identified best practice for VR interventions, it fell into the remit of a VR service as it 
followed best practice with respect to ensuring early intervention, liaising with the workplace to 
implement workplace accommodations and rehabilitation was work focused. However, 
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organisation 1’s VR service did not use a formalised step care approach, nor did the service consist 
of a multi-disciplinary team.  Organisation 2 was also lacking a multi-disciplinary team and did not 
facilitate early access to treatment. It did follow a clear stepped-care approach, uses a case 
management model, and liaises with the workplace to implement temporary work modifications to 
facilitate an early RTW. Organisation 1 and 2 can be identified as meeting the requirements of a 
VR service. 
 
The primary outcomes to be used in the CBA tool were those identified in phase 1 of the research 
project. Organisation 1 explored sickness absence levels using data provided from an electronic 
database. The secondary outcomes collected as part of the wider VR service evaluation in 
organisation 1, not to be used within the CBA tool, were psychological distress using the GHQ-12 
(Goldberg, 1972), job satisfaction using the JSS (Warr et al., 1979) and patients’ functional ability 
using the PSFS (Stratford et al., 1995). Organisation 2’s primary outcomes to be used in the CBA 
tool were sickness absence and turnover. In addition, presenteeism using the Work Limitations 
Questionnaire (Lerner et al., 2001), and sickness absence from a self-report questionnaire (Work 
Limitations Questionnaire Work Absence Module) (Lerner et al., 2001) were collected and planned 
to be used within the CBA tool, however insufficient participants (n=3) rendered this unfeasible. 
The secondary outcome collected in organisation 2, as part of the wider VR service evaluation, was 
Quality of Life using the EQ-5D-5L (EuroQol Group, 1990). In organisation 1, sickness absence 
data was provided by the organisation from the electronic sickness absence records. However, 
inaccuracies in the data were noted, presumed to be due to human error. Additionally, when 
considering the potential uses of the CBA tool, both for VR services and organisations, it was 
considered that VR services may not always have the ability to access organisational sickness 
absence data. In order to overcome this problem, in organisation 2, two methods of collecting 
sickness absence were used. The first approach was, as in organisation 1, obtaining sickness 
absence from the organisations central database, which again was anecdotally reported to have 
inaccuracies due to the time-consuming nature of entering sickness absence data, and managers not 
entering all absences. The second was via self-report (WLQ sickness absence module (Lerner et 
al., 2001)). Self-reports have been reported to have accuracy for recall up to three months prior to 
completing the self-report (Zhang et al. 2012, cited in Krol et al., 2013).  However, due to the low 
number of participants self-reported sickness absence was not included in the CBA tool. 
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The primary outcome data collected from VR organisation 1, and used within the service 
evaluation, indicates that attending the VR Service led to a decrease in employee psychological 
distress (n = 62), participants’ dissatisfaction with work (n = 34), and their identified functional 
limitations (n = 27) which is positive. This improvement was maintained at 3-months follow-up. 
However, the limitations of the study, namely; the high number of drop-outs, lack of comparator 
control group, possible bias due to the clinician handing out and collecting the questionnaires, and 
the minimal 6-month data, mean that no comment can be made on the sustainability of the 
improvements beyond three months, and although positive the generalisability of these results are 
questionable. The secondary outcome data, used within the CBA tool, was collected from the 
electronic staff record.  Sickness absence due to MSDs highlighted a significant (p = 0.009) 
decrease in the mean number of sickness absence days, and associated costs, from 12-months pre 
to 12-months post VR. This data was collected for a larger number of participants (n=127), 
increasing the strength of this positive finding.   
 
Organisation 2 failed to recruit sufficient participants (n = 3). This was noted during the study and 
was raised a number of times during the recruitment phase, via email, telephone calls and face to 
face meetings with the individuals responsible for recruiting participants and collecting the data. 
In spite of this the measures proposed during these interactions did not increase participation. Due 
to the low number of participants (n = 3) in organisation 2, no analysis was conducted on the 
primary outcome data. As in organisation 1, organisations 2’s secondary outcome data provided 
on sickness absence days and cost for MSDs (n = 9) showed a decrease from 3-months pre to 3-
months post VR. Although again these findings were positive, due to the small numbers and the 
lack of a comparator group, these results need to be read with caution and cannot be generalised to 
all individuals accessing the VR service. Interestingly, sickness absence due to mental health 
conditions and ‘no reasons’ were greater following the VR referral than before. Although again 
based on a small number (n=34), and with only a 3-month follow-up period, these finding support 
the literature’s ambiguity over the effectiveness of VR for mental health conditions. This finding, 
along with the findings from the literature review highlights the need for research and development 
of VR interventions for employees with mental health conditions.  
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It is recommended that intervention evaluations contain an economic analysis to ensure the 
appropriate allocation of resources (Rabarison, Bish, Massoudi and Giles, 2015; NICE, 2013a; 
NICE, 2012; HM Treasury, 2011; MRC, no date).  Yet, the evidence-base regarding the cost-
effectiveness of VR for the SAW population is limited.  The challenges experienced in this research 
sheds light on some of the difficulties in evaluating VR for the SAW population and may be 
extrapolated further to explain why the evidence-base in VR is poor. In order to inform future 
research in this field, it is necessary to reflect on the pragmatic challenges encountered in this 
research and consider possible solutions.  Recruitment was a challenge encountered in organisation 
2. Recruitment is a common challenge to research projects (Newington & Metcalfe, 2014; Kaur, 
Smyth & Williamson, 2012; Steinke, 2004).  This challenge is particularly evident when exploring 
sensitive topics (Steinke, 2004; Doloriert & Sambrook, 2009; Lee, 1999). Although the definition 
of sensitive topics is debated (Elmir, Schmeid, Jackson & Wilkes, 2011; Lee, 1999), in the broadest 
sense it can be identified when considering whether the research poses a risk or threat to the 
participant or researcher (Fahie, 2014; Lee, 1999).  The threat may be intrusive such as exploring 
private or stressful areas, potentially stigmatising or incriminating to the participants, or political, 
i.e. considering the vested interested of organisations or powerful people (Fahie, 2014; Lee, 1999). 
This study’s research topic could potentially be viewed by the participants as a sensitive topic, both 
from an internal and political viewpoint. Sickness absence and disability are stressful topics for 
affected individuals, and as employees were referred to the VR service by their managers, the 
research could be viewed by the employees to be in the interests of the employer/organisation as 
opposed to the participants. These perceived potential conflicts of interest may explain the poor 
recruitment.  
 
In addition to the recruitment challenges in organisation 2, challenges in collecting meaningful data 
were encountered in both organisations. Organisation 1 had a large loss to follow-up, in both the 
primary and secondary data. It was hypothesised that this may have been a result of a change of 
clinician mid-way through the evaluation and the organisation undergoing major transformation. 
Moreover the question is raised as to whether the battery of questionnaires used needs to be 
streamlined in order to encourage completion. In organisation 2, the secondary data provided was 
of poor quality. The sickness absence and VR service data were provided by two different internal 
recording systems, this resulted in a mismatch of dates consequently reducing the number of cases 
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analysed. The challenges of conducting systematic research in organisations are well documented 
(Giga, Cooper & Faragher, 2003; Olsen et al., 2008) and the challenges encountered in this research 
could in part explain why the evidence-base is so poor.  Moving forwards there is a need to identify 
simple solutions to enhance data collection in VR evaluations.  
 
Although both studies had data collection challenges leading to low numbers, possibly highlighting 
the sensitive nature of the research topic and inherent difficulties in collecting the data needed for 
economic analyses, these results further substantiate and add to the existing UK evidence-base that 
VR is an effective intervention for MSDs (Dibben et al., 2012; Black, 2008; Waddell et al., 2008). 
However, effectiveness does not necessarily equate to cost-effectiveness, which was further 
explored in phase 3 (objective 4) of this research. 
 
5.7 Objective 4: To implement and test the revised practical CBA tool 
incorporating the developed outcomes to identify the cost-benefits of the VR 
interventions and services in a real-world setting 
 
Phase 3 was reliant on the data collected from the organisations in phase 2.  
 
Although there are a number of economic analysis tools, when weighing up the benefits and 
limitations of the different models in relation to VR, a CBA tool was chosen.  A CBA tool allows 
for the comparison of any intervention/programme regardless of whether it is focused on health or 
non-health outcomes or has different underpinning goals (Gray, 2011; House, 1998). VR services 
are by the nature of the definition of VR varied in the services they provide, the interventions they 
use, the populations they target and the practitioners delivering the service. This heterogeneity in 
the provision of VR services is a limiting factor in developing the evidence-base, thus the 
development of a user-friendly CBA tool for VR services, would facilitate comparison between 
services and identification of what elements of VR are effective. Moreover, it is often difficult to 
have a comparison group within VR interventions, thus a CBA tool with deadweight incorporated 
negates this need. These two elements of this CBA tool make this an ideal economic analysis to 
further the evidence-base in VR. 
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The refined CBA tool was based on an organisational perspective i.e. looking at the costs and 
benefits to the host organisation purchasing the VR intervention. The CBA tool for organisation 1 
indicates that the economic costs are greater than the benefits (BCR = 0.05). Whereas for 
organisation 2, the results indicate that the economic benefits outweigh the costs (BCR = 1.17). 
Organisation 1’s CBA tool did not include the outcome ‘turnover’ as during the research time 
period the organisation underwent major restructuring with a high number of redundancies. 
Interestingly, if turnover had not been included in organisation 2s’s CBA tool, then the economic 
costs would also have outweighed the benefits, resulting in a BCR less than 1. This seems to 
indicate that turnover plays an important role when assessing the economic effectiveness of VR 
services, although further research would be needed to establish this. In addition, there was a 
question surrounding the accuracy of the data provided for Organisation 1 that may also account 
for the differences in the BCRs between the organisations. This highlights the need for there to be 
consolidation and standardisation of the data that is collected on work outcomes, as this type of 
standardisation will enable the evidence of what works for whom, and the associated costs to be 
further developed (Bartys et al., 2017). The results from the CBA tool for organisation 2, add to 
the existing UK evidence-base on the cost-effectiveness of VR, although it is necessary to take into 
account the limitations highlighted.     
 
When conducting a sensitivity and scenario analysis for organisation 1, it was seen that the BCR 
did not vary greatly when adjusting the variables up or down by a set percentage. For the outcome 
‘sickness absence > 6-months’ varying deadweight did not change the BCR. This was due to it 
been a single case in the organisation for that outcome. Deadweight was based on the net 
effectiveness of VR interventions, determined from the mean differences between the post sickness 
absence data of the intervention and control groups in the underpinning literature.  A very small 
sample size would not be representative of the mean and would produce skewed results. This 
finding illustrates that the CBA tool is not valid when using very small sample sizes.   In 
organisation 2, varying the net effectiveness and consequently the deadweight resulted in changes 
to the BCR from above 1 to below 1, indicating that the deadweight variable has a large influence 
on the results. Deadweight is based on the net effectiveness, which in this research was determined 
from the literature, highlighting the need for the underpinning evidence-base to be robust, valid 
and reliable. From the sensitivity and scenario analysis it can be concluded that the variables, 
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except deadweight, used in the CBA tool are robust, as the BCR does not vary greatly when 
adjusting them by a set percentage (Pilgrim et al., 2008; Pannell, 1997; Keating & Keating, 2014; 
Snell, 2011, CEEU, 2011). As changing the key assumptions and uncertainties around the net 
effectiveness and deadweight changed the results, one cannot say with certainty that the results are 
illustrative of the truth (Pilgrim et al., 2008; Pannell, 1997; Keating & Keating, 2014; Snell, 2011, 
CEEU, 2011). However, even though the results are sensitive to the value inputted to determine 
deadweight, the results are in line with Squire et al.’s (2012) estimate.  
 
Additionally, the indirect benefits to staff members attending the VR service were not included in 
the CBA, which although there was a justification for their inclusion, when presenting the results 
of the CBA tool, the additional potential costs and benefits must be mentioned, allowing the reader 
of the results, to form their own conclusion.  It can be hypothesised that, if the indirect savings not 
accounted for within the CBA tool were included, the BCR might change. Moreover, due to 
insufficient data the HC approach was utilised for calculating the costs of sickness absence which 
may have either under or overestimated the costs of sickness absence (Krol et al., 2013, Rost et al., 
2014). As this CBA tool is a decision-making aid, other considerations need to be highlighted to 
the users of the CBA tool. 
 
Through implementing and testing the new CBA tool a number of strengths and weaknesses were 
identified. The strengths highlighted include the ability of the tool to compare different VR services 
with different underpinning service designs; to incorporate a number of health and non-health 
related outcomes; and to evaluate the costs and benefits of a VR service without the need for a 
control group. The weaknesses identified when implementing the model are that there are a number 
of benefits of VR that cannot be monetised which may lead to incorrect conclusions; the limited 
evidence-base prevented robust conclusions being drawn, weakening the assumptions within the 
CBA tool; and the difficulties in collecting data to input into the model, which may impact on the 
validity of the results.    
 
Notwithstanding the small sample sizes, the CBA tool developed in this research is a suitable 
practical tool to explore the cost effectiveness of VR interventions. This research determined the 
most suitable outcomes, and added to the knowledge in this area by developing new reference and 
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intervention cases for these outcomes in line with the current evidence-base. In addition, this 
research tested the CBA tool in real-world settings, which highlighted the strengths and weakness 
of the CBA tool, and identified areas for future research.  The sensitivity and scenario analysis 
demonstrated that the validity of the results of the CBA tool is dependent on the underpinning 
evidence-base. The assumptions underpinning the net effectiveness, and consequently deadweight, 
are based on the evidence-base sourced for this research. As deadweight is the variable that has the 
greatest impact on the results of the CBA tool, it is hypothesised that as the literature base for VR 
develops, this CBA tool will adjust accordingly, increasing its validity. 
 
5.8 Objective 5: To appraise the value of the revised practical CBA tool to the VR 
provider and the organisation to which VR is provided. 
 
Phase 4 addressed objective 5 through conducting a focus group.  
 
The participants of the focus group highlighted that there is currently no similar CBA tool available, 
as supported by the literature. They were enthusiastic about the tool and its potential. The 
participants felt that this tool would be beneficial for VR services in a number of ways. They were 
of the opinion that it would be useful in marketing and building customer relationships, as it would 
enable them to have conversations with future and existing customers around the costs and benefits 
of VR. However, this use of the tool would only be realised if the results supported their marketing 
agenda. No focus group was conducted with Organisation 1. Organisations 1’s results did not show 
a positive cost benefit ratio and therefore their thoughts on the uses of the CBA tool might have 
differed. Organisation 2 thought that the results from the CBA tool would facilitate service design 
through assisting in identifying where to focus their resources. It is anticipated that this would be 
a potential benefit of the tool for Organisation 1, as although the findings were negative they could 
be further explored to see how the service design/delivery could adapt to improve the cost benefits 
of the service.  Organisation 2 believed that it would add a useful dimension to a package of 
measures incorporating findings from employee satisfaction surveys, or data about employee 
engagement. This is supported by the literature which situates economic models as part of the 
decision-making process, as opposed to providing the full picture (Cox, 2011; Keating & Keating, 
2014; Snell, 2011; Sculpher et al., 2006). The participants found the CBA tool user-friendly, and 
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were able to input the necessary data and understand the results produced. The participants 
expressed concerns regarding the collection of the data and suggested an aide memoir would assist.   
 
The participants suggested a number of further developments for the CBA tool, including 
highlighting the ‘hidden’ benefits and costs of VR within the CBA tool. Whilst the need to consider 
‘hidden’ costs and benefits is widely accepted (Cagno, et al., 2013; Oxenburgh & Marlow, 2005; 
Barham & Begum, 2005; Bevan and Hayday, 2001), in previous studies that have attempted to 
quantify them the ratios and estimates have varied greatly (Oxenburgh & Marlow, 2005). In 
addition, including these in the CBA tool incurs the risk of measuring the same effect twice (Zhang, 
Bansbak, & Anus, 2011) Thus, it is recommended that each organisation derive the hidden costs 
specific to them (Oxenburgh & Marlow, 2005), and include them as an adjunct to the CBA tool.  
 
The participants also mentioned that a CBA tool including a wider range of causes of sickness 
absence would help to create a more comprehensive picture of the costs and benefits of VR. The 
CBA tool developed within this research was focused on MSDs and mental health conditions, as 
they were the most common causes of sickness absence when the research commenced and in 2014 
MSDS were the reason for the greatest loss of work days (ONS, 2014). Moreover, MSDs and 
mental health conditions are leading causes of global disability (Joyce et al., 2015; Hoy et al., 
2014). Therefore, it is anticipated that the greatest cost savings would result from targeting these 
two conditions. However, other conditions causing long-term sickness absence such as cancer and 
stroke are commonly addressed by VR and as the model develops these would be useful outcomes 
to include. The participants queried whether the CBA tool could be tailored to different industries; 
however, currently the limited evidence-base dose not facilitate this.  Notwithstanding this, the 
CBA tool does allow the users to insert their own costs of sickness absence, and as the net 
effectiveness of VR interventions is used within the CBA tool to calculate the deadweight (i.e. 
what % of people would RTW without the intervention) it limits the effect of different populations 
on the result; rendering the CBA tool appropriate to be used across industry types. Lastly, the 
participants suggested useful structural changes to the CBA tool, such as including a front-end 
template and allowing the easy inclusion/exclusion of costs.  
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The potential value and ease of use of the CBA tool was clearly identified by the participants who 
were excited by the potential it offered. In this regard they asked if could use it (after the study 
period) as recompense for having taken part in the research. This is an extremely positive 
endorsement of the tool, although their enthusiasm needs to be countered by the small sample size 
(Litosseliti, 2003; Morgan, 1996), the acknowledgement that a focus group was not conducted in 
Organisation 1, and the fact that bias may have been introduced as the researcher was the focus 
group facilitator (Litosseliti, 2003; Morgan, 1996). 
 
6. Conclusion and recommendations 
 
This chapter concludes the research study, by summarising the key findings and putting forward 
recommendations for future research and practice. The limitations of this research are 
acknowledged, and suggestions for future work are included. 
 
6.1 Summary of the research 
 
The cost effectiveness of VR within the workplace, focusing on assisting individuals to SAW, is 
not established within the literature.  This lack of evidence is a barrier to the implementation of VR 
within the UK and internationally, as in the UK’s current economic climate it is imperative for 
organisations to be able to consider the costs and benefits of their investments.  To my knowledge 
there is no academically robust CBA tool available within the UK to measure the costs and benefits 
of VR services. This research commenced with the objective of identifying and creating a practical 
CBA tool that would enable the cost effectiveness of VR within the UK to be established within 
the evidence-base, and that could used in a non-academic setting i.e. by organisations themselves. 
This research provides the foundations required to establish the cost effectiveness of VR services 
within the UK. 
 
The research went through a series of phases, identifying the deadweight and costs of included 
outcomes i.e. sickness absence due to MSDs and mental health, presenteeism and turnover, 
culminating in the production of a CBA tool, capable of analysing the costs and benefits of the VR 
249 
 
service presented in organisations 1 and 2. The data used to adapt the CBA tool e.g. net 
effectiveness values were subjected to robustness tests in order to further ascertain the tools 
efficacy in evaluating VR. The sensitivity and scenario analysis tests identified that in order for the 
CBA tool to be able to analyse the costs and benefits of VR services samples with normal 
distributions are needed. Moreover, these tests identified that should the net effectiveness of VR, 
which was determined from the literature, become more robust, this would improve the 
effectiveness and robustness of the CBA tool and subsequently its use as an analysis tool. This 
study highlights that the CBA tool is still in its early stages of development and that further 
refinement will occur as the VR evidence-base improves. Ultimately this will increase its 
application for commercial and research purposes.  
 
Phase 1 aimed to identify the key outcomes of VR and assimilate these into an already existing 
model, the GM New Economy CBA, through adapting and changing the assumptions of the model. 
The following outcomes: sickness absence due to MSDS, sickness absence due to mental health 
conditions, turnover and presenteeism; have been successfully developed and incorporated into the 
CBA tool. In order to achieve this, the reference and intervention cases specifically for VR 
interventions for each outcome were determined; this is the first time this has been done.  This was 
achieved through flipping/using a mirror image of the usual CBA tool, which again has not been 
done before.  Due to limitations in the evidence-base of the impact of VR on sickness absence due 
to mental health conditions and presenteeism, for the purpose of the CBA model deadweight was 
set to equal the impact of the intervention i.e. concluding that the intervention will not have an 
effect on mental health conditions and presenteeism.  
 
Phase 2 aimed to collect the relevant data to input into the CBA tool and test its efficacy in 
evaluating VR services. This was achieved by evaluating two VR services using pre-experimental 
repeated-measures within-group (time series) (pre-intervention, post-intervention, 3 and 6-month 
post-intervention follow-up) research design, collecting primary data from the participants of the 
study and secondary data from the host organisation. Organisation 1’s results indicated that the VR 
service had a significant improvement on the employees’ health, as well as lowering their absence 
levels, however, due to the large loss to follow-up these results need to be read with caution as they 
may be biased and lack validity. Organisation 2 only recruited 3 participants, thus no analysis was 
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conducted on the primary outcomes.  The secondary data provided for organisation 2 indicated that 
the VR service lowered sickness absence levels. These tentative findings indicate positive 
outcomes post attending VR services, adding to the evidence-base on the effectiveness of VR.  
 
Phase 3 was a continuation of the proceeding work, amalgamating the outcomes developed in phase 
1 with the data collected in phase 2, to implement the revised CBA tool and test its efficacy. In the 
application of the CBA tool, the robustness of the variables adapted in the CBA tool were tested 
through sensitivity analysis and scenario analysis, with the results indicating that these variables 
are robust with sufficient sample sizes that allow for a normally distributed sample.  
 
Phase 4 looked at the ease of use and usefulness of the CBA tool within the commercial sector. 
This was ascertained through a focus group in organisation 2. The participants were enthusiastic 
about the CBA tool, the user-friendliness of the model, and the potential uses such as marketing 
and service development. The participants identified the difficulties in collecting the data to be 
utilised within the CBA tool, as well as identifying areas for further development/refinement of the 
CBA tool. However, these results need to be read with caution as a focus group was not conducted 
in Organisation 1, where the results were not as favourable.  
 
6.2 Recommendations  
6.2.1 For research 
 
Through the literature review and the results obtained in phase 1 of this research it is clear that the 
evidence-base for cost-effectiveness of VR in the SAW population is in its infancy. Limitations 
noted in the evidence-base were a lack of homogeneity in the populations, conditions, 
interventions, and outcome measures used within VR research, an inconsistency in reporting the 
impact of VR on sickness absence, differing definitions of long and short-term sickness absence, a 
lack of comparator/control groups, and the varied definitions of VR. Moreover, it was identified 
that health conditions vary greatly in their impact on sickness absence, and by not exploring sub-
sets of conditions the effect of VR may not be adequately captured or understood. In addition, the 
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need for solutions to enhance data collection was identified. In order to develop the evidence-base, 
a structured approach consisting of the following actions is recommended: 
 Ensure that the VR intervention aligns with the definition of a VR approach (for further 
discussion on the VR approach see section 2.2.1.4), allowing a body of work on VR 
interventions to be developed.  
 Establish a standardised set of outcome measures to be used within workplace research, 
considering the effectiveness and cost-effectiveness of VR interventions. This research has 
indicated that the following core data is needed, this could be used to inform the 
standardised set of outcome measures: 
- Sickness absence data for employees, separated into two groups namely: greater 
than and less than 6-months absence duration. Sickness absence data collected to 
include the cause of sickness absence, the number of work days off sick, the number 
of episodes, and length of episodes, during a set time period pre- and post-
intervention.   
- Organisation annual turnover.  
- Presenteeism, as a measurement of how the health condition impact on their 
productivity, the Work Limitations Questionnaire (WLQ) (Lerner et al., 2001) is 
suggested as an appropriate outcome measure to capture this. 
- Costs of the VR service. 
- Number of employees referred to the VR service. 
- Number of employees attending the VR service. 
- Number of employees completing the VR intervention. 
- Total number of employees in the organisation. 
- Average salary of employees in the organisation or the cost of sickness absence per 
day per employee. 
 Produce an evaluation guidance document that highlights the data needed and ways in 
which to overcome challenges in researching VR for the SAW population. 
 Consider further adapting the CBA tool in order to streamline the outcome measures 
required, simplifying data collection.  
 Review the outcome measurement tools used in order to streamline data collection.  
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 Produce a data collection guidance document for organisations and VR services. Outlining 
the data needed to effectively evaluate the costs and benefits of VR, as well as practical 
suggestions for service redesign to incorporate effective data collection. 
 Document and report the activities underpinning VR services in order to determine which 
aspects of VR interventions work. 
 Standardise sickness absence reporting, to facilitate meta-analysis of the literature,  
 Include comparator/control groups, to facilitate attribution of results to the VR intervention.  
 Analyse sub-groups of the various mental and physical health conditions, to enable a 
detailed exploration of the effectiveness of VR services on different mental and physical 
health conditions.   
 Further research on the effects of VR on presenteeism. 
 Further research exploring the impact of VR on turnover and the link between this and the 
cost effectiveness of VR. 
 
6.2.2 For practice 
 
Through this research, it was identified that VR services do not routinely collect outcome measures 
that facilitate determining the cost/benefits of the service. Moreover, there are often a number of 
inaccuracies in the data they do collect.  As the evidence-base for VR is limited, it is necessary for 
VR services/interventions to collect data in respect of the effectiveness of their interventions which 
will enable the knowledge base to grow. It is proposed that standardised outcome measures and 
data collection processes are built into service design and delivery, and that organisations only 
commission VR services collecting and evaluating core data as outlined in section 6.2.1. To ensure 
comparability of the VR services/interventions and evaluations it is recommended that the VR 
services record the specific interventions provided to clientele.  
 
6.3 Limitations of the research 
 
The limitations of this project are outlined and discussed in sub-categories: the methodology used, 
the data collected, and the CBA tool itself. 
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The methodology used in this research had limitations. In phase 1, the research design was 
influenced by the quantity and quality of the existing literature, which, as this research is in a newly 
emerging field, was limited. This resulted in a review/synthesis of the literature being conducted, 
as opposed to a meta-analysis; the gold standard.  Consequently, the results and assumptions drawn 
must be viewed with this in mind. In phase 2, the research, participants were recruited voluntarily 
and convenience sampling, as opposed to a more robust method of sampling, was used. This may 
have resulted in a biased sample, as people with an interest in the cost effectiveness of the service 
may have been more motivated to participate. The pragmatic research design used in phase 2 meant 
that there was no comparator group; although this is allowed for within the CBA tool, it is a 
limitation that needs to be considered when interpreting the results. Overall, the mixed methods 
approach, although allowing one to build on the first three phases, thereby further exploring the 
usefulness of the CBA tool in VR, is limited in that the findings from phase 4 are not generalisable 
and the focus group was only conducted in one organisation, although it illuminates emerging 
themes. 
 
Considering the data collected, in phase 2 inaccuracies were noticed in the sickness absence data 
provided by the organisations. Additionally, the accuracy of the primary outcome data collected by 
the clinician in organisation 1 was questioned due to a change of clinician part way through the 
project. However, the findings of the study support those of the existing evidence-base. In 
organisation 2 the project failed to recruit sufficient numbers, highlighting the sensitive nature of 
this topic area and possible bias in participants recruited.  
 
The key limitation of the developed CBA tool is the weakness of the evidence-base underpinning 
the assumptions which was outside of the control of the researcher, however, this is accommodated 
for with the inclusion of optimism bias ratios, conducting sensitivity analysis and scenario analysis. 
However, in order to develop the evidence-base a CBA tool is needed. Thus, it is accepted that this 
is a starting point and will add to the body of knowledge by laying the foundations for future 
research. 
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6.4 Future work  
 
Although this current body of work contributes to the limited evidence-base by providing evidence 
from two VR interventions and a practical, user-friendly CBA tool for the economic analysis of 
VR, there is scope for improvement and further development to enhance the value of the CBA tool 
currently developed.  
 
During the sensitivity analysis, deadweight was identified as the variable with the most influence 
on the CBA tool results. Deadweight is reliant on the evidence-base on the net effectiveness of VR; 
however as the evidence-base is weak there is a need to further test the robustness of the deadweight 
variable. Future research could include alternative methods of calculating deadweight, which could 
then be compared and contrasted to the results in this research.  
 
The research in this project provides a clear methodology for developing outcomes to be used in 
the CBA tool. This research focused on the two most common causes of sickness absence and risk 
of long-term disability, MSDs and mental health conditions. However, to enable the tool to capture 
the full impact of VR interventions from the organisational perspective future studies could use 
this outlined methodology to expand the scope of the model to include a number of causes of 
sickness absence such as cancer and long-term conditions e.g. neurological conditions and 
respiratory conditions. Moreover, future studies could further adapt this tool to include the costs 
and benefits of helping employees SAW from societal and individual perspectives.  
 
This research outlines the core data needed to be able to use the CBA tool. These findings can 
inform a paper highlighting the core data to be included in research standards or guidelines.  
 
In order to improve the commercial acceptability of the model, a front-end template could be 
developed. This would enable the organisation to simply enter their data on the template and 
produce a result, without having to see the underlying excel spreadsheet. Moreover, creating a data 
collection guide alongside the model would assist organisations in identifying the data needed to 
populate the CBA tool. Allowing organisations to build data collection into their service design, 
with the aim to improve the accuracy of the data collected, as well as increase participation.  
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The following articles are planned to be written: 
1) Is VR an essentially contested concept (paper in preparation) 
2) Development of a CBA tool capable of analysing the effects of VR for the SAW population 
3) Core data needed to establish the cost-effectiveness of VR interventions 
 
6.5 Conclusion 
 
The work within this research project overhauled an existing CBA model and its underlying 
assumptions, using a mirror image of the traditional CBA model to develop the model specifically 
for VR services. These activities resulted in a practical, user-friendly CBA tool, based on academic 
rigour, capable of analysing the cost benefits of VR services for employed individuals. The cost-
effectiveness literature in the VR field is limited and there is no CBA tool within the UK for VR. 
A need has been identified for a tool that can be easily used within the commercial world, for 
organisations to assess the worth of their investments and to inform service developments within 
VR services, and within the research world to enable research into the costs and benefits of VR for 
the employed population, increase the comparability of research findings, and to help determine 
within the heterogeneity of the VR services which elements/services have the greater economic 
return. This tool is the first step towards meeting this identified need and lays the foundations for 
further research in this field.
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8. Appendix 
 
Appendix 1: EQ-5D-5L 
 
(English version for the UK) 
 
UK (English) v.2 © 2009 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
Under each heading, please tick the ONE box that best describes your health TODAY  
 
MOBILITY 
I have no problems in walking about     
I have slight problems in walking about     
I have moderate problems in walking about     
I have severe problems in walking about      
I am unable to walk about        
 
SELF-CARE 
I have no problems washing or dressing myself    
I have slight problems washing or dressing myself    
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself     
I am unable to wash or dress myself     
 
USUAL ACTIVITIES (e.g. work, study, housework,  
family or leisure activities) 
I have no problems doing my usual activities    
I have slight problems doing my usual activities    
I have moderate problems doing my usual activities     
I have severe problems doing my usual activities     
I am unable to do my usual activities      
 
PAIN / DISCOMFORT 
I have no pain or discomfort       
I have slight pain or discomfort       
I have moderate pain or discomfort      
I have severe pain or discomfort       
I have extreme pain or discomfort       
 
ANXIETY / DEPRESSION 
I am not anxious or depressed       
I am slightly anxious or depressed       
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I am moderately anxious or depressed     
I am severely anxious or depressed       
I am extremely anxious or depressed      
 
UK (English) v.2 © 2009 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
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 We would like to know how good or bad your health is  
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TODAY. 
 This scale is numbered from 0 to 100. 
 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
 Mark an X on the scale to indicate how your health is TODAY.  
 Now, please write the number you marked on the scale in the box 
below.  
                     
 
 
 
YOUR HEALTH TODAY  = 
 
UK (English) v.2 © 2009 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
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Appendix 2 : Work Limitations Questionnaire 
 
 
CONFIDENTIAL 
 
 
Work Limitations Questionnaire© 
Self-Administered Online Long-Form 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Work Limitations Questionnaire, © 1998, The Health Institute, Tufts Medical Center f/k/a New 
England Medical Center Hospitals, Inc.; Debra Lerner, Ph.D.; Benjamin Amick III, Ph.D.; and 
GlaxoWellcome, Inc.  All Rights Reserved. 
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Instructions 
 
 
Health problems can make it difficult for working people to perform certain parts of 
their jobs.  We are interested in learning about how your health may have affected 
you at work during the past 2 weeks. 
 
(1) The questions will ask you to think about your physical health or emotional 
problems.  These refer to any ongoing or permanent medical conditions you may 
have and the effects of any treatments you are taking for these.  Emotional 
problems may include feeling depressed or anxious. 
 
(2) Most of the questions are multiple choice.  They ask you to answer by placing a 
mark in a box.   
 
 For example: 
 
 a. How satisfied are you with your local schools?  
 
                                                             (Mark one box.) 
Not At All Satisfied  
Moderately Satisfied  
Very Satisfied  
 
b. How satisfied are you with your local police department?  
                                                  
          (Mark one box.) 
Not At All Satisfied  
Moderately Satisfied  
Very Satisfied  
 
            
 These marks tell us you are very satisfied with your local schools and    
        moderately satisfied with your local police department.  
  
 
OPTIONAL PAGE 
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3. Before you begin answering any questions, we would like you to write some 
 information on the calendar. 
 
 Find today’s date.  Mark that box. 
 Count back 2 weeks and mark that box too. 
 
This 2-week period is the subject of most of the questions.  Feel free to mark other 
important dates such as birthdays, family events, or work deadlines.  Please use the 
calendar to help you answer correctly.  
 
 
 
Insert calendar here.  
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These questions ask you to rate the amount of time you had difficulty handling certain parts 
of your job.  Please read and answer every question.  Then choose a response. 
 
 Mark the “Does Not Apply to My Job” box only if the question describes something 
that is not part of your job.   
 If you have more than one job, report on your main job only. 
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1a. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to work the required number of 
hours? 
 
(Mark one box.) 
Difficult all of the time (100%)  
Difficult most of the time  
Difficult some of the time 
(about 50%) 
 
Difficult a slight bit of the time  
Difficult none of the time (0%)  
Does not apply to my job  
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1b. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to get going easily at the 
beginning of the workday?  
 
                                                   (Mark one box.) 
Difficult all of the time (100%)  
Difficult most of the time  
Difficult some of the time 
(about 50%) 
 
Difficult a slight bit of the time  
Difficult none of the time (0%)  
Does not apply to my job  
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1c. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to start on your job as soon as 
you arrived at work?  
 
                                                   (Mark one box.) 
Difficult all of the time (100%)  
Difficult most of the time  
Difficult some of the time 
(about 50%) 
 
Difficult a slight bit of the time  
Difficult none of the time (0%)  
Does not apply to my job  
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1d. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to do your work without stopping 
to take breaks or rests?  
 
                                                   (Mark one box.) 
Difficult all of the time (100%)  
Difficult most of the time  
Difficult some of the time 
(about 50%) 
 
Difficult a slight bit of the time  
Difficult none of the time (0%)  
Does not apply to my job  
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1e. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to stick to a routine or schedule?  
 
                                                   (Mark one box.) 
Difficult all of the time (100%)  
Difficult most of the time  
Difficult some of the time 
(about 50%) 
 
Difficult a slight bit of the time  
Difficult none of the time (0%)  
Does not apply to my job  
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PLEASE READ CAREFULLY 
 
 
 
These questions ask you to rate the amount of time you were  
able to handle certain parts of your job without difficulty. 
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2a. In the past 2 weeks, how much of the time were you able to walk or move 
around different work locations (for example, go to meetings), without difficulty 
caused by physical health or emotional problems?  
 
                                                   (Mark one box.) 
Able all of the time (100%)    
Able most of the time    
Able some of the time (about 
50%)   
 
Able a slight bit of the time    
Able none of the time (0%)    
Does not apply to my job    
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 2b. In the past 2 weeks, how much of the time were you able to lift, carry, or 
move objects at work weighing more than 10 lbs., without difficulty caused by 
physical health or emotional problems? 
 
                                                   (Mark one box.) 
Able all of the time (100%)    
Able most of the time    
Able some of the time (about 
50%)   
 
Able a slight bit of the time    
Able none of the time (0%)    
Does not apply to my job    
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2c. In the past 2 weeks, how much of the time were you able to sit, stand, or 
stay in one position for longer than 15 minutes while working, without difficulty 
caused by physical health or emotional problems?  
 
                                                   (Mark one box.) 
Able all of the time (100%)    
Able most of the time    
Able some of the time (about 
50%)   
 
Able a slight bit of the time    
Able none of the time (0%)    
Does not apply to my job    
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2d. In the past 2 weeks, how much of the time were you able to repeat the 
same motions over and over again while working, without difficulty caused by 
physical health or emotional problems?  
 
(Mark one box.) 
Able all of the time (100%)    
Able most of the time    
Able some of the time (about 
50%)   
 
Able a slight bit of the time    
Able none of the time (0%)    
Does not apply to my job    
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2e. In the past 2 weeks, how much of the time were you able to bend, twist, or 
reach while working, without difficulty caused by physical health or emotional 
problems?  
                                                   (Mark one box.) 
Able all of the time (100%)    
Able most of the time    
Able some of the time (about 
50%)   
 
Able a slight bit of the time    
Able none of the time (0%)    
Does not apply to my job    
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2f. In the past 2 weeks, how much of the time were you able to use hand-held 
tools or equipment (e.g., a phone, pen, keyboard, computer mouse, drill, 
hairdryer, or sander), without difficulty caused by physical health or emotional 
problems?  
 
                                                    (Mark one box.) 
Able all of the time (100%)    
Able most of the time    
Able some of the time (about 
50%)   
 
Able a slight bit of the time    
Able none of the time (0%)    
Does not apply to my job    
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PLEASE READ CAREFULLY 
 
 
 
These questions ask about difficulties you may have had at work. 
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3a. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to keep your mind on your work? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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3b. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to think clearly when working? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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3c. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to do work carefully? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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3d. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to concentrate on your work? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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3e. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to work without losing your train 
of thought? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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3f. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to easily read or use your eyes 
when working? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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The next questions ask about difficulties in relation to the people you came in 
contact with while working.  These may include employers, supervisors, co-workers, 
clients, customers, or the public. 
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4a. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to speak with people in-person, in 
meetings or on the phone? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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4b. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to control your temper around 
people when working? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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4c. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to help other people to get work 
done? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
 
 
 
 
  
351 
 
These questions ask about how things went at work overall. 
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5a. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to handle the workload? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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5b. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to work fast enough? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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5c. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to  finish work on time? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
 
  
355 
 
5d. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to do your work without making 
mistakes? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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5e. In the past 2 weeks, how much of the time did your physical health or 
emotional problems make it difficult for you to feel you’ve done what you are 
capable of doing? 
 
                                                    (Mark one box.) 
Difficult all of the time (100%)    
Difficult most of the time    
Difficult some of the time 
(about 50%)   
 
Difficult a slight bit of the time    
Difficult none of the time (0%)    
Does not apply to my job    
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Appendix 3: WLQ Time Loss Module 
WLQ 4-Question Time Loss Module 
Copyright 2002, Debra Lerner, MS, PhD and The Institute for Clinical  
Research and Health Policy Studies, Tufts Medical Center 
 
1. How many hours do you usually work each week in your main job? 
 
 
(Fill in Hours.) 
 
2. How many hours do you usually work each day in your main job?  
 
 
(Fill in Hours.) 
 
 
Questions 3 and 4 ask about time missed from work during the past two weeks. If you are self-
employed or work at home, think about the time you missed on days you expected to work. 
Report on your main job only. 
 
3. In the past 2 weeks, how many full workdays did you miss because of your health or medical care?  
Health includes physical health and emotional problems.  (Mark one box.) 
 
                         
None 
 
1 2 3 4 5 6 7 8 9 10 11 or More 
 
  
4. In the past 2 weeks, what was the total number of days on which you missed part of a workday 
because of your health or medical care (for example, you came in late or left early)?  Health includes 
physical health and emotional problems.  (Mark one box.)  
 
                         
None 
 
1 2 3 4 5 6 7 8 9 10 11 or More 
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Appendix 4: General Health Questionnaire (GHQ-12), Job Satisfaction Scale 
(JSS), and Patient-Specific Functional Scale (PSFS)  
 
General Health Questionnaire 
 
Please answer all the following questions by putting a circle around the answer that you feel is the closest to 
the way you feel at the moment, or have been feeling for the past few weeks. 
 
Have you recently: 
 
Been able to concentrate on whatever        better than same as less than much less 
you’re doing?                                                     Usual usual usual than usual 
 
 
Lost much sleep over worry?                           not at all no more rather more much more 
                                                                       than usual than usual than usual         than usual 
 
 
Felt that you are playing a useful part            more so same as less so much less 
 in things?                                                             than usual usual than usual capable 
 
 
Felt capable over making decisions                more so same as less so much less 
 about things?                                                     than usual usual than usual capable 
 
 
Felt constantly under strain?                           not at all no more  rather more much more 
                                                                                               than usual than usual than usual 
 
Felt you could not overcome your                  not at all no more rather more much more 
difficulties?  than usual than usual than usual 
 
  
Been able to enjoy your normal day to day   more so same as less so much less 
activities?                                                             than usual usual than usual than usual 
 
  
Been able to face up to your problems?         more so same as less able much less 
                                                                           than usual usual than usual able 
  
 
Been feeling unhappy and depressed?            not at all no more  rather more much more 
 than usual than usual than usual 
 
Been losing confidence in yourself?                 not at all no more  rather more much more 
 than usual than usual than usual 
 
 
Been thinking of yourself as a worthless        not at all no more  rather more much more 
person? than usual than usual than usual 
 
  
Been feeling reasonably happy all                    more so same as less so much less  
things considered?                                              than usual usual than usual than usual 
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Job Satisfaction  
 Please rate how satisfied you are with each item by circling the number that corresponds most 
 closely with how you feel. 
  
  I’m extremely dissatisfied 1 
  I’m very dissatisfied 2 
  I’m moderately dissatisfied 3 
  I’m not sure 4 
  I’m moderately satisfied 5 
  I’m very satisfied 6 
  I’m extremely satisfied 7 
   
 
The physical work conditions (noise/temp 
etc.) 1 2 3 4 5 6
 7 
  
The freedom to choose your own method  
  of 
working 1 2 3 4 5 6
 7 
 
Your fellow 
workers 1 2 3 4 5 6
 7 
 
The recognition you get for good 
work 1 2 3 4 5 6
 7 
  
Your immediate 
boss 1 2 3 4 5 6
 7 
  
The amount of responsibility you are 
given 1 2 3 4 5 6
 7 
  
Your rate of 
pay 1 2 3 4 5 6 7 
  
Your opportunity to use your 
abilities 1 2 3 4 5 6
 7 
  
Industrial relations between management 
360 
 
  and 
workers 1 2 3 4 5 6
 7 
  
Your chance of 
promotion 1 2 3 4 5 6
 7 
  
The way your firm is 
managed 1 2 3 4 5 6
 7 
  
The attention paid to suggestions you 
make 1 2 3 4 5 6
 7 
  
The hours of 
work 1 2 3 4 5 6
 7 
  
The amount of variety in your 
job 1 2 3 4 5 6 7 
 
Your job 
security 1 2 3 4 5 6
 7 
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The Patient-Specific Functional Scale
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Appendix 5: Search terms: 
5.1 Sickness absence due to MSDs reference and intervention case search 
strategy 
 
Sickness absence OR sick leave OR attitude to sickness OR sick role OR sickness impact profile 
OR RTW OR sick listed employee OR job re-entry OR time to RTW OR stay at work 
AND 
Musculoskeletal OR musculoskeletal disorders OR musculoskeletal conditions OR 
musculoskeletal injuries OR musculoskeletal diseases OR musculoskeletal system diseases OR 
musculoskeletal problems 
AND  
Cost OR economic cost OR economic evaluation OR cost benefit ratio OR economic aspect of 
illness OR cost benefit analysis OR cost and cost analysis OR health care costs OR cost control 
OR cost savings OR cost of living 
AND 
Vocational rehabilitation OR Workplace intervention 
 
5.2 Sickness absence due to mental health conditions reference and 
intervention case search strategy 
 
Sick$ OR “Sick$ absence”.mp. OR “Sickness impact profile” OR Employment OR 
Absenteeism OR “Attitude to sickness” OR Sick role OR “Return to work” OR “Sick listed 
employee” OR “Job re-entry” OR “Stay at work” OR “Sickness absence” OR  Ill-health OR 
“Workers compensation” OR “Insurance disability” OR “Sick leave “OR Work*.mp OR 
“Work disability”.mp 
AND 
“Mental health” OR “mental health condition$.mp.” OR Depression OR “Affective disorders” 
OR Stress OR “Anxiety disorders” OR Psychological OR Burnout OR “Common mental health 
condition” OR “Occupational Diseases” OR “Adjustment disorders” OR “mental 
function$.mp.” OR “mental stress$.mp.” OR “depressed worker$.mp.” OR “Depressed 
employee$.mp.” OR Psychosocial.mp. OR “Emotional problem$.mp.“    
AND  
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Cost OR economic cost OR economic evaluation OR cost benefit ratio OR economic aspect of 
illness OR cost benefit analysis OR cost and cost analysis OR health care costs OR cost control 
OR cost savings OR cost of living 
AND 
Work$ OR “Work capacity evaluation” OR “Occupational health” OR “Vocational 
rehabilitation” OR “diagnostic services” OR “Occupational Health services” OR “Disability 
management” OR “occupational therapy” OR “occupational medicine” OR “Attendance 
management” OR Vocational OR “vocational guidance” OR “Occupational therapist$.mp.” OR 
“Occupational intervention$.mp.” OR “Job intervention$.mp.” OR “Job accommodation$.mp.” 
OR “Work intervention$.mp.” OR Rehabilitation OR “Workplace adjustments” OR 
“Psychosocial rehabilitation.mp.” OR “Work rehabilitation.mp.” OR “Occupational 
rehabilitation.mp.” OR “Case manage$.mp.” OR “Return to work.mp.” OR “stay at work.mp.” 
OR “occupational physician$.mp.” OR “modified work.mp.” OR “modified dut$.mp.” OR 
“disability prevention.mp.” OR “alternative work$.mp.” OR “alternative dut$.mp.” OR “stress 
management.mp.” OR “early contact.mp.” OR “self management.mp.” OR “work re-
design.mp.” 
 
5.4 Turnover reference and intervention case 
 
Inclusion / exclusion criteria 
 
* Inclusion criteria: a population of employed individuals who are off work due to a common 
mental health condition or a musculoskeletal condition, a return to work intervention, turnover 
as an outcome measure, the inclusion of a control or comparator group. 
*Exclusion criteria: individuals off work for any condition that is not mental health or 
musculoskeletal i.e. cancer, stroke, brain injury, trauma; studies which do not include a control 
or comparator group, interventions which are not helping individuals who are off sick return to 
work. 
Key concepts: 
 
Concept 1 Concept 2 Concept 3 Concept 4 Concept 5 
Workplace health 
intervention 
Employees off 
work due to ill-
health 
Common mental 
health condition 
Musculoskeletal Turnover 
Keywords used to search for each concept 
“Workplace health 
intervention” 
Sick “Mental health” 
Musculoskeletal 
(use adj) 
Turnover  
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“Work capacity 
evaluation” 
“Sick 
absence”.mp. 
“mental health 
condition”.mp. 
“musculoskeletal 
system diseases” 
“Employee 
turnover” 
“Occupational health” 
“Sickness impact 
profile” 
“Mental ill health” “Back pain” 
“Staff 
turnover” 
“Vocational 
rehabilitation” 
Employment Depression 
“musculoskeletal 
disorders”  
“Personnel 
turnover” 
“diagnostic services” Absenteeism 
“Affective 
disorders” 
“musculoskeletal 
diseases” 
“Ill-health 
retirement” 
“Occupational Health 
services” 
“Attitude to 
sickness” 
Stress 
“musculoskeletal 
conditions” 
Retention 
“Disability 
management” 
“Sick role” “Anxiety disorders” 
“musculoskeletal 
injuries” 
“job loss” 
“occupational therapy” 
“Occupational 
therapist”.mp. 
Ill-health 
“musculoskeletal 
problems” 
 
“occupational 
medicine” 
“Sick listed 
employee” 
Burnout   
“Attendance 
management” 
“Job re-entry” 
“Common mental 
health condition” 
  
Vocational “Sick leave” 
“Occupational 
Diseases” 
  
“vocational guidance” 
“Sickness 
absence” 
“Adjustment 
disorders” 
  
“Workplace 
adjustments” 
“Insurance 
disability” 
“mental 
function.mp.” 
  
“Occupational 
intervention”.mp 
“Workers 
compensation” 
“mental stress.mp.”   
“Job intervention”.mp. 
“Work 
disability”.mp 
“depressed 
worker.mp.” 
  
“Job 
accommodation.mp.” 
 
“Depressed 
employee.mp.” 
  
“Work 
intervention.mp.” 
 Psychosocial.mp.   
Rehabilitation  
“Emotional 
problem”.mp. 
  
“work re-design”.mp.     
“Psychosocial 
rehabilitation”.mp. 
    
“Work 
rehabilitation”.mp. 
    
“Occupational 
rehabilitation”.mp. 
    
“Case manage”.mp.     
“Return to work”.mp.     
“stay at work”.mp.     
“occupational 
physician$.mp. 
    
“modified work”.mp.     
“modified dut”.mp.     
“disability 
prevention”.mp. 
    
“alternative work.mp.     
“alternative dut”.mp.     
“stress 
management”.mp. 
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“early contact”.mp.     
“self management”.mp.     
 
Search statement 1 (Truncation may vary according to database $,*, !, ?, #) 
 
Work$ OR “Work capacity evaluation” OR “Occupational health” OR “Vocational 
rehabilitation” OR “diagnostic services” OR “Occupational Health services” OR “Disability 
management” OR “occupational therapy” OR “occupational medicine” OR “Attendance 
management” OR Vocational OR “vocational guidance” OR “Occupational therapist$”.mp. OR 
“Occupational intervention$”.mp. OR “Job intervention$”.mp. OR “Job accommodation$”.mp. 
OR “Work intervention$”.mp. OR Rehabilitation OR “Workplace adjustments” OR 
“Psychosocial rehabilitation.mp.” OR “Work rehabilitation”.mp. OR “Occupational 
rehabilitation”.mp. OR “Case manage$”.mp. OR “Return to work”.mp. OR “stay at work”.mp. 
OR “occupational physician$”.mp. OR “modified work”.mp. OR “modified dut$”.mp. OR 
“disability prevention”.mp. OR “alternative work$.mp. OR “alternative dut$”.mp. OR “stress 
management”.mp. OR “early contact”.mp. OR “self management”.mp. OR “work re-
design”.mp. 
AND 
Sick$ OR “Sick$ absence”.mp. OR “Sickness impact profile” OR Employment OR 
Absenteeism OR “Attitude to sickness” OR Sick role OR “Return to work” OR “Sick listed 
employee” OR “Job re-entry” OR “Stay at work” OR “Sickness absence” OR  Ill-health OR 
“Workers compensation” OR “Insurance disability” OR “Sick leave “OR Work*.mp OR 
“Work disability”.mp 
AND  
Turnover OR “employee turnover” OR “staff turnover” OR “personnel turnover” OR “Ill-
health retirement” OR Retention OR “job loss” 
AND  
“Musculoskeletal*” OR “musculoskeletal system diseases” OR “Back pain” OR 
“musculoskeletal disorders”  OR “musculoskeletal diseases” OR “musculoskeletal conditions” 
OR “musculoskeletal injuries” OR “musculoskeletal problems” 
 
Search statement 2 (Truncation may vary according to database $,*, !, ?, #) 
Work$  OR “Work capacity evaluation” OR “Occupational health” OR “Vocational 
rehabilitation” OR “diagnostic services” OR “Occupational Health services” OR “Disability 
management” OR “occupational therapy” OR “occupational medicine” OR “Attendance 
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management” OR Vocational OR “vocational guidance” OR “Occupational therapist$”.mp. OR 
“Occupational intervention$”.mp. OR “Job intervention$”.mp. OR “Job accommodation$”.mp. 
OR “Work intervention$”.mp. OR Rehabilitation OR “Workplace adjustments” OR 
“Psychosocial rehabilitation.mp.” OR “Work rehabilitation”.mp. OR “Occupational 
rehabilitation”.mp. OR “Case manage$”.mp. OR “Return to work”.mp. OR “stay at work”.mp. 
OR “occupational physician$”.mp. OR “modified work”.mp. OR “modified dut$”.mp. OR 
“disability prevention”.mp. OR “alternative work$.mp. OR “alternative dut$”.mp. OR “stress 
management”.mp. OR “early contact”.mp. OR “self management”.mp. OR “work re-
design”.mp. 
AND 
Sick$ OR “Sick$ absence”.mp. OR “Sickness impact profile” OR Employment OR 
Absenteeism OR “Attitude to sickness” OR Sick role OR “Return to work” OR “Sick listed 
employee” OR “Job re-entry” OR “Stay at work” OR “Sickness absence” OR  Ill-health OR 
“Workers compensation” OR “Insurance disability” OR “Sick leave “OR Work*.mp OR 
“Work disability”.mp 
AND  
Turnover OR “employee turnover” OR “staff turnover” OR “personnel turnover” OR “Ill-
health retirement” OR retention OR “job loss” 
AND  
“Mental health” OR “mental health condition$.mp.” OR Depression OR “Affective disorders” 
OR Stress OR “Anxiety disorders” OR Psychological OR Burnout OR “Common mental health 
condition” OR “Occupational Diseases” OR “Adjustment disorders” OR “mental 
function$.mp.” OR “mental stress$.mp.” OR “depressed worker$.mp.” OR “Depressed 
employee$.mp.” OR Psychosocial.mp. OR “Emotional problem$”.mp.     
 
5.5 Presenteeism reference and intervention case 
 
In order to determine the reference and intervention case, for presenteeism, the following search 
strategy was followed. 
A search of the following databases was conducted: Cinahl, Medline (EBSCO, OVID, Web of 
Science (WoS)), Cochrane and Business Source Premium (BSP). In addition, citation tracking 
was utilised.  
The following terms were used and exploded. 
Presenteeism  AND  workplace interventions OR vocational rehabilitation 
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This resulted in no articles been identified. Thus a second search was conducted, using the term 
Presenteeism 
Appendix 6:  Focus group questions 
 
Title: The revision of a cost-benefit analysis model in order for it to be capable of analysing the 
effects of Vocational Rehabilitation: monetising outcomes and testing the CBA tool.   
Objective of phase 4: To appraise the value of the revised CBA tool to the VR provider and the 
organisation to which VR is provided. 
 
Introduction – include the following key points: 
□ Thank you to all of you for taking time to participate in this focus group. Your 
input will provide a valuable perspective to our analysis and I really appreciate 
you giving me your time.  
□ The data from this focus group will be stored securely at the University and will 
not be shared with any other agency  
□ I will analyse the transcripts from this session and produce a summary of the 
findings in my thesis. The information presented in the thesis will be 
anonymised, direct quotes may be used but individuals will not be identifiable.  
□ You can withdraw your consent at any time, if you say something in the focus 
group and then later wish to withdraw it you can contact me and that comment 
will be taken out of the data set. 
□ The focus group will be recorded for transcription and data analysis purposes 
and will be stored securely as outlined earlier. 
 
 
 
Ground rules: 
 
□ Please treat this focus group as confidential.  
□ As this is recorded please try to ensure that only one person speaks at a time 
as it is difficult to transcribe otherwise. 
□ Please remember that everyone’s opinion is important here and should be 
respected as such 
 
□ Does anyone have any additional ground rules they would like to agree before 
we start? 
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Focus group questions: 
 
I am exploring to what extent the cost benefit analysis is of value to individuals such 
as yourselves i.e. responsible for purchasing the Vocational Rehabilitation Service, or 
as an individual who either collects the data used in the CBA tool, inputs data into the 
CBA tool, or reviews the results of the CBA tool. As well as identify plans for further 
improvement and development of the CBA tool. I want your perspective on this so 
we’re going to explore some key areas here: 
 
 
1. Tell me about your initial responses on reading the cost benefit analysis report? 
Did you think it was useful? Were you surprised at the results? Was there anything you felt was 
missing from the report?  
 
2. From this morning’s training on the use of the CBA tool, has this changed any of 
your views on the usefulness of the cost benefit analysis model?  
In what ways?  
 
3. Do you feel that you would be confident to use the CBA tool? 
If not, what further information / training would you need to enable you to feel confident in using 
the CBA tool? 
 
4. Do you feel this model provides useful information?  If not, what further information 
would you want to be included? 
 
5. Which features did you feel were useful regarding the CBA tool? 
 
6. In what ways do you think this model could be further developed?  
Considering the benefits included? The costs included? The data collected? The health conditions 
included? 
 
7. What thoughts do you have on the data the organisation collects? 
Is this something that the organisation has to look into to ensure it is collecting the correct data in 
a useable format? What data are you collecting that could be used within the CBA tool? What are 
the difficulties in collecting this data?  
 
8. In your job role, how would you use the CBA tool or the results from the CBA 
tool? 
Advertising? To improve your service? To make purchasing decisions? 
 
9. Any other comments? 
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Appendix 7:  Ethical approval letters  
Appendix 7.1:  Ethical approval letters for organisation 1 
 
Ethical approval from the University of Salford 7/4/2010 
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Letter from NHS Salford R&D confirming that ethical approval is not needed 28/5/20109 
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Appendix 7.2:  Ethical approval letters for organisation 2 
 
Ethical approval 9/10/2014 
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Amendment ethical proposal 12/12/2014 
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Appendix 8:  SPPS results for normal distribution of mental health sickness 
absence data 
 
9.1 Pre-sickness absence data normality test results 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
VAR00001 34 100.0% 0 0.0% 34 100.0% 
 
 
Descriptives 
 Statistic Std. Error 
VAR00001 Mean 11.9412 1.72273 
95% Confidence Interval for 
Mean 
Lower Bound 8.4362  
Upper Bound 15.4461  
5% Trimmed Mean 11.5458  
Median 11.0000  
Variance 100.906  
Std. Deviation 10.04517  
Minimum .00  
Maximum 31.00  
Range 31.00  
Interquartile Range 16.50  
Skewness .451 .403 
Kurtosis -.904 .788 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
VAR00001 .117 34 .200* .915 34 .012 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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9.2  Post sickness absence data normality test results 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
VAR00002 34 100.0% 0 0.0% 34 100.0% 
 
 
Descriptives 
 Statistic Std. Error 
VAR00002 Mean 15.3235 3.14779 
95% Confidence Interval for 
Mean 
Lower Bound 8.9193  
Upper Bound 21.7278  
5% Trimmed Mean 14.0817  
Median 8.0000  
377 
 
Variance 336.892  
Std. Deviation 18.35462  
Minimum .00  
Maximum 53.00  
Range 53.00  
Interquartile Range 28.25  
Skewness 1.023 .403 
Kurtosis -.387 .788 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
VAR00002 .202 34 .001 .794 34 .000 
a. Lilliefors Significance Correction 
 
 
 
 
378 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
379 
 
Appendix 9: New CBA tool, case study and glossary of key terms used for the 
focus group 
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Screenshots of the new CBA tool, the costs and benefits sheets within the excel workbook 
 
Costs sheet in excel workbook: 
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Benefits sheet in excel workbook: 
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Benefits sheet in excel workbook continued: 
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Benefits sheet in excel worksheet continued: 
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Fictional case study used to demonstrate the CBA tool 
 
Using the below data, have a play with the model. Once you have entered the data, turn on and 
off outcomes to see how this impacts on the output metrics.  
 
Case study: an evaluation of a new VR service, that is limited to assisting employees with 
sickness absence due to musculoskeletal disorders (MSDs) or mental ill-health conditions. The 
main aims of the service are to reduce sickness absence in employees who are off work with 
MSDs and mental ill-health, and enable employees who are struggling at work due to an MSD 
and mental ill-health to stay in work. Additional aims of the service are to decrease levels of 
presenteeism.  
 
Data collected to populate the cost-benefit analysis model: 
Total number of employees in organisation: n = 2480 
Total number of employees attending the VR service in one year: n = 200 
Costs: 
Type of cost Spend(total) £ 
Marketing and Advertising of service      £1,000.00 
VR case managers salaries    £66,940.00 
Clinical involvement, as appropriate         £333.00 
Supply of technical skills    £10,000.00 
Travel         £485.00 
Total    £70,958.00 
 
Benefits: 
1) Sickness absence due to MSDS short term and long term: 
 
 
No of 
employees 
Total 
No. of 
days 
pre 
Total 
No. of 
days 
post 
Impact / 
% 
reduction 
Cost of 
sickness 
absence 
pre 
Cost of 
sickness 
absence post 
1st 
appointment 
Difference 
in sickness 
absence 
cost pre 
and post 
Sickness 
absence < 6 
months  
125 615.4 76.4 87.59% £54,302.90 £6741.54 £47,561.36 
Sickness 
absence > 6 
months  
1 196 22 88.78% £17,295.04 £1,941.28 £15,353.76 
* The cost of sickness absence is calculated using the average salary i.e. average employee = 
£22,942.75, therefore £88.24 daily rate  
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Additional costs included are the employers national insurance payments, which are calculated 
at 13.8% of the wage (Gov.UK, 2015), thus, 13.8% of £88.24 = £12.18. 
Thus, total value per day of sickness absence = £100.42 
 
2) Sickness absence due to Mental ill-health conditions short term and long term 
 
No of 
employees 
Total 
No. of 
days 
pre 
Total 
No. of 
days 
post 
Impact / 
% 
reduction 
Cost of 
sickness 
absence 
pre 
Cost of 
sickness 
absence post 
1st 
appointment 
Difference 
in sickness 
absence 
cost pre 
and post 
Sickness 
absence < 6 
months  
75 432 107 
 
75.23% 
 
£38,119.68 £9,441.68 £28,678.00 
Sickness 
absence > 6 
months  
2 392 60 84.69% £34,590.08 £5,294.40 £29,295.68 
* The cost of sickness absence is calculated using the average salary i.e. average employee = 
£22,942.75, therefore £88.24 daily rate 
 
Additional costs included are the employers national insurance payments, which are calculated 
at 13.8% of the wage (gov.uk, 2015), thus, 13.8% of £88.24 = £12.18. 
Thus, total value per day of sickness absence = £100.42 
 
3) Presenteeism 
 No of employees 
% of employees with 
presenteeism 
Individuals self-reported presenteeism levels  Pre – 1st 
VR appointment 
200 27% (n =34) 
Individuals self-reported presenteeism levels 3- months 
post 1st appointment 
200 7% (n = 14) 
Impact/ % reduction = 74%   
 
4) Turnover 
 
Annual turnover rate for the organisation is approximately 16%. 
 
Additional data that was collected that was of interest to the investors: 
 Quality of life 
 Job satisfaction  
 General mental health and wellbeing 
 
386 
 
Results for the above three indicated that all employees attending the service had an 
improvement in quality of life, job satisfaction and general mental health and wellbeing.  
 
From the above information and using the optimism bias tables the following data can be 
extracted to be inputted into the model: (I have put explanations alongside the data for 
clarity – in some cases when data is not provided one needs to make best evidenced 
assumptions) 
 
Costs: 
Cost Category: Cost for MSDs   Predicted costs: £44,042.90 (126 employees attended the 
service. It is assumed that the cost of the service is proportional for each employee i.e. 
£70958.00 is the cost for 203 employees. Thus, the cost for 126 employees is £44,042.90) 
Cost Category: Cost for MENTAL HEALTH     Predicted costs: £26,915.10 (77 
employees attended the service) 
Who pays: Organisation 
Capital / revenue / in-kind: Revenue 
 
Benefits: 
Outcome: MSD sickness absence less than 6 months 
 Included outcome?: If no, turn to yes 
 Target population: n = 125 
 Affected population / Predicted incidents: n = 615.4 
 Level of engagement (%): 100% 
 Retention rate (%): 92.5%. No data was collected on the retention rate. The UK 
national average did not attend (DNA) rate for physiotherapy musculoskeletal 
outpatients is 7.5% (Health and Social Care Information Centre, 2012) 
 Starting point:  = 615.4 
 Outcome: = 76.4 
 Unit fiscal benefit (Value): £100.42 
 
Outcome: MSD sickness absence greater than 6 months 
 Included outcome?: If no, turn to yes 
 Target population: n = 1 
 Affected population / Predicted incidents: n = 196 
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 Level of engagement (%): 100% 
 Retention rate (%): 100% 
 Starting point:  = 196 
 Outcome: = 22 
 Unit fiscal benefit (Value): n = £50.21  
In this organisation, at 6 months sickness absence pay drops from full to half pay. 
 
Outcome: mental health conditions sickness absence less than 6 months 
 Included outcome?: If no, turn to yes 
 Target population: n = 75 
 Affected population / Predicted incidents: n = 432 
 Level of engagement (%): 100% 
 Retention rate (%): 100% 
 Starting point:  = 432 
 Outcome: = 107 
 Unit fiscal benefit (Value): n = £100.42 
 
Outcome: mental health conditions sickness absence greater than 6 months 
 Included outcome?: If no, turn to yes 
 Target population: n = 2 
 Affected population / Predicted incidents: n = 392 
 Level of engagement (%): 100% 
 Retention rate (%): 100% 
 Starting point:  = 392 
 Outcome: = 60 
 Unit fiscal benefit (Value): n = £50.21  
 
Outcome: Turnover 
 Included outcome?: If no, turn to yes 
 Target population: n = 200 
 Affected population / Predicted incidents n = 200 
 Level of engagement (%): 100% 
 Retention rate (%): 100% 
 Turnover: 16% 
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Outcome: Presenteeism 
 Included outcome?: If no, turn to yes 
 Target population: n = 200 
 Affected population / Predicted incidents: n = 200 
 Level of engagement (%): 100% 
 Retention rate (%): 100% 
 Starting point:  = 27 
 Outcome: = 7 
 
Explanation of key terms and data to be inputted into the model. 
 
Blue columns – organisation to complete 
Pink columns – model will automatically complete 
 
COSTS tab in excel spreadsheet 
 
Column name Definition 
 
Cost Category 
 
What the cost is for 
 
Predicted Costs 
 
How much will that cost 
 
Who pays? 
 
Choose who will pay e.g. organisation 
Capital / Revenue / In kind 
Capital (once off costs for the service), revenue (costs of managing the 
service), in-kind (volunteer costs 
Optimism bias correction 
This is a correction applied to the data which accounts for the fact that 
you will be collecting and inputting your own data, as opposed to being 
independently monitored. 
 
Costs year 1 
 
% of costs to be realised within 1 year 
 
BENEFITS tab in excel spreadsheet 
 
 
Target population 
 
Number of employees referred to the service 
 
Affected population / predicted 
incidents 
 
Predicted total number of sickness absence days due to this condition 
over a year 
 
Level of engagement  
 
Number of target population attending the service 
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Retention rate 
 
Number of people completing the intervention 
 
Annual turnover 
 
Organisations annual turnover for all employees 
 
% Impact 
 
Effectiveness of the intervention 
Starting point 
Number of sickness absence days for the target population for a set time 
period e.g. 3 months prior to intervention 
Outcome 
Number of sickness absence days for the target population for a set time 
period e.g. 3 months post intervention 
Net effect 
% improvement assumed to be gained by using the VR intervention, 
this is based on the literature 
 
Deadweight 
 
What would have happened if VR was not in place 
 
Unit fiscal benefit 
 
Cost of the benefit e.g. cost of sickness absence per employee per day 
Optimism bias 
 
This is a correction applied to the data which accounts for the fact that 
you will be collecting and inputting your own data, as opposed to being 
independently monitored. 
 
OUTPUT METRICS tab in excel spreadsheet 
 
Economic case 
The results page cannot be amended for my model as boxes are locked. 
 
The results for this case study are in the economic case box. 
The net present value of costs and benefits are presented.  
The figure in the Public Value Return on Investments is in fact a 
Benefit Cost Ratio (BCR) as opposed to a Return on Investment 
(ROI). 
I.e. it shows the benefits / costs. 
 
The result for this case study is 1.15 indicating that the benefits are 15% 
greater than the costs, i.e. for every £100 spent the organisation is 
getting £115 pounds.  
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Appendix 10: Focus group consent form 
 
 
Participant Identification Number for this trial: 
 
CONSENT FORM 
 
Title of Project:   The revision of a Cost-benefit Analysis model in order for it to be 
capable of analysing the effects of Vocational rehabilitation: monetising 
outcomes and testing the model. 
 
Name of Researcher: Tamara Brown 
         
 
1. I confirm that I have read and understand the information sheet dated  
... ….for the above study and have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason. I am aware my contribution to the discussion 
up to that point will remain part of the data. 
 
3. I understand that all data is anonymised and never shared with any other agency. 
 
4. I understand that all information shared within this focus group is to be kept 
confidential  
 
5. I agree to take part in the above study. 
 
6. I agree for the focus group to be audio taped. 
 
7. I agree for anonymised direct quotations to be used. 
 
 
 
    
_______________________ ________________ ____________________ 
Name of Participant Date Signature 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date Signature 
(if different from researcher) 
 
 
_________________________ ________________ ____________________ 
Researcher Date  Signature 
 
When completed: 1 for participant; 1 for researcher 
 
Please initial box 
